ARCHIVED — Vol. 151, No. 2 — January 14, 2017

Warning This Web page has been archived on the Web.

Archived Content

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

GOVERNMENT NOTICES

DEPARTMENT OF THE ENVIRONMENT

CANADIAN ENVIRONMENTAL PROTECTION ACT, 1999

Notice of intent concerning Significant New Activity Notice No. 13712a (variation to Significant New Activity Notice No. 13712)

Notice of intent: Significant New Activity Notice

(Section 85 of the Canadian Environmental Protection Act, 1999)

Whereas the Minister of the Environment and the Minister of Health (the ministers) have assessed information in respect of the substance Clarified oils (petroleum), catalytic cracked, reaction products with cresol and poly-methylene polyphenylene isocyanate, Chemical Abstracts Service Registry No. 68920-56-9, under section 83 of the Canadian Environmental Protection Act, 1999;

Whereas the Minister of the Environment published on June 18, 2005, Significant New Activity Notice No. 13712 in Part I of the Canada Gazette, Vol. 139, No. 25;

Whereas the substance is not specified on the Domestic Substances List;

And whereas the ministers suspect that a significant new activity in relation to the substance may result in the substance becoming toxic within the meaning of section 64 of the Canadian Environmental Protection Act, 1999,

Therefore, the Minister of the Environment hereby proposes to vary Significant New Activity Notice No. 13712, pursuant to subsection 85(2) of the Canadian Environmental Protection Act, 1999, in accordance with the following Annex.

George Enei
Assistant Deputy Minister Science and Technology Branch
On behalf of the Minister of the Environment

ANNEX

1. The Annex to Significant New Activity Notice No. 13712 is proposed to be replaced by the following:

ANNEX

Information Requirements

(Section 85 of the Canadian Environmental Protection Act, 1999)

  • 1. In relation to the substance Clarified oils (petroleum), catalytic cracked, reaction products with cresol and polymethylene polyphenylene isocyanate, Chemical Abstracts Service Registry No. 68920-56-9, a significant new activity is
    • (a) the use of the substance in the manufacture of a consumer product to which the Canada Consumer Product Safety Act applies; or
    • (b) any activity involving a consumer product to which the Canada Consumer Product Safety Act applies that contains the substance, if the product involved in the activity, during any one calendar year, contains a total quantity of the substance greater than 10 kg.
  • 2. Despite item 1, the use of the substance as a research and development substance or as a site-limited intermediate substance as these expressions are defined in subsection 1(1) of the New Substances Notification Regulations (Chemicals and Polymers), or as an export-only substance, is not a significant new activity.
  • 3. For each proposed significant new activity, the following information must be provided to the Minister at least 90 days before the commencement of the proposed new activity:
    • (a) a description of the proposed significant new activity in relation to the substance;
    • (b) the anticipated annual quantity of the substance to be used in relation to the significant new activity;
    • (c) the information specified in items 3 to 7 of Schedule 4 of the New Substances Notification Regulations (Chemicals and Polymers); and
    • (d) the test data and test reports from a Local Lymph Node Assay toxicity study that is conducted according to the methodology described in OECD Test Guideline 429, entitled Skin Sensitization: Local Lymph Node Assay.
    • (e) a description of the consumer product that contains the substance, the intended use of that consumer product and the function of the substance in that consumer product;
    • (f) a description of how the consumer product is intended to be used or applied;
    • (g) the total quantity of the consumer product expected to be sold in Canada in a calendar year by the person undertaking the significant new activity;
    • (h) a summary of all other information or test data in respect of the substance that are in the possession of the person proposing the significant new activity, or to which they have access, and that are relevant to identifying hazards of the substance to the environment and human health and the degree of environmental and public exposure to the substance;
    • (i) the identification of every other government agency, either outside or within Canada, that the person proposing the significant new activity has notified of the substance and, if known, the agency’s file number, the outcome of the assessment and the risk management actions in relation to the substance imposed by the agency;
    • (j) the name, civic and postal addresses and telephone number and, if any, the fax number and email address of the person proposing the significant new activity and, if they are not resident in Canada, of the person resident in Canada that is authorized to act on behalf of that person; and
    • (k) a certification that the information is accurate and complete, dated and signed by the person proposing the significant new activity if they are resident in Canada or, if not, by the person resident in Canada that is authorized to act on their behalf.
  • 4. The above information will be assessed within 90 days after the day on which it is received by the Minister.

EXPLANATORY NOTE

(This explanatory note is not part of the notice of intent.)

Description

The notice of intent (NOI) is an opportunity for the public to comment on proposed variations to the Significant New Activity (SNAc) Notice issued by the Minister of the Environment to apply the SNAc provisions of the Canadian Environmental Protection Act, 1999 (CEPA) to the substance Clarified oils (petroleum), catalytic cracked, reaction products with cresol and polymethylene polyphenylene isocyanate (Chemical Abstracts Service [CAS] Registry No. 68920-56-9), pursuant to section 85 of CEPA.

In January 2015, a public commitment was made by Environment Canada and Health Canada to review all orders and notices that were adopted between 2001 and 2014 (see footnote 1) to impose SNAc requirements. The purpose of the review is to ensure that SNAc orders and notices are consistent with current information, policies and approaches. (see footnote 2) Resulting changes to SNAc orders and notices are expected to provide greater clarity of scope and improved ease of compliance by industry, while protecting Canadians and their environment. This NOI reflects the results of the review of the SNAc Notice on the substance Clarified oils (petroleum), catalytic cracked, reaction products with cresol and polymethylene polyphenylene isocyanate identified by stakeholders as a priority.

Within 60 days of publication of the NOI, any person may submit comments to the Minister of the Environment. These comments will be taken into consideration during the development of the final notice to vary the SNAc requirements in relation to this substance.

A number of other SNAc instruments are to be published in the near future that will also target consumer products. As a result, stakeholder input provided in response to the consumer product language proposed in this NOI may not be reflected in upcoming NOIs due to publication timelines. However, any input received will be taken into consideration during the development of all related orders and notices that pertain to consumer products.

Current SNAc requirements (see footnote 3) remain in effect until such time as the variations proposed in this NOI are published as a final notice.

Applicability of the proposed SNAc Notice

At this time it is proposed that the notice would require any person (individual or corporation) engaging in a significant new activity in relation to Clarified oils (petroleum), catalytic cracked, reaction products with cresol and polymethylene polyphenylene isocyanate (CAS Registry No. 68920-56-9), to submit a Significant New Activity Notification (SNAN) containing all of the information prescribed in the notice at least 90 days prior to any use of the substance for the significant new activity.

In order to address human health concerns, the notice would target the use of the substance in consumer products to which the Canada Consumer Product Safety Act (CCPSA) (see footnote 4) applies. Notification would be required for any manufacture of such products with the substance. For any other consumer product–related activity, notification would also be required if the total quantity of the substance used that is contained in the product is greater than 10 kg, for any given calendar year. The substance is not known to be currently used in consumer products in Canada.

Activities not subject to the SNAc Notice

Industrial or commercial activities not related to consumer products are proposed to be excluded from the variation to the notice.

Any activity involving a consumer product that contains the substance Clarified oils (petroleum), catalytic cracked, reaction products with cresol and polymethylene polyphenylene isocyanate, other than the manufacture of such a product, would not be subject to the SNAc Notice if the product contains a total quantity of the substance of 10 kg or less in a calendar year.

Activities involving the use of the substance as a research and development substance, a site-limited intermediate substance or an export-only substance would be excluded from the SNAc Notice, as the potential exposure concerns related to health are from the use of consumer products. The terms “research and development substance” and “site-limited intermediate substance” are defined in subsection 1(1) of the New Substances Notification Regulations (Chemicals and Polymers). (see footnote 5) An export-only substance is a substance that is manufactured or imported in Canada and destined solely for foreign markets.

The proposed SNAc Notice would not apply to products to which the CCPSA does not apply (see Annex A for the CCPSA definition of “consumer product” and exemptions) or to uses of the substance that are regulated under the acts of Parliament listed in Schedule 2 of CEPA, including the Pest Control Products Act, the Fertilizers Act and the Feeds Act. The SNAc Notice would also not apply to transient reaction intermediates, impurities, contaminants or partially unreacted intermediates, or in some circumstances to the substance when it is in items such as, but not limited to, wastes or manufactured items.

Furthermore, it should be noted that individual components of a mixture may be subject to notification under the SNAc Notice. See subsection 81(6) and section 3 of CEPA and section 3.2 of the Guidelines for the Notification and Testing of New Substances (Chemicals and Polymers) for additional information. (see footnote 6)

Information to be submitted

The NOI sets out the proposed requirements for information that would need to be provided to the Minister 90 days before the day on which the substance Clarified oils (petroleum), catalytic cracked, reaction products with cresol and polymethylene polyphenylene isocyanate is used for a significant new activity. The Department of the Environment and the Department of Health will use the information submitted in the SNAN to conduct a human health and environmental assessment within 90 days after the complete information is received.

The information requirements in the proposed SNAc Notice relate to general information in respect of the substance, details surrounding its use, and exposure information.

As an outcome of the assessment of the substance, potential concerns related to irritation, skin sensitization, and carcinogenicity to humans from potential new activities were identified. The test prescribed under section 3 of the SNAc Notice will allow the characterization of the aforementioned toxicity endpoints, and will address the areas of potential concern.

Additional guidance on preparing a SNAN can be found in section 4 of the Guidelines for the Notification and Testing of New Substances: Chemicals and Polymers.

Compliance

When assessing whether or not a substance is subject to the SNAc provisions, (see footnote 7) a person is expected to make use of information in their possession or to which they ought to have access. The phrase “to which they ought to have access” means information in any of the notifier’s offices worldwide or other locations where the notifier can reasonably have access to the information. For example, manufacturers are expected to have access to their formulations, while importers or users of a substance, mixture, or product are expected to have access to import records, usage information, and the relevant Safety Data Sheet (SDS). (see footnote 8)

Although an SDS is an important source of information on the composition of a purchased product, it should be noted that the goal of the SDS is to protect the health of workers in the workplace from specific hazards of chemical products. Therefore, an SDS may not list all substances that may be subject to a notice due to human health or environmental concerns. Any person requiring more detailed information on product composition is encouraged to contact their supplier.

If any information becomes available that reasonably supports the conclusion that this substance is toxic or capable of becoming toxic, the person who is in possession or has knowledge of the information and is involved in certain activities with the substance is obligated, under section 70 of CEPA, to provide that information to the Minister without delay.

A company can submit a SNAN on behalf of its clients. For example, in cases where a person takes possession and control of a substance from another person, they may not be required to submit a SNAN, under certain conditions, if their activities were covered by the original SNAN. The Substances Management Advisory Note Clarification in relation to the submission of Significant New Activity Notifications in application of the Canadian Environmental Protection Act, 1999 provides more detail on this subject. (see footnote 9)

Under section 86 of CEPA, any person who transfers the physical possession or control of a substance subject to a notice shall notify all persons to whom the physical possession or control is transferred of the obligation to comply with the notice, including the obligation to notify the Minister of any significant new activity and to provide all the required information outlined above.

A pre-notification consultation (PNC) is recommended for notifiers who wish to consult during the planning or preparation of their SNAN to discuss any questions or concerns they have about the prescribed information and test plans.

Where a person has questions concerning their obligations to comply with a notice, believes they may be out of compliance, or would like to request a PNC, they are encouraged to discuss their particular circumstances with the program by contacting the Substances Management Information Line. (see footnote 10)

CEPA is enforced in accordance with the publicly available Compliance and Enforcement Policy for the Canadian Environmental Protection Act, 1999. (see footnote 11) In instances of non-compliance, consideration is given to factors such as the nature of the alleged violation, potential harm, intent, and history of compliance.

ANNEX A: “Consumer product” definition in the Canada Consumer Product Safety Act (CCPSA) (see footnote 12)

In section 2 of the CCPSA, “consumer product” means a product, including its components, parts or accessories, that may reasonably be expected to be obtained by an individual to be used for non-commercial purposes, including for domestic, recreational and sports purposes, and includes its packaging. Section 4 of the CCPSA describes the application of the Act as follows:

Consumer products

4. (1) This Act applies to consumer products with the exception of those listed in Schedule 1.

Tobacco products

(2) This Act applies to tobacco products as defined in section 2 of the Tobacco Act but only in respect of their ignition propensity.

Natural health products

(3) For greater certainty, this Act does not apply to natural health products as defined in subsection 1(1) of the Natural Health Products Regulations made under the Food and Drugs Act.

CCPSA, Schedule 1 (Subsection 4(1) and paragraph 37(1)(c))

  • 1. Explosives within the meaning of section 2 of the Explosives Act.
  • 2. Cosmetics within the meaning of section 2 of the Food and Drugs Act.
  • 3. Devices within the meaning of section 2 of the Food and Drugs Act.
  • 4. Drugs within the meaning of section 2 of the Food and Drugs Act.
  • 5. Food within the meaning of section 2 of the Food and Drugs Act.
  • 6. Pest control products within the meaning of subsection 2(1) of the Pest Control Products Act.
  • 7. Vehicles within the meaning of section 2 of the Motor Vehicle Safety Act and a part of a vehicle that is integral to it — as it is assembled or altered before its sale to the first retail purchaser — including a part of a vehicle that replaces or alters such a part.
  • 8. Feeds within the meaning of section 2 of the Feeds Act.
  • 9. Fertilizers within the meaning of section 2 of the Fertilizers Act.
  • 10. Vessels within the meaning of section 2 of the Canada Shipping Act, 2001.
  • 11. Firearms within the meaning of section 2 of the Criminal Code.
  • 12. Ammunition within the meaning of subsection 84(1) of the Criminal Code.
  • 13. Cartridge magazines within the meaning of subsection 84(1) of the Criminal Code.
  • 14. Cross-bows within the meaning of subsection 84(1) of the Criminal Code.
  • 15. Prohibited devices within the meaning of paragraphs (a) to (d) of the definition “prohibited device” in subsection 84(1) of the Criminal Code.
  • 16. Plants within the meaning of section 3 of the Plant Protection Act, except for Jequirity beans (abrus precatorius).
  • 17. Seeds within the meaning of section 2 of the Seeds Act, except for Jequirity beans (abrus precatorius).
  • 18. Controlled substances within the meaning of subsection 2(1) of the Controlled Drugs and Substances Act.
  • 19. Aeronautical products within the meaning of subsection 3(1) of the Aeronautics Act.
  • 20. Animals within the meaning of subsection 2(1) of the Health of Animals Act.

[2-1-o]

DEPARTMENT OF THE ENVIRONMENT

CANADIAN ENVIRONMENTAL PROTECTION ACT, 1999

Notice of intent to amend the Domestic Substances List under subsection 87(3) of the Canadian Environmental Protection Act, 1999

Whereas the 26 substances set out in this Notice are specified on the Domestic Substances List; (see footnote a)

Whereas the Minister of the Environment previously published Orders in the Canada Gazette, Part II, pursuant to subsection 87(3) of the Canadian Environmental Protection Act, 1999, (see footnote b) amending the Domestic Substances List to indicate that subsection 81(3) of that Act applies to those substances; (see footnote c), (see footnote d), (see footnote e), (see footnote f), (see footnote g), (see footnote h), (see footnote i), (see footnote j), (see footnote k), (see footnote l), (see footnote m), (see footnote n), (see footnote o), (see footnote p)

Whereas the Minister of the Environment and the Minister of Health (the ministers) are satisfied that the 26 substances are only being manufactured in or imported into Canada by any person for a limited number of uses;

And whereas the ministers suspect that the information concerning a significant new activity in relation to 24 of those substances may contribute to determining the circumstances in which these substances are toxic or capable of becoming toxic within the meaning of section 64 of the Canadian Environmental Protection Act, 1999;

Therefore, notice is hereby given that the Minister of the Environment intends to amend the Domestic Substances List pursuant to subsection 87(3) of the Canadian Environmental Protection Act, 1999, by varying or rescinding the significant new activities in relation to those substances set out in this Notice.

Public comment period

Any person may, within 60 days of publication of this Notice, file with the Minister of the Environment comments with respect to this proposal. All comments must cite the Canada Gazette, Part I, and the date of publication of this Notice and be sent by mail to the Executive Director, Program Development and Engagement Division, Department of the Environment, Gatineau, Quebec K1A 0H3, by fax to 819-938-5212, or by email to eccc.substances.eccc@canada.ca.

The final screening assessments for these substances may be obtained from the Government of Canada’s Chemical Substances website (www.chemicalsubstanceschimiques.gc.ca).

In accordance with section 313 of the Canadian Environmental Protection Act, 1999, any person who provides information in response to this Notice may submit with the information a request that it be treated as confidential.

George Enei
Assistant Deputy Minister
Science and Technology Branch
On behalf of the Minister of the Environment

Mike Beale
Assistant Deputy Minister
Environmental Protection Branch
On behalf of the Minister of the Environment

ANNEX

1. Column 2 of Part 2 of the Domestic Substances List, opposite the reference to the substances “64-67-5 S′”, “75-56-9 S′”, “77-78-1 S′”, “100-44-7 S′”, “106-88-7 S′”, “106-89-8 S′”, and “123-31-9 S′” in column 1, is proposed to be replaced by the following:

Column 1


Substance

Column 2

Significant new activity for which substance is subject to subsection 81(3) of the Act

64-67-5 S′

75-56-9 S′

77-78-1 S′

100-44-7 S′

106-88-7 S′

106-89-8 S′

123-31-9 S′

  • 1. In relation to any substance in column 1 opposite to this section,
    • (a) the use of the substance in the manufacture of a consumer product to which the Canada Consumer Product Safety Act applies that contains the substance at a concentration equal to or greater than 0.1% by weight; or
    • (b) any activity involving a consumer product to which the Canada Consumer Product Safety Act applies that contains the substance at a concentration equal to or greater than 0.1% by weight, if the product involved in the activity, during any one calendar year, contains a total quantity of the substance greater than 10 kg.
  • 2. Despite item 1, the use of the substance as a research and development substance or as a site-limited intermediate substance as these expressions are defined in subsection 1(1) of the New Substances Notification Regulations (Chemicals and Polymers), or as an export-only substance, is not a significant new activity.
  • 3. For each proposed significant new activity, the following information must be provided to the Minister at least 180 days before the commencement of the proposed new activity:
    • (a) a description of the significant new activity in relation to the substance;
    • (b) the anticipated annual quantity of the substance to be used in relation to the significant new activity;
    • (c) the information specified in items 3 to 7 of Schedule 4 to the New Substances Notification Regulations (Chemicals and Polymers);
    • (d) the information specified in paragraphs 2(d) to (f) and 8(f) and (g) of Schedule 5 to those Regulations;
    • (e) a description of the consumer product that contains the substance, the intended use of that consumer product and the function of the substance in that consumer product;
    • (f) a description of how the consumer product is intended to be used or applied;
    • (g) the total quantity of the consumer product expected to be sold in Canada in a calendar year by the person undertaking the significant new activity;
    • (h) a summary of all other information or test data in respect of the substance that are in the possession of the person proposing the significant new activity, or to which they ought to have access, and that are relevant to identifying hazards of the substance to the environment and human health and the degree of environmental and public exposure to the substance;
    • (i) the identification of every other government agency, either outside or within Canada, that the person proposing the significant new activity has notified of the substance and, if known, the agency’s file number, the outcome of the assessment and the risk management actions in relation to the substance imposed by the agency;
    • (j) the name, civic and postal addresses and telephone number and, if any, the fax number and email address of the person proposing the significant new activity and, if they are not resident in Canada, of the person resident in Canada that is authorized to act on their behalf; and
    • (k) a certification that the information is accurate and complete, dated and signed by the person proposing the significant new activity if they are resident in Canada or, if not, by the person resident in Canada that is authorized to act on their behalf.
  • 4. The above information will be assessed within 180 days after the day on which it is received by the Minister.

2. Column 2 of Part 2 of the Domestic Substances List, opposite the reference to the substance “62-56-6 S′” in column 1, is proposed to be replaced by the following:

Column 1


Substance

Column 2

Significant new activity for which substance is subject to subsection 81(3) of the Act

62-56-6 S′

  • 1. In relation to the substance thiourea,
    • (a) the use of the substance in the manufacture of a consumer product to which the Canada Consumer Product Safety Act applies that contains the substance at a concentration equal to or greater than 0.1% by weight, other than its use in the manufacture of a silver polish or metal cleaner that contains the substance at a concentration equal to or less than 7% by weight and that is to be used with gloves; or
    • (b) any activity involving a consumer product to which the Canada Consumer Product Safety Act applies — other than a silver polish or metal cleaner that contains the substance at a concentration of less than 7% by weight and that is to be used with gloves — that contains the substance at a concentration equal to or greater than 0.1% by weight, if the product involved in the activity, during any one calendar year, contains a total quantity of the substance greater than 10 kg.
  • 2. Despite item 1, the use of the substance as a research and development substance or as a site-limited intermediate substance as these expressions are defined in subsection 1(1) of the New Substances Notification Regulations (Chemicals and Polymers), or as an export-only substance, is not a significant new activity.
  • 3. For each proposed significant new activity, the following information must be provided to the Minister at least 180 days before the commencement of the proposed new activity:
    • (a) a description of the significant new activity in relation to the substance;
    • (b) the anticipated annual quantity of the substance to be used in relation to the significant new activity;
    • (c) the information specified in items 3 to 7 of Schedule 4 to the New Substances Notification Regulations (Chemicals and Polymers);
    • (d) the information specified in paragraphs 2(d) to (f) and 8(f) and (g) of Schedule 5 to those Regulations;
    • (e) a description of the consumer product that contains the substance, the intended use of that consumer product and the function of the substance in that consumer product;
    • (f) a description of how the consumer product is intended to be used or applied;
    • (g) the total quantity of the consumer product expected to be sold in Canada in a calendar year by the person undertaking the significant new activity;
    • (h) a summary of all other information or test data in respect of the substance that are in the possession of the person proposing the significant new activity, or to which they ought to have access, and that are relevant to identifying hazards of the substance to the environment and human health and the degree of environmental and public exposure to the substance;
    • (i) the identification of every other government agency, either outside or within Canada, that the person proposing the significant new activity has notified of the substance and, if known, the agency’s file number, the outcome of the assessment and the risk management actions in relation to the substance imposed by the agency;
    • (j) the name, civic and postal addresses and telephone number and, if any, the fax number and email address of the person proposing the significant new activity and, if they are not resident in Canada, of the person resident in Canada that is authorized to act on their behalf; and
    • (k) a certification that the information is accurate and complete, dated and signed by the person proposing the significant new activity if they are resident in Canada or, if not, by the person resident in Canada that is authorized to act on their behalf.
  • 4. The above information will be assessed within 180 days after the day on which it is received by the Minister.

3. Column 2 of Part 2 of the Domestic Substances List, opposite the reference to the substances “79-46-9 S′” and “115-96-8 S′” in column 1, is proposed to be replaced by the following:

Column 1


Substance

Column 2

Significant new activity for which substance is subject to subsection 81(3) of the Act

79-46-9 S′

115-96-8 S′

  • 1. In relation to any substance in Column 1 opposite to this section,
    • (a) the use of the substance in the manufacture of any of the following products containing the substance at a concentration equal to or greater than 0.1% by weight:
      • (i) a consumer product to which the Canada Consumer Product Safety Act applies, or
      • (ii) a cosmetic, within the meaning of section 2 of the Food and Drugs Act; or
    • (b) any activity involving any of the following products containing the substance at a concentration equal to or greater than 0.1% by weight, if the product involved in the activity, during any one calendar year, contains a total quantity of the substance greater than 10 kg:
      • (i) a consumer product to which the Canada Consumer Product Safety Act applies, or
      • (ii) a cosmetic, within the meaning of section 2 of the Food and Drugs Act.
  • 2. Despite item 1, the use of the substance as a research and development substance or as a site-limited intermediate substance as these expressions are defined in subsection 1(1) of the New Substances Notification Regulations (Chemicals and Polymers), or as an export-only substance, is not a significant new activity.
  • 3. For each proposed significant new activity, the following information must be provided to the Minister at least 180 days before the commencement of the proposed new activity:
    • (a) a description of the significant new activity in relation to the substance;
    • (b) the anticipated annual quantity of the substance to be used in relation to the significant new activity;
    • (c) the information specified in items 3 to 7 of Schedule 4 to the New Substances Notification Regulations (Chemicals and Polymers);
    • (d) the information specified in paragraphs 2(d) to (f) and 8(f) and (g) of Schedule 5 to those Regulations;
    • (e) a description of the consumer product or cosmetic that contains the substance, the intended use of that consumer product or cosmetic and the function of the substance in that consumer product or cosmetic;
    • (f) a description of how the consumer product or cosmetic is intended to be used or applied;
    • (g) the total quantity of the consumer product or cosmetic expected to be sold in Canada in a calendar year by the person undertaking the significant new activity;
    • (h) a summary of all other information or test data in respect of the substance that are in the possession of the person proposing the significant new activity, or to which they ought to have access, and that are relevant to identifying hazards of the substance to the environment and human health and the degree of environmental and public exposure to the substance;
    • (i) the identification of every other government agency, either outside or within Canada, that the person proposing the significant new activity has notified of the substance and, if known, the agency’s file number, the outcome of the assessment and the risk management actions in relation to the substance imposed by the agency;
    • (j) the name, civic and postal addresses and telephone number and, if any, the fax number and email address of the person proposing the significant new activity and, if they are not resident in Canada, of the person resident in Canada that is authorized to act their behalf; and
    • (k) a certification that the information is accurate and complete, dated and signed by the person proposing the significant new activity if they are resident in Canada or, if not, by the person resident in Canada that is authorized to act on their behalf.
  • 4. The above information will be assessed within 180 days after the day on which it is received by the Minister.

4. Column 2 of Part 2 of the Domestic Substances List, opposite the reference to the substance “90-94-8 S′” in column 1, is proposed to be replaced by the following:

Column 1


Substance

Column 2

Significant new activity for which substance is subject to subsection 81(3) of the Act

90-94-8 S’

  • 1. In relation to the substance methanone, bis[4-(dimethylamino) phenyl]-,
    • (a) the use of the substance in the manufacture of a consumer product to which the Canada Consumer Product Safety Act applies that contains the substance at a concentration equal to or greater than 0.1% by weight, other than its use in the manufacture of:
      • (i) dyes or pigments that contain the substance at a concentration of less than 5% by weight, or
      • (ii) inks that contain the substance at a concentration of less than 3% by weight; or
    • (b) any activity involving a consumer product to which the Canada Consumer Product Safety Act applies that contains the substance at a concentration equal to or greater than 0.1% by weight, if the product involved in the activity, during any one calendar year, contains a total quantity of the substance greater than 10 kg, other than an activity involving:
      • (i) a dye or pigment that contains the substance at a concentration of less than 5% by weight, or
      • (ii) an ink that contains the substance at a concentration of less than 3% by weight.
  • 2. Despite item 1, the use of the substance as a research and development substance or as a site-limited intermediate substance as these expressions are defined in subsection 1(1) of the New Substances Notification Regulations (Chemicals and Polymers), or as an export-only substance, is not a significant new activity.
  • 3. For each proposed significant new activity, the following information must be provided to the Minister at least 180 days before the commencement of the proposed new activity:
    • (a) a description of the significant new activity in relation to the substance;
    • (b) the anticipated annual quantity of the substance to be used in relation to the significant new activity;
    • (c) the information specified in items 3 to 7 of Schedule 4 to the New Substances Notification Regulations (Chemicals and Polymers);
    • (d) the information specified in paragraphs 2(d) to (f) and 8(f) and (g) of Schedule 5 to those Regulations
    • (e) a description of the consumer product that contains the substance, the intended use of that consumer product and the function of the substance in that consumer product;
    • (f) a description of how the consumer product is intended to be used or applied;
    • (g) the total quantity of the consumer product expected to be sold in Canada in a calendar year by the person undertaking the significant new activity;
    • (h) a summary of all other information or test data in respect of the substance that are in the possession of the person proposing the significant new activity, or to which they ought to have access, and that are relevant to identifying hazards of the substance to the environment and human health and the degree of environmental and public exposure to the substance;
    • (i) the identification of every other government agency, either outside or within Canada, that the person proposing the significant new activity has notified of the substance and, if known, the agency’s file number, the outcome of the assessment and the risk management actions in relation to the substance imposed by the agency;
    • (j) the name, civic and postal addresses and telephone number and, if any, the fax number and email address of the person proposing the significant new activity and, if they are not resident in Canada, of the person resident in Canada that is authorized to act their behalf; and
    • (k) a certification that the information is accurate and complete, dated and signed by the person proposing the significant new activity, if they are resident in Canada or, if not, by the person resident in Canada that is authorized to act on their behalf.
  • 4. The above information will be assessed within 180 days after the day on which it is received by the Minister.

5. Column 2 of Part 2 of the Domestic Substances List, opposite the reference to the substance “93-15-2 S′” in column 1, is proposed to be replaced by the following:

Column 1


Substance

Column 2

Significant new activity for which substance is subject to subsection 81(3) of the Act

93-15-2 S′

  • 1. In relation to the substance benzene, 1,2-dimethoxy-4-(2-propenyl)-,
    • (a) the use of the substance in its isolated form in the manufacture of a consumer product to which the Canada Consumer Product Safety Act applies that contains the substance at a concentration equal to or greater than 0.0002% by weight; or
    • (b) any activity involving a consumer product to which the Canada Consumer Product Safety Act applies that contains the substance at a concentration equal to or greater than 0.0002% by weight, if the isolated form of the substance was used to manufacture this product and if the product involved in the activity, during any one calendar year, contains a total quantity of the substance greater than 10 kg.
  • In this section, the expression “isolated form of the substance” refers to the substance when it is extracted from its naturally occurring sources or when it is manufactured.
  • 2. Despite item 1, the use of the substance as a research and development substance or as a site-limited intermediate substance as these expressions are defined in subsection 1(1) of the New Substances Notification Regulations (Chemicals and Polymers), or as an export-only substance, is not a significant new activity.
  • 3. For each proposed significant new activity, the following information must be provided to the Minister at least 180 days before the commencement of the proposed new activity:
    • (a) a description of the significant new activity in relation to the substance;
    • (b) the anticipated annual quantity of the substance to be used in relation to the significant new activity;
    • (c) the information specified in items 3 to 7 of Schedule 4 to the New Substances Notification Regulations (Chemicals and Polymers);
    • (d) the information specified in paragraphs 2(d) to (f) and 8(f) and (g) of Schedule 5 to those Regulations;
    • (e) a description of the consumer product that contains the substance, the intended use of that consumer product and the function of the substance in that consumer product;
    • (f) a description of how the consumer product is intended to be used or applied;
    • (g) the total quantity of the consumer product expected to be sold in Canada in a calendar year by the person undertaking the significant new activity;
    • (h) a summary of all other information or test data in respect of the substance that are in the possession of the person proposing the significant new activity, or to which they ought to have access, and that are relevant to identifying hazards of the substance to the environment and human health and the degree of environmental and public exposure to the substance;
    • (i) the identification of every other government agency, either outside or within Canada, that the person proposing the significant new activity has notified of the substance and, if known, the agency’s file number, the outcome of the assessment and the risk management actions in relation to the substance imposed by the agency;
    • (j) the name, civic and postal addresses and telephone number and, if any, the fax number and email address of the person proposing the significant new activity and, if they are not resident in Canada, of the person resident in Canada that is authorized to act on behalf of that person; and
    • (k) a certification stating that the information is accurate and complete, dated and signed by the person proposing the significant new activity if they are resident in Canada or, if not, by the person resident in Canada that is authorized to act on their behalf.
  • 4. The above information will be assessed within 180 days after the day on which it is received by the Minister.

6. Column 2 of Part 2 of the Domestic Substances List, opposite the reference to the substance “111-15-9 S′” in column 1, is proposed to be replaced by the following:

Column 1


Substance

Column 2

Significant new activity for which substance is subject to subsection 81(3) of the Act

111-15-9 S’

  • 1. In relation to the substance ethanol, 2-ethoxy-, acetate,
    • (a) the use of the substance in the manufacture of a consumer product to which the Canada Consumer Product Safety Act applies that contains the substance at a concentration equal to or greater than 0.1% by weight; or
    • (b) any activity involving a consumer product to which the Canada Consumer Product Safety Act applies that contains the substance at a concentration equal to or greater than 0.1% by weight, if the product involved in the activity, during any one calendar year, contains a total quantity of the substance greater than 10 kg.
  • 2. Despite item 1, the use of the substance as a research and development substance or as a site-limited intermediate substance as these expressions are defined in subsection 1(1) of the New Substances Notification Regulations (Chemicals and Polymers), or as an export-only substance, is not a significant new activity.
  • 3. For each proposed significant new activity, the following information must be provided to the Minister at least 90 days before the commencement of the proposed new activity:
    • (a) a description of the significant new activity in relation to the substance;
    • (b) the anticipated annual quantity of the substance to be used in relation to the significant new activity;
    • (c) the information specified in items 3 to 7 of Schedule 4 to the New Substances Notification Regulations (Chemicals and Polymers);
    • (d) the information specified in paragraphs 2(d) to (f) and 8(f) and (g) of Schedule 5 to those Regulations;
    • (e) a description of the consumer product that contains the substance, the intended use of that consumer product and the function of the substance in that consumer product;
    • (f) a description of how the consumer product is intended to be used or applied;
    • (g) the total quantity of the consumer product expected to be sold in Canada in a calendar year by the person undertaking the significant new activity;
    • (h) a summary of all other information or test data in respect of the substance that are in the possession of the person proposing the significant new activity, or to which they ought to have access, and that are relevant to identifying hazards of the substance to the environment and human health and the degree of environmental and public exposure to the substance;
    • (i) the identification of every other government agency, either outside or within Canada, that the person proposing the significant new activity has notified of the substance and, if known, the agency’s file number, the outcome of the assessment and the risk management actions in relation to the substance imposed by the agency;
    • (j) the name, civic and postal addresses and telephone number and, if any, the fax number and email address of the person proposing the significant new activity and, if they are not resident in Canada, of the person resident in Canada that is authorized to act on their behalf; and
    • (k) a certification that the information is accurate and complete, dated and signed by the person proposing the significant new activity if they are resident in Canada or, if not, by the person resident in Canada that is authorized to act on their behalf.
  • 4. The above information will be assessed within 90 days after the day on which it is received by the Minister.

7. The note to Group B in Part 2 of the Domestic Substances List is proposed to be amended by deleting the following:

122-60-1 S′

8. Part 2 of the Domestic Substances List is proposed to be amended by adding the following:

Column 1


Substance

Column 2

Significant new activity for which substance is subject to subsection 81(3) of the Act

122-60-1 S′

  • 1. In relation to the substance oxirane, (phenoxymethyl)-,
    • (a) the use of the substance in the manufacture of any of the following products containing the substance at a concentration equal to or greater than 0.1% by weight:
      • (i) a consumer product to which the Canada Consumer Product Safety Act applies, or
      • (ii) a cosmetic, within the meaning of section 2 of the Food and Drugs Act;
    • (b) any activity involving any of the following products containing the substance at a concentration equal to or greater than 0.1% by weight, if the product involved in the activity, during any one calendar year, contains a total quantity of the substance greater than 10 kg:
      • (i) a consumer product to which the Canada Consumer Product Safety Act applies, or
      • (ii) a cosmetic, within the meaning of section 2 of the Food and Drugs Act; or
    • (c) any other activity involving, during any one calendar year, more than 100 kg of the substance.
  • 2. Despite item 1, the use of the substance as a research and development substance or as a site-limited intermediate substance as these expressions are defined in subsection 1(1) of the New Substances Notification Regulations (Chemicals and Polymers), or as an export-only substance, is not a significant new activity.
  • 3. For each proposed significant new activity, the following information must be provided to the Minister at least 90 days before the commencement of the proposed new activity:
    • (a) a description of the significant new activity in relation to the substance;
    • (b) the anticipated annual quantity of the substance to be used in relation to the significant new activity;
    • (c) the information specified in paragraphs 8(f) and (g) of Schedule 5 to the New Substances Notification Regulations (Chemicals and Polymers);
    • (d) a summary of all other information or test data concerning the substance that are in the possession of the person proposing the significant new activity, or to which they ought to have access, and that are relevant to identifying hazards to the environment and human health and the degree of environmental and public exposure to the substance;
    • (e) the identification of every other government agency, either outside or within Canada, that the person proposing the significant new activity has notified of the substance and, if known, the agency’s file number and the outcome of the assessment and, if any, the risk management actions in relation to the substance imposed by the agency;
    • (f) the name, civic and postal addresses and telephone number and, if any, the fax number and email address of the person proposing the significant new activity and, if they are not resident in Canada, of the person resident in Canada that is authorized to act on their behalf;
    • (g) a certification that the information is accurate and complete, dated and signed by the person proposing the significant new activity if they are resident in Canada or, if not, by the person resident in Canada that is authorized to act on their behalf;
    • (h) for each proposed significant new activity described in 1(a) or 1(b), the following information must also be provided to the Minister at least 90 days before the commencement of the proposed new activity:
      • (i) a description of the product that contains the substance and the intended use of that product and the function of the substance in that product,
      • (ii) a description of how the product is intended to be used or applied,
      • (iii) the total quantity of the product expected to be sold in Canada in a calendar year by the person undertaking the significant new activity; and
    • (i) for each proposed significant new activity described in 1(c), the following information must also be provided to the Minister at least 90 days before the commencement of the proposed new activity:
      • (i) if known, the three sites in Canada where the greatest quantity of the substance, in relation to the significant new activity, is anticipated to be used or processed and the estimated quantity by site,
      • (ii) the information specified in Schedule 6 to the New Substances Notification Regulations (Chemicals and Polymers),
      • (iii) the information specified in Schedule 4 to the New Substances Notification Regulations (Chemicals and Polymers), and
      • (iv) when the quantity of substance used for the significant new activity is expected to exceed 1 000 kg in a calendar year the information specified in Schedule 5 to the New Substances Notification Regulations (Chemicals and Polymers) other than items 6 and 7 and paragraph 8(f) and 8(g).
  • 4. The above information will be assessed within 90 days after the day on which it is received by the Minister.

9. Column 2 of Part 2 of the Domestic Substances List, opposite the reference to the substance “1314-62-1 S′” in column 1, is proposed to be replaced by the following:

Column 1


Substance

Column 2

Significant new activity for which substance is subject to subsection 81(3) of the Act

1314-62-1 S′

  • 1. Any activity involving, during any one calendar year, the use of more than 100 kg of the substance vanadium pentoxide, including the use of the substance as a research and development substance or a site-limited intermediate substance as these expressions are defined in subsection 1(1) of the New Substances Notification Regulations (Chemicals and Polymers), or as an export-only substance, other than an activity involving its use
    • (a) in a ferrovanadium alloy;
    • (b) as a catalyst for an industrial process;
    • (c) as an oxidizing agent;
    • (d) as a corrosion inhibitor;
    • (e) in a chemical fertilizer; or
    • (f) in a bismuth vanadate pigment.
  • 2. For each proposed significant new activity, the following information must be provided to the Minister at least 180 days before the day on which the quantity of the substance exceeds 100 kg during any one calendar year:
    • (a) a description of the significant new activity in relation to the substance;
    • (b) the anticipated annual quantity of the substance to be used;
    • (c) if known, the three sites in Canada where the greatest quantity of the substance is anticipated to be used or processed and the estimated quantity by site;
    • (d) the information specified in items 3 to 7 of Schedule 4 to the New Substances Notification Regulations (Chemicals and Polymers);
    • (e) the products and, if known, end-use products that are anticipated to contain the substance, the intended use of those products and the function of the substance in those products;
    • (f) the information specified in paragraphs 2(d) to (f) and 8(a), (b) and (d) to (g) of Schedule 5 to those Regulations;
    • (g) the quantity of the substance anticipated to be released in each component of the environment;
    • (h) the information specified in item 11 of Schedule 6 to those Regulations;
    • (i) a summary of all other information or test data in respect of the substance that are in the possession of the person proposing the significant new activity, or to which they ought to have access, and that are relevant to identifying hazards of the substance to the environment and human health and the degree of environmental and public exposure to the substance;
    • (j) the identification of every other government agency, either outside or within Canada, to which the person proposing the significant new activity has provided information regarding the substance and, if known, the agency’s file number, the outcome of the assessment and the risk management actions in relation to the substance imposed by the agency;
    • (k) the name, civic and postal addresses and telephone number and, if any, the fax number and email address of the person proposing the significant new activity and, if they are not resident in Canada, of the person resident in Canada that is authorized to act on their behalf; and
    • (l) a certification that the information is accurate and complete, dated and signed by the person proposing the significant new activity if they are resident in Canada or, if not, by the person resident in Canada that is authorized to act on their behalf.
  • 3. The above information will be assessed within 180 days after the day on which it is received by the Minister.

10. Column 2 of Part 2 of the Domestic Substances List, opposite the reference to the substance “2425-85-6 S′” in column 1, is proposed to be replaced by the following:

Column 1


Substance

Column 2

Significant new activity for which substance is subject to subsection 81(3) of the Act

2425-85-6 S’

  • 1. In relation to the substance -naphthalenol, 1-[(4-methyl-2-nitrophenyl)azo]-,
    • (a) the use of the substance in the manufacture of a consumer product to which the Canada Consumer Product Safety Act applies that contains the substance at a concentration equal to or greater than 1% by weight, other than its use in the manufacture of paint; or
    • (b) any activity involving a consumer product to which the Canada Consumer Product Safety Act applies — other than a paint — that contains the substance at a concentration equal to or greater than 1% by weight, if the product involved in the activity, during any one calendar year, contains a total quantity of the substance greater than 10 kg.
  • 2. Despite item 1, the use of the substance as a research and development substance or as a site-limited intermediate substance as these expressions are defined in subsection 1(1) of the New Substances Notification Regulations (Chemicals and Polymers), or as an export-only substance, is not a significant new activity.
  • 3. For each proposed significant new activity, the following information must be provided to the Minister at least 180 days before the commencement of the proposed new activity:
    • (a) a description of the significant new activity in relation to the substance;
    • (b) the anticipated annual quantity of the substance to be used in relation to the significant new activity;
    • (c) the information specified in items 3 to 7 of Schedule 4 to the New Substances Notification Regulations (Chemicals and Polymers);
    • (d) the information specified in paragraphs 2(d) to (f) and 8(f) and (g) of Schedule 5 to those Regulations;
    • (e) a description of the consumer product that contains the substance, the intended use of that consumer product and the function of the substance in that consumer product;
    • (f) a description of how the consumer product is intended to be used or applied;
    • (g) the total quantity of the consumer product expected to be sold in Canada in a calendar year by the person undertaking the significant new activity;
    • (h) a summary of all other information or test data in respect of the substance that are in the possession of the person proposing the significant new activity, or to which they ought to have access, and that are relevant to identifying hazards of the substance to the environment and human health and the degree of environmental and public exposure to the substance;
    • (i) the identification of every other government agency, either outside or within Canada, that the person proposing the significant new activity has notified of the substance and, if known, the agency’s file number, the outcome of the assessment and the risk management actions in relation to the substance imposed by the agency;
    • (j) the name, civic and postal addresses and telephone number and, if any, the fax number and email address of the person proposing the significant new activity and, if they are not resident in Canada, of the person resident in Canada that is authorized to act on behalf of that person; and
    • (k) a certification stating that the information is accurate and complete, dated and signed by the person proposing the significant new activity if they are resident in Canada or, if not, by the person resident in Canada that is authorized to act on their behalf.
  • 4. The above information will be assessed within 180 days after the day on which it is received by the Minister.

11. Column 2 of Part 2 of the Domestic Substances List, opposite the reference to the substances “2426-08-6 S′” and “7328-97-4 S′” in column 1, is proposed to be replaced by the following:

Column 1


Substance

Column 2

Significant new activity for which substance is subject to subsection 81(3) of the Act

2426-08-6 S′

7328-97-4 S′

  • 1. In relation to any substance in Column 1 opposite to this section,
    • (a) the use of the substance in the manufacture of any of the following products containing the substance at a concentration equal to or greater than 0.1% by weight:
      • (i) a consumer product to which the Canada Consumer Product Safety Act applies that is to be sold in a container larger than 250 mL, or
      • (ii) a cosmetic, within the meaning of section 2 of the Food and Drugs Act; or
    • (b) any activity involving any of the following products containing the substance at a concentration equal to or greater than 0.1% by weight, if the product involved in the activity, during any one calendar year, contains a total quantity of the substance greater than 10 kg:
      • (i) a consumer product to which the Canada Consumer Product Safety Act applies that is to be sold in a container larger than 250 mL, or
      • (ii) a cosmetic, within the meaning of section 2 of the Food and Drugs Act.
  • 2. Despite item 1, the use of the substance as a research and development substance or as a site-limited intermediate substance as these expressions are defined in subsection 1(1) of the New Substances Notification Regulations (Chemicals and Polymers), or as an export-only substance, is not a significant new activity.
  • 3. For each proposed significant new activity, the following information must be provided to the Minister at least 180 days before the commencement of the proposed new activity:
    • (a) a description of the significant new activity in relation to the substance;
    • (b) the anticipated annual quantity of the substance to be used in relation to the significant new activity;
    • (c) the information specified in items 3 to 7 of Schedule 4 to the New Substances Notification Regulations (Chemicals and Polymers);
    • (d) the information specified in paragraphs 2(d) to (f) and 8(f) and (g) of Schedule 5 to those Regulations;
    • (e) a description of the consumer product or cosmetic that contains the substance, the intended use of that consumer product or cosmetic and the function of the substance in that consumer product or cosmetic;
    • (f) a description of how the consumer product or cosmetic is intended to be used or applied;
    • (g) the total quantity of the consumer product or cosmetic expected to be sold in Canada in a calendar year by the person undertaking the significant new activity;
    • (h) a summary of all other information or test data in respect of the substance that are in the possession of the person proposing the significant new activity, or to which they ought to have access, and that are relevant to identifying hazards of the substance to the environment and human health and the degree of environmental and public exposure to the substance;
    • (i) the identification of every other government agency, either outside or within Canada, that the person proposing the significant new activity has notified of the substance and, if known, the agency’s file number and the outcome of the assessment and, if any, the risk management actions in relation to the substance imposed by the agency;
    • (j) the name, civic and postal addresses and telephone number and, if any, the fax number and email address of the person proposing the significant new activity and, if they are not resident in Canada, of the person resident in Canada that is authorized to act on their behalf; and
    • (k) a certification that the information is accurate and complete, dated and signed by the person proposing the significant new activity if they are resident in Canada or, if not, by the person resident in Canada that is authorized to act on their behalf.
  • 4. The above information will be assessed within 180 days after the day on which it is received by the Minister.

12. Column 2 of Part 2 of the Domestic Substances List, opposite the reference to the substance “3445-11-2 N-S” in column 1, is proposed to be replaced by the following:

Column 1


Substance

Column 2

Significant new activity for which substance is subject to subsection 81(3) of the Act

3445-11-2 N-S

  • 1. In relation to the substance 2-pyrrolidinone, 1-(2-hydroxyethyl)-,
    • (a) the use of the substance in the manufacture of a cosmetic or drug as defined in section 2 of the Food and Drugs Act or in any natural health product as defined in subsection 1(1) of the Natural Health Products Regulations; or
    • (b) any activity involving a cosmetic or drug as defined in section 2 of the Food and Drugs Act or in any natural health product as defined in subsection 1(1) of the Natural Health Products Regulations, if the cosmetic, drug or product involved in the activity, during any one calendar year, contains a total quantity of the substance greater than 10 kg.
  • 2. Despite item 1, the use of the substance as a research and development substance or as a site-limited intermediate substance as these expressions are defined in subsection 1(1) of the New Substances Notification Regulations (Chemicals and Polymers), or as an export-only substance, is not a significant new activity.
  • 3. For each proposed significant new activity, the following information must be provided to the Minister at least 90 days before the commencement of the proposed new activity:
    • (a) a description of the significant new activity in relation to the substance;
    • (b) the information specified in item 7 of Schedule 4 of the New Substances Notification Regulations (Chemicals and Polymers);
    • (c) the test data and test reports from a 90-day repeated dose dermal toxicity study, which is conducted according to the methodology described in OECD Test Guideline 411 and in conformity with the OECD Principles of Good Laboratory Practice, or other similar study or information, which will permit assessment of the dermal toxicity of the substance and its ability to be dermally absorbed;
    • (d) a summary of all other information or test data in respect of the substance that are in the possession of the person proposing the significant new activity, or to which they ought to have access, and that are relevant to identifying hazards of the substance to the environment and human health and the degree of environmental and public exposure to the substance;
    • (e) the identification of every other government agency, either outside or within Canada, that the person proposing the significant new activity has notified of the substance and, if known, the agency’s file number, the outcome of the assessment and the risk management actions in relation to the substance imposed by the agency;
    • (f) the name, civic and postal addresses and telephone number and, if any, fax number and email address of the person proposing the significant new activity and, if they are not resident in Canada, of the person resident in Canada that is authorized to act on their behalf; and
    • (g) a certification stating that the information is accurate and complete, dated and signed by the person proposing the significant new activity if they are resident in Canada or, if not, by the person resident in Canada that is authorized to act on their behalf.
  • 4. The above information will be assessed within 90 days after the day on which it is received by the Minister.

13. Column 2 of Part 2 of the Domestic Substances List, opposite the reference to the substance “6786-83-0 S′” in column 1, is proposed to be replaced by the following:

Column 1


Substance

Column 2

Significant new activity for which substance is subject to subsection 81(3) of the Act

6786-83-0 S’

  • 1. Any activity involving, during any one calendar year, the use of more than 1 000 kg of the substance 1-naphthalenemethanol, α,α-bis[4-(dimethylamino)phenyl]-4-(phenylamino)-, including the use of the substance as a research and development substance or a site-limited intermediate substance as these expressions are defined in subsection 1(1) of the New Substances Notification Regulations (Chemicals and Polymers), or as an export-only substance.
  • 2. For each proposed significant new activity, the following information must be provided to the Minister at least 90 days before the commencement of the proposed new activity:
    • (a) a description of the significant new activity in relation to the substance;
    • (b) the information specified in items 2, 3 and 11 of Schedule 6 to the New Substances Notification Regulations (Chemicals and Polymers);
    • (c) the information specified in items 3 to 9 of Schedule 4 to the New Substances Notification Regulations (Chemicals and Polymers);
    • (d) the information specified in items 2 to 5, 8 and 9 of Schedule 5 to those Regulations;
    • (e) the test data and the test report obtained from a sediment toxicity test conducted according to the methodology described in the OECD Test Guidelines for the Testing of Chemicals No. 218, entitled Sediment-Water Chironomid Toxicity Using Spiked Sediment that is current at the time the test data are developed;
    • (f) the concentration in percent of the substance methanone, bis[4-(dimethylamino)phenyl]- (Michler’s ketone) found in the substance;
    • (g) a summary of all other information or test data in respect of the substance that are in the possession of the person proposing the significant new activity, or to which they ought to have access, and that are relevant to identifying hazards of the substance to the environment and human health and the degree of environmental and public exposure to the substance;
    • (h) the identification of every other government agency, either outside or within Canada, that the person proposing the significant new activity has notified of the substance and, if known, the agency’s file number, the outcome of the assessment and the risk management actions in relation to the substance imposed by the agency;
    • (i) the name, civic and postal addresses and telephone number and, if any, the fax number and email address of the person proposing the significant new activity and, if they are not resident in Canada, of the person resident in Canada that is authorized to act on their behalf; and
    • (j) a certification that the information is accurate and complete, dated and signed by the person proposing the significant new activity if they are resident in Canada or, if not, by the person resident in Canada that is authorized to act on their behalf.
  • 3. The above information will be assessed within 90 days after the day on which it is received by the Minister.

14. Column 2 of Part 2 of the Domestic Substances List, opposite the reference to the substance “7758-01-2 S′” in column 1, is proposed to be replaced by the following:

Column 1


Substance

Column 2

Significant new activity for which substance is subject to subsection 81(3) of the Act

7758-01-2 S′

  • 1. In relation to the substance bromic acid, potassium salt,
    • (a) the use of the substance in the manufacture of a consumer product to which the Canada Consumer Product Safety Act applies that contains the substance at a concentration equal to or greater than 0.1% by weight;
    • (b) any activity involving a consumer product to which the Canada Consumer Product Safety Act applies that contains the substance at a concentration equal to or greater than 0.1% by weight, if the product involved in the activity, during any one calendar year, contains a total quantity of the substance greater than 10 kg; or
    • (c) any other activity involving, during any one calendar year, the use of more than 1 000 kg of the substance, other than an activity involving its use as
      • (i) an oxidizer in flour milling for export,
      • (ii) a component of an industrial or commercial cleaning product, or
      • (iii) a component of an industrial or commercial paint or coating.
  • 2. Despite item 1, the use of the substance as a research and development substance or as a site-limited intermediate substance as these expressions are defined in subsection 1(1) of the New Substances Notification Regulations (Chemicals and Polymers), or as an export-only substance, is not a significant new activity.
  • 3. For each proposed significant new activity, the following information must be provided to the Minister at least 180 days before the commencement of the proposed new activity:
    • (a) a description of the significant new activity in relation to the substance;
    • (b) the anticipated annual quantity of the substance to be used in relation to the significant new activity;
    • (c) the information specified in items 3 to 7 of Schedule 4 to the New Substances Notification Regulations (Chemicals and Polymers);
    • (d) the information specified in paragraphs 2(d) to (f) and 8(f) and (g) of Schedule 5 to those Regulations;
    • (e) a description of the consumer product that contains the substance, the intended use of that consumer product and the function of the substance in that consumer product;
    • (f) a description of how the consumer product is intended to be used or applied;
    • (g) the total quantity of the consumer product expected to be sold in Canada in a calendar year by the person undertaking the significant new activity;
    • (h) a summary of all other information or test data in respect of the substance that are in the possession of the person proposing the significant new activity, or to which they ought to have access, and that are relevant to identifying hazards of the substance to the environment and human health and the degree of environmental and public exposure to the substance;
    • (i) the identification of every other government agency, either outside or within Canada, that the person proposing the significant new activity has notified of the substance and, if known, the agency’s file number, the outcome of the assessment and the risk management actions in relation to the substance imposed by the agency;
    • (j) the name, civic and postal addresses and telephone number and, if any, the fax number and email address of the person proposing the significant new activity and, if they are not resident in Canada, of the person resident in Canada that is authorized to act on their behalf; and
    • (k) a certification that the information is accurate and complete, dated and signed by the person proposing the significant new activity if they are resident in Canada or, if not, by the person resident in Canada that is authorized to act on their behalf.
  • 4. The above information will be assessed within 180 days after the day on which it is received by the Minister.

15. Column 2 of Part 2 of the Domestic Substances List, opposite the reference to the substance “10448-09-6 S′” in column 1, is proposed to be replaced by the following:

Column 1


Substance

Column 2

Significant new activity for which substance is subject to subsection 81(3) of the Act

10448-09-6 S’

  • 1. Any activity involving, during any one calendar year, the use of more than 1 000 kg of the substance cyclotetrasiloxane, heptamethylphenyl-, including the use of the substance as a research and development substance or a site-limited intermediate substance as these expressions are defined in subsection 1(1) of the New Substances Notification Regulations (Chemicals and Polymers) or as an export-only substance.
  • 2. For each proposed significant new activity, the following information must be provided to the Minister at least 90 days before the commencement of the proposed new activity:
    • (a) a description of the significant new activity in relation to the substance;
    • (b) the information specified in Schedule 4 to the New Substances Notification Regulations (Chemicals and Polymers);
    • (c) the information specified in item 2, paragraphs 3(a), (b), (e) and (f) and items 6 to 9 of Schedule 5 to those Regulations where
      • (i) the information specified in those paragraphs is obtained from an experimental study and excludes modelling or alternative data, and
      • (ii) the information specified in paragraph 3(f) is obtained according to the methodology described in the Organisation for Economic Co-operation and Development (“OECD”) Test Guidelines for the Testing of Chemicals No. 123, entitled Partition Coefficient (1-Octanol/Water): Slow-Stirring Method;
    • (d) the information specified in item 5 of Schedule 6 to those Regulations;
    • (e) the test data and the test report obtained from a study to determine the adsorption-desorption in respect of the substance and excluding modelling or alternative data;
    • (f) the data and report from a study to determine the hydrolysis rate as a function of pH of the substance and, if known, the hydrolysis products resulting from that study, and excluding modelling or alternative data;
    • (g) the data and the reports obtained from the following tests, and excluding modelling or alternative data:
      • (i) acute algae toxicity test conducted according to the methodology described in the OECD Test Guidelines for the Testing of Chemicals No. 201, entitled Freshwater Alga and Cyanobacteria, Growth Inhibition Test that is current at the time the test data are developed,
      • (ii) early-life stage toxicity test with rainbow trout conducted according to the methodology described in the OECD Test Guidelines for the Testing of Chemicals No. 210, entitled Fish, Early-Life Stage Toxicity Test that is current at the time the test data are developed,
      • (iii) fish reproduction test conducted according to the methodology described in the OECD Test Guidelines for the Testing of Chemicals No. 229, entitled Fish Short Term Reproduction Assay that is current at the time the test data are developed,
      • (iv) daphnia reproduction test conducted according to the methodology described in the OECD Test Guidelines for the Testing of Chemicals No. 211, entitled Daphnia magna Reproduction Test that is current at the time the test data are developed, and
      • (v) sediment toxicity test conducted according to the methodology described in the OECD Test Guidelines for the Testing of Chemicals No. 218, entitled Sediment-Water Chironomid Toxicity Using Spiked Sediment that is current at the time the test data are developed;
    • (h) a summary of all other information or test data in respect of the substance that are in the possession of the person proposing the significant new activity, or to which they ought to have access, and that are relevant to identifying hazards of the substance to the environment and human health and the degree of environmental and public exposure to the substance;
    • (i) the identification of every other government agency, either outside or within Canada, that the person proposing the significant new activity has notified of the substance and, if known, the agency’s file number, the outcome of the assessment and the risk management actions in relation to the substance imposed by the agency;
    • (j) the name, civic and postal addresses and telephone number and, if any, the fax number and email address of the person proposing the significant new activity and, if they are not resident in Canada, of the person resident in Canada that is authorized to act on their behalf; and
    • (k) a certification that the information is accurate and complete, dated and signed by the person proposing the significant new activity if they are resident in Canada or, if not, by the person resident in Canada that is authorized to act on their behalf.
  • 3. The above information will be assessed within 90 days after the day on which it is received by the Minister.

16. Column 2 of Part 2 of the Domestic Substances List, opposite the reference to the substance “17540-75-9 S′” in column 1, is proposed to be replaced by the following:

Column 1


Substance

Column 2

Significant new activity for which substance is subject to subsection 81(3) of the Act

17540-75-9 S′

  • 1. Any activity involving, during any one calendar year, the use of more than 100 kg of the substance phenol, 2,6-bis(1,1-dimethylethyl)-4-(1-methylpropyl)-, including the use of the substance as a research and development substance or a site-limited intermediate substance as these expressions are defined in subsection 1(1) of the New Substances Notification Regulations (Chemicals and Polymers) or as an export-only substance, but excluding any activity involving its use in brake fluid at a concentration of less than or equal to 1% by weight.
  • 2. For each proposed significant new activity, the following information must be provided to the Minister at least 180 days before the commencement of the proposed new activity:
    • (a) a description of the significant new activity in relation to the substance;
    • (b) the anticipated annual quantity of the substance to be used in relation to the significant new activity;
    • (c) the information specified in items 3 to 7 of Schedule 4 to the New Substances Notification Regulations (Chemicals and Polymers);
    • (d) if known, the three sites in Canada where the greatest quantity of the substance is anticipated to be used or processed and the estimated quantity by site;
    • (e) the products and, if known, end-use products that are anticipated to contain the substance, the intended use of those products and the function of the substance in those products;
    • (f) the information specified in paragraphs 2(d) to (f), 3(a) to (d), 3(f) and 8(a) to (g) of Schedule 5 to those Regulations;
    • (g) the information specified in paragraph 3(e) of Schedule 5 to those Regulations — following the modifications for slow-stirring techniques and equilibration study in accordance with the flask method described in Section R.7.1.7 (Water solubility) of the document entitled Guidance on information requirements and chemical safety assessment, Chapter R.7a: Endpoint specific guidance, published by the European Chemicals Agency in 2012;
    • (h) the information specified in item 11 of Schedule 6 to those Regulations, including a description of the procedures for cleaning empty containers and disposing of the rinsate;
    • (i) the test data and the test report obtained from a sediment toxicity test conducted according to the methodology described in the OECD Test Guidelines for the Testing of Chemicals No. 218, entitled Sediment-Water Chironomid Toxicity Using Spiked Sediment that is current at the time the test data are developed;
    • (j) a summary of all other information or test data in respect of the substance that are in the possession of the person proposing the significant new activity, or to which they ought to have access, and that are relevant to identifying hazards of the substance to the environment and human health and the degree of environmental and public exposure to the substance;
    • (k) the identification of every other government agency, either outside or within Canada, that the person proposing the significant new activity has notified of the substance and, if known, the agency’s file number and the outcome of the assessment and, if any, the risk management actions in relation to the substance imposed by the agency;
    • (l) the name, civic and postal addresses and telephone number and, if any, the fax number and email address of the person proposing the significant new activity and, if they are not resident in Canada, of the person resident in Canada that is authorized to act on their behalf; and
    • (m) a certification that the information is accurate and complete, dated and signed by the person proposing the significant new activity if they are resident in Canada or, if not, by the person resident in Canada that is authorized to act on their behalf.
  • 3. The above information will be assessed within 180 days after the day on which it is received by the Minister.

17. Column 2 of Part 2 of the Domestic Substances List, opposite the reference to the substance “72102-55-7 S′” in column 1, is proposed to be replaced by the following:

Column 1


Substance

Column 2

Significant new activity for which substance is subject to subsection 81(3) of the Act

72102-55-7 S′

  • 1. In relation to the substance methylium, [4-(dimethylamino)phenyl]bis[4-(ethylamino)-3-methylphenyl]-, acetate,
    • (a) the use of the substance in the manufacture of any of the following products containing the substance at a concentration equal to or greater than 1% by weight, other than its use as a dye in the manufacture of wood products or pulp or paper products:
      • (i) a consumer product to which the Canada Consumer Product Safety Act applies, or
      • (ii) a cosmetic, within the meaning of section 2 of the Food and Drugs Act; or
    • (b) any activity involving any of the following products — other than a wood product or pulp or paper product — containing the substance at a concentration equal to or greater than 1% by weight, if the product involved in the activity, during any one calendar year, contains a total quantity of the substance greater than 10 kg:
      • (i) a consumer product to which the Canada Consumer Product Safety Act applies, or
      • (ii) a cosmetic, within the meaning of section 2 of the Food and Drugs Act.
  • 2. Despite item 1, the use of the substance as a research and development substance or as a site-limited intermediate substance as these expressions are defined in subsection 1(1) of the New Substances Notification Regulations (Chemicals and Polymers), or as an export-only substance is not a significant new activity.
  • 3. For each proposed significant new activity, the following information must be provided to the Minister at least 180 days before the commencement of the proposed new activity:
    • (a) a description of the significant new activity in relation to the substance;
    • (b) the anticipated annual quantity of the substance to be used in relation to the significant new activity;
    • (c) the information specified in items 3 to 7 of Schedule 4 to the New Substances Notification Regulations (Chemicals and Polymers);
    • (d) the information specified in paragraphs 2(d) to (f) and 8(f) and (g) of Schedule 5 to those Regulations;
    • (e) a description of the consumer product or cosmetic that contains the substance, the intended use of that consumer product or cosmetic and the function of the substance in that consumer product or cosmetic;
    • (f) a description of how the consumer product or cosmetic is intended to be used or applied;
    • (g) the total quantity of the consumer product or cosmetic expected to be sold in Canada in a calendar year by the person undertaking the significant new activity;
    • (h) the data and report from an acute mammalian toxicity test in respect of the substance, administered orally, dermally or by inhalation based on the most significant route of potential human exposure to the substance;
    • (i) if the substance is administered by inhalation for the purposes of the test referred to in paragraph (h), the data and report from a second acute mammalian toxicity test that is administered orally or dermally based on the most significant route of potential human exposure to the substance;
    • (j) the following additional information in respect of each of the tests referred to in paragraphs (h) and (i):
      • (i) the age, sex, number, species, strain and source of the animals tested,
      • (ii) the route by which the substance is administered and the conditions under which the test is conducted, and
      • (iii) the dose of the substance, the vehicle by means of which the substance is administered and the concentration of the substance in the vehicle;
    • (k) the mutagenicity data obtained from one in vitro test for chromosomal aberrations in mammalian cells in respect of the substance, with and without metabolic activation;
    • (l) the mutagenicity data obtained from at least two in vitro tests for gene mutations in both bacterial and mammalian cells in respect of the substance, with and without metabolic activation;
    • (m) a summary of all other information or test data in respect of the substance that are in the possession of the person proposing the significant new activity, or to which they ought to have access, and that are relevant to identifying hazards of the substance to the environment and human health and the degree of environmental and public exposure to the substance;
    • (n) the identification of every other government agency, either outside or within Canada, that the person proposing the significant new activity has notified of the substance and, if known, the agency’s file number, the outcome of the assessment and the risk management actions in relation to the substance imposed by the agency;
    • (o) the name, civic and postal addresses and telephone number and, if any, the fax number and email address of the person proposing the significant new activity and, if they are not resident in Canada, of the person resident in Canada that is authorized to act on their behalf; and
    • (p) a certification that the information is accurate and complete, dated and signed by the person proposing the significant new activity if they are resident in Canada or, if not, by the person resident in Canada that is authorized to act on their behalf.
  • 4. The tests referred to in paragraphs 2(h), (i), (k) and (l) must be conducted in conformity with the laboratory practices described in OECD Principles of Good Laboratory Practice, set out in Annex II of the Decision of the Council Concerning the Mutual Acceptance of Data in the Assessment of Chemicals adopted by the Organization for Economic Co-operation and Development on May 12, 1981, that are current at the time the test is conducted.
  • 5. The above information will be assessed within 180 days after the day on which it is received by the Minister.

18. Part 1 of the Domestic Substances List is proposed to be amended by adding the following in numerical order:

  • 68551-44-0
  • 69430-47-3

19. Part 2 of the Domestic Substances List is proposed to be amended by deleting the following in numerical order:

  • 68551-44-0 S′
  • 69430-47-3 S′

Coming into Force

20. This Order would come into force on the day on which it is registered.

EXPLANATORY NOTE

(This explanatory note is not part of the Notice of Intent.)

Description

The Notice of Intent (NOI) is an opportunity for the public to comment on proposed amendments to the Domestic Substances List (DSL), to vary the significant new activity (SNAc) requirements of the Canadian Environmental Protection Act, 1999 (CEPA), for 24 substances and to rescind the SNAc requirements for 2 substances, pursuant to subsection 87(3).

In January 2015, Environment Canada and Health Canada published a document outlining an initiative to review all Orders and notices that were adopted between 2001 and 2014 to impose SNAc requirements. (see footnote q) The purpose of the review is to ensure that SNAc Orders and notices are consistent with current information, policies and approaches. (see footnote r) Resulting changes to SNAc Orders and notices are expected to provide greater clarity of scope and improved ease of compliance by industry, while protecting Canadians and their environment. Key elements of the review include the following:

  • a review of completed risk assessments for substances subject to the SNAc provisions of CEPA, including assessments of Significant New Activity Notifications (SNANs) received on epichlorohydrin (CAS RN 106-89-8), benzyl chloride (CAS RN 100-44-7), and hydroquinone (CAS RN 123-31-9), (see footnote s) and other available information to confirm that the rationale for applying the SNAc is consistent with current policies;
  • confirmation that the information requested in the SNAc Order or notice is consistent with the current SNAc policy and approach; and
  • an analysis of wording to ensure clarity and consistency with the current approach to the drafting of SNAc definitions.

This NOI reflects the results of the review of SNAc requirements identified by stakeholders as priorities, as well as SNAc requirements targeting the use of existing substances in consumer products (Consumer Product SNAc Review Group (see footnote 13).

Within 60 days of publication of the Notice of Intent, any person may submit comments to the Minister of the Environment. These comments will be taken into consideration during the development of the Order amending the DSL to vary the SNAc requirements for 24 substances and to rescind the SNAc requirements for 2 substances.

A number of other SNAc instruments are to be published in the near future that will also target consumer products. As a result, stakeholder input provided in response to the consumer product language proposed in this NOI may not be reflected in upcoming NOIs due to publication timelines. However, any input received will be taken into consideration during the development of all related Orders and notices that pertain to consumer products.

The DSL amendments are not in force until the Order is adopted by the Minister pursuant to subsection 87(3) of CEPA. The Order must be published in the Canada Gazette, Part II. Any current SNAc requirements remain in effect until such time as an Order is published.

Applicability of the proposed Order

At this time, it is proposed that the Order amending the DSL would require any person (individual or corporation) engaging in a significant new activity in relation to the substances listed in the tables below, to submit a SNAN containing all of the information prescribed in the Order at least 90 or 180 days, as specified in the Order, prior to the import, manufacture or use of the substance for the significant new activity. Potential activities with respect to the substances requiring a SNAN submission would include, but would not be limited to, the activities summarized in Tables 1–5. Tables 1–5 also summarize whether activities involving the use of the substance as a research and development substance, or as a site-limited intermediate or export-only substance (i.e. special categories) would require the submission of a SNAN. The terms “research and development substance” and “site-limited intermediate substance” are defined in subsection 1(1) of the New Substances Notification Regulations (Chemicals and Polymers). (see footnote t) An export-only substance is a substance that is manufactured or imported in Canada and destined solely for foreign markets.

Activities not subject to the proposed Order

Tables 1–5 provide a summary of substance-specific activities that would not be subject to the Order amending the DSL. Tables 1–5 also summarize whether special categories (i.e. use of the substance as a research and development substance, or as a site-limited intermediate or export-only substance) would be excluded from the proposed Order.

For activities in relation to consumer products the proposed Order would not apply to products to which the Canada Consumer Product Safety Act (CCPSA) does not apply (see Annex A for the CCPSA definition of “consumer product” and exemptions), with the exception of cosmetics (in some cases) within the meaning of section 2 of the Food and Drugs Act. The Order would not apply to uses of the substances that are regulated under any of the following Acts of Parliament listed in Schedule 2 of CEPA, including the Pest Control Products Act, the Fertilizers Act and the Feeds Act. The Order would also not apply to transient reaction intermediates, impurities, contaminants or partially unreacted intermediates, or in some circumstances to items such as, but not limited to, wastes, mixtures or manufactured items. However, it should be noted that individual components of a mixture may be notifiable under the Order. See subsection 81(6) and section 3 of CEPA, and section 3 of the Guidelines for the Notification and Testing of New Substances: Chemicals and Polymers for additional information on the activities and conditions described above. (see footnote 14)

Table 1: List of substances under review where the original SNAc Order targets consumer products

Chemical substance (CAS RN)

Activities targeted by the current Orders

Activities targeted by the proposed Order

Activities excluded from the proposed Order

Methyl eugenol (93-15-2)

The current Order applies to any activity involving, in any one calendar year, more than 100 kg of the substance in its isolated (synthesized or extracted) form, in consumer products.

Given the concerns for human health, the Orders are proposed to be varied to clarify the consumer products to which the Orders apply.

The application of the term "consumer product" in SNAc definitions is proposed to be consistent with the Canada Consumer Product Safety Act (CCPSA). (see footnote u)

In order to minimize the availability of products to consumers at concentrations of concern, the notification threshold for the manufacturing of consumer products containing these substances is proposed to be aligned with the safety data sheet (SDS) disclosure concentration threshold. For most substances, these concentration thresholds are set at either ≥0.1% or ≥1.0%, depending on the hazard class. In the case of methyl eugenol, the proposed concentration threshold is ≥0.0002% to align with the limit set by the Pest Management Regulatory Agency for methyl eugenol in pest control products applied to the skin and with Health Canada’s Cosmetic Ingredient Hotlist entry that describes a limit of 0.0002% for methyl eugenol in other leave-on and oral hygiene products.

For all other activities relating to consumer products containing the substance at or above the concentration specified in the Order, it is proposed that the quantity threshold be lowered from 100 kg to 10 kg. While the concentration threshold will capture activities of concern, the 10 kg quantity threshold will help ensure that small quantity users are not subject to notification requirements. Users of consumer products are unlikely to exceed the 10 kg quantity threshold; however, this threshold would enable all other activities to be subject to notification and thus would be protective of human health.

Industrial and commercial activities not related to consumer products would be excluded. Consumer products to which the CCPSA does not apply would be excluded from the requirements of the Order. See section 2 and Schedule 1 of the Act for the definition of "consumer product" and exemptions.

Activities involving the use of the substance as a research and development substance, a site-limited intermediate substance or an export-only substance would be excluded from the proposed Order as the potential exposure concerns related to health are from use of consumer products. The terms "research and development substance" and "site-limited intermediate substance" are defined in subsection 1(1) of the New Substances Notification Regulations (Chemicals and Polymers). An export-only substance is a substance that is manufactured or imported in Canada and destined solely for foreign markets.

Diethyl sulfate (64-67-5)

The current Order applies to any activity involving, in any one calendar year, more than 100 kg of the substance in a consumer product.

Dimethyl sulfate (77-78-1)

Potassium bromate (7758-01-2)

The current Order applies to any activity involving, in any one calendar year, more than 100 kg of the substance in a consumer product, as well as any industrial or commercial activity involving, in any one calendar year, more than 1 000 kg of the substance, with a few exclusions.

It is proposed that the Order for this substance be applicable in the same fashion as for the above substances.

In addition, the Order would maintain the requirement for notification of use of the substance in any other activities not involving consumer products above 1 000 kg with some exceptions.

Any industrial or commercial activity relating to cleaning products, paints and coatings, and as an oxidizer in flour milling would be excluded. Consumer products to which the CCPSA does not apply would be excluded from the requirements of the Order.

Activities involving the use of the substance as a research and development substance, a site-limited intermediate substance and an export-only substance would be excluded from the proposed Order, as the potential exposure concerns related to health are from use of consumer products.

n-BGE (2426-08-6)

The current Order applies to any activity involving, in any one calendar year, more than 100 kg of the substance in the manufacture of consumer products.

Given the concerns for human health, the SNAc Orders are proposed to be varied to clarify the consumer products to which the SNAc Orders apply, which includes cosmetics.

The application of the term "consumer product" in SNAc definitions is proposed to be consistent with the CCPSA, while the application of the term "cosmetic" in SNAc definitions is consistent with the meaning of section 2 of the Food and Drugs Act.

In order to minimize the availability of products to consumers at concentrations of concern, the notification threshold for the manufacturing of consumer products or cosmetics containing these substances is proposed to be aligned with SDS disclosure concentration thresholds. For most substances, these concentration thresholds are set at either ≥0.1% or ≥1.0%, depending on the hazard class.

There would also be an additional notification threshold (250 mL) for the size of the consumer product containing these substances.

For all other activities relating to consumer products or cosmetics containing the substance at or above the concentration specified in the Order, it is proposed that the quantity threshold be lowered from 100 kg to 10 kg. While the concentration threshold will capture activities of concern, the 10 kg quantity threshold will help ensure that small quantity users are not subject to notification requirements. Users of consumer products or cosmetics are unlikely to exceed the 10 kg quantity threshold; however, this threshold will enable all other activities to be subject to notification and thus would be protective of human health.

Industrial and commercial activities not related to consumer products would be excluded. Consumer products to which the CCPSA does not apply would be excluded from the requirements of the Order, with the exception of cosmetics within the meaning of section 2 of the Food and Drugs Act.

Activities involving the use of the substance as a research and development substance, a site-limited intermediate substance and an export-only substance would be excluded from the proposed Order as the potential exposure concerns related to health are from the use of consumer products or cosmetics.

TGOPE (7328-97-4)

The current Order applies to any activity involving, in any one calendar year, more than 100 kg of the substance, in its uncured or undried form, in consumer products, other than an activity involving its use in an epoxy-based paint, epoxy-based coating or epoxy-based adhesive.

Table 2: List of substances under review where amendments are proposed to target activities relating to consumer products

Chemical substance (CAS RN)

Activities targeted by the current Orders

Activities targeted by the proposed Order

Activities excluded from the proposed Order

Methyloxirane (75-56-9)

The current Order applies to activities involving, in any one calendar year, more than 1 000 kg of the substance as a component in polyurethane foam, as well as other activities involving, in any one calendar year, more than 100 kg of the substance. Use as a stabilizer in benzyl chloride is excluded.

Given the concerns for human health, the Orders are proposed to be varied to be more targeted and to only require notification for activities related to consumer products.

The application of the term "consumer product" in SNAc definitions is proposed to be consistent with the CCPSA.

In order to minimize the availability of products to consumers at concentrations of concern, the notification threshold for the manufacturing of consumer products containing these substances is proposed to be aligned with SDS disclosure concentration thresholds. These concentration thresholds are set at either ≥0.1% or ≥1.0%, depending on the hazard class.

For all other activities relating to consumer products containing the substance at or above the concentration specified in the Order, it is proposed that the quantity threshold be lowered from 100 kg to 10 kg. While the concentration threshold will capture activities of concern, the 10 kg quantity threshold will help ensure that small quantity users are not subject to notification requirements. Users of consumer products are unlikely to exceed the 10 kg quantity threshold; however, this threshold will enable all other activities to be subject to notification and thus protective of human health.

Industrial and commercial activities not related to consumer products would be excluded. Consumer products to which the CCPSA does not apply would be excluded from the requirements of the Order.

For thiourea, the use of the substance in a silver polish or metal cleaner that contains the substance at a concentration equal to or less than 7% with proper labelling (i.e. instructions to wear gloves when using the product) would also be excluded.

Activities involving the use of the substance as a research and development substance, a site-limited intermediate substance and an export-only substance are excluded from the proposed Order as the potential exposure concerns related to health are from use of consumer products.

Epichlorohydrin (106-89-8)

The current Order applies to any activity involving, in any one calendar year, more than 100 kg of the substance.

Benzyl chloride (100-44-7)

The current Order applies to activities involving, in any one calendar year, more than 100 kg of the substance with some exclusions.

Hydroquinone (123-31-9)

Ethyloxirane (106-88-7)

Thiourea (62-56-6)

2-EEA (111-15-9)

Pigment Red 3 (2425-85-6)

Industrial and commercial activities not related to consumer products would be excluded. In addition, any activity relating to a paint containing the substance would also be excluded. Consumer products to which the CCPSA does not apply would be excluded from the requirements of the Order.

Activities involving the use of the substance as a research and development substance, a site-limited intermediate substance or an export-only substance would be excluded from the proposed Order as the potential exposure concerns related to health are from use of consumer products.

Michler’s ketone (90-94-8)

   

Industrial and commercial activities not related to consumer products would be excluded. In addition, any activity relating to a dye or pigment containing the substance at a concentration of less than 5%, or to an ink containing the substance at a concentration of less than 3%, would also be excluded. Consumer products to which the CCPSA does not apply would be excluded from the requirements of the Order.

Activities involving the use of the substance as a research and development substance, a site-limited intermediate substance or an export-only substance would be excluded from the proposed Order as the potential exposure concerns related to health are from use of consumer products.

TCEP (115-96-8)

The current Order applies to any activity involving, in any one calendar year, more than 100 kg of the substance.

Given the concerns for human health, the SNAc Orders are proposed to be varied to be more targeted and to require notification for activities related to consumer products and cosmetics.

In order to minimize the availability of products to consumers at concentrations of concern, the notification threshold for the manufacturing of consumer products or cosmetics containing these substances is proposed to be aligned with SDS disclosure concentration thresholds. These concentration thresholds are set at either ≥0.1% or ≥1.0%, depending on the hazard class.

For all other activities relating to consumer products or cosmetics containing the substance at or above the concentration specified in the Order, it is proposed that the quantity threshold be lowered from 100 kg to 10 kg. While the concentration threshold will capture activities of concern, the 10 kg quantity threshold will help ensure that small quantity users are not subject to notification requirements. Users of consumer products or cosmetics are unlikely to exceed the 10 kg quantity threshold; however, this threshold will enable all other activities to be subject to notification and thus protective of human health.

In addition, the Order for phenoxymethyl oxirane would also maintain the requirement for notification of use of the substance in any other activities not involving consumer products or cosmetics above the notification threshold of 100 kg.

Industrial and commercial activities not related to consumer products or cosmetics are excluded. Consumer products to which the CCPSA does not apply would be excluded from the requirements of the Order, with the exception of cosmetics within the meaning of section 2 of the Food and Drugs Act.

The use of the substance MAPBAP acetate in wood products or pulp and paper products would also be excluded.

Activities involving the use of the substance as a research and development substance, a site-limited intermediate substance and an export-only substance would be excluded from the proposed Order as the potential exposure concerns related to health are from use of consumer products or cosmetics.

2-Nitropropane (79-46-9)

The current Order applies to activities involving, in any one calendar year, more than 100 kg of the substance, with some exclusions.

MAPBAP acetate (72102-55-7)

Phenoxymethyl oxirane (122-60-1)

The current Order applies to any activity involving, in any one calendar year, more than 100 kg of the substance with exceptions for use in drugs.

Table 3: List of substances under review where notification thresholds are proposed to be increased

Chemical substance (CAS RN)

Activities targeted by the current Orders

Activities targeted by the proposed Order

Activities excluded from the proposed Order

Solvent Blue 4 (6786-83-0)

The current Order applies to any activity involving, in any one calendar year, more than 100 kg of the substance.

The quantity threshold for these SNAcs is proposed to be increased from 100 kg/year to 1 000 kg/year, which would still be considered protective of the environment.

Activities involving the use of the substance as a research and development substance, a site-limited intermediate substance or an export-only substance could result in the release of the substance to the Canadian environment. Given the ecological concerns (in addition to human health concerns) associated with the substance, the above-mentioned activities would require the submission of a SNAN.

There are no additional exclusions.

Phenyl-D4 (10448-09-6)

The current Order applies to any activity involving, in any one calendar year, more than 100 kg of the substance.

Table 4: List of substances under review to clarify SNAc definition

Chemical substance (CAS RN)

Activities targeted by the current Orders

Activities targeted by the proposed Order

Activities excluded from proposed Order

DTBSBP (17540-75-9)

The current Order applies to any activity involving, in any one calendar year, more than 100 kg of the substance, other than an activity involving its use as an antioxidant or corrosion inhibitor in brake fluid at a concentration of less than or equal to 1% by weight.

Given the potential risks to the environment of this substance, it is proposed to clarify the SNAc definition and remove any functional descriptor while maintaining the applicability of any activity involving the substance. Significant new activities could include, but are not limited to, its use in polyurethane foam, or in PVC resin.

Activities involving the use of the substance as a research and development substance, a site-limited intermediate substance or an export-only substance could result in the release of the substance to the Canadian environment. Given the ecological concerns associated with the substance, the above-mentioned activities would require the submission of a SNAN.

Any activity related to brake fluid containing the substance at a concentration of less than or equal to 1% is excluded.

2-Pyrrolidinone, 1-(2-hydroxyethyl)(3445-11-2)

The current Order applies to any activity involving the substance as a component in personal care products.

Given the potential human health risks of this substance and potential use in cosmetics and personal care products, it is proposed to replace reference to "personal care products" with any activity relating to "cosmetics, drugs or natural health products." Significant new activities could include, but are not limited to, cosmetics and personal care products that are applied dermally.

Industrial and commercial activities and activities related to the use of the substance in consumer products other than in cosmetics, drugs or natural health products are excluded.

Activities involving the use of the substance as a research and development substance, a site-limited intermediate substance and an export-only substance are excluded from the proposed Order as the potential exposure concerns related to health are from use of consumer products.

Vanadium pentoxide (1314-62-1)

The current Order applies to any activity involving, in any one calendar year, more than 100 kg of the substance, other than its use in a ferrovanadium alloy, as a catalyst for an industrial process, as an oxidizing agent, as a corrosion inhibitor, in a chemical fertilizer, or in a bismuth vanadate pigment.

Given that the SNAc requirements are still considered relevant for this substance, it is proposed to maintain the same definition of significant new activities, which could include, but are not limited to, its use in production of other metals or as a medicinal ingredient.

Activities involving the use of the substance as a research and development substance, a site-limited intermediate substance or an export–only substance could result in the release of the substance to the Canadian environment. Given the ecological concerns (in addition to human health concerns) associated with the substance, the above-mentioned activities would require the submission of a SNAN.

Any activity related to use in an alloy, fertilizer, pigment, or as an oxidizing agent or corrosion inhibitor is excluded.

Table 5: List of substances under review to be rescinded

Chemical substance (CAS RN)

Activities targeted by the current Orders

Activities targeted by the proposed Order

Activities excluded from proposed Order

MDnM-hydride (69430-47-3)

The current Order applies to any activity involving, in any one calendar year, more than 100 kg of the substance.

The review concluded that no environmental risk would be identified related to notification of new uses of these two substances. Therefore, the SNAc Orders are proposed to be rescinded.

There are no additional exclusions.

FAZ (68551-44-0)

Information to be submitted

The NOI sets out the proposed requirements for information that would need to be provided to the Minister 90–180 days, as specified in the Order, before the day on which the substances are imported, manufactured or used for a significant new activity. The Department of the Environment and the Department of Health will use the information submitted in the SNAN to conduct human health and environmental assessments within 90–180 days after the complete information is received.

The information requirements in the proposed Order relate to general information in respect of the substance, details surrounding its use, and to exposure information.

As an outcome of the review process, specific information requirements for a toxicity study with a dermal mode of action and sediment toxicity studies are being proposed for the substances bearing the following CAS RNs: 3445-11-2, 6786-83-0, and 17540-75-9. The data from these tests will help to assess human use scenarios that could lead to high exposures and risk to human health (for 3445-11-2) or clarify if the substance would partition to sediments if released to water (for 6786-83-0 and 17540-75-9).

Similarly, the information requirements for acute and chronic toxicity, reproductive and developmental toxicity, mutagenicity, and sediment toxicity studies, are being maintained for the substances bearing CAS RNs 10448-09-6, and 72102-55-7, since the review confirmed that there was concern for future uses to the environment and human health given the hazardous nature of and potential for exposure to these substances.

Additional guidance on preparing a SNAN can be found in section 4 of the Guidelines for the Notification and Testing of New Substances: Chemicals and Polymers.

Compliance

When assessing whether or not a substance is subject to the SNAc provisions, (see footnote v) a person is expected to make use of information in their possession or to which they ought to have access. The phrase “to which they ought to have access” means information in any of the notifier’s offices worldwide or other locations where the notifier can reasonably have access to the information. For example, manufacturers are expected to have access to their formulations, while importers or users of a substance, mixture, or product are expected to have access to import records, usage information, and the relevant SDS. (see footnote w)

Although an SDS is an important source of information on the composition of a purchased product, it should be noted that the goal of the SDS is to protect the health of workers in the workplace from specific hazards of chemical products. Therefore, an SDS may not list all product ingredients that may be subject to an order due to human health or environmental concerns. Any person requiring more detailed information on product composition is encouraged to contact their supplier.

If any information becomes available that reasonably supports the conclusion that a substance is toxic or capable of becoming toxic, the person who is in possession or who has knowledge of the information and is involved in certain activities with the substance is obligated, under section 70 of CEPA, to provide that information to the Minister without delay.

A company can submit a SNAN on behalf of its clients. For example, in cases where a person takes possession and control of a substance from another person, they may not be required to submit a SNAN, under certain conditions, if the activities were covered by the original SNAN. The Substances Management Advisory Note “Clarification in relation to the submission of Significant New Activity Notifications in application of the Canadian Environmental Protection Act, 1999” provides more detail on this subject. (see footnote x)

Any person who transfers the physical possession or control of a substance subject to an order should notify all persons to whom the physical possession or control is transferred of the obligation to comply with the order, including the obligation to notify the Minister of any significant new activity and to provide all of the required information outlined above.

A pre-notification consultation (PNC) is recommended for notifiers who wish to consult during the planning or preparation of their SNAN to discuss any questions or concerns they have about the prescribed information and test plans.

Where a person has questions concerning their obligations to comply with an order, believes they may be out of compliance, or would like to request a PNC, they are encouraged to discuss their particular circumstances with the program by contacting the Substances Management Information Line. (see footnote y)

CEPA is enforced in accordance with the publicly available Compliance and Enforcement Policy for the Canadian Environmental Protection Act, 1999. (see footnote z) In instances of non-compliance, consideration is given to factors such as the nature of the alleged violation, potential harm, intent, and history of compliance.

ANNEX A

Consumer Product Definition in the Canada Consumer Product Safety Act (CCPSA) (see footnote 15)

In section 2 of the CCPSA, “consumer product” means a product, including its components, parts or accessories, that may reasonably be expected to be obtained by an individual to be used for non-commercial purposes, including for domestic, recreational and sports purposes, and includes its packaging. Section 4 of the CCPSA describes the application of the Act as follows:

Consumer products

4. (1) This Act applies to consumer products with the exception of those listed in Schedule 1.

Tobacco products

(2) This Act applies to tobacco products as defined in section 2 of the Tobacco Act but only in respect of their ignition propensity.

Natural health products

(3) For greater certainty, this Act does not apply to natural health products as defined in subsection 1(1) of the Natural Health Products Regulations made under the Food and Drugs Act.

Schedule 1 of the CCPSA (Subsection 4(1) and paragraph 37(1)(c))

  1. Explosives within the meaning of section 2 of the Explosives Act.
  2. Cosmetics within the meaning of section 2 of the Food and Drugs Act.
  3. Devices within the meaning of section 2 of the Food and Drugs Act.
  4. Drugs within the meaning of section 2 of the Food and Drugs Act.
  5. Food within the meaning of section 2 of the Food and Drugs Act.
  6. Pest control products within the meaning of subsection 2(1) of the Pest Control Products Act.
  7. Vehicles within the meaning of section 2 of the Motor Vehicle Safety Act and a part of a vehicle that is integral to it — as it is assembled or altered before its sale to the first retail purchaser — including a part of a vehicle that replaces or alters such a part.
  8. Feeds within the meaning of section 2 of the Feeds Act.
  9. Fertilizers within the meaning of section 2 of the Fertilizers Act.
  10. Vessels within the meaning of section 2 of the Canada Shipping Act, 2001.
  11. Firearms within the meaning of section 2 of the Criminal Code.
  12. Ammunition within the meaning of subsection 84(1) of the Criminal Code.
  13. Cartridge magazines within the meaning of subsection 84(1) of the Criminal Code.
  14. Cross-bows within the meaning of subsection 84(1) of the Criminal Code.
  15. Prohibited devices within the meaning of paragraphs (a) to (d) of the definition “prohibited device” in subsection 84(1) of the Criminal Code.
  16. Plants within the meaning of section 3 of the Plant Protection Act, except for Jequirity beans (abrus precatorius).
  17. Seeds within the meaning of section 2 of the Seeds Act, except for Jequirity beans (abrus precatorius).
  18. Controlled substances within the meaning of subsection 2(1) of the Controlled Drugs and Substances Act.
  19. Aeronautical products within the meaning of subsection 3(1) of the Aeronautics Act.
  20. Animals within the meaning of subsection 2(1) of the Health of Animals Act.

[2-1-o]

DEPARTMENT OF THE ENVIRONMENT

CANADIAN ENVIRONMENTAL PROTECTION ACT, 1999

Notice with respect to substances included as part of the 2017 Inventory Update

Pursuant to paragraph 71(1)(b) of the Canadian Environmental Protection Act, 1999 (hereinafter referred to as the “Act”), notice is hereby given that the Minister of the Environment requires, for the purpose of assessing whether the substances listed in Schedule 1 to this notice are toxic or are capable of becoming toxic, or for the purpose of assessing whether to control, or the manner in which to control the listed substances, any person described in Schedule 2 to this notice who possesses or who may reasonably be expected to have access to the information required in Schedule 3 to this notice to provide that information no later than July 17, 2017, 3 p.m., Eastern Daylight Saving Time.

Responses to this notice shall be submitted to the Minister of the Environment, using the online reporting system available through Environment and Climate Change Canada’s Single Window at https://ec.ss.ec.gc.ca/. Inquiries concerning the notice may be directed to the Substances Management Coordinator at 1-800-567-1999 (toll-free in Canada), 819-938-3232 (outside of Canada) [telephone], or eccc.substances.eccc@canada.ca (email).

Pursuant to section 313 of the Act, any person who provides information in response to this notice may submit, with the information, a written request that the information or part of it be treated as confidential.

Pursuant to subsection 71(4) of the Act, the Minister of the Environment may, on request in writing from any person to whom this notice applies, extend the time or times within which the person shall comply with this notice. The person seeking such extension shall submit, prior to the deadline, a request to the Minister of the Environment, to the attention of the Substances Management Coordinator, Chemicals Management Plan, Gatineau, Quebec K1A 0H3 or eccc.substances.eccc@canada.ca (email).

Jacqueline Gonçalves
Director General
Science and Risk Assessment Directorate
On behalf of the Minister of the Environment

SCHEDULE 1

Substances

Part 1

CAS RN (see footnote 16)

Name of the substance

Nom de la substance

52-68-6

Phosphonic acid, (2,2,2-trichloro-1-hydroxyethyl)-, dimethyl ester

Acide phosphonique, (2,2,2-trichloro-1-hydroxyéthyl)-, diester méthylique

75-15-0

Carbon disulfide

Disulfure de carbone

80-08-0

Benzenamine, 4,4′-sulfonylbis-

Dapsone

84-76-4

1,2-Benzenedicarboxylic acid, dinonyl ester

Phtalate de dinonyle

84-77-5

1,2-Benzenedicarboxylic acid, didecyl ester

Phtalate de didécyle

84-78-6

1,2-Benzenedicarboxylic acid, butyl octyl ester

Phtalate de butyle et d’octyle

85-69-8

1,2-Benzenedicarboxylic acid, butyl 2-ethylhexyl ester

Phtalate de butyle et de 2-éthylhexyle

94-96-2

1,3-Hexanediol, 2-ethyl-

2-Éthylhexane-1,3-diol

98-56-6

Benzene, 1-chloro-4-(trifluoromethyl)-

4-Chloro-α,α,α-trifluorotoluène

101-20-2

Urea, N-(4-chlorophenyl)-N′-(3,4-dichlorophenyl)-

Triclocarban

110-82-7

Cyclohexane

Cyclohexane

111-30-8

Pentanedial

Glutaral

119-07-3

1,2-Benzenedicarboxylic acid, decyl octyl ester

Phtalate de décyle et d’octyle

120-56-9

Ethanol, 2,2′-[1,2-ethanediylbis(oxy)]bis-, dibenzoate

Dibenzoate de éthylènebis(oxyéthylène)

121-75-5

Butanedioic acid, [(dimethoxyphosphinothioyl)thio]-, diethyl ester

Malathion

123-33-1

3,6-Pyridazinedione, 1,2-dihydro-

Pyridazine-3,6-diol

131-54-4

Methanone, bis(2-hydroxy-4-methoxyphenyl)-

2,2′-Dihydroxy-4,4′-diméthoxybenzophénone

142-59-6

Carbamodithioic acid, 1,2-ethanediylbis-, disodium salt

Nabame

142-82-5

Heptane

Heptane

540-84-1

Pentane, 2,2,4-trimethyl-

2,2,4-Triméthylpentane

1071-93-8

Hexanedioic acid, dihydrazide

Adipohydrazide

1312-46-5

Iridium oxide (Ir2O3)

Tétrahydroxyde d’iridium

1314-08-5

Palladium oxide (PdO)

Monoxyde de palladium

1314-15-4

Platinum oxide (PtO2)

Dioxyde de platine

1322-94-7

1,2-Benzenedicarboxylic acid, mono(dimethylcyclohexyl) ester

Hydrogénophtalate de (diméthylcyclohexyle)

1461-25-2

Stannane, tetrabutyl-

Tétrabutylstannane

2164-17-2

Urea, N,N-dimethyl-N′-[3-(trifluoromethyl)phenyl]-

Fluométuron

2226-96-2

1-Piperidinyloxy, 4-hydroxy-2,2,6,6-tetramethyl-

4-Hydroxy-2,2,6,6-tétraméthylpipéridinoxyle

2432-90-8

1,2-Benzenedicarboxylic acid, didodecyl ester

Phtalate de didodécyle

3741-80-8

2-Benzothiazolesulfenamide, N-(2-benzothiazolylthio)-N-(1,1-dimethylethyl)-

N-(2-Benzothiazolylthio)-N-(tert-butyl)-2-benzothiazolsulfénamide

7439-88-5

Iridium

Iridium

7440-04-2

Osmium

Osmium

7440-05-3

Palladium

Palladium

7440-06-4

Platinum

Platine

7440-16-6

Rhodium

Rhodium

7440-18-8

Ruthenium

Ruthénium

7647-10-1

Palladium chloride (PdCl2)

Dichlorure de palladium

10025-65-7

Platinum chloride (PtCl2)

Dichlorure de platine

10025-83-9

Iridium chloride (IrCl3)

Trichlorure d’iridium

10025-99-7

Platinate(2-), tetrachloro-, dipotassium, (SP-4-1)-

Tétrachloroplatinate de dipotassium

10026-00-3

Platinate(2-), tetrachloro-, disodium, (SP-4-1)-

Tétrachloroplatinate de disodium

10049-07-7

Rhodium chloride (RhCl3)

Trichlorure de rhodium

10049-08-8

Ruthenium chloride (RuCl3)

Trichlorure de ruthénium

10102-05-3

Nitric acid, palladium(2++) salt

Dinitrate de palladium

10489-46-0

Sulfuric acid, rhodium(3++) salt (3:2)

Trisulfate de dirhodium

12030-49-8

Iridium oxide (IrO2)

Dioxyde d’iridium

12035-82-4

Platinum oxide (PtO)

Oxyde de platine

12036-10-1

Ruthenium oxide (RuO2)

Oxyde de ruthénium (IV)

12036-35-0

Rhodium oxide (Rh2O3)

Trioxyde de dirhodium

12044-52-9

Platinum arsenide (PtAs2)

Arséniure de platine (PtAs2)

12135-42-1

Ruthenium hydroxide (Ru(OH)3)

Trihydroxyde de ruthénium

12137-21-2

Platinum oxide (PtO2), monohydrate

Monohydrate d’oxyde de platine (PtO2)

12137-76-7

Palladium selenide (PdSe)

Séléniure de palladium (PdSe)

12237-63-7

C.I. Pigment Red 169

Hexakis(cyano-C)ferrate(4-)/2-[6-(éthylamino)-3-(éthylimino)-2,7-diméthyl-3H-xanthén-9-yl]benzoate d’éthyle et de cuivre(2++)

12307-90-3

Rhodium, chloro[(1,2,5,6-<C)-1,3,5,7-cyclooctatetraene](pyridine)-

Chloro[(1,2,5,6-<C)cycloocta-1,3,5,7-tétraène](pyridine)rhodium

13444-93-4

Osmium chloride (OsCl3)

Trichlorure d’osmium

13454-96-1

Platinum chloride (PtCl4), (SP-4-1)-

Tétrachlorure de platine

13569-65-8

Rhodium chloride (RhCl3), trihydrate

Trihydrate de chlorure de rhodium (RhCl3)

13820-53-6

Palladate(2-), tetrachloro-, disodium, (SP-4-1)-

Tétrachloropalladate de disodium

14024-41-0

Iridate(3-), hexachloro-, tripotassium, (OC-6-11)-

Hexachloroiridate de tripotassium

14284-93-6

Ruthenium, tris(2,4-pentanedionato-O,O′)-, (OC-6-11)-

Tris(pentane-2,4-dionato-O,O’)ruthénium

14898-67-0

Ruthenium chloride (RuCl3), hydrate

Trihydrate de chlorure de ruthénium (RuCl3)

14972-70-4

Rhodate(3-), hexachloro-, trisodium, (OC-6-11)-

Hexachlororhodate de trisodium

14996-60-2

Osmium chloride (OsCl3), hydrate

Hydrate de chlorure d’osmium (OsCl3)

14996-61-3

Iridium chloride (IrCl3), hydrate

Hydrate de chlorure d’iridium (IrCl3)

15231-91-1

2-Naphthalenol, 6-bromo-

6-Bromonapht-2-ol

15336-18-2

Rhodate(3-), hexachloro-, triammonium, (OC-6-11)-

Hexachlororhodate de triammonium

15752-05-3

Iridate(3-), hexachloro-, triammonium, (OC-6-11)-

Hexachloroiridate de triammonium

15869-63-3

Platinum chloride (PtCl4), pentahydrate

Pentahydrate de chlorure de platine (PtCl4)

16871-54-8

Platinate(2-), hexachloro-, (OC-6-11)-

Hexachloroplatinate(2-) (OC-6-11)

16919-58-7

Platinate(2-), hexachloro-, diammonium, (OC-6-11)-

Hexachloroplatinate de diammonium

16921-30-5

Platinate(2-), hexachloro-, dipotassium, (OC-6-11)-

Hexachloroplatinate de dipotassium

16923-58-3

Platinate(2-), hexachloro-, disodium, (OC-6-11)-

Hexachloroplatinate de disodium

16940-92-4

Iridate(2-), hexachloro-, diammonium, (OC-6-11)-

Hexachloroiridate de diammonium

16941-12-1

Platinate(2-), hexachloro-, dihydrogen, (OC-6-11)-

Acide hexachloroplatinique

16941-92-7

Iridate(2-), hexachloro-, dihydrogen, (OC-6-11)-

Acide hexachloroiridique

18497-13-7

Platinate (2-), hexachloro-, dihydrogen, hexahydrate, (OC-6-11)-

Hexahydrate d’acide (OC-6-11)-hexachloroplatinique

19186-97-1

Tris[2,2-bis(bromomethyl)-3-bromopropyl]-phosphate

3-Bromo-2,2-bis(bromométhyl)propan-1-ol, phosphate (3:1)

19223-55-3

1-Propanaminium, 2-hydroxy-N,N-dimethyl-N-[3-[(1-oxododecyl)amino]propyl]-3-sulfo-, hydroxide, inner salt

Hydroxyde de (2-hydroxy-3-sulfopropyl)diméthyl[3-[(1-oxododécyl)amino]propyl]ammonium

20765-98-4

Rhodium chloride (RhCl3), hydrate

Hydrate de chlorure de rhodium (RhCl3),

20816-12-0

Osmium oxide (OsO4), (ß-4)-

Tétraoxyde d’osmium

20845-92-5

Hexanoic acid, 2-ethyl-, rhodium(3++) salt

Tris(2-éthylhexanoate) de rhodium

21360-80-5

Rhodium(2++), pentaamminechloro-, (OC-6-22)-, sulfate (1:1)

Sulfate de pentaamminechlororhodium

21656-02-0

Rhodium hydroxide (Rh(OH)3)

Trihydroxyde de rhodium

23013-82-3

Ruthenate(2-), hexachloro-, dipotassium, (OC-6-11)-

Hexachlororuthénate de dipotassium

25057-89-0

1H-2,1,3-Benzothiadiazin-4(3H)-one, 3-(1-methylethyl)-, 2,2-dioxide

Bentazone

25085-20-5

Hexanedioic acid, polymer with N-(2-aminoethyl)-1,2-ethanediamine

Acide adipique polymérisé avec la N-(2-aminoéthyl)éthane-1,2-diamine

25724-58-7

1,2-Benzenedicarboxylic acid, decyl hexyl ester

Phtalate de décyle et d’hexyle

25973-55-1

Phenol, 2-(2H-benzotriazol-2-yl)-4,6-bis(1,1-dimethylpropyl)-

2-(2H-Benzotriazol-2-yl)-4,6-di-tert-pentylphénol

26023-84-7

Platinate (2-), hexachloro-, dihydrogen, hydrate, (OC-6-11)-

Hydrate d’acide (OC-6-11)-hexachloroplatinique

27636-21-1

1,6-Hexanediamine, polymer with (chloromethyl)oxirane

Hexane-1,6-diamine polymérisée avec le (chlorométhyl)oxirane

30980-84-8

Iridium oxide (IrO2), hydrate

Hydrate d’oxyde d’iridium (IrO2)

32740-79-7

Ruthenium oxide (RuO2), hydrate

Hydrate d’oxyde de ruthénium (RuO2)

32916-07-7

Nitric acid, palladium(2+), dihydrate

Dihydrate de nitrate de palladium (2+)

35541-81-2

1,4-Cyclohexanedimethanol, dibenzoate

Dibenzoate de cyclohexane-1,4-diméthanol

36550-26-2

Palladate(2-), hexachloro-, dihydrogen, (OC-6-11)-

Hexachloropalladate(2-) de dihydrogène

36732-58-8

Rhodate(2-), hexachloro-, dihydrogen, (OC-6-11)-

Hexachlororhodate(2-) de dihydrogène (OC-6-11)

36861-47-9

Bicyclo[2.2.1]heptan-2-one, 1,7,7-trimethyl-3-[(4-methylphenyl)methylene]-

(±)-1,7,7-Triméthyl-3-[(4méthylphényl)méthylène]bicyclo[2.2.1]heptan-2-one

39373-27-8

Rhodium oxide (Rh2O3), pentahydrate

Pentahydrate d’oxyde de rhodium (Rh2O3)

44470-26-0

Ruthenate(2-), hexachloro-, dihydrogen, (OC-6-11)-

Hexachlororuthénate(2-) de dihydrogène (OC-6-11)

52734-36-8

2-Propenoic acid, 2-methyl-, 2-(3-oxazolidinyl)ethyl ester, homopolymer

Méthacrylate de 2-(oxazolidin-3-yl)éthyle homopolymérisé

52785-06-5

Platinum oxide (PtO2), hydrate

Hydrate d’oxyde de platine (PtO2),

54968-01-3

Iridium hydroxide (Ir(OH)3)

Hydroxyde d’iridium [Ir(OH)3]

55127-80-5

Oxirane, 2,2′-[(1-methylethylidene)bis(4,1-phenyleneoxymethylene)]bis-, homopolymer, di-2-propenoate

2,2′-[Isopropylidènebis(p-phénylèneoxyméthylène)]dioxirane homopolymérisé, diacrylate

57214-10-5

Formaldehyde, polymer with 1,3-benzenedimethanamine and phenol

Formaldéhyde polymérisé avec le benzène-1,3-diméthanamine et le phénol

57876-28-5

Iridate(2-), hexachloro-, dihydrogen, hexahydrate, (OC-6-11)-

Hexahydrate d’acide (OC-6-11)-hexachloroiridique

61827-62-1

1,2-Benzenedicarboxylic acid, hexyl octyl ester

Phtalate d’hexyle et d’octyle

64109-12-2

Palladium oxide (PdO), hydrate

Hydrate d’oxyde de palladium (PdO)

64741-73-7

Distillates (petroleum), alkylate

Distillats (pétrole), alkylation

67703-99-5

Hexanedioic acid, polymer with N¹-(2-aminoethyl)-1,2-ethanediamine and 1,2-dichloroethane

Polymère de l’acide hexanedioïque avec la N¹-(2-aminoéthyl)éthane-1,2-diamine et le 1,2-dichloroéthane

67859-71-6

Phosphoric acid, rhodium(3++) salt (1:1)

Phosphate de rhodium

68071-36-3

Ethanol, 2,2′,2″-nitrilotris-, compds. with polyethylene glycol mono-C12-15-alkyl ethers phosphates

2,2′,2″-Nitrilotriéthanol, composés avec des phosphates d’éthers mono-C12-15-alkyliques du polyéthylèneglycol

68188-19-2

Paraffin waxes and Hydrocarbon waxes, chloro, chlorosulfonated

Cires de paraffine et cires d’hydrocarbures, chloro, sulfochlorées

68228-02-4

Neodecanoic acid, palladium(2++) salt

Néodécanoate de palladium(2++)

68412-56-6

Platinum, chloro octanol complexes

Platine, complexes chloro d’octanol

68425-21-8

Turpentine, oil, mixed with Venice turpentine, sulfurized, tetrachloropalladates

Essence de térébenthine, mélangée avec la térébenthine de mélèze, sulfurisée, tétrachloropalladates

68425-76-3

Ethanol, 2,2′-iminobis-, polymer with α-tridecyl-ω-hydroxypoly(oxy-1,2-ethanediyl) phosphate

2,2′-Iminodiéthanol polymérisé avec le phosphate de l’α-tridécyl-ω-hydroxypoly(oxyéthylène)

68442-70-6

1,2-Benzenedicarboxylic acid, mixed cetyl and stearyl esters

Phtalates mixtes de cétyle et de stéaryle

68478-92-2

Platinum, 1,3-diethenyl-1,1,3,3-tetramethyldisiloxane complexes

Platine complexé avec le 1,1,3,3-tétraméthyl-1,3-divinyldisiloxane

68515-41-3

1,2-Benzenedicarboxylic acid, di-C7-9-branched and linear alkyl esters

Phtalates de dialkyles en C7-9, ramifiés et linéaires

68515-42-4

1,2-Benzenedicarboxylic acid, di-C7-11-branched and linear alkyl esters

Phtalates de dialkyles en C7-11, ramifiés et linéaires

68515-44-6

1,2-Benzenedicarboxylic acid, diheptyl ester, branched and linear

Phtalates de diheptyle ramifié et linéaire

68515-45-7

1,2-Benzenedicarboxylic acid, dinonyl ester, branched and linear

Phtalates de dinonyle ramifié et linéaire

68585-32-0

Platinate(2-), hexachloro-, (OC-6-11)-, dihydrogen, reaction products with 2,4,6,8-tetraethenyl-2,4,6,8-tetramethylcyclotetrasiloxane

Hexachloroplatinate(2-) de dihydrogène (OC-6-11), produits de réaction avec le 2,4,6,8-tétraméthyl-2,4,6,8-tétravinylcyclotétrasiloxane

68648-91-9

1,2-Benzenedicarboxylic acid, di-C7-11-alkyl esters

Phtalates de dialkyles en C7-11

68916-29-0

Balsams, Douglas-fir, sulfurized, iridium salts

Baumes de Douglas sulfurisés, sels d’iridium

68916-30-3

Balsams, Douglas-fir, sulfurized, rhodium salts

Baumes de Douglas sulfurisés, sels de rhodium

68916-31-4

Balsams, Douglas-fir, sulfurized, ruthenium salts

Baumes de Douglas sulfurisés, sels de ruthénium

68916-35-8

Balsams, copaiba, sulfurized, platinum salts

Baumes de copahu sulfurisés, sels de platine

68917-69-1

Turpentine, Venice, sulfurized, hexachlororhodate

Térébenthine de mélèze sulfurisée, hexachlororhodate

70321-75-4

Balsams, Douglas-fir, sulfurized, palladium salts

Baumes de Douglas sulfurisés, sels de palladium

71033-08-4

Oxirane, 2,2′-[(1-methylethylidene)bis[4,1-phenyleneoxy[1-(butoxymethyl)-2,1-ethanediyl]oxymethylene]]bis-

2,2’-[(1-Méthyléthylidène)bis[4,1-phénylénoxy[1-(butoxyméthyl)éthylène]oxyméthylène]]bisoxirane

71832-62-7

Phenol, 4,4′-(1-methylethylidene)bis-, polymer with N,N’-bis(2-aminoethyl)-1,2-ethanediamine, (chloromethyl)oxirane, [(dodecyloxy)methyl]oxirane, [(methylphenoxy)methyl]oxirane and [(tetradecyloxy)methyl]oxirane

p,p′-Isopropylidènediphénol polymérisé avec la N,N′-bis(2-aminoéthyl)éthylènediamine, le (chlorométhyl)oxirane, le (dodécyloxy)méthyloxirane, le (méthylphénoxy)méthyloxirane et le (tétradécyloxy)méthyloxirane

72245-02-4

Amines, tallow alkyl, ethoxylated, 2-ethylhexanoates

2-Éthylhexanoates d’alkyl(de suif)amines éthoxylées

72854-22-9

Paraffin waxes and Hydrocarbon waxes, chloro, sulfonated, ammonium salts

Sels d’ammonium de cires de paraffines et de cires d’hydrocarbures chlorées et sulfonées

73018-55-0

Platinum, dicarbonyldichloro-, reaction products with 2,4,6-triethenyl-2,4,6-trimethylcyclotrisiloxane

Dicarbonyldichloroplatine(II), produits de réaction avec le 2,4,6-trivinyl-2,4,6-triméthylcyclotrisiloxane

73936-91-1

Phenol, 2-(2H-benzotriazol-2-yl)-6-(1-methyl-1-phenylethyl)-4-(1,1,3,3-tetramethylbutyl)-

2-(2H-Benzotriazol-2-yl)-6-(1-méthyl-1-phényléthyl)-4-(1,1,3,3-tétraméthylbutyl)phénol

85204-21-3

2-Butenoic acid, 4-[(2-ethylhexyl)amino]-4-oxo-, (Z)-, compd. with 2,2’,2’’-nitrilotris[ethanol] (1:1)

Acide 4-[(2-éthylhexyl)amino]-4-oxoisocrotonique, composé avec le 2,2′,2″-nitrilotris[éthanol] (1:1)

89415-87-2

2,4-Imidazolidinedione, 1,3-dichloro-5-ethyl-5-methylimidazolidine-2,4-dione

1,3-Dichloro-5-éthy1-5-méthylimidazolidine-2,4-dione

90193-94-5

1,2-Benzenedicarboxylic acid, mixed decyl and octyl diesters

Acide phtalique, mélange de diesters de décyle et d’octyle

91082-67-6

Turpentine, Venice, sulfurized, reaction products with dihydrogen hexachloroiridate(2-)

Térébenthine de mélèze sulfurisée, produits de réaction avec l’hexachloroiridate(2-) diacide

91082-70-1

Turpentine, Venice, sulfurized, reaction products with osmium chloride (OsCl3)

Térébenthine de mélèze sulfurisée, produits de réaction avec le chlorure d’osmium (OsCl3)

94266-84-9

Amines, polyethylenepoly-, polymers with adipic acid, 1,2-dichloroethane and diethylenetriamine, hydrochlorides

Polyéthylènepolyamines polymérisées avec l’acide adipique, le 1,2-dichloroéthane et la 3-azapentane-1,5-diamine, chlorhydrates

95193-73-0

1,2-Benzenedicarboxylic acid, di-C16-18 and C18-unsatd. alkyl esters

Acide benzènedicarboxylique-1,2, esters de dialkyles en C16-18 et insaturés en C18

97375-25-2

Platinum, carbonyl chloro 2,4,6,8-tetraethenyl-2,4,6,8-tetramethylcyclotetrasiloxane complexes

Platine, complexée avec le 2,4,6,8-tétraméthyl-2,4,6,8-tétravinyltétrasiloxane, chlorés et carbonylés

97765-58-7

Balsams, Canada, sulfurized, iridium salts

Baumes du Canada sulfurisés, sels d’iridium

97766-48-8

Turpentine, Venice, sulfurized, platinum salt

Térébenthine de mélèze sulfurisée, sel de platine

100402-68-4

Palladium, isooctyl 3-mercaptopropanoate complexes

Palladium, complexé avec le 3-mercaptopropionate d’isooctyle

100432-49-3

Bicyclo[3.1.1]heptane-3-thiol, 2,6,6-trimethyl-, rhodium(3++) salt

2,6,6-Triméthylbicyclo[3.1.1]heptane-3-thiolate de rhodium(3++)

100432-50-6

Bicyclo[3.1.1]heptane-2-thiol, 2,6,6-trimethyl-, rhodium(3++) salt

2,6,6-Triméthylbicyclo[3.1.1]heptane-2-thiolate de rhodium(3++)

109909-39-9

Poly(oxy-1,2-ethanediyl), α-sulfo-ω-[2,4,6-tris(1-methylpropyl)phenoxy]-, sodium salt

α-Sulfo-ω-(2,4,6-tri-sec-butylphénoxy)poly(oxyéthylène), sel de sodium

111381-90-9

1,2-Benzenedicarboxylic acid, heptyl undecyl ester, branched and linear

Phtalate d’heptyle/undécyle, ramifiés et linéaires

111905-52-3

Alcohols, C9-11-branched and linear, butoxylated ethoxylated

Alcools en C9-11 ramifiés ou linéaires, butoxylés, éthoxylés

118421-10-6

1,2-Cyclohexanediamine, reaction products with N-[4-oxiranylmethoxy)phenyl]-N-(oxiranylmethyl)oxiranemethanamine

Cyclohexane-1,2-diamine, produits de réaction avec la N-[4-(oxiranylméthoxy)phényl]-N-(oxiranylméthyl)oxiraneméthanamine

124232-16-2

Poly(oxy-1,2-ethanediyl), α-(3-carboxy-1-oxopropyl)-ω-(tridecyloxy)-

α-(3-Carboxy-1-oxopropyl)-ω-(tridécyloxy)poly(oxyéthylène)

126019-82-7

Phenol, 2(or 4)-C9-10-branched alkyl derivs., phosphorothioates (3:1)

Phosphorothioates (3:1) de (dérivés alkyliques 2(ou 4)-ramifiés en C9-10)phénol

126820-93-7

Bicyclo[3.1.1]heptanethiol, 2,6,6-trimethyl-, gold(1++) salt, reaction products with palladium isooctyl 3-mercaptopropanoate complexes and sulfur

Sel d’or(1++) du 2,6,6-triméthylbicyclo[3.1.1]heptanethiol, produits de réaction avec des complexes de 3-mercaptopropionate d’isooctyle palladium et le soufre

126820-94-8

Bicyclo[3.1.1]heptanethiol, 2,6,6-trimethyl-, gold(1++) salt, reaction products with palladium isooctyl 3-mercaptopropanoate complexes, sulfur and 2,6,6-trimethylbicyclo[3.1.1]heptanethiol silver(1++) salt

Sel d’or(1++) du 2,6,6-triméthylbicyclo[3.1.1]heptanethiol, produits de réaction avec des complexes de 3-mercaptopropionate d’isooctyle palladium, le soufre et le sel d’argent(1++) du 2,6,6-triméthylbicyclo[3.1.1]heptanethiol

129828-23-5

Fatty acids, tall-oil, reaction products with Bu phenylmethyl phthalate, 2-(dimethylamino)ethanol, morpholine and overbased calcium petroleum sulfonates

Acides gras, produits de réaction du tallöl avec le phtalate de butylphénylméthyle, le 2-(diméthylamino)éthanol, la morpholine et des sulfonates de pétrole à proportion plus que stoechiométrique de calcium

131298-44-7

C9-11-branched alkyl benzoate

Esters alkyliques en C9-11 ramifiés de l’acide benzoïque

134112-54-2

Phenol, 4,4′-(1-methylethylidene)bis-, polymer with 4-amino-α,α,4-trimethylcyclohexanemethanamine, 5-amino-1,3,3-trimethylcyclohexanmethanamine, (chloromethyl)oxirane, 2,2,4-trimethyl-1,6-hexanediamine and 2,4,4-trimethyl-1,6-hexanediamine

4,4′-(Isopropylidène)diphénol polymérisé avec la 4-amino-α,α-4-triméthylcyclohexaneméthanamine, la 5-amino-1,3,3-triméthylcyclohexaneméthanamine, le (chlorométhyl)oxirane, la 2,2,4-triméthylhexane-1,6-diamine et la 2,4,4-triméthylhexane-1,6-diamine

137397-37-6

Decanedioic acid, polymer with carbonic dichloride and 4,4′-(1-methylethylidene)bis(phenol), 4-(1-methyl-1-phenylethyl) phenyl ester (9CI)

Acide décanedioïque polymérisé avec du dichlorure carbonique et du 4,4′-(propane-2,2-diyl)bis(phénol), ester 4-(2-phénylpropane-2-yl) phénylique (9CI)

146729-34-2

Poly(oxy-1,2-ethanediyl), α-(3-carboxy-1-oxopropyl)-ω-(pentadecyloxy)-

α-(3-Carboxyoxoprop-1-yl)-ω-(pentadécyloxy)poly(oxyéthylène)

147170-44-3

1-Propanaminium, 3-amino-N-(carboxymethyl)-N,N-dimethyl-, N-(C8-18 and C18-unsatd. acyl) derivs., inner salts

Dérivés N-(acyliques en C8-18 et en C18-insaturé) du 3-amino-N-(carboxyméthyl)-N,N-diméthylpropan-1-aminium, sels internes

149778-23-4

Ethanaminium, N,N,N-trimethyl-2-[(1-oxo-2-propenyl)oxy]-, chloride, polymer with 2-ethylhexyl 2-propenoate and 2-propenamide

Chlorure de N,N,N-triméthyl-2-[oxy(acryloyl)]éthanaminium polymérisé avec l’acrylate de 2-éthylhexyle et l’acrylamide

149879-98-1

1-Propanaminium, N-(carboxymethyl)-N,N-dimethyl-3-[[(13Z)-1-oxo-13-docosenyl]amino]-, inner salt

N-(carboxyméthyl)-N,N-diméthyl-3-[[(13Z)-1-oxo-13-docosényl]amino]-1-propanaminium, sel interne

151574-14-0

Ammonium α-sulfo-ω-[2-(1-propenyl)-4-nonyl(branched)phenoxy]poly(1-30)(oxyethylene)

α-Sulfo-ω-(4-nonyl-2-allylphénoxy)poly(oxyéthylène), ramifié, sels d’ammonium

154862-43-8

2,4,8,10-Tetraoxa-3,9-diphosphaspiro[5.5]undecane, 3,9-bis[2,4-bis(1-methyl-1-phenylethyl)phenoxy]-

3,9-Bis[2,4-bis(1-méthyl-1-phénéthyl)phénoxy]-2,4,8,10-tétraoxa-3,9-diphosphaspiro[5.5]undécane

162030-42-4

1,4-Benzenedicarboxylic acid, di-C11-14-isoalkyl esters, C13-rich

Téréphtalates de diisoalkyle en C11-14, enrichis en C13

163149-26-6

Tall oil polymeric reaction products with maleic anhydride, rosin, zinc oxide and calcium hydroxide

Tallöl, produits de réaction avec l’anhydride maléique, la colophane, l’oxyde de zinc et l’hydroxyde de calcium

165883-95-4

Siloxanes and Silicones, di-Me, 3-(ethylamino)-2-methylpropyl group-terminated

Di-Me siloxanes et silicones terminés par le groupe 3-(éthylamino)-2-méthylpropyle 

180685-83-0

Tannins, polymers with N,N,N-trimethyl-2-[(1-oxo-2-propenyl)oxy]ethanaminium chloride, graft

Tannins polymérisés avec le chlorure de N,N,N-triméthyl-2-[(1-oxo-2-propényl)oxy]éthanaminium, greffé

182371-64-8

Hexanedioic acid, polymer with N-(2-aminoethyl)-N′-[2-[(2-aminoethyl)amino]ethyl]-1,2-ethanediamine, N-(2-aminoethyl)-1,2-ethanediamine and (chloromethyl)oxirane, sulfate

Acide adipique, polymérisé avec la N-(2-aminoéthyl)-N′-[2-[(2-aminoéthyl)amino]éthyl]-éthylènediamine, la N-(2-aminoéthyl)-éthylènediamine et le (chlorométhyl)oxirane, sulfate

185857-36-7

Alkanes, C10-C13-branched and linear

Alcanes en C10-C13 linéaires et ramifiés

188627-10-3

Siloxanes and Silicones, di-Me, [[[3-[(2-aminoethyl)amino]-2-methylpropyl]methoxymethylsilyl]oxy]- and (C13-15-alkyloxy)-terminated

Di-Me siloxanes et silicones terminés par les groupes [({3-[(2-aminoéthyl)amino]-2-méthylpropyl}méthoxyméthylsilyl)oxy] et (C13-15-alkyloxy) 

190085-41-7

Benzoic acid, 2-hydroxy-, 2-butyloctyl ester

Salicylate de 2-butyloctyle

193098-40-7

1,6-Hexanediamine, N,N′-bis(2,2,6,6-tetramethyl-4-piperidinyl)-, polymers with morpholine-2,4,6-trichloro-1,3,5-triazine reaction products, methylated

1,6-Hexanediamine, N,N′-bis(2,2,6,6-tétraméthyl-4-pipéridinyl)-, polymères formés avec des produits de réaction de la morpholine-2,4,6-trichloro-1,3,5-triazine, méthylés

207596-32-5

Nitric acid, palladium(2+) salt, hydrate (2:1:?)

Hydrate de nitrate de palladium (2+) (?/2/1)

210920-40-4

Tin, Butyl, 1-dodecanethio, 2-mercaptoethanol thio complexes

Complexes de Bu dodécane-1-thiol 2-mercaptoéthanol thioxo étain

220689-12-3

Phosphonium, tetrabutyl-, salt with 1,1,2,2,3,3,4,4,4-nonafluoro-1-butanesulfonic acid (1:1)

Perfluorobutane-1-sulfonate de tétrabutylphosphonium (1/1)

237753-63-8

Alcohols, C13-15, reaction products with N-[3-(dimethoxymethylsilyl)-2-methylpropyl]1,2-ethanediamine, glycidol, and hydroxy-terminated di-Me siloxanes

Produits de réaction d’alcools C13-15 avec la N-[3-(diméthoxyméthylsilyl)-2-méthylpropyl]éthane-1,2-diamine, le glycidol et les di-Me siloxanes terminés par le groupe hydroxy  

671756-61-9

1-Tetradecanesulfonic acid, (dimethylphenyl)-

Acide xylyltétradécane-1-sulfonique

676143-36-5

1-Hexadecanesulfonic acid, (dimethylphenyl)-

Acide xylylhexadécane-1-sulfonique

848301-65-5

Naphtha (Fischer-Tropsch), light, C4-10-branched and linear

Naphta (Fischer-Tropsch), léger, linéaire et ramifié en C4-10

848301-66-6

Kerosine (Fischer-Tropsch), full-range, C8-16-branched and linear

Kérosène (Fischer-Tropsch), pleine gamme, linéaire et ramifié en C8-16

848301-67-7

Distillates (Fischer-Tropsch), C8-26- branched and linear

Distillats (Fischer-Tropsch), linéaires et ramifiés en C8-26

848301-71-3

Residual oils (Fischer-Tropsch), base oil production, C40-70-branched, cyclic and linear aliphatic hydrocarbon fraction

Huiles résiduelles (Fischer-Tropsch) de la production d’huile de base, fraction d’hydrocarbures aliphatiques linéaires, ramifiés et cycliques en C40-70

866259-61-2

N,N-dicoco-2-hydroxy-acetamide

N,N-Di(alkyl de coco)-2-hydroxyacétamide

928771-01-1

Alkanes, C10-20 - branched and linear

Alcanes en C10-20, ramifiés ou linéaires

944747-28-8

Fatty acids, C18-unsatd., dimers, polymers, with bisphenol A, diethylenetriamine, epichlorohydrin, N1, N1-1,2-ethanediylbis[1,3-propanediamine], tall-oil fatty acids and triethylenetetramine

Dimères d’acides gras insaturés en C18, polymérisés avec du 4,4′-(propane-2,2-diyl)bisphénol, de la 3-azapentane-1,5-diamine, du 1-chloro-2,3-époxypropane, de la N,N-éthane-1,2-diylbis[propane-1,3-diamine], des acides gras de tallöl et de la 3,6 diazaoctane-1,8-diamine

1000817-22-0

Fatty acids, C8-18 and C18-unsatd, reaction products with diethanolamine and propylene oxide

Acides gras en C8-18 et en C18 insaturés, produits de la réaction avec du 2,2′ aminobiséthanol et du 1,2-époxypropane

1001320-38-2

Carbamic acid, [(butylthio) thioxomethyl]-,butyl ester

[(Butylthio) thioxométhyl]-carbamate de butyle

1013910-41-2

Oxirane, 2-ethyl-, polymer with oxirane, mono-C12-14-sec-alkyl ethers

2-Éthyloxirane polymérisé avec de l’oxirane, oxydes mono(sec-alkyl(C12-14)iques)

1022990-65-3

Oxirane, 2-ethyl-, polymer with oxirane, mono-C11-15-sec-alkyl ethers

2-éthyloxirane polymérisé avec de l’oxirane, oxydes mono-sec-alkyliques en C11-15

1174918-46-7

Alkanes, C14-16-branched and linear

Alcanes en C14-16 linéaires et ramifiés

1224429-82-6

Phosphoric acid, mixed esters with polyethylene glycol and 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluoro-1-octanol, ammonium salts

Acide phosphorique, esters mixtes avec du polyéthylèneglycol et du 3,3,4,4,5,5,6,6,7,7,8,8,8-tridécafluoro-1-octanol, sels ammoniacaux

1437280-84-6

Alkanes, C9-C13-branched and linear

Alcanes en C9-C13 linéaires et ramifiés

1437280-85-7

Alkanes, C18-C24-branched and linear

Alcanes en C18-C24 linéaires et ramifiés

1437281-01-0

Alkanes, C15-C19-branched and linear

Alcanes en C15-C19 linéaires et ramifiés

1437281-03-2

Alkanes, C12-C15-branched and linear

Alcanes en C12-C15 linéaires et ramifiés

1437281-04-3

Alkanes, C9-C12-branched and linear

Alcanes en C9-C12 linéaires et ramifiés

1538409-50-5

Poly(oxy-1,2-ethanediyl), α-[2-[tetrahydro-1 (2H)-pyrimidinyl) ethyl]-ω-hydroxy-, N-tallow alkyl derivs., di-Me sulfate-quaternized

α-[2-[tétrahydro-(2H)-pyrimidin-1-yl)ethyle]-ω-hydroxypoly(oxyéthane-1,2-diyle), dérivés N-(alkyle de suif), quaternarisés avec du sulfate de diméthyle

Part 1 masked substances

Confidential Accession Number (see footnote 17)

Masked name

Nom maquillé

13811-5

2-Propenoic acid, 2-methyl-, methyl ester, telomer with alkyl 2-propenoate, tert-dodecanethiol, ethenylbenzene, oxiranylmethyl 2-methyl-2-propenoate and 1,2-propanediol mono(2-methyl-2-propenoate), reaction products with 2,2′-thiobis[ethanol], lactates (salts)

2-Méthyl-2-propènoate de méthyle télomérisé avec le 2-propènoate d’alkyle, le tert-dodécanethiol, l’éthénylbenzène, le 2-méthyl-2-propènoate d’oxiranylméthyle et le mono(2-méthyl-2-propènoate) de propane-1,2-diol, produits de réaction avec le 2,2′-thiodiéthanol, lactates (sels)

13697-8

The reaction product of dihydro-undecyl-heteromonocycleethanamine, with oxirane, mono[(C12-14-alkyloxy)methyl] derivs. and 2-hydroxypropanoic acid

Le produit de réaction de la dihydro-undécyl-hétéromonocycleéthanamine, avec les dérivés mono[(C12-14-alkyloxy)méthyliques d’oxirane et l’acide 2-hydroxypropanoïque

17963-8

Amines, alkyl, compounds with 2-mercapto-dialkyl-1,3,2-dioxaphosphorinane 2-oxide (1:1)

Alcanamines, composés avec du 2-oxyde de 2 mercapto-dialkyl-1,3,2-dioxaphosphinane (1/1)

18735-6

1-substituted Propane, 3-(triethoxysilyl)-, reaction products with polyethylene glycol mono-(branched tridecyl) ether

Propane substitué en position 1, 3-(triéthoxysilyl)-, produits de la réaction avec de l’éther tridécylique monoramifié de polyéthylèneglycol

13568-5

Phenol, 4,4′-(1-methylethylidene)bis-, polymer with (chloromethyl)heteromonocycle, 2(methylamino)ethanol, N-(1,3-dimethylbutylidene)-N′-[2-[(1,3-dimethylbutylidene)amino]ethyl]-1,2-ethanediamine and 2-hydroxypropanoic acid

4,4′-(1-Méthyléthylidène)bisphénol polymérisé avec le (chlorométhyl)hétéromonocycle, le 2-(méthylamino)éthanol, la N-(1,3-diméthylbutylidène)-N′-{2-[(1,3-diméthylbutylidène)amino]éthyl}éthane-1,2-diamine et l’acide 2-hydroxypropanoïque

13668-6

Polymer of 4,4′-(1-methylethylidene)bisphenol polymer with (chloromethyl)oxirane, 4,4′-(1-methylidene)bisphenol, alkylphenols, alkanolamines and alkylamines, lactic acid salt of

Polymère du 4,4′-(1-méthyléthylidène)diphénol polymérisé avec le (chlorométhyl)oxirane, le 4,4′-(1-méthylidène)diphénol, des alkylphénols, des alcanolamines et des alkylamines, sel de l’acide lactique

13680-0

Phenol, 4,4′-(1-methylethylidene)bis-, polymer with chloromethyloxirane, 4,4′-(1methylethylidene)bisphenol, hexahydro-1,3-isobenzofurandione, α,α′-[(1-methylethylidene)di4,1-phenylene]bis(ω-hydroxy)poly(oxy-1,2-ethanediyl), sulfamic acid, 2(methylamino)ethanol, N,N-dimethyl-1,3-alkanediamine and 2-aminoethanol

4,4′-(1-Méthyléthylidène)diphéhol polymérisé avec le chlo rométhyloxirane, le 4,4′-(1méthyléthylidène)diphénol, l’hexahydro-1,3-isobenzofurandione, l’α,α′-[(1-méthyléthylidène)di-4,1-phénylène]bis(ω-hydroxy)poly(oxyéthane-1,2-diyl), l’acide sulfamique, le 2-(méthylamino)éthanol, la N,N-diméthylalcane-1,3-diamine et le 2-aminoéthanol

13702-4

Phenol, 4,4′-(1-methylethylidene)bis-, polymer with (chloromethyl)heteromonocycle, 1,3-propanediamine, 2-methyl-N,N-dimethyl-1,5-pentanediamine, neodecanoic acid, hetermonocyclicmethyl ester, capped with 2,2′-iminobisethanol, salt with 2-hydroxypropanoic acid

4,4′-(1-Méthyléthylidène)bisphénol polymérisé avec le (chlorométhyl)hétéromonocycle, la propane-1,3-diamine, la 2-méthyl-N,N-diméthylpentane-1,5-diamine, le néodécanoate d’hétérmonocycliqueméthyle, terminé avec le 2,2′-iminobiséthanol, sel avec l’acide 2-hydroxypropanoïque

14236-7

(Chloromethyl)oxirane, polymer with 4,4′-(1-methylethylidene)bis[phenol] and N,N-dialkyl-1-octadecanamine, acetates (salts)

(Chlorométhyl)oxirane polymérisé avec le 4,4′-(1-méthyléthylidène)diphénol et la N,N-dialkyloctadécan-1-amine, acétates (sels)

15099-6

Propanoic acid, 2-hydroxy-, (2S)-, compds. with bisphenol A-epichlorohydrin polymer dodecylphenol Ph ether-polyamine-N,N-dimethyl-1, 3-propanediamine-2-(methylamino) ethanol reaction products

Acide lactique, (2S)-, composés avec un polymère de bisphénol A et d’épichlorhydrine, de l’oxyde de dodécylphénol et de phényle, une polyamine, de la N,N-diméthylpropane-1,3-diamine, produits de la réaction avec du 2-(méthylamino)éthanol

16285-4

Oxirane, alkyl-, homopolymer, 3-aminopropyl 4-dodecylphenyl ether

Alkyloxirane, homopolymérisé, éther 4-dodécylphényl 3-aminopropylique

17772-6

Polymer of aliphatic amine, epichlorohydrin, oxalic acid and urea

Polymère d’une amine aliphatique, l’épichlorhydrine, l’acide oxalique et l’urée

14857-7

1,3-Diisocyanatoalkylbenzene, polymer with α,α′-[(methylimino)di-2,1-ethanediyl]bis[ω-hydroxypoly[oxy(methyl-1,2-ethanediyl)], acetates (salts)

1,3-Diisocyanatoalkylbenzène polymérisé avec l’α,α′[(méthylimino)diéthane-1,2-diyl]bis[ω-hydroxypoly[oxy(méthyléthane-1,2-diyl)], acétates (sels)

14971-4

4,4′-(1-Methylethylidene)bisphenol, polymer with (chloromethyl)oxirane, and 2(dimethylamino)ethanol-blocked polyalkylenepolyphenylene isocyanate, lactates (salts)

4,4′-Isopropylidènebisphénol polymérisé avec du (chlorométhyl)oxirane et de l’isocyanate de polyalkylènepolyphénylène séquencé avec du 2 (diméthylamino)éthanol, lactates (sels)

18253-1

1-Alkanol, polyfluoro-, reaction products with phosphorus oxide (P2O5), ammonium salts

polyfluoroalcan-1-ol, produits de réaction avec le pentoxyde de diphosphore (P2O5), sels d’ammonium,

15232-4

Poly[oxy(1,2-propanediyl)], α-(3-aminopropyl)-ω-hydroxy-, alkyl ethers

α-(3-Aminopropyl)-ω-hydroxypoly[oxy(propane-1,2-diyl)], éthers alkyliques

18475-7

Alkanediol, reaction products with phosphorus oxide (P2O5), polyfluoro-1-alkanol,-ammonium salts

Alcanediol, produits de la réaction avec de l’oxyde de phosphore (P2O5), polyfluoro 1-alcanol, sels ammoniacaux

Part 2

CAS RN

Name of the substance

Nom de la substance

95-31-8

2-Benzothiazolesulfenamide, N-(1,1-dimethylethyl)-

N-tert-Butylbenzothiazole-2-sulfénamide

95-33-0

2-Benzothiazolesulfenamide, N-cyclohexyl-

N-Cyclohexylbenzothiazole-2-sulfénamide

120-78-5

Benzothiazole, 2,2′-dithiobis-

Disulfure de di(benzothiazol-2-yle)

149-30-4

2(3H)-Benzothiazolethione

Benzothiazole-2-thiol

1321-69-3

Naphthalenesulfonic acid, sodium salt

Naphtalènesulfonate de sodium

2492-26-4

2(3H)-Benzothiazolethione, sodium salt

Sulfure de sodium et de benzothiazol-2-yle

3147-75-9

Phenol, 2-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)-

2-(2H-Benzotriazol-2-yl)-4-(1,1,3,3tétraméthylbutyl)phénol

3846-71-7

Phenol, 2-(2H-benzotriazol-2-yl)-4,6-bis(1,1-dimethylethyl)-

2-Benzotriazol-2-yl-4,6-di-tert-butylphénol

3896-11-5

Phenol, 2-(5-chloro-2H-benzotriazol-2-yl)-6-(1,1-dimethylethyl)-4-methyl-

Bumétrizole

4221-80-1

Benzoic acid, 3,5-bis(1,1-dimethylethyl)-4-hydroxy-, 2,4-bis(1,1-dimethylethyl)phenyl ester

3,5-Di-tert-butyl-4-hydroxybenzoate de 2,4-di-tert-butylphényle

4979-32-2

2-Benzothiazolesulfenamide, N,N-dicyclohexyl-

N,N-Dicyclohexylbenzothiazole-2-sulfénamide

7726-95-6

Bromine

Brome

21564-17-0

Thiocyanic acid, (2-benzothiazolylthio)methyl ester

Thiocyanate de (benzothiazol-2-ylthio)méthyle

23128-74-7

Benzenepropanamide, N,N′-1,6-hexanediylbis[3,5-bis(1,1-dimethylethyl)-4-hydroxy-

N,N′-Hexane-1,6-diylbis[3-(3,5-di-tert-butyl-4-hydroxyphénylpropionamide]

25167-32-2

Benzenesulfonic acid, oxybis[dodecyl-, disodium salt

2,2′(ou 3,3′)-Oxybis[5(ou 2)-dodécylbenzènesulfonate] de disodium

25322-17-2

Naphthalenesulfonic acid, dinonyl-

Acide dinonylnaphtalènesulfonique

25619-56-1

Naphthalenesulfonic acid, dinonyl-, barium salt

Bis(dinonylnaphtalènesulfonate) de baryum

25638-17-9

Naphthalenesulfonic acid, butyl-, sodium salt

Butylnaphtalènesulfonate de sodium

29385-43-1

1H-Benzotriazole, 4(or 5)-methyl-

Méthyl-1H-benzotriazole

36437-37-3

Phenol, 2-(2H-benzotriazol-2-yl)-4-(1,1-dimethylethyl)-6-(1-methylpropyl)-

2-(2H-Benzotriazol-2-yl)-4-(tert-butyl)-6-(secbutyl)phénol

36443-68-2

Benzenepropanoic acid, 3-(1,1-dimethylethyl)-4-hydroxy-5-methyl-, 1,2-ethanediylbis(oxy-2,1-ethanediyl) ester

Bis[3-(5-tert-butyl-4-hydroxy-m-tolyl)propionate] d’éthylènebis(oxyéthylène)

60223-95-2

Naphthalenedisulfonic acid, dinonyl-

Acide dinonylnaphtalènedisulfonique

70321-86-7

Phenol, 2-(2H-benzotriazol-2-yl)-4,6-bis(1-methyl-1-phenylethyl)-

2-(2H-Benzotriazol-2-yl)-4,6-bis(1-méthyl-1-phényléthyl)phénol

80584-90-3

1H-Benzotriazole-1-methanamine, N,N-bis(2-ethylhexyl)-4-methyl-

N,N-Bis(2-éthylhexyl)-4-méthyl-1H-benzotriazole-1-méthylamine

80595-74-0

1H-Benzotriazole-1-methanamine, N,N-bis(2-ethylhexyl)-5-methyl-

N,N-Bis(2-éthylhexyl)-5-méthyl-1H-benzotriazole-1-méthylamine

94270-86-7

1H-Benzotriazole-1-methanamine, N,N-bis(2-ethylhexyl)-ar-methyl-

N,N-Bis(2-éthylhexyl)-ar-méthyl-1H-benzotriazole-1-méthanamine

Part 3

CAS RN

Name of the substance

Nom de la substance

50-27-1

Estra-1,3,5(10)-triene-3,16,17-triol, (16α,17β)-

Oestriol

50-28-2

Estra-1,3,5(10)-triene-3,17-diol (17β)-

Estra-1,3,5(10)-triène-3,17-diol (17β)-

57-11-4

Octadecanoic acid

Acide stéarique

57-88-5

Cholest-5-en-3-ol (3β)-

Cholestérol

58-93-5

2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3,4-dihydro-, 1,1-dioxide

Hydrochlorothiazide

61-73-4

Phenothiazin-5-ium, 3,7-bis(dimethylamino)-, chloride

Chlorure de méthylthioninium

67-20-9

2,4-Imidazolidinedione, 1-[[(5-nitro-2-furanyl)methylene]amino]-

Nitrofurantoïne

67-43-6

Glycine, N,N-bis[2-[bis(carboxymethyl)amino]ethyl]-

Acide N-carboxyméthyliminobis(éthylènenitrilo)tétraacétique

67-68-5

Methane, sulfinylbis-

Diméthylsulfoxyde

68-12-2

Formamide, N,N-dimethyl-

N,N-Diméthylformamide

74-93-1

Methanethiol

Méthanethiol

75-08-1

Ethanethiol

Éthanethiol

75-33-2

2-Propanethiol

Propane-2-thiol

75-75-2

Methanesulfonic acid

Acide méthanesulfonique

75-77-4

Silane, chlorotrimethyl-

Chlorotriméthylsilane

75-79-6

Silane, trichloromethyl-

Trichloro(méthyl)silane

77-58-7

Stannane, dibutylbis[(1-oxododecyl)oxy]-

Dilaurate de dibutylstannane

77-90-7

1,2,3-Propanetricarboxylic acid, 2-(acetyloxy)-, tributyl ester

O-Acétylcitrate de tributyle

78-04-6

1,3,2-Dioxastannepin-4,7-dione, 2,2-dibutyl-

Maléate de dibutylstannane

78-06-8

6H-1,3,2-Oxathiastannin-6-one, 2,2-dibutyldihydro-

2,2-Dibutyldihydro-6H-1,3,2-oxathiastannin-6-one

78-70-6

1,6-Octadien-3-ol, 3,7-dimethyl-

Linalol

79-11-8

Acetic acid, chloro-

Acide chloroacétique

79-14-1

Acetic acid, hydroxy-

Acide glycolique

79-34-5

Ethane, 1,1,2,2-tetrachloro-

1,1,2,2-Tétrachloroéthane

79-36-7

Acetyl chloride, dichloro-

Chlorure de dichloroacétyle

79-92-5

Bicyclo[2.2.1]heptane, 2,2-dimethyl-3-methylene-

Camphène

80-07-9

Benzene, 1,1′-sulfonylbis[4-chloro-

Bis(4-chlorophényl)sulfone

80-46-6

Phenol, 4-(1,1-dimethylpropyl)-

p-(1,1-Diméthylpropyl)phénol

80-62-6

2-Propenoic acid, 2-methyl-, methyl ester

Méthacrylate de méthyle

83-44-3

Cholan-24-oic acid, 3,12-dihydroxy-, (3α,5β,12α)-

Acide 3α,12α-dihydroxy-5β-cholan-24-oïque

83-86-3

myo-Inositol, hexakis(dihydrogen phosphate)

Acide phytique

84-65-1

9,10-Anthracenedione

Anthraquinone

85-43-8

1,3-Isobenzofurandione, 3a,4,7,7a-tetrahydro-

Anhydride 1,2,3,6-tétrahydrophtalique

87-29-6

2-Propen-1-ol, 3-phenyl-, 2-aminobenzoate

Anthranilate de cinnamyle

87-69-4

Butanedioic acid, 2,3-dihydroxy- [R-(R,R)]-

Acide (++)-tartrique

88-89-1

Phenol, 2,4,6-trinitro-

Acide picrique

89-78-1

Cyclohexanol, 5-methyl-2-(1-methylethyl)-, (1α,2β,5α)-

Menthol

89-82-7

Cyclohexanone, 5-methyl-2-(1-methylethylidene)-, (R)-

p-Menth-4(8)-én-3-one

90-43-7

[1,1′-Biphenyl]-2-ol

Biphényl-2-ol

91-17-8

Naphthalene, decahydro-

Décahydronaphtalène

92-69-3

[1,1′-Biphenyl]-4-ol

Biphényl-4-ol

92-84-2

10H-Phenothiazine

Phénothiazine

92-88-6

[1,1′-Biphenyl]-4,4′-diol

Biphényle-4,4′-diol

94-13-3

Benzoic acid, 4-hydroxy-, propyl ester

4-Hydroxybenzoate de propyle

94-18-8

Benzoic acid, 4-hydroxy-, phenylmethyl ester

4-Hydroxybenzoate de benzyle

94-26-8

Benzoic acid, 4-hydroxy-, butyl ester

4-Hydroxybenzoate de butyle

94-36-0

Peroxide, dibenzoyl

Peroxyde de dibenzoyle

94-60-0

1,4-Cyclohexanedicarboxylic acid, dimethyl ester

Cyclohexane-1,4-dicarboxylate de diméthyle

95-14-7

1H-Benzotriazole

Benzotriazole

95-47-6

Benzene, 1,2-dimethyl-

o-Xylène

95-49-8

Benzene, 1-chloro-2-methyl-

2-Chlorotoluène

95-63-6

Benzene, 1,2,4-trimethyl-

1,2,4-Triméthylbenzène

96-05-9

2-Propenoic acid, 2-methyl-, 2-propenyl ester

Méthacrylate d’allyle

96-14-0

Pentane, 3-methyl-

3-Méthylpentane

96-26-4

2-Propanone, 1,3-dihydroxy-

1,3-Dihydroxyacétone

96-37-7

Cyclopentane, methyl-

Méthylcyclopentane

96-48-0

2(3H)-Furanone, dihydro-

γ-Butyrolactone

96-49-1

1,3-Dioxolan-2-one

Carbonate d’éthylène

97-00-7

Benzene, 1-chloro-2,4-dinitro-

1-Chloro-2,4-dinitrobenzène

97-63-2

2-Propenoic acid, 2-methyl-, ethyl ester

Méthacrylate d’éthyle

97-65-4

Butanedioic acid, methylene-

Acide itaconique

97-77-8

Thioperoxydicarbonic diamide ([(H2N)C(S)]2S2), tetraethyl-

Disulfirame

97-90-5

2-Propenoic acid, 2-methyl-, 1,2-ethanediyl ester

Diméthacrylate d’éthylène

97-99-4

2-Furanmethanol, tetrahydro-

Alcool tétrahydrofurfurylique

98-29-3

1,2-Benzenediol, 4-(1,1-dimethylethyl)-

4-tert-Butylpyrocatéchol

98-73-7

Benzoic acid, 4-(1,1-dimethylethyl)-

Acide 4-tert-butylbenzoïque

98-83-9

Benzene, (1-methylethenyl)-

2-Phénylpropène

98-86-2

Ethanone, 1-phenyl-

Acétophénone

99-08-1

Benzene, 1-methyl-3-nitro-

3-Nitrotoluène

99-62-7

Benzene, 1,3-bis(1-methylethyl)-

1,3-Diisopropylbenzène

99-97-8

Benzenamine, N,N,4-trimethyl-

N,N-Diméthyl-p-toluidine

100-18-5

Benzene, 1,4-bis(1-methylethyl)-

1,4-Diisopropylbenzène

100-20-9

1,4-Benzenedicarbonyl dichloride

Dichlorure de téréphtaloyle

100-21-0

1,4-Benzenedicarboxylic acid

Acide téréphtalique

100-42-5

Benzene, ethenyl-

Styrène

101-02-0

Phosphorous acid, triphenyl ester

Phosphite de triphényle

101-72-4

1,4-Benzenediamine, N-(1-methylethyl)-N′-phenyl-

N-Isopropyl-N′-phényl-p-phénylènediamine

102-06-7

Guanidine, N,N′-diphenyl-

1,3-Diphénylguanidine

102-77-2

Morpholine, 4-(2-benzothiazolylthio)-

2-(Morpholinothio)benzothiazole

103-09-3

Acetic acid, 2-ethylhexyl ester

Acétate de 2-éthylhexyle

104-43-8

Phenol, 4-dodecyl-

p-Dodécylphénol

104-93-8

Benzene, 1-methoxy-4-methyl-

4-Méthylanisole

105-08-8

1,4-Cyclohexanedimethanol

Cyclohexane-1,4-diméthanol

105-11-3

2,5-Cyclohexadiene-1,4-dione, dioxime

p-Benzoquinone-dioxime

105-59-9

Ethanol, 2,2′-(methylimino)bis-

2,2′-Méthyliminodiéthanol

105-76-0

2-Butenedioic acid (Z)-, dibutyl ester

Maléate de dibutyle

105-83-9

1,3-Propanediamine, N-(3-aminopropyl)-N-methyl-

N,N-Bis(3-aminopropyl)méthylamine

106-20-7

1-Hexanamine, 2-ethyl-N-(2-ethylhexyl)-

Bis(2-éthylhexyl)amine

106-23-0

6-Octenal, 3,7-dimethyl-

Citronellal

106-42-3

Benzene, 1,4-dimethyl-

p-Xylène

106-50-3

1,4-Benzenediamine

p-Phénylènediamine

106-91-2

2-Propenoic acid, 2-methyl-, oxiranylmethyl ester

Méthacrylate de 2,3-époxypropyle

106-98-9

1-Butene

But-1-ène

107-01-7

2-Butene

But-2-ène

107-12-0

Propanenitrile

Propiononitrile

107-19-7

2-Propyn-1-ol

Prop-2-yn-1-ol

107-71-1

Ethaneperoxoic acid, 1,1-dimethylethyl ester

Peracétate de tert-butyle

108-01-0

Ethanol, 2-(dimethylamino)-

2-Diméthylaminoéthanol

108-05-4

Acetic acid ethenyl ester

Acétate de vinyle

108-30-5

2,5-Furandione, dihydro-

Anhydride succinique

108-38-3

Benzene, 1,3-dimethyl-

m-Xylène

108-77-0

1,3,5-Triazine, 2,4,6-trichloro-

2,4,6-Trichloro-1,3,5-triazine

108-87-2

Cyclohexane, methyl-

Méthylcyclohexane

108-95-2

Phenol

Phénol

108-98-5

Benzenethiol

Benzènethiol

109-08-0

Pyrazine, methyl-

2-Méthylpyrazine

109-16-0

2-Propenoic acid, 2-methyl-, 1,2-ethanediylbis(oxy-2,1-ethanediyl) ester

Diméthacrylate de 2,2′-éthylènedioxydiéthyle

109-28-4

9-Octadecenamide, N-[3-(dimethylamino)propyl]-, (Z)-

N-[3-(Diméthylamino)propyl]oléamide

109-55-7

1,3-Propanediamine, N,N-dimethyl-

3-Aminopropyldiméthylamine

109-65-9

Butane, 1-bromo-

1-Bromobutane

109-69-3

Butane, 1-chloro-

1-Chlorobutane

109-70-6

Propane, 1-bromo-3-chloro-

1-Bromo-3-chloropropane

109-74-0

Butanenitrile

Butyronitrile

110-05-4

Peroxide, bis(1,1-dimethylethyl)

Peroxyde de di-tert-butyle

110-86-1

Pyridine

Pyridine

110-97-4

2-Propanol, 1,1′-iminobis-

1,1′-Iminodipropan-2-ol

111-66-0

1-Octene

Oct-1-ène

112-18-5

1-Dodecanamine, N,N-dimethyl-

Dodécyldiméthylamine

112-35-6

Ethanol, 2-[2-(2-methoxyethoxy)ethoxy]-

2-[2-(2-Méthoxyéthoxy)éthoxy]éthanol

112-36-7

Ethane, 1,1′-oxybis[2-ethoxy-

Oxyde de bis(2-éthoxyéthyle)

112-62-9

9-Octadecenoic acid (Z)-, methyl ester

Oléate de méthyle

112-73-2

Butane, 1,1′-[oxybis(2,1-ethanediyloxy)]bis-

Oxyde de bis(2-butoxyéthyle)

115-11-7

1-Propene, 2-methyl-

2-Méthylpropène

115-27-5

4,7-Methanoisobenzofuran-1,3-dione, 4,5,6,7,8,8-hexachloro-3a,4,7,7a-tetrahydro-

Anhydride 1,4,5,6,7,7-hexachloro-8,9,10-trinorborn-5-ène-2,3-dicarboxylique

117-39-5

4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-

3,3′,4′,5,7-Pentahydroxyflavone

118-55-8

Benzoic acid, 2-hydroxy-, phenyl ester

Salicylate de phényle

118-79-6

Phenol, 2,4,6-tribromo-

2,4,6-Tribromophénol

119-36-8

Benzoic acid, 2-hydroxy-, methyl ester

Salicylate de méthyle

119-84-6

2H-1-Benzopyran-2-one, 3,4-dihydro-

3,4-Dihydrocoumarine

120-32-1

Phenol, 4-chloro-2-(phenylmethyl)-

Clorofène

120-47-8

Benzoic acid, 4-hydroxy-, ethyl ester

4-Hydroxybenzoate d’éthyle

120-61-6

1,4-Benzenedicarboxylic acid, dimethyl ester

Téréphtalate de diméthyle

121-54-0

Benzenemethanaminium, N,N-dimethyl-N-[2-[2-[4-(1,1,3,3-tetramethylbutyl)phenoxy]ethoxy]ethyl]-, chloride

Chlorure de benzethonium

121-79-9

Benzoic acid, 3,4,5-trihydroxy-, propyl ester

3,4,5-Trihydroxybenzoate de propyle

122-32-7

9-Octadecenoic acid (Z)-, 1,2,3-propanetriyl ester

Trioléate de 1,2,3-propanetriyle

122-69-0

2-Propenoic acid, 3-phenyl-, 3-phenyl-2-propenyl ester

Cinnamate de cinnamyle

122-99-6

Ethanol, 2-phenoxy-

2-Phénoxyéthanol

123-51-3

1-Butanol, 3-methyl-

3-Méthylbutan-1-ol

123-79-5

Hexanedioic acid, dioctyl ester

Adipate de dioctyle

124-17-4

Ethanol, 2-(2-butoxyethoxy)-, acetate

Acétate de 2-(2-butoxyéthoxy)éthyle

124-18-5

Decane

Décane

124-22-1

1-Dodecanamine

Dodécylamine

124-28-7

1-Octadecanamine, N,N-dimethyl-

Dimantine

124-63-0

Methanesulfonyl chloride

Chlorure de méthanesulfonyle

124-68-5

1-Propanol, 2-amino-2-methyl-

2-Amino-2-méthylpropanol

125-46-2

1,3(2H,9bH)-Dibenzofurandione, 2,6-diacetyl-7,9-dihydroxy-8,9b-dimethyl-

2,6-Diacétyl-1,2,3,9b-tétrahydro-7,9-dihydroxy-8,9b-diméthyldibenzofurane-1,3-dione

126-00-1

Benzenebutanoic acid, 4-hydroxy-γ-(4-hydroxyphenyl)-γ-methyl-

Acide 4,4-bis(4-hydroxyphényl)valérique

127-65-1

Benzenesulfonamide, N-chloro-4-methyl-, sodium salt

Tosylchloramide sodique

127-91-3

Bicyclo[3.1.1]heptane, 6,6-dimethyl-2-methylene-

Pin-2(10)-ène

128-04-1

Carbamodithioic acid, dimethyl-, sodium salt

Diméthyldithiocarbamate de sodium

129-17-9

Ethanaminium, N-[4-[[4-(diethylamino)phenyl](2,4disulfophenyl)methylene]-2,5-cyclohexadien-1-ylidene]-N-ethyl-, hydroxide, inner salt, sodium salt

Hydrogéno[4-[4-(diéthylamino)-2′,4′-disulfonatobenzhydrylidène]cyclohexa-2,5-dién-1-ylidène]diéthylammonium, sel de sodium

131-17-9

1,2-Benzenedicarboxylic acid, di-2-propenyl ester

Phtalate de diallyle

131-53-3

Methanone, (2-hydroxy-4-methoxyphenyl)(2hydroxyphenyl)-

Dioxybenzone

131-55-5

Methanone, bis(2,4-dihydroxyphenyl)-

2,2′,4,4′-Tétrahydroxybenzophénone

131-56-6

Methanone, (2,4-dihydroxyphenyl)phenyl-

2,4-Dihydroxybenzophénone

131-57-7

Methanone, (2-hydroxy-4-methoxyphenyl)phenyl-

Oxybenzone

135-19-3

2-Naphthalenol

2-Naphtol

135-37-5

Glycine, N-(carboxymethyl)-N-(2-hydroxyethyl)-, disodium salt

2-Hydroxyéthyliminodi(acétate) de disodium

135-57-9

Benzamide, N,N′-(dithiodi-2,1-phenylene)bis-

N,N′-Dithiodi-o-phénylènedibenzamide

136-30-1

Carbamodithioic acid, dibutyl-, sodium salt

Dibutyldithiocarbamate de sodium

139-13-9

Glycine, N,N-bis(carboxymethyl)-

Acide nitrilotriacétique

140-10-3

2-Propenoic acid, 3-phenyl-, (E)-

Acide trans-cinnamique

140-67-0

Benzene, 1-methoxy-4-(2-propenyl)-

4-Allylanisole

142-16-5

2-Butenedioic acid (Z)-, bis(2-ethylhexyl) ester

Maléate de bis(2-éthylhexyle)

142-83-6

2,4-Hexadienal, (E,E)-

Hexa-2,4-diénal

143-28-2

9-Octadecen-1-ol, (Z)-

(Z)-Octadéc-9-énol

149-44-0

Methanesulfinic acid, hydroxy-, monosodium salt

Hydroxyméthanesulfinate de sodium

149-57-5

Hexanoic acid, 2-ethyl-

Acide 2-éthylhexanoïque

287-92-3

Cyclopentane

Cyclopentane

288-32-4

1H-Imidazole

Imidazole

301-10-0

Hexanoic acid, 2-ethyl-, tin(2++) salt

Bis(2-éthylhexanoate) d’étain

314-13-6

1,3-Naphthalenedisulfonic acid, 6,6′-[(3,3′-dimethyl[1,1′-biphenyl]-4,4′-diyl)bis(azo)]bis[4-amino-5-hydroxy-, tetrasodium salt

6,6′-[3,3′-Diméthyl-(1,1′-biphényl-4,4′diyl)bis(azo)bis(4-amino-5-hydroxy-1,3-naphtalènedisulfonate) de tétrasodium

330-54-1

Urea, N′-(3,4-dichlorophenyl)-N,N-dimethyl-

Diuron

396-01-0

2,4,7-Pteridinetriamine, 6-phenyl-

Triamtérène

513-35-9

2-Butene, 2-methyl-

2-Méthylbut-2-ène

520-36-5

4H-1-Benzopyran-4-one, 5,7-dihydroxy-2-(4-hydroxyphenyl)-

5,7-dihydroxy-2-(hydroxy4-phényl)-4H-1-benzopyran-4-one

540-72-7

Thiocyanic acid, sodium salt

Thiocyanate de sodium

546-80-5

Bicyclo[3.1.0]hexan-3-one, 4-methyl-1-(1-methylethyl)-, [1S-(1α,4α,5α)]-

1-Isopropyl-4-méthylbicyclo[3.1.0]hexan-3-one

552-89-6

Benzaldehyde, 2-nitro-

2-Nitrobenzaldéhyde

556-63-8

Formic acid, lithium salt

Formiate de lithium

563-80-4

2-Butanone, 3-methyl-

3-Méthylbutanone

590-18-1

2-Butene, (Z)-

(Z)-But-2-ène

593-56-6

Hydroxylamine, O-methyl-, hydrochloride

Chlorure de méthoxyammonium

597-82-0

Phosphorothioic acid, O,O,O-triphenyl ester

Thiophosphate de O,O,O-triphényle

616-45-5

2-Pyrrolidinone

2-Pyrrolidone

624-64-6

2-Butene, (E)-

(E)-But-2-ène

624-92-0

Disulfide, dimethyl

Disulfure de diméthyle

628-96-6

1,2-Ethanediol, dinitrate

Dinitrate d’éthylène

629-59-4

Tetradecane

Tétradécane

646-06-0

1,3-Dioxolane

1,3-Dioxolane

683-18-1

Stannane, dibutyldichloro-

Dichlorure de dibutylstannane

753-73-1

Stannane, dichlorodimethyl-

Dichlorure de diméthylstannane

756-79-6

Phosphonic acid, methyl-, dimethyl ester

Méthylphosphonate de diméthyle

818-08-6

Stannane, dibutyloxo-

Oxyde de dibutylstannane

822-06-0

Hexane, 1,6-diisocyanato-

Diisocyanate d’hexaméthylène

868-77-9

2-Propenoic acid, 2-methyl-, 2-hydroxyethyl ester

Méthacrylate de 2-hydroxyéthyle

924-42-5

2-Propenamide, N-(hydroxymethyl)-

N-(Hydroxyméthyl)acrylamide

931-36-2

1H-Imidazole, 2-ethyl-4-methyl-

2-Éthyl-4-méthylimidazole

947-04-6

Azacyclotridecan-2-one

Dodécane-12-lactame

982-57-0

Butanedioic acid, mono[(2R,3R)-2-[(dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propyl] ester, monosodium salt

Ester mono[(2R,3R)-2-[(dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophényl)propylique] de l’acide butanedioïque, sel monosodique

989-38-8

Xanthylium, 9-[2-(ethoxycarbonyl)phenyl]-3,6-bis(ethylamino)-2,7-dimethyl-, chloride

Chlorure de 9-[2-(éthoxycarbonyl)phényl]3,6-bis(éthylamino)-2,7-diméthylxanthylium

993-16-8

Stannane, trichloromethyl-

Trichlorométhylstannane

999-97-3

Silanamine, 1,1,1-trimethyl-N-(trimethylsilyl)-

1,1,1,3,3,3-Hexaméthyldisilazane

1064-48-8

2,7-Naphthalenedisulfonic acid, 4-amino-5-hydroxy-3-[(4-nitrophenyl)azo]-6-(phenylazo)-, disodium salt

4-Amino-5-hydroxy-3-(4-nitrophénylazo)-6-(phénylazo)naphtalène-2,7-disulfonate de sodium

1067-33-0

Stannane, bis(acetyloxy)dibutyl-

Di(acétate) de dibutylstannane

1067-53-4

2,5,7,10-Tetraoxa-6-silaundecane, 6-ethenyl-6-(2-methoxyethoxy)-

Tris(2-méthoxyéthoxy)vinylsilane

1072-63-5

1H-Imidazole, 1-ethenyl-

1-Vinylimidazole

1118-46-3

Stannane, butyltrichloro-

Trichlorure de butylstannane

1185-55-3

Silane, trimethoxymethyl-

Triméthoxy(méthyl)silane

1185-81-5

Stannane, dibutylbis(dodecylthio)-

Dibutylbis(dodécylthio)stannane

1222-05-5

Cyclopenta[g]-2-benzopyran, 1,3,4,6,7,8-hexahydro-4,6,6,7,8,8-hexamethyl-

1,3,4,6,7,8-Hexahydro-4,6,6,7,8,8-hexaméthylindéno[5,6-c]pyrane

1241-94-7

Phosphoric acid, 2-ethylhexyl diphenyl ester

Phosphate de 2-éthylhexyle et de diphényle

1304-28-5

Barium oxide (BaO)

Oxyde de baryum, obtenu par calcination de la withérite

1306-38-3

Cerium oxide (CeO2)

Dioxyde de cérium

1309-64-4

Antimony oxide (Sb2O3)

Trioxyde de diantimoine

1311-10-0

Strontium hydroxide (Sr(OH)2), octahydrate

Octahydrate d’hydroxyde de strontium (Sr(OH)2)

1317-35-7

Manganese oxide (Mn3O4)

Tétraoxyde de trimanganèse

1330-20-7

Benzene, dimethyl-

Xylène, mélange d’isomères, pur

1506-02-1

Ethanone, 1-(5,6,7,8-tetrahydro-3,5,5,6,8,8-hexamethyl-2-naphthalenyl)-

1-(5,6,7,8-Tétrahydro-3,5,5,6,8,8-hexaméthyl-2naphtyl)éthan-1-one

1562-00-1

Ethanesulfonic acid, 2-hydroxy-, monosodium salt

2-Hydroxyéthanesulfonate de sodium

1569-02-4

2-Propanol, 1-ethoxy-

1-Éthoxypropan-2-ol

1633-05-2

Carbonic acid, strontium salt (1:1)

Carbonate de strontium

1634-04-4

Propane, 2-methoxy-2-methyl-

Oxyde de tert-butyle et de méthyle

1638-22-8

Phenol, 4-butyl-

4-Butylphénol

1806-26-4

Phenol, 4-octyl-

p-Octylphénol

1936-15-8

1,3-Naphthalenedisulfonic acid, 7-hydroxy-8-(phenylazo)-, disodium salt

7-Hydroxy-8-phénylazonaphtalène-1,3-disulfonate de disodium

1962-75-0

1,4-Benzenedicarboxylic acid, 1,4-dibutyl ester

téréphtalate de dibutyle,

1987-50-4

Phenol, 4-heptyl-

4-Heptylphénol

2173-57-1

Naphthalene, 2-(2-methylpropoxy)-

Oxyde d’isobutyle et de 2-naphtyle

2216-51-5

Cyclohexanol, 5-methyl-2-(1-methylethyl)-, [1R-(1α,2β,5α)]-

2-Menthol

2315-67-5

Ethanol, 2-[4-(1,1,3,3-tetramethylbutyl)phenoxy]-

2-[4-(1,1,3,3-Tétraméthylbutyl)phénoxy]éthanol

2386-87-0

7-Oxabicyclo[4.1.0]heptane-3-carboxylic acid, 7-oxabicyclo[4.1.0]hept-3-ylmethyl ester

7-Oxabicyclo[4.1.0]heptane-3-carboxylate de 7-oxabicyclo[4.1.0]hept-3-ylméthyle

2432-99-7

Undecanoic acid, 11-amino-

Acide 11-aminoundécanoïque

2440-22-4

Phenol, 2-(2H-benzotriazol-2-yl)-4-methyl-

2-(2H-Benzotriazol-2-yl)-p-crésol

2463-53-8

2-Nonenal

Non-2-énal

2530-83-8

Silane, trimethoxy[3-(oxiranylmethoxy)propyl]-

[3-(2,3-Époxypropoxy)propyl]triméthoxysilane

2530-85-0

2-Propenoic acid, 2-methyl-, 3-(trimethoxysilyl)propyl ester

Méthacrylate de 3-triméthoxysilylpropyle

2530-87-2

Silane, (3-chloropropyl)trimethoxy-

3-Chloropropyltriméthoxysilane

2610-05-1

1,3-Naphthalenedisulfonic acid, 6,6′-[(3,3′-dimethoxy[1,1′-biphenyl]-4,4′-diyl)bis(azo)]bis[4-amino-5-hydroxy-, tetrasodium salt

1-naphtalénol, 2-méthyl-, 1-acétate

2650-18-2

Benzenemethanaminium, N-ethyl-N-[4-[[4-[ethyl[(3-sulfophenyl)methyl]amino]phenyl](2sulfophenyl)methylene]-2,5-cyclohexadien-1-ylidene]-3-sulfo-, hydroxide, inner salt, diammonium salt

Diammonio(éthyl)[4-({4-[éthyl(3-sulfonatobenzyl)amino]phényl}(2-sulfonatophényl)méthylène)cyclohexa-2,5-dién-1-ylidène](3-sulfonatobenzyl)ammonium

2680-03-7

2-Propenamide, N,N-dimethyl-

N,N-Diméthylacrylamide

2768-02-7

Silane, ethenyltrimethoxy-

Triméthoxyvinylsilane

2781-10-4

Stannane, dibutylbis[(2-ethyl-1-oxohexyl)oxy]-

Bis(2-éthylhexanoate) de dibutylétain

2855-13-2

Cyclohexanemethanamine, 5-amino-1,3,3-trimethyl-

3-Aminométhyl-3,5,5-triméthylcyclohexylamine

2935-90-2

Propanoic acid, 3-mercapto-, methyl ester

3-Mercaptopropionate de méthyle

2996-92-1

Silane, trimethoxyphenyl-

Triméthoxyphénylsilane

3081-01-4

1,4-Benzenediamine, N-(1,4-dimethylpentyl)-N′-phenyl-

N-(1,4-Diméthylpentyl)-N′-phénylbenzène-1,4-diamine

3164-85-0

Hexanoic acid, 2-ethyl-, potassium salt

2-Éthylhexanoate de potassium

3248-91-7

Benzenamine, 4-[(4-amino-3-methylphenyl)(4-imino-3-methyl-2,5-cyclohexadien-1-ylidene)methyl]-2-methyl-, monohydrochloride

4-[(4-Amino-m-tolyl)(4-imino-3-méthylcyclohexa-2,5-dién-1-ylidène)méthyl]-o-toluidine, monochlorhydrate

3268-49-3

Propanal, 3-(methylthio)-

3-(Méthylthio)propionaldéhyde

3302-10-1

Hexanoic acid, 3,5,5-trimethyl-

Acide 3,5,5-triméthylhexanoïque

3322-93-8

Cyclohexane, 1,2-dibromo-4-(1,2-dibromoethyl)-

1,2-Dibromo-4-(1,2-dibromoéthyl)cyclohexane

3520-42-1

Xanthylium, 3,6-bis(diethylamino)-9-(2,4-disulfophenyl)-, hydroxide, inner salt, sodium salt

Hydrogéno-3,6-bis(diéthylamino)-9-(2,4-disulfonatophényl)xanthylium, sel de sodium

3648-18-8

Stannane, dioctylbis[(1-oxododecyl)oxy]-

Dilaurate de dioctylétain

3669-02-1

Distannoxane, 1,1,3,3-tetrabutyl-1,3-bis[(1-oxododecyl)oxy]-

1,1,3,3,-Tétrabutyl-1,3-bis[(1-oxododécyl)oxy]distannoxane

3864-99-1

Phenol, 2-(5-chloro-2H-benzotriazol-2-yl)-4,6-bis(1,1-dimethylethyl)-

2,4-Di-tert-butyl-6-(5-chlorobenzotriazol-2-yl)phénol

3926-62-3

Acetic acid, chloro-, sodium salt

Chloroacétate de sodium

3982-87-4

Phosphine sulfide, tris(2-methylpropyl)-

Sulfure de triisobutylphosphine

4065-45-6

Benzenesulfonic acid, 5-benzoyl-4-hydroxy-2-methoxy-

Sulisobenzone

4067-16-7

3,6,9,12-Tetraazatetradecane-1,14-diamine

3,6,9,12-Tétraazatétradécaméthylènediamine

4191-73-5

Benzoic acid, 4-hydroxy-, 1-methylethyl ester

4-Hydroxybenzoate d’isopropyle

4198-19-0

2,7-Naphthalenedisulfonic acid, 3,3′-[(3,3′dimethoxy[1,1′-biphenyl]-4,4′-diyl)bis(azo)]bis[4,5-dihydroxy-, tetrasodium salt

3,3′-{[3,3′-Diméthoxy(1,1′-biphényl)-4,4′diyl]bis(azo)}bis(4,5-dihydroxynaphtalène-2,7-disulfonate) de tétrasodium

4247-02-3

Benzoic acid, 4-hydroxy-, 2-methylpropyl ester

4-Hydroxybenzoate d’isobutyle

4253-22-9

Stannane, dibutylthioxo-

Dibutylthioxostannane

4403-90-1

Benzenesulfonic acid, 2,2′-[(9,10-dihydro-9,10-dioxo-1,4-anthracenediyl)diimino]bis[5-methyl-, disodium salt

2,2′-(9,10-Dioxoanthracène-1,4-diyldiimino)bis(5-méthylsulfonate de disodium

4424-06-0

Bisbenzimidazo[2,1-b:2′,1′i]benzo[lmn][3,8]phenanthroline-8,17-dione

Bisbenzimidazo[2,1-b:2′,1′-i]benzo[lmn][3,8]phénanthroline-8,17-dione

4712-55-4

Phosphonic acid, diphenyl ester

Phosphonate de diphényle

4719-04-4

1,3,5-Triazine-1,3,5(2H,4H,6H)-triethanol

2,2′,2″-(Hexahydro-1,3,5-triazine-1,3,5-triyl)triéthanol

5026-74-4

Oxiranemethanamine, N-[4-(oxiranylmethoxy)phenyl]-N-(oxiranylmethyl)-

p-(2,3-Époxypropoxy)-N,N-bis(2,3-époxypropyl)aniline

5039-78-1

Ethanaminium, N,N,N-trimethyl-2-[(2-methyl-1-oxo-2-propenyl)oxy]-, chloride

Chlorure de [2(méthacryloyloxy)éthyl]triméthylammonium

5124-30-1

Cyclohexane, 1,1′-methylenebis[4-isocyanato-

Diisocyanate de 4,4′-méthylènedicyclohexyle

5141-20-8

Benzenemethanaminium, N-ethyl-N-[4-[[4-[ethyl[(3-sulfophenyl)methyl]amino]phenyl](4-sulfophenyl)methylene]-2,5-cyclohexadien-1-ylidene]-3-sulfo-, hydroxide, inner salt, disodium salt

Dihydrogéno(éthyl)(4-{p-[éthyl(msulfonatobenzyl)amino]-p′sulfonatobenzhydrylène}cyclohexa-2,5-dién-1ylidène)(m-sulfonatobenzyl)ammonium, sel de disodium

5146-66-7

2,6-Octadienenitrile, 3,7-dimethyl-

3,7-Diméthylocta-2,6-diènenitrile

5153-25-3

Benzoic acid, 4-hydroxy-, 2-ethylhexyl ester

4-Hydroxybenzoate de 2-éthylhexyle

5165-97-9

1-Propanesulfonic acid, 2-methyl-2-[(1-oxo-2-propenyl)amino]-, monosodium salt

2-Méthyl-2-[(1-oxoallyl)amino]propanesulfonate de sodium

5392-40-5

2,6-Octadienal, 3,7-dimethyl-

Citral

5435-64-3

Hexanal, 3,5,5-trimethyl-

3,5,5-Triméthylhexanal

5466-77-3

2-Propenoic acid, 3-(4-methoxyphenyl)-, 2-ethylhexyl ester

4-Méthoxycinnamate de 2-éthylhexyle

5847-55-2

Stannane, dibutylbis[(1-oxooctadecyl)oxy]-

Dibutylbis(stéaroyloxy)stannane

5989-27-5

Cyclohexene, 1-methyl-4-(1-methylethenyl)-, (R)-

(R)-p-Mentha-1,8-diène

6104-30-9

Urea, N,N″-(2-methylpropylidene)bis-

N,N″-(Isobutylidène)diurée

6197-30-4

2-Propenoic acid, 2-cyano-3,3-diphenyl-, 2-ethylhexyl ester

Octocrylène

6259-76-3

Benzoic acid, 2-hydroxy-, hexyl ester

Salicylate d’hexyle

6362-79-4

1,3-Benzenedicarboxylic acid, 5-sulfo-, monosodium salt

Hydrogéno-5-sulfoisophtalate de sodium

6373-74-6

Benzenesulfonic acid, 5-[(2,4-dinitrophenyl)amino]-2-(phenylamino)-, monosodium salt

2-Anilino-5-(2,4-dinitroanilino)benzènesulfonate de sodium

6419-19-8

Phosphonic acid, [nitrilotris(methylene)]tris-

Acide nitrilotriméthylènetriphosphonique

6422-86-2

1,4-Benzenedicarboxylic acid, bis(2-ethylhexyl) ester

Téréphtalate de bis(2-éthylhexyle)

6528-34-3

Butanamide, 2-[(4-methoxy-2-nitrophenyl)azo]N-(2-methoxyphenyl)-3-oxo-

2-[(4-Méthoxy-2-nitrophényl)azo]-N-(2-méthoxyphényl)-3-oxobutyramide

6728-26-3

2-Hexenal, (E)-

trans-Hex-2-énal

6731-36-8

Peroxide, (3,3,5-trimethylcyclohexylidene)bis[(1,1dimethylethyl)

Diperoxyde de di-tert-butyle et de 3,3,5-triméthylcyclohexylidène

6739-62-4

Benzoic acid, 2-[[2-amino-6-[[4′-[(3-carboxy-4-hydroxyphenyl)azo]-3,3′-dimethoxy[1,1′-biphenyl]-4-yl]azo]-5-hydroxy-7-sulfo-1-naphthalenyl]azo]-5-nitro-, trisodium salt

2-[[2-Amino-6-[[4′-[(3-carboxylato-4hydroxyphényl)azo]-3,3′-diméthoxy[1,1′-biphényl]-4-yl]azo]-5-hydroxy-7-sulfonato-1-naphtyl]azo]-5-nitrobenzoate de trisodium

6834-92-0

Silicic acid (H2SiO3), disodium salt

Métasilicate de disodium

6842-15-5

1-Propene, tetramer

Prop-1-ène tétramérisé

6864-37-5

Cyclohexanamine, 4,4′-methylenebis[2-methyl-

2,2′-Diméthyl-4,4′-méthylènebis(cyclohexylamine)

7381-01-3

Dodecanoic acid, 2-sulfoethyl ester, sodium salt

Laurate de sodium et de 2-sulfonatoéthyle

7398-69-8

2-Propen-1-aminium, N,N-dimethyl-N-2-propenyl-, chloride

Chlorure de diallyldiméthylammonium

7488-55-3

Sulfuric acid, tin(2++) salt (1:1)

Sulfate d’étain

7492-66-2

2,6-Octadiene, 1,1-diethoxy-3,7-dimethyl-

1,1-Diéthoxy-3,7-diméthylocta-2,6-diène

7563-33-9

Butanoic acid, 3-methyl-, ammonium salt

Isovalérate d’ammonium

7601-89-0

Perchloric acid, sodium salt

Perchlorate de sodium

7631-95-0

Molybdate (MoO42-), disodium, (ß-4)-

Molybdate de disodium

7637-07-2

Borane, trifluoro-

Trifluorure de bore

7646-78-8

Stannane, tetrachloro-

Tétrachlorure d’étain

7647-15-6

Sodium bromide (NaBr)

Bromure de sodium

7699-43-6

Zirconium, dichlorooxo-

Oxydichlorure de zirconium

7719-09-7

Thionyl chloride

Dichlorure de thionyle

7722-64-7

Permanganic acid (HMnO4), potassium salt

Permanganate de potassium

7757-74-6

Disulfurous acid, disodium salt

Anhydrosulfite disodique

7757-86-0

Phosphoric acid, magnesium salt (1:1)

Hydrogénoorthophosphate de magnésium

7758-02-3

Potassium bromide (KBr)

Bromure de potassium

7758-09-0

Nitrous acid, potassium salt

Nitrite de potassium

7758-19-2

Chlorous acid, sodium salt

Chlorite de sodium

7773-01-5

Manganese chloride (MnCl2)

Dichlorure de manganèse

7775-14-6

Dithionous acid, disodium salt

Dithionite de sodium

7775-27-1

Peroxydisulfuric acid ([(HO)S(O)2]2O2), disodium salt

Peroxodisulfate de disodium

7783-47-3

Tin fluoride (SnF2)

Difluorure d’étain

7785-87-7

Sulfuric acid, manganese(2++) salt (1:1)

Sulfate de manganèse

7789-23-3

Potassium fluoride (KF)

Fluorure de potassium

7791-07-3

Sodium perchlorate, monohydrate

Monohydrate de perchlorate de sodium

7791-25-5

Sulfuryl chloride

Dichlorure de sulfuryle

7803-51-2

Phosphine

Phosphine

8012-00-8

C.I. Pigment Yellow 41

Pyrochlore, jaune d’antimoine et de plomb

8068-05-1

Lignin, alkali

Thiolignine

9003-36-5

Formaldehyde, polymer with (chloromethyl)oxirane and phenol

Formaldéhyde polymérisé avec le (chlorométhyl)oxirane et le phénol

9006-27-3

Poly(oxy-1,2-ethanediyl), α-(1-oxododecyl)-ω-methoxy-

α-Lauroyl-ω-méthoxypoly(oxyéthylène)

9017-01-0

Benzene, 1,3-diisocyanatomethyl-, homopolymer

Diisocyanate de m-tolylidène, homopolymérisé

9046-10-0

Poly[oxy(methyl-1,2-ethanediyl)], α-(2-aminomethylethyl)-ω-(2-aminomethylethoxy)-

α-[2-(Aminométhyl)éthyl]-ω-[2(aminométhyl)éthoxy]poly[oxy(méthyléthylène)]

10025-70-4

Strontium chloride (SrCl2), hexahydrate

chlorure de strontium, 6-hydrate

10026-06-9

Stannane, tetrachloro-, hydrate (1:5)

Hydrate de tétrachlorostannane (5/1)

10042-84-9

Glycine, N,N-bis(carboxymethyl)-, sodium salt

2,2′,2″-Nitrilotriacétate de sodium

10102-40-6

Molybdate (MoO42-), sodium, hydrate (1:2:2), (T-4)-

Dihydrate de (T 4) molybdate(MoO42-) de disodium

10117-38-1

Sulfurous acid, dipotassium salt

Sulfite de potassium

10213-10-2

Tungstate (WO42-), disodium, dihydrate, (T-4)-

Dihydrate de (T-4)-tungstate (WO42-) de disodium

10377-60-3

Nitric acid, magnesium salt

Nitrate de magnésium

10476-85-4

Strontium chloride (SrCl2)

Chlorure de strontium

10584-98-2

8-Oxa-3,5-dithia-4-stannatetradecanoic acid, 4,4-dibutyl-10-ethyl-7-oxo-, 2-ethylhexyl ester

4,4-Dibutyl-10-éthyl-7-oxo-8-oxa-3,5-dithia-4-stannatétradécanoate de 2-éthylhexyle

11070-44-3

1,3-Isobenzofurandione, tetrahydromethyl-

Anhydride tétrahydrométhylphtalique

12040-43-6

Silicic acid, aluminum magnesium sodium salt

Acide silicique, sel d’aluminium, de magnésium et de sodium

12058-66-1

Stannate (SnO32-), disodium

Trioxyde d’étain et de disodium

12070-12-1

Tungsten carbide (WC)

Carbure de tungstène

12125-03-0

Stannate (SnO32-), dipotassium, trihydrate

Trihydrate de stannate (SnO32-) de dipotassium

12142-33-5

Stannate (SnO32-), dipotassium

Trioxyde d’étain et de dipotassium

12222-00-3

Cuprate(4-), [µ-[[4,4′-[(3,3′-dihydroxy[1,1′-biphenyl]-4,4′-diyl)bis(azo)]bis[3-hydroxy-2,7-naphthalenedisulfonato]](8-)]]di-, tetrasodium

[µ-[[4,4′-[(3,3′-Dihydroxy[1,1′-biphényl]-4,4′diyl)bis(azo)]bis[3-hydroxynaphtalène-2,7disulfonato]](8-)]]dicuprate(4-) de tétrasodium

13311-84-7

Propanamide, 2-methyl-N-[4-nitro-3(trifluoromethyl)phenyl]-

2-méthyl-N-[4-nitro-3(trifluorométhyl)phényl]propanamide

13323-62-1

Stannane, dibutylbis[(1-oxo-9-octadecenyl)oxy]-, (Z,Z)-

Dibutylbis(octadéc-9(Z)-énoyloxy)stannane

13446-34-9

Manganese chloride (MnCl2), tetrahydrate;

Tétrahydrate de chlorure de manganèse (MnCl2)

13455-21-5

Potassium fluoride dihydrate

Dihydrate de fluorure de potassium

13466-08-5

Sodium bromide dihydrate

Dihydrate de bromure de sodium

13472-45-2

Tungstate (WO42-), disodium, (ß-4)-

Tungstate de disodium

13473-26-2

Spiro[isobenzofuran-1(3H),9′-[9H]xanthen]-3-one, 2′,4′,5′,7′-tetrabromo-4,5,6,7-tetrachloro-3′,6′-dihydroxy-

2′,4′,5′,7′-Tétrabromo-4,5,6,7-tétrachloro-3′,6′-dihydroxyspiro[isobenzofurane-1(3H),9′[9H]xanthène]-3-one

13475-82-6

Heptane, 2,2,4,6,6-pentamethyl-

2,2,4,6,6-Pentaméthylheptane

13520-92-8

Zirconium, dichlorooxo-, octahydrate

Octahydrate d’oxyde de dichlorozirconium

13752-51-7

Morpholine, 4-[(4-morpholinylthio)thioxomethyl]-

4-[(Morpholinothio)thioxométhyl]morpholine

13775-53-6

Aluminate(3-), hexafluoro-, trisodium, (OC-6-11)-

Hexafluoroaluminate de trisodium

14025-21-9

Zincate(2-), [[N,N′-1,2-ethanediylbis[N-(carboxymethyl)glycinato]](4-)-N,N′,O,O′,ON,ON′]-, disodium, (OC-6-21)-

({N,N′-Éthylènediylbis[N(carboxylatométhyl)glycinato(4-)]}N,N′,O,O′,ON,ON′)zincate(2-) de disodium

14254-22-9

Stannane, butoxydibutylchloro-

Butoxydibutylchlorostannane

14901-07-6

3-Buten-2-one, 4-(2,6,6-trimethyl-1-cyclohexen-1-yl)-

4-(2,6,6-Triméthylcyclohex-1-én-1-yl)-but-3-én-2-one

15546-11-9

2,7,9-Trioxa-8-stannatrideca-4,11-dien-13-oic acid, 8,8-dibutyl-3,6,10-trioxo-, methyl ester, (Z,Z)-

(Z,Z)-8,8-Dibutyl-3,6,10-trioxo-2,7,9-trioxa-8-stannatridéca-4,11-dién-13-oate de méthyle

15546-12-0

5,7,12-Trioxa-6-stannaoctadeca-2,9-dienoic acid, 6,6-dibutyl-14-ethyl-4,8,11-trioxo-, 2-ethylhexyl ester

6,6-Dibutyl-14-éthyl-4,8,11-trioxo-5,7,12-trioxa-6-stannaoctadéca-2,9-diénoate de 2-éthylhexyle

15546-16-4

5,7,12-Trioxa-6-stannahexadeca-2,9-dienoic acid, 6,6-dibutyl-4,8,11-trioxo-, butyl ester, (Z,Z)-

(Z,Z)-6,6-Dibutyl-4,8,11-trioxo-5,7,12-trioxa-6-stannahexadéca-2,9-diénoate de butyle

15571-58-1

8-Oxa-3,5-dithia-4-stannatetradecanoic acid, 10-ethyl-4,4-dioctyl-7-oxo-, 2-ethylhexyl ester

10-Éthyl-4,4-dioctyl-7-oxo-8-oxa-3,5-dithia-4-stannatétradécanoate de 2-éthylhexyle

15625-89-5

2-Propenoic acid, 2-ethyl-2-[[(1-oxo-2propenyl)oxy]methyl]-1,3-propanediyl ester

Diacrylate de 2-éthyl-2-[[(1oxoallyl)oxy]méthyl]propane-1,3-diyle

15630-89-4

Carbonic acid disodium salt, compd. with hydrogen peroxide (H2O2) (2:3)

Carbonate de disodium, composé avec le peroxyde d’hydrogène(2:3)

16056-95-4

Strontium chloride (SrCl2), dihydrate;

Dihydrate de chlorure de strontium (SrCl2)

16091-18-2

1,3,2-Dioxastannepin-4,7-dione, 2,2-dioctyl-

Maléate de dioctylstannane

16409-43-1

2H-Pyran, tetrahydro-4-methyl-2-(2-methyl-1-propenyl)-

Tétrahydro-4-méthyl-2-(2-méthylprop-1-ényl)pyrane

16423-68-0

Spiro[isobenzofuran-1(3H),9′-[9H]xanthen]-3-one, 3′,6′-dihydroxy-2′,4′,5′,7′-tetraiodo-, disodium salt

2-(2,4,5,7-Tétraiodo-6-oxydo-3-oxoxanthén-9yl)benzoate de disodium

16470-24-9

Benzenesulfonic acid, 2,2′-(1,2-ethenediyl)bis[5-[[4-[bis(2-hydroxyethyl)amino]-6-[(4-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-, tetrasodium salt

4,4′-Bis[[4-[bis(2-hydroxyéthyl)amino]-6-(4-sulfonatoanilino)-1,3,5-triazin-2-yl]amino]stilbène-2,2′-disulfonate] de tétrasodium

16731-55-8

Disulfurous acid, dipotassium salt

Bisulfite de dipotassium

17372-87-1

Spiro[isobenzofuran-1(3H),9′-[9H]xanthen]-3-one, 2′,4′,5′,7′-tetrabromo-3′,6′-dihydroxy-, disodium salt

2-(2,4,5,7-Tétrabromo-6-oxydo-3-oxoxanthén-9yl)benzoate de disodium

17589-24-1

1,3-Diazetidine-2,4-dione, 1,3-bis[4-[(4-isocyanatophenyl)methyl]phenyl]-

Diisocyanate de 2,4-dioxo-1,3-diazétidine-1,3-diylbis[p-phénylèneméthylène-p-phénylène]

17796-82-6

1H-Isoindole-1,3(2H)-dione, 2-(cyclohexylthio)-

N-(Cyclohexylthio)phtalimide

18127-01-0

Benzenepropanal, 4-(1,1-dimethylethyl)-

3-(4-tert-Butylphényl)propionaldéhyde

18172-67-3

Bicyclo[3.1.1]heptane, 6,6-dimethyl-2-methylene-, (1S)-

(-)-Pin-2(10)-ène

18282-10-5

Tin oxide (SnO2)

Dioxyde d’étain

18480-07-4

Strontium hydroxide (Sr(OH)2)

Hydroxyde de strontium

19438-60-9

1,3-Isobenzofurandione, hexahydro-5-methyl-

Anhydride hexahydro-4-méthylphtalique

19766-89-3

Hexanoic acid, 2-ethyl-, sodium salt

2-Éthylhexanoate de sodium

20325-40-0

[1,1′-Biphenyl]-4,4′-diamine, 3,3′-dimethoxy-, dihydrochloride

Dichlorure de 3,3′-diméthoxybiphényl-4,4′-ylènediammonium

20603-88-7

Manganese chloride (MnCl2), dihydrate

Dihydrate de chlorure de manganèse (MnCl2)

21145-77-7

Ethanone, 1-(5,6,7,8-tetrahydro-3,5,5,6,8,8-hexamethyl-2-naphthalenyl)-

1-(5,6,7,8-Tétrahydro-3,5,5,6,8,8-hexaméthyl-2naphtyl)éthan-1-one

22205-30-7

Stannane, bis(dodecylthio)dioctyl-

Bis(dodécylthio)dioctylstannane

22373-78-0

Monensin, monosodium salt

Monensin, sel monosodique

22464-99-9

Hexanoic acid, 2-ethyl-, zirconium salt

Acide 2-éthylhexanoïque, sel de zirconium

22673-19-4

Tin, dibutylbis(2,4-pentanedionato-O,O′)-, (OC-6-11)-

Dibutylbis(pentane-2,4-dionato-O,O′)stannane

25155-25-3

Peroxide, [1,3(or 1,4)-phenylenebis(1-methylethylidene)]bis[(1,1-dimethylethyl)

Peroxyde de [1,3(ou et de 1,4)-phénylènebis(1-méthyléthylidène)]bis[tert-butyle]

25167-67-3

Butene

Butène

25167-70-8

Pentene, 2,4,4-trimethyl-

2,4,4-Triméthylpentène

25168-21-2

2-Butenoic acid, 4,4′-[(dibutylstannylene)bis(oxy)]bis[4-oxo-, diisooctyl ester, (Z,Z)-

4,4′-[(Dibutylstannylène)bis(oxy)]bis[4-oxoisocrotonate] de diisooctyle

25168-22-3

Stannane, dibutylbis[(1-oxoneodecyl)oxy]-

Dibutylbis[(1-oxonéodécyl)oxy]stannane

25168-24-5

Acetic acid, 2,2′-[(dibutylstannylene)bis(thio)]bis-, diisooctyl ester

2,2′-[(Dibutylstannylène)bis(thio)]diacétate de diisooctyle

25214-63-5

1,2-Ethanediamine, polymer with methyloxirane

Éthane-1,2-diamine polymérisée avec le méthyloxirane

25214-70-4

Formaldehyde, polymer with benzenamine

Formaldéhyde polymérisé avec l’aniline

25321-09-9

Benzene, bis(1-methylethyl)-

Diisopropylbenzène

25340-17-4

Benzene, diethyl-

Diéthylbenzène

25584-83-2

2-Propenoic acid, monoester with 1,2-propanediol

Acide acrylique, monoester avec le propane-1,2-diol

25686-28-6

Benzene, 1,1′-methylenebis[4-isocyanato-, homopolymer

Diisocyanate de 4,4′-méthylènediphényle homopolymérisé

25723-16-4

Poly[oxy(methyl-1,2-ethanediyl)], α-hydro-ω-hydroxy-, ether with 2-ethyl-2-(hydroxymethyl)-1,3-propanediol (3:1)

α-Hydro-ω-hydroxypoly[oxy(méthyléthylène)], éther (3:1) avec le propylidynetriméthanol

26401-86-5

Acetic acid, 2,2′,2″-[(octylstannylidyne)tris(thio)]tris-, triisooctyl ester

2,2′,2″-[(Octylstannylidyne)tris(thio)]triacétate de triisooctyle

26401-97-8

Acetic acid, 2,2′-[(dioctylstannylene)bis(thio)]bis-, diisooctyl ester

2,2′-[(Dioctylstannylène)bis(thio)]diacétate de diisooctyle

26472-00-4

4,7-Methano-1H-indene, 3a,4,7,7a-tetrahydrodimethyl-

Méthylcyclopentadiène

26658-42-4

1,2-Ethanediamine, N-(2-aminoethyl)-N′-[2-[(2-aminoethyl)amino]ethyl]-, polymer with (chloromethyl)oxirane

3,6,9-Triazaundécane-1,11-diamine polymérisée avec le (chlorométhyl)oxirane

26761-45-5

Neodecanoic acid, oxiranylmethyl ester

Néodécanoate de 2,3-époxypropyle

27029-41-0

1,3-Propanediamine, N,N-dimethyl-, polymer with (chloromethyl)oxirane

N,N-Diméthylpropane-1,3-diamine polymérisée avec le (chlorométhyl)oxirane

27107-89-7

8-Oxa-3,5-dithia-4-stannatetradecanoic acid, 10-ethyl-4-[[2-[(2-ethylhexyl)oxy]-2-oxoethyl]thio]-4-octyl-7-oxo-, 2-ethylhexyl ester

10-Éthyl-4-[[2-[(2-éthylhexyl)oxy]-2-oxoéthyl]thio]-4-octyl-7-oxo-8-oxa-3,5-dithia-4-stannatétradécanoate de 2-éthylhexyle

27247-96-7

Nitric acid, 2-ethylhexyl ester

Nitrate de 2-éthylhexyle

27344-41-8

Benzenesulfonic acid, 2,2′-([1,1′-biphenyl]-4,4′-diyldi-2,1-ethenediyl)bis-, disodium salt

2,2′-([1,1′-Biphényl]-4,4′diyldivinylène)bis(benzènesulfonate) de disodium

27813-02-1

2-Propenoic acid, 2-methyl-, monoester with 1,2-propanediol

Acide méthacrylique, monoester avec le propane-1,2-diol

28407-37-6

Cuprate(4-), [µ-[[3,3′-[(3,3′-dihydroxy[1,1′-biphenyl]-4,4′-diyl)bis(azo)]bis[5-amino-4-hydroxy-2,7-naphthalenedisulfonato]](8-)]]di-, tetrasodium

[µ-[[3,3′-[(3,3′-Dihydroxy[1,1′-biphényl]-4,4′diyl)bis(azo)]bis[5-amino-4-hydroxynaphtalène-2,7-disulfonato]](8-)]]dicuprate(4-) de tétrasodium

28472-97-1

Nonanedioic acid, diisodecyl ester

Azélate de diisodécyle

28883-73-0

Poly(oxy-1,2-ethanediyl), α,α′[(octadecylimino)di-2,1-ethanediyl]bis[ω-hydroxy-, hydrochloride

α,α′-{[(Octadécyl)imino]diéthylène}bis[ω-hydroxypoly(oxyéthylène)], chlorhydrate

28961-43-5

Poly(oxy-1,2-ethanediyl), α-hydro-ω-[(1-oxo-2-propenyl)oxy]-, ether with 2-ethyl-2-(hydroxymethyl)-1,3-propanediol (3:1)

α-Hydro-ω-(acryloyloxy)poly(oxyéthylène), éther (3:1) avec le propylidynetriméthanol

30499-70-8

1,3-Propanediol, 2-ethyl-2-(hydroxymethyl)-, polymer with (chloromethyl)oxirane

2-Éthyl-2-(hydroxyméthyl)propane-1,3-diol polymérisé avec le (chlorométhyl)oxirane

31107-36-5

1,3-Diazetidin-2-one, 1,3-bis[4-[(4isocyanatophenyl)methyl]phenyl]-4-[[4-[(4-isocyanatophenyl)methyl]phenyl]imino]-

Diisocyanate de 4-[[p-(pisocyanatobenzyl)phényl]imino]-2-oxo-1,3-diazétidine-1,3-diylbis(p-phénylèneméthylène-p-phénylène)

31394-54-4

Isoheptane

Isoheptane

32388-55-9

Ethanone, 1-(2,3,4,7,8,8a-hexahydro-3,6,8,8-tetramethyl-1H-3a,7-methanoazulen-5-yl)-, [3R-(3α,3aβ,7β,8aα)]-

[3R-(3α,3aβ,7β,8aα)]-1-(2,3,4,7,8,8a-Hexahydro-3,6,8,8-tétraméthyl-1H-3a,7-méthanoazulén-5-yl)éthan-1-one

32492-61-8

Poly(oxy-1,2-ethanediyl), α,α′-[(1-methylethylidene)di4,1-phenylene]bis[ω-hydroxy-

α,α′-(Isopropylidènedi-p-phénylène)bis[ωhydroxypoly(oxyéthylène)]

33145-10-7

Phenol, 2,2′-(2-methylpropylidene)bis[4,6-dimethyl-

2,2′-(2-Méthylpropylidène)bis[4,6-xylénol]

34041-09-3

Hexanoic acid, 2-ethyl-, molybdenum salt

Acide 2-éthylhexanoïque, sel de molybdène

35176-06-8

Ethanol, 2,2′-iminobis-, polymer with methyloxirane

2,2′-Iminodiéthanol polymérisé avec le méthyloxirane

36631-30-8

1,2,4-Benzenetricarboxylic acid, 1,2,4-triisodecyl ester

Benzène-1,2,4-tricarboxylate de triisodécyle

37353-75-6

Poly[oxy(methyl-1,2-ethanediyl)], α,α′-[(1-methylethylidene)di-4,1-phenylene]bis[ω-hydroxy-

α,α′-(Isopropylidènedi-p-phénylène)bis{ωhydroxypoly[oxy(méthyléthylène)]}

37640-57-6

1,3,5-Triazine-2,4,6(1H,3H,5H)-trione, compd. with 1,3,5-triazine-2,4,6-triamine (1:1)

1,3,5-Triazine-2,4,6(1H,3H,5H)-trione, composé avec la 1,3,5-triazine-2,4,6-triamine (1:1)

37853-59-1

Benzene, 1,1′-[1,2ethanediylbis(oxy)]bis[2,4,6-tribromo-

1,1′-(Éthane-1,2-diylbisoxy)bis(2,4,6-tribromobenzène)

37971-36-1

1,2,4-Butanetricarboxylic acid, 2-phosphono-

Acide 2-phosphonobutane-1,2,4-tricarboxylique

40530-60-7

Carbonic acid, 2-[(1-amino-9,10-dihydro-4-hydroxy-9,10-dioxo-2-anthracenyl)oxy]ethyl ethyl ester

Carbonate d’éthyle et de 2-[(1-amino-9,10-dihydro-4-hydroxy-9,10-dioxo-2-anthryl)oxy]éthyle

41272-40-6

Methanaminium, N-[4-[[4-(dimethylamino)phenyl]phenylmethylene]-2,5-cyclohexadien-1-ylidene]-N-methyl-, acetate

Acétate de [4-[α-[4(diméthylamino)phényl]benzylidène]cyclohexa-2,5-dién-1-ylidène]diméthylammonium

42978-66-5

2-Propenoic acid, (1-methyl-1,2ethanediyl)bis[oxy(methyl-2,1-ethanediyl)] ester

Diacrylate de (1-méthyléthane-1,2diyl)bis[oxy(méthyléthylène)]

44992-01-0

Ethanaminium, N,N,N-trimethyl-2-[(1-oxo-2propenyl)oxy]-, chloride

Chlorure de [2-(acryloyloxy)éthyl]triméthylammonium

50586-59-9

Poly(oxy-1,2-ethanediyl), α-hydro-ω-hydroxy-, ether with 2-ethyl-2-(hydroxymethyl)-1,3-propanediol (3:1)

α-Hydro-ω-hydroxypoly(oxyéthylène), éther (3:1) avec le 2-éthyl-2-(hydroxyméthyl)propane-1,3-diol

52408-84-1

Poly[oxy(methyl-1,2-ethanediyl)], α,α′,α″-1,2,3-propanetriyltris[ω-[(1-oxo-2-propenyl)oxy]-

α,α′,α″-Propane-1,2,3-triyltris{ω(acryloyloxy)poly[oxy(méthyléthylène)]}

52625-13-5

Poly[oxy(methyl-1,2-ethanediyl)], α-hydro-ω-hydroxy-, ether with D-glucitol (6:1)

α-Hydro-ω-hydroxypoly[oxy(méthyléthylène)], éther (6:1) avec le D-glucitol

53148-32-6

Hexanoic acid, 2-ethyl-, 1,4-cyclohexanediylbis(methylene) ester

Bis(2-éthylhexanoate) de cyclohexane-1,4-diylbisméthylène

53306-54-0

1,2-Benzenedicarboxylic acid, bis(2-propylheptyl) ester

Phtalate de bis(2-propylheptyle)

53988-10-6

2H-Benzimidazole-2-thione, 1,3-dihydro-4(or 5)-methyl-

1,3-Dihydro-4(ou-5)-méthyl-2H-benzimidazole-2-thione

54076-97-0

Ethanaminium, N,N,N-trimethyl-2-[(1-oxo-2-propenyl)oxy]-, chloride, homopolymer

Chlorure de [2-(acryloyl)oxy]triméthylammonium homopolymérisé

54423-67-5

Neononanoic acid, ethenyl ester

Néononanoate de vinyle

54464-57-2

Ethanone, 1-(1,2,3,4,5,6,7,8-octahydro-2,3,8,8-tetramethyl-2-naphthalenyl)-

1-(1,2,3,4,5,6,7,8-Octahydro-2,3,8,8-tétraméthyl-2-naphtyl)éthan-1-one

54464-59-4

Ethanone, 1-(1,2,3,4,5,6,7,8-octahydro-2,3,5,5-tetramethyl-2-naphthalenyl)-

1-(1,2,3,4,5,6,7,8-Octahydro-2,3,5,5-tétraméthyl-2-naphtyl)éthan-1-one

54849-38-6

Acetic acid, 2,2′,2″-[(methylstannylidyne)tris(thio)]tris-, triisooctyl ester

2,2′,2″-[(Méthylstannylidyne)tris(thio)]triacétate de triisooctyle

57018-52-7

2-Propanol, 1-(1,1-dimethylethoxy)-

1-tert-Butoxypropan-2-ol

57219-64-4

Zirconium, [µ-[carbonato(2-)-O:O′]]dihydroxydioxodi-

[µ-[Carbonéato(2-)-O:O′]]dihydroxydioxodizirconium

57583-34-3

8-Oxa-3,5-dithia-4-stannatetradecanoic acid, 10-ethyl-4-[[2-[(2-ethylhexyl)oxy]-2-oxoethyl]thio]-4-methyl-7-oxo-, 2-ethylhexyl ester

10-Éthyl-4-[[2-[(2-éthylhexyl)oxy]-2-oxoéthyl]thio]-4-méthyl-7-oxo-8-oxa-3,5-dithia-4-stannatétradécanoate de 2-éthylhexyle

57583-35-4

8-Oxa-3,5-dithia-4-stannatetradecanoic acid, 10-ethyl-4,4-dimethyl-7-oxo-, 2-ethylhexyl ester

10-Éthyl-4,4-diméthyl-7-oxo-8-oxa-3,5-dithia-4-stannatétradécanoate de 2-éthylhexyle

61791-39-7

1H-Imidazole-1-ethanol, 4,5-dihydro-, 2-nortall-oil alkyl derivs.

4,5-Dihydro-1H-imidazole-1-éthanol, dérivés de 2-nortallöl alkyles

63500-71-0

2H-Pyran-4-ol, tetrahydro-4-methyl-2-(2-methylpropyl)-

2-Isobutyl-4-méthyltétrahydro-2H-pyran-4-ol

64742-10-5

Extracts (petroleum), residual oil solvent

Extraits au solvant (pétrole), huile résiduelle

65997-17-3

Glass, oxide, chemicals

Verre aux oxydes, produits chimiques

66418-17-5

Cuprate(3-), [µ-[4-[[4′-[(6-amino-1-hydroxy-3-sulfo-2-naphthalenyl)azo]-3,3′-dihydroxy[1,1′-biphenyl]-4yl]azo]-3-hydroxy-2,7-naphthalenedisulfonato(7-)]]di-, trisodium

[µ-[4-[[4′-[(6-Amino-1-hydroxy-3-sulfo-2-naphtyl)azo]3,3′-dihydroxy[1,1′-biphényl]-4-yl]azo]-3-hydroxynaphtalène-2,7-disulfonato(7-)]]dicuprate(3-) de trisodium

67762-79-2

2,5-Furandione, dihydro-, monopolybutenyl derivs.

Anhydride succinique, dérivés mono[poly(butényliques)]

67800-94-6

1,3-Benzenediamine, ar-methyl-, polymer with methyloxirane and oxirane

Benzène-1,3-diamine, ar-méthylée, polymérisée avec le méthyloxirane et l’oxirane

67989-23-5

1,2,4-Benzenetricarboxylic acid, decyl octyl ester

Acide benzène-1,2,4-tricarboxylique, ester de décyle et d’octyle

68092-47-7

Benzoic acid, 3-methyl-, barium salt

m-Toluate de baryum

68131-73-7

Amines, polyethylenepoly-

Amines, polyéthylènepoly-

68155-66-8

Ethanone, 1-(1,2,3,5,6,7,8,8a-octahydro-2,3,8,8-tetramethyl-2-naphthalenyl)-

1-(1,2,3,5,6,7,8,8a-Octahydro-2,3,8,8-tétraméthyl-2-naphtyl)éthan-1-one

68155-67-9

Ethanone, 1-(1,2,3,4,6,7,8,8a-octahydro-2,3,8,8-tetramethyl-2-naphthalenyl)-

1-(1,2,3,4,6,7,8,8a-Octahydro-2,3,8,8-tétraméthyl-2-naphtyl)éthan-1-one

68186-85-6

C.I. Pigment Green 50

Spinelle vert de titanite de cobalt

68186-90-3

C.I. Pigment Brown 24

Rutile couleur chamois de chrome, d’antimoine et de titane

68187-10-0

C.I. Pigment Brown 34

Spinelle brun de ferrite de nickel

68299-15-0

Stannane, dioctylbis[(1-oxoneodecyl)oxy]-

Bis(néodécanoyloxy)dioctylstannane

68412-21-5

Neodecanoic acid, rare earth salts

Acide néodécanoïque, sels de terres rares

68439-70-3

Amines, C12-16-alkyldimethyl

Amines, alkyle en C12-16 diméthyles

68479-98-1

Benzenediamine, ar,ar-diethyl-ar-methyl-

Diéthylméthylbenzènediamine

68514-09-0

Sulfite liquors and Cooking liquors, spent, oxidized

Lessives de sulfite et lessives de cuisson usées, oxydées

68515-50-4

1,2-Benzenedicarboxylic acid, dihexyl ester, branched and linear

Phtalates de dihexyle ramifié et linéaire

68515-51-5

1,2-Benzenedicarboxylic acid, di-C6-10-alkyl esters

Phtalates de dialkyles en C6-10

68515-73-1

D-Glucopyranose, oligomeric, decyl octyl glycosides

Éthers décyliques et octyliques du D-glucose, oligomères

68526-83-0

Alcohols, C7-9-iso-, C8-rich

Alcools en C7-9, iso-, riches en C8

68609-97-2

Oxirane, mono[(C12-14-alkyloxy)methyl] derivs.

Oxirane, dérivés mono[(alcoolates en C12-14)méthyle]

68855-45-8

Phenol, dodecyl-, sulfurized, calcium salts

Phénol, dodécyl-, sulfurisé, sels de calcium

68891-38-3

Poly(oxy-1,2-ethanediyl), α-sulfo-ω-hydroxy-, C12-14-alkyl ethers, sodium salts

α-Sulfo-ω-hydroxypoly(oxyéthylène), éthers C12-14-alkyliques, sels de sodium

68928-76-7

Stannane, dimethylbis[(1-oxoneodecyl)oxy]-

Diméthylbis[(1-oxonéodécyl)oxy]stannane

68938-03-4

Octene, hydroformylation products, low-boiling

Octène, produits d’hydroformylation, fraction à bas point d’ébullition

68990-67-0

Quillaja saponaria, ext.

Extrait de Quillaja saponaria

70210-32-1

Benzenesulfonic acid, 3-(benzoylamino)-4-hydroxy-5-[[1-[[[4′-[[2-[[2-hydroxy-5(methylsulfonyl)phenyl]azo]-1,3-dioxobutyl]amino]-3,3′-dimethoxy[1,1′-biphenyl]-4-yl]amino]carbonyl]-2-oxopropyl]azo]-, monosodium salt

3-Benzamido-4-hydroxy-5-[[1-[[4′-[[2-[[2-hydroxy-5-(méthylsulfonyl)phényl]azo]-1,3-dioxobutyl]amino]-3,3′-diméthoxy[1,1′-biphényl]-4-yl]carbamoyl]-2-oxopropyl]azo]benzènesulfonate de sodium

70714-66-8

Phosphonic acid, [[(phosphonomethyl)imino]bis[2,1-ethanediylnitrilobis(methylene)]]tetrakis-, ammonium salt

Acide [[(phosphonométhyl)imino]bis[éthylènenitrilobis(méthylène)]]tétraphosphonique, sel d’ammonium

71566-41-1

Benzoic acid, 2-[[2-amino-5-hydroxy-6-[[4′-[(2-hydroxy-6-sulfo-1-naphthalenyl)azo]-3,3′-dimethoxy[1,1′-biphenyl]-4-yl]azo]-7-sulfo-1-naphthalenyl]azo]-5-nitro-, trisodium salt

2-[[2-Amino-5-hydroxy-6-[[4′-[(2-hydroxy-6-sulfonato-1-naphtyl)azo]-3,3′-diméthoxy[1,1′-biphényl]-4-yl]azo]7-sulfonato-1-naphtyl]azo]-5-nitrobenzoate de trisodium

71617-10-2

2-Propenoic acid, 3-(4-methoxyphenyl)-, 3-methylbutyl ester

p-Méthoxycinnamate d’isopentyle

71631-15-7

C.I. Pigment Black 30

Spinelle noir de chromite de fer et de nickel

71868-10-5

1-Propanone, 2-methyl-1-[4-(methylthio)phenyl]2-(4-morpholinyl)-

2-Méthyl-1-[4-(méthylthio)phényl]-2-(morpholin-4-yl)propan-1-one

71873-63-7

Cuprate(4-), [µ-[7-[[3,3′-dihydroxy-4′-[(4-hydroxy-2-sulfobenzo[a]phenazin-3-yl)azo][1,1′-biphenyl]-4-yl]azo]-8-hydroxy-1,3,6-naphthalenetrisulfonato(8-)]]di-, tetrasodium

[µ-[7-[[3,3′-Dihydroxy-4′-[(4-hydroxy-2sulfobenzo[a]phénazin-3-yl)azo][1,1′-biphényl]-4yl]azo]-8-hydroxynaphtalène-1,3,6trisulfonato(8-)]]dicuprate(4-) de tétrasodium

72903-27-6

1,4-Cyclohexanedicarboxylic acid, 1,4-diethyl ester

Ester 1,4-diéthylique de l’acide cyclohexane-1,4-dicarboxylique

73913-06-1

Manganese chloride (MnCl2), hydrate

Hydrate de chlorure de manganèse (MnCl2)

75782-86-4

Alcohols, C12-13

Alcools en C12-13

75782-87-5

Alcohols, C14-15

Alcools en C14-15

75880-28-3

Propanol, [(1-methyl-1,2-ethanediyl)bis(oxy)]bis-, polymer with 1-isocyanato-2-[(4-isocyanatophenyl)methyl]benzene and 1,1′-methylenebis[4-isocyanatobenzene]

(Propylènedioxy)dipropanol polymérisé avec le diisocyanate de 2,4′-méthylènediphényle et le diisocyanate de 4,4′-méthylènediphényle

75980-60-8

Phosphine oxide, diphenyl(2,4,6-trimethylbenzoyl)-

Oxyde de diphényl(2,4,6-triméthylbenzoyl)phosphine

84896-44-6

Propanoic acid, 3,3′-[(dibutylstannylene)bis(thio)]bis-, diisotridecyl ester

3,3′-[(Dibutylstanylène)bis(thio)]dipropionate de diisotridécyle

84989-41-3

2-Oxetanone, 3-C12-16-alkyl-4-C13-17-alkylidene derivs.

Oxétan-2-one, dérivés 3-C12-16-alkyl-4-C13-17-alkylidéniques

85017-91-0

Strontium chloride (SrCl2), hydrate

Hydrate de chlorure de strontium (SrCl2)

85117-41-5

Benzene, mono-C10-14-alkyl derivs., fractionation bottoms

Benzène, dérivés mono-C10-14-alkyliques, produits de queue de fractionnement

87735-26-0

3,5,7,9-Tetraoxa-4,8-disila-6-stannaundecane, 6,6-dibutyl-4,4,8,8-tetraethoxy-

6,6-Dibutyl-4,4,8,8-tétraéthoxy-3,5,7,9-tétraoxa-4,8-disila-6-stannaundécane

94279-36-4

1,2,4-Benzenetricarboxylic acid, tri-C9-11 alkyl esters

Mélange de benzène-1,2,4-tricarboxylates de trialkyle en C9-11

97488-98-7

Oils, fish, oxidized, bisulfited, sodium salts

Huiles de poisson oxydées, bisulfitées, sels de sodium

101200-51-5

Benzoic acid, 2-[[2-amino-5-hydroxy-6-[[4′-[(2-hydroxy-6-sulfo-1-naphthalenyl)azo]-3,3′-dimethoxy[1,1′-biphenyl]-4-yl]azo]-7-sulfo-1-naphthalenyl]azo]-5-nitro-, disodium salt

Sel disodique de l’acide 2-{2-amino-5-hydroxy-6-[4′-(2-hydroxy-6-sulfo-1-naphtylazo)-3,3′-diméthoxybiphényl-4-ylazo]-7-sulfo-1-naphtylazo}-5-nitrobenzoïque

111850-24-9

Phenol, 2,6-bis(1-methylpropyl)-4-[(4-nitrophenyl)azo]-

2,6-Bis(1-méthylpropyl)-4-[(4-nitrophényl)azo]phénol

117527-94-3

Amines, C12_14-tert-alkyl, compds. with 1-[[5-(1,1-dimethylpropyl)-2-hydroxy-3-nitrophenyl]azo]-2-naphthalenol 1-[[2-hydroxy-4(or 5)-nitrophenyl]azo]-2-naphthalenol chromium complexes

tert-Alkylamines en C12-14, composés avec des complexes de chrome du 1-[(2-hydroxy-3-nitro-5-tert-pentylphényl)azo]-2-naphtol et du 1-[(2-hydroxy-4(ou 5)-nitrophényl)azo]-2-naphtol

118832-72-7

Acetic acid, [[[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]methyl]thio]-, C10-14-isoalkyl esters

Esters C10-14-alkyliques de l’acide ({[3,5-bis(tert-butyl)-4-hydroxyphényl]méthyl}thio)acétique

119313-12-1

1-Butanone, 2-(dimethylamino)-1-[4-(4-morpholinyl)phenyl]-2-(phenylmethyl)-

2-(Diméthylamino)-1-[4-(morpholin-4-yl)phényl]-2-(phénylmethyl)butan-1-one

121246-28-4

1,3,5-Triazine-2,4,6-triamine, N,N′,N″-tris[4-[(1,4-dimethylpentyl)amino]phenyl]-

N,N′,N″-Tris[4-[(1,4diméthylpentyl)amino]phényl]mélamine

125997-21-9

Phosphoryl chloride, polymer with 1,3-benzenediol, phenyl ester

Chlorure de phosphoryle polymérisé avec le résorcinol, éther phénylique

206770-18-5

1,2,4-Benzenetricarboxylic acid, mixed 2-ethylhexyl and stearyl triesters

Triesters mixtes 2-éthylhexyliques et stéaryliques de l’acide benzène-1,2,4-tricarboxylique

207683-20-3

Sodium perchlorate hydrate

Hydrate de perchlorate de sodium

474919-59-0

1,2-Cyclohexanedicarboxylic acid, 1,2-dinonyl ester, branched and linear

Cyclohexane-1,2-dicarboxylates de dinonyle (ramifiés ou linéaires)

866625-93-6

Benzotriazole, 1(or 2)-[1-(cyclohexyloxy)heptyl]methyl-

1(ou 2)-[1-(Cyclohexyloxy)heptyl]méthylbenzotriazole

1163775-81-2

1,2,4-Benzenetricarboxylic acid, mixed lauryl and octyl triesters

Mélange de triesters dodécyliques et/ou octyliques de l’acide benzène-1,2,4-tricarboxylique

Part 3 masked substances

Confidential Accession Number

Masked name

Nom maquillé

13827-3

Phosphonic acid, dibutyl ester, reaction products with alkyl substituted ethanol

Phosphonate de dibutyle, produits de réaction avec de l’éthanol substitué avec un alkyle

Part 4 — Substances from the In-Commerce List (ICL)

CAS RN

Substance name

Nom de la substance

52-01-7

Pregn-4-ene-21-carboxylic acid, 7-(acetylthio)-17-hydroxy-3-oxo-, γ-lactone, (7α,17α)-

Spironolactone

53-43-0

Androst-5-en-17-one, 3-hydroxy-, (3β)-

Prastérone

57-85-2

Androst-4-en-3-one, 17-(1-oxopropoxy)-, (17β)-

Propionate de testostérone

60-13-9

Benzeneethanamine, α-methyl-, sulfate (2:1)

sulfate d’amphétamine

60-31-1

Ethanaminium, 2-(acetyloxy)-N,N,N-trimethyl-, chloride

Chlorure d’acétylcholine

66-40-0

Ethanaminium, N,N,N-triethyl-

tétraéthylammonium

68-05-3

Ethanaminium, N,N,N-triethyl-, iodide

Iodure de tétraéthylammonium

73-31-4

Acetamide, N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-

N-(2-(5-méthoxyindole-3-yl)éthyl)acetamide

79-17-4

Hydrazinecarboximidamide

aminoguanidine

83-43-2

Pregna-1,4-diene-3,20-dione, 11,17,21-trihydroxy-6-methyl-, (6α,11β)-

Méthylprednisolone

85-19-8

Methanone, (5-chloro-2-hydroxyphenyl)phenyl-

5-chloro-2-hydroxybenzophénone

85-70-1

1,2-Benzenedicarboxylic acid, 2-butoxy-2-oxoethyl butyl ester

Phtalate de butoxycarbonylméthyle et de butyle

87-18-3

Benzoic acid, 2-hydroxy-, 4-(1,1-dimethylethyl)phenyl ester

Salicylate de 4-tert-butylphényle

91-68-9

Phenol, 3-(diethylamino)-

3-Diéthylaminophénol

94-43-9

Mercury, (benzoato-O)phenyl-

benzoate de phénylmercure

94-51-9

1-Propanol, 3,3′-oxybis-, 1,1′-dibenzoate

dibenzoate de 3,3′-oxydipropyle

95-84-1

Phenol, 2-amino-4-methyl-

2-Amino-p-crésol

97-18-7

Phenol, 2,2′-thiobis[4,6-dichloro-

Bithionol

99-57-0

Phenol, 2-amino-4-nitro-

2-Amino-4-nitrophénol

102-29-4

1,3-Benzenediol, monoacetate

Acétate de 3-hydroxyphényle

102-98-7

Mercurate(2-), [orthoborato(3-)-κO]phenyl-, hydrogen (1:2)

[orthoborato(3-)-O]phénylmercurate(2-) de dihydrogéno

104-98-3

2-Propenoic acid, 3-(1H-imidazol-4-yl)-

Acide 3-imidazol-4-ylacrylique

116-38-1

Benzenaminium, N-ethyl-3-hydroxy-N,N-dimethyl-, chloride (1:1)

chlorure de d’édrophonium

122-11-2

Benzenesulfonamide, 4-amino-N-(2,6-dimethoxy-4-pyrimidinyl)-

sulfadiméthoxine

123-78-4

4-Octadecene-1,3-diol, 2-amino-, (2S,3R,4E)-

2-aminooctadec-4-ène-1,3-diol

130-95-0

Cinchonan-9-ol, 6′-methoxy-, (8α,9R)-

Quinine

132-69-4

1-Propanamine, N,N-dimethyl-3-[[1-(phenylmethyl)-1H-indazol-3-yl]oxy]-, hydrochloride (1:1)

3-[[1-benzyl-1H-indazole-3-yl]oxy]-N,N-diméthylpropylamine, monochlorhydrate

137-88-2

Pyridinium, 1-[(4-amino-2-propyl-5- pyrimidinyl)methyl]-2-methyl-, chloride, hydrochloride (1:1:1)

Pyridinium, 1-[(4-amino-2-propyl-5-pyrimidinyl)méthyl]-2-méthyl-, chlorure, chlorhydrate (1:1:1)

141-02-6

2-Butenedioic acid (E)-, bis(2-ethylhexyl) ester

Fumarate de bis(2-éthylhexyle)

141-86-6

2,6-Pyridinediamine

Pyridine-2,6-diyldiamine

141-94-6

5-Pyrimidinamine, 1,3-bis(2-ethylhexyl)hexahydro-5-methyl-

Héxétidine

142-55-2

2-hydroxypropyl laurate

laurate de 2-hydroxypropyle

145-13-1

Pregn-5-en-20-one, 3-hydroxy-, (3β)-

prégnenolone

148-01-6

Benzamide, 2-methyl-3,5-dinitro-

dinitolmide

148-79-8

1H-Benzimidazole, 2-(4-thiazolyl)-

Thiabendazole

153-61-7

5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[(acetyloxy)methyl]-8-oxo-7-[[2-(2-thienyl)acetyl]amino]-, (6R,7R)-

céfalotine

293-51-6

Cyclotetrasiloxane

Cyclotétrasiloxane

303-98-0

2,5-Cyclohexadiene-1,4-dione, 2-(3,7,11,15,19,23,27,31,35,39-decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-, (all-E)-

Coenzyme Q-10

306-94-5

Naphthalene, octadecafluorodecahydro-

Perflunafène

317-34-0

1H-Purine-2,6-dione, 3,7-dihydro-1,3-dimethyl-, compd. with 1,2-ethanediamine (2:1)

Aminophylline

330-95-0

Urea, N,N′-bis(4-nitrophenyl)-, compd. with 4,6-dimethyl-2(1H)-pyrimidinone (1:1)

1,3-Bis(4-nitrophényl)urée--4,6-diméthylpyrimidin-2-ol (1:1)

362-74-3

Adenosine, N-(1-oxobutyl)-, cyclic 3′,5′-(hydrogen phosphate) 2′-butanoate

bucladesine

404-86-4

6-Nonenamide, N-[(4-hydroxy-3-methoxyphenyl)methyl]-8-methyl-, (E)-

Capsaïcine

500-38-9

1,2-Benzenediol, 4,4′-(2,3-dimethyl-1,4-butanediyl)bis-

4,4′-(2,3-diméthyltétraméthylene)dipyrocatéchol

501-30-4

4H-Pyran-4-one, 5-hydroxy-2-(hydroxymethyl)-

5-hydroxy-2-hydroxyméthyl-4-pyrone

508-02-1

Olean-12-en-28-oic acid, 3-hydroxy-, (3β)-

Acide 3β-hydroxyoléan-12-én-28-oïque

518-40-1

Benzoic acid, 2-(6-hydroxy-4,5-diiodo-3-oxo-3H-xanthen-9-yl)-

Acide 2-(6-hydroxy-4,5-diiodo-3-oxo-3H-xanthén-9-yl)benzoïque

522-48-5

1H-Imidazole, 4,5-dihydro-2-(1,2,3,4-tetrahydro-1-naphthalenyl)-, monohydrochloride

Tétryzoline, chlorhydrate

522-51-0

Quinolinium, 1,1′-(1,10-decanediyl)bis[4-amino-2-methyl-, dichloride

cotarmine de déqualinium

530-43-8

Hexadecanoic acid, (2R,3R)-2-[(2,2-dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propyl ester

palmitate de chloramphénicol

538-02-3

Cyclopentaneethanamine, N,α-dimethyl-, hydrochloride

cyclopentamine, chlorhydrate

546-46-3

1,2,3-Propanetricarboxylic acid, 2-hydroxy-, zinc salt (2:3)

Dicitrate de trizinc

556-38-7

Pentanoic acid, zinc salt

Divalérate de zinc

557-61-9

1-Octacosanol

Octacosan-1-ol

576-55-6

Phenol, 2,3,4,5-tetrabromo-6-methyl-

3,4,5,6-Tétrabromo-o-crésol

594-45-6

Ethanesulfonic acid

Acide éthanesulfonique

603-85-0

Phenol, 2-amino-3-nitro-

2-amino-3-nitrophénol

611-75-6

Benzenemethanamine, 2-amino-3,5-dibromo-N-cyclohexyl-N-methyl-, monohydrochloride 

bromhexine, chlorhydrate

660-27-5

Acetic acid, dichloro-, compd. with N-(1-methylethyl)-2-propanamine (1:1)

Dichloroacétate de diisopropylammonium

719-59-5

Methanone, (2-amino-5-chlorophenyl)phenyl-

2-Amino-5-chlorobenzophénone

820-66-6

1-Octadecanaminium, N-(carboxymethyl)-N,N-dimethyl-, hydroxide, inner salt

(Carboxylatométhyl)diméthyl(octadécyl)ammonium

832-01-9

2-Propenoic acid, 3-(4-methoxyphenyl)-, methyl ester

p-méthoxycinnamate de méthyle

865-44-1

Iodine chloride (ICl3)

Trichlorure d’iode

866-82-0

1,2,3-Propanetricarboxylic acid, 2-hydroxy-, copper(2++) salt (1:2)

Citrate de dicuivre

1093-16-9

Spiro[naphthalene-2(1H),2′-oxirane]-1-propanol, α-ethenyloctahydro-α,5,5,8a-tetramethyl-

α-Vinyloctahydro-α,5,5,8a-tétraméthyl-spiro[naphtalène-2(1H),2′-oxirane]propan-1-ol

1109-11-1

2,4,6,8,10,12,14,16-Heptadecaoctaenoic acid, 2,6,11,15-tetramethyl-17-(2,6,6-trimethyl-1-cyclohexen-1-yl)-, ethyl ester, (2E,4E,6E,8E,10E,12E,14E,16E)-

8′-apo-.bêta.-carotène-8′-oate d’éthyle

1112-38-5

Phosphorothioic acid, O,O-dimethyl ester

Phosphorothioate d’O,O-diméthyle

1314-84-7

Zinc phosphide (Zn3P2)

Diphosphure de trizinc

1315-04-4

Antimony sulfide (Sb2S5)

Pentasulfure de diantimoine

1317-26-6

Aluminum magnesium hydroxide (AlMg2(OH)7), monohydrate

magaldrate

1319-53-5

Malachite (Cu2(CO3)(OH)2)

malachite

1322-14-1

10-Undecenoic acid, calcium salt

Diundéc-10-énoate de calcium

1335-26-8

Magnesium peroxide

Peroxyde de magnésium

1337-20-8

Chlorophyllins, copper potassium sodium

chlorophyllines, cuivre, potassium et sodium

1399-80-0

Benzenedimethanaminium, ar-dodecyl-ar,N,N,N,N′,N′,N′-heptamethyl-, dichloride, mixt. with ar-dodecyl-ar,N,N,N-tetramethylbenzenemethanaminium chloride

Benzènediméthanaminium, ar-dodécyl-ar,N,N,N,N′,N′,N′-heptaméthyl-, dichlorure, mélange avec le chlorure d’ar-dodécyl-ar,N,N,N-tétraméthylbenzèneméthanaminium

1405-89-6

Bacitracin zinc

Bacitracine zincique

1463-95-2

Pyridinium, 2-[2-[(5-bromo-2-pyridinyl)amino]ethenyl]-1-ethyl-6-methyl-, iodide (1:1)

iodure de 2-[2-[(5-bromo-2-pyridyl)amino]vinyl]-1-éthyl-6-méthylpyridinium

1553-41-9

5,8,11,14,17-Eicosapentaenoic acid

acide 5Z,8Z,11Z,14Z,17Z-eicosapentaénoïque

1570-64-5

Phenol, 4-chloro-2-methyl-

4-Chloro-o-crésol

1641-17-4

Methanone, (2-hydroxy-4-methoxyphenyl)(4-methylphenyl)-

mexénone

1778-02-5

Pregn-5-en-20-one, 3-(acetyloxy)-, (3β)-

acétate de prégnenolone

1929-30-2

2-Propenoic acid, 3-(4-methoxyphenyl)-, ethyl ester

p-méthoxycinnamate d’éthyle

1976-28-9

3-Pyridinecarboxylic acid, aluminum salt (3:1)

trinicotinate d’aluminium

2016-45-7

1-Hexadecanamine, N,N-dimethyl-, hydrochloride (1:1)

chlorure de hexadécyldiméthylammonium

2040-10-0

Ethanone, 1-[4-(1,1-dimethylethyl)-2,6-dimethylphenyl]-

4′-tert-Butyl-2′,6′-diméthylacétophénone

2136-71-2

Ethanol, 2-(hexadecyloxy)-

2-(hexadécyloxy)éthanol

2180-18-9

Acetic acid, manganese salt

Acide acétique, sel de manganèse

2197-63-9

1-Hexadecanol, hydrogen phosphate

Hydrogénophosphate de dihexadécyle

2224-49-9

Dodecanoic acid, compd. with 2,2′,2″-nitrilotris[ethanol] (1:1)

Acide laurique, composé avec le 2,2′,2″-nitrilotriéthanol (1:1)

2315-66-4

3,6,9,12,15,18,21,24,27-Nonaoxanonacosan-1-ol, 29-[4-(1,1,3,3-tetramethylbutyl)phenoxy]-

3,6,9,12,15,18,21,24,27-nonaoxanonacosan-1-ol, 29-[4-(1,1,3,3-tétraméthylbutyl)phénoxy]-

2370-64-1

Dodecanoic acid, 17-hydroxy-3,6,9,12,15-pentaoxaheptadec-1-yl ester

laurate de 17-hydroxy-3,6,9,12,15-pentaoxaheptadec-1-yle

2380-86-1

1H-Indol-6-ol

6-hydroxyindole

2420-29-3

3,6,9,12,15,18-Hexaoxahexatriacontan-1-ol

3,6,9,12,15,18-Hexaoxahexatriacontan-1-ol

2487-40-3

6H-Purin-6-one, 1,2,3,7-tetrahydro-2-thioxo-

1,2,3,7-Tétrahydro-2-thioxo-6H-purin-6-one

2565-36-8

Ethanol, 2,2′-[methylenebis(oxy)]bis-

2,2′-[méthylènebis(oxy)]biséthanol

2568-33-4

1, 3-Butanediol, 3-methyl

1,3-butanediol, 3-méthyl-

2638-43-9

3,6,9,12,15,18,21-Heptaoxatricosan-1-ol, 23-[4-(1,1,3,3-tetramethylbutyl)phenoxy]-

3,6,9,12,15,18,21-heptaoxatricosan-1-ol, 23-[4-(1,1,3,3-tétraméthylbutyl)phénoxy]-

2748-88-1

Pyridinium, 4-methyl-1-tetradecyl-, chloride

Chlorure de 4-méthyl-1-tétradécylpyridinium

2784-94-3

Ethanol, 2,2′-[[4-(methylamino)-3nitrophenyl]imino]bis-

2,2′-[[4-(Méthylamino)-3-nitrophényl]imino]diéthanol

2835-98-5

Phenol, 2-amino-5-methyl-

6-amino-m-cresol

2835-99-6

Phenol, 4-amino-3-methyl-

4-Amino-m-crésol

2919-66-6

Pregna-4,6-diene-3,20-dione, 17-(acetyloxy)-6-methyl-16-methylene-

acétate de mélengestrol

2944-65-2

Butanedioic acid, 2,3-dihydroxy- (2R,3R)-, iron(2+) salt (1:1)

[R-(R*,R*)]-tartrate de fer

3069-40-7

Silane, trimethoxyoctyl-

Triméthoxyoctylsilane

3184-65-4

Phenol, 4-chloro-2-(phenylmethyl)-, sodium salt

2-Benzyl-4-chlorophénolate de sodium

3251-56-7

Phenol, 2-methoxy-4-nitro-

2-Méthoxy-4-nitrophénol

3305-68-8

9-Octadecen-1-ol, phosphate (3:1), (9Z,9′Z,9″Z)-

phosphate de trioléyle

3374-30-9

Benzenemethanaminium, N-ethyl-N-[4-[[4-[ethyl(phenylmethyl)amino]phenyl](5-hydroxy-2,4-disulfophenyl)methylene]-2,5-cyclohexadien-1-ylidene]-, hydroxide, inner salt, calcium salt (2:1)

Bis[hydrogéno(benzyl)[4-[[4-(benzyléthylamino)phényl](5-hydroxy-2,4-disulfonatophényl)méthylène]cyclohexa-2,5-dién-1-ylidène](éthyl)ammonium], sel de calcium

3397-16-8

L-Glutamic acid, N-(1-oxooctadecyl)-

acide N-(1-oxooctadécyl)-L-glutamique

3520-90-9

3,6,9,12,15,18,21-Heptaoxatricosan-1-ol, 23-(4-octylphenoxy)-

3,6,9,12,15,18,21-heptaoxatricosan-1-ol, 23-(4-octylphénoxy)-

3521-84-4

D-Glucitol, 1-deoxy-1-(methylamino)-, 3,3′-[(1,6-dioxo-1,6-hexanediyl)diimino]bis[2,4,6-triiodobenzoate] (2:1) (salt)

adipiodone, sel de dimeglumine

3564-09-8

2,7-Naphthalenedisulfonic acid, 3-hydroxy-4-[2-(2,4,5-trimethylphenyl)diazenyl]-, sodium salt (1:2)

3-hydroxy-4-[(2,4,5-triméthylphényl)azo]naphtalène-2,7-disulfonate de disodium

3599-32-4

1H-Benz[e]indolium, 2-[7-[1,3-dihydro-1,1-dimethyl-3-(4-sulfobutyl)-2H-benz[e]indol-2-ylidene]-1,3,5-heptatrienyl]-1,1-dimethyl-3-(4-sulfobutyl)-, hydroxide, inner salt, sodium salt

2-{7-[1,3-Dihydro-1,1-diméthyl-3-(4-sulfobutyl)-2H-benz[e]indol-2-ylidène]hepta-1,3,5-triényl}-1,1-diméthyl-3-(4-sulfobutyl)-1H-benz[e]indolium, hydroxyde, sel interne, sel de sodium

3697-42-5

2,4,11,13-Tetraazatetradecanediimidamide, N,N″-bis(4-chlorophenyl)-3,12-diimino-, hydrochloride (1:2)

chlorhexidine, dichlorhydrate

4316-73-8

Glycine, N-methyl-, monosodium salt

Sarcosinate de sodium

4372-02-5

Spiro[isobenzofuran-1(3H),9′-[9H]xanthen]-3-one, 4′,5′-dibromo-3′,6′-dihydroxy-, sodium salt (1:2)

2-(4,5-dibromo-6-oxydo-3-oxoxanthène-9-yl)benzoate de disodium

4478-97-1

3,6,9,12,15-Pentaoxahentriacontan-1-ol

3,6,9,12,15-pentaoxahentriacontan-1-ol

4618-23-9

Benzoic acid, 2,3,4,5-tetrachloro-6-(2,4,5,7-tetrabromo-6-hydroxy-3-oxo-3H-xanthen-9-yl)-, disodium salt

Acide 2,3,4,5-tétrachloro-6-(2,4,5,7-tétrabromo-6-hydroxy-3-oxo-3H-xanthén-9-yl)benzoïque, sel disodique

4861-19-2

Urea, phosphate (1:1)

Phosphate d’urée

4991-65-5

1,3-Benzoxathiol-2-one, 6-hydroxy-

tioxolone

5353-26-4

3,6,9,12-Tetraoxatriacont-21-en-1-ol, (Z)-

3,6,9,12-tétraoxatriacont-21-én-1-ol, (Z)-

5697-02-9

1-naphthalenol, 2-methyl-, acetate

1-naphtalénol, 2-méthyl-, 1-acétate

5725-96-2

Methanamine, N-hydroxy-N-methyl-

N-Hydroxydiméthylamine

5836-69-1

Phosphinic amide, P,P-dibutyl-N,N-dipropyl-

Amide phosphinique, P,P-dibutyl-N,N-dipropyl-

5858-61-7

2,7-Naphthalenedisulfonic acid, 3-[[4-(acetylamino)phenyl]azo]-4-hydroxy-, disodium salt

3-[[4-(acétylamino)phényl]azo]-4-hydroxynaphtalène-2,7-disulfonate de disodium

5863-51-4

Benzenemethanaminium, N-[4-[(2-chlorophenyl)[4-[ethyl[(3-sulfophenyl)methyl]amino]-2-methylphenyl]methylene]-3-methyl-2,5-cyclohexadien-1-ylidene]-N-ethyl-3-sulfo-, hydroxide, inner salt, sodium salt

Hydrogéno[4-[(2-chlorophényl)[4-[éthyl(3-sulfonatobenzyl)amino]-o-tolyl]méthylène]-3-méthylcyclohexa-2,5-dién-1-ylidène](éthyl)(3-sulfonatobenzyl)ammonium, sel de sodium

5905-52-2

Propanoic acid, 2-hydroxy-, iron(2+) salt (2:1)

dilactate de fer

6159-41-7

10-Undecenoic acid, potassium salt (1:1)

Acide 10-undécénoïque, sel de potassium (1:1)

6182-11-2

Octadecanoic acid, 1-methyl-1,2-ethanediyl ester

Distéarate de propylène

6219-67-6

1,3-Benzenediamine, 4-methoxy-, sulfate

Sulfate de 4-méthoxybenzène-1,3-diamine

6219-69-8

1,3-Benzenediamine, 4-ethoxy-, sulfate

1,3-benzènediamine, 4-éthoxy-, sulfate

6273-99-0

Mercury, [.mu.-[orthoborato(2-)-κO:κO′]]diphenyldi-

[.mu.-[orthoborato(2-)-O:O′]]diphényldimercure

6358-53-8

2-Naphthalenol, 1-[(2,5-dimethoxyphenyl)azo]-

1-[(2,5-Diméthoxyphényl)azo]napht-2-ol

6371-76-2

2-Naphthalenecarboxylic acid, 3-hydroxy-4-(phenylazo)-, calcium salt (2:1)

Bis[3-hydroxy-4-(phénylazo)-2-naphtoate] de calcium

6371-96-6

Butanamide, 2-[(4-methoxy-2-nitrophenyl)azo]-N-(2-methylphenyl)-3-oxo-

2-[(4-Méthoxy-2-nitrophényl)azo]-3-oxo-N-(o-tolyl)butyramide

6505-30-2

Benzenemethanaminium, N-[4-[[4-(diethylamino)phenyl][4-[ethyl[(3-sulfophenyl)methyl]amino]-2-methylphenyl]methylene]-3-methyl-2,5-cyclohexadien-1-ylidene]-N-ethyl-3-sulfo-, hydroxide, inner salt, sodium salt

Hydrogéno[4-[[4-(diéthylamino)phényl][4-[éthyl[(3-sulfonatobenzyl)amino]-o-tolyl]méthylène]-3-méthylcyclohexa-2,5-dién-1-ylidène](éthyl)(3-sulfonatobenzyl)ammonium, sel de sodium

6548-12-5

Benzenemethanaminium, N-ethyl-N-[4-[[4-[ethyl[(3-sulfophenyl)methyl]amino]phenyl](2-sulfophenyl)methylene]-2,5-cyclohexadien-1-ylidene]-3-sulfo-, inner salt, barium salt (1:1)

dihydrogéno(éthyl)[4-[[4-[éthyl(3-sulfonatobenzyl)amino]phényl](2-sulfonatophényl)methylène]cyclohexa-2,5-diène-1-ylidène](3-sulfonatobenzyl)ammonium, sel de baryum

6640-03-5

1-Tetradecanol, hydrogen phosphate

Hydrogénophosphate de ditétradécyle

6966-09-2

Cyclohexanone, 2-(1-piperidinylmethyl)-, hydrochloride (1:1)

Cyclohexanone, 2-(1-pipéridinylméthyl)-, chlorhydrate (1:1)

7091-57-8

8-Quinolinol, benzoate (salt)

acide benzoïque, composé avec quinoléine-8-ol (1:1)

7147-34-4

1,2,3-Propanetricarboxylic acid, 2-hydroxy-, 1,2,3-tris(2-ethylhexyl)ester

2-hydroxypropane-1,2,3-tricarboxylate de tris(2-éthylhexyle)

7211-53-2

Docosanoic acid, potassium salt (1:1)

Sel de potassium de l’acide docosanoïque (1:1) 

7230-93-5

Dodecanoic acid, aluminum salt (3:1)

trilaurate d’aluminium

7360-38-5

Hexanoic acid, 2-ethyl-, 1,2,3-propanetriyl ester

2-ethylhexanoate de propane-1,2,3-triyle

7446-27-7

Phosphoric acid, lead(2++) salt (2:3)

Bis(orthophosphate) de triplomb

7492-68-4

Carbonic acid, copper salt

acide carbonique, sel de cuivre

7651-99-2

Phosphonic acid, [1,2-ethanediylbis[nitrilobis (methylene)]]tetrakis-, pentasodium salt

[Éthylènebis(nitrilobisméthylène)]tétrakisphosphonate pentasodique

7704-67-8

Erythromycin, thiocyanate (salt)

thiocyanate d’érythromycine

7773-03-7

Sulfurous acid, monopotassium salt

Hydrogénosulfite de potassium

7789-46-0

Iron bromide (FeBr2)

Dibromure de fer

7790-44-5

Stibine, triiodo-

Triiodure d’antimoine

8007-56-5

Aqua regia

Acide nitrochlorhydrique

9022-75-7

Poly[oxy[hydroxymethyl)-1,2-ethanediyl]], α-dodecyl-ω-hydroxy-

Poly[oxy[hydroxyméthyl)-1,2-éthanediyl]], α-dodécyl-oméga-hydroxy-

9050-93-5

β-D-Glucan, (1→3)-, carboxymethyl ether, sodium salt

β-D-glucane, (1→3)-, éther carboxyméthylique, sel sodique

9065-63-8

Oxirane, methyl-, polymer with oxirane, butyl ether

Oxirane, méthyl-, polymérisé avec l’oxirane, éther butylique

10031-23-9

Radium bromide (RaBr2)

bromure de radium

10031-59-1

Sulfuric acid, thallium salt

Sulfate de thallium

10101-63-0

Lead iodide (PbI2)

Diiodure de plomb

10124-48-8

Mercury amide chloride (Hg(NH2)Cl)

Chlorure d’aminomercure

10124-49-9

Sulfuric acid, iron salt

Acide sulfurique, sel de fer

10139-47-6

Zinc iodide (ZnI2)

Iodure de zinc

10161-34-9

Estra-4,9,11-trien-3-one, 17-(acetyloxy)-, (17β)-

17-acétate de 17.bêta.-hydroxyestra-4,9,11-triène-3-one

10192-46-8

Boric acid (H3BO3), zinc salt (2:3)

Acide borique (H3BO3), sel de zinc (2:3)

10233-14-4

9-Octadecenoic acid (Z)-, 2-[2-(2-hydroxyethoxy)ethoxy]ethyl ester

Oléate de 2-[2-(2-hydroxyéthoxy)éthoxy]éthyle

10279-59-1

Phosphoric acid, aluminum sodium salt (8:2:3)

Acide phosphorique, sel d’aluminium et de sodium (8:2:3)

10294-31-2

Gold iodide (AuI)

Monoiodure d’or

10294-70-9

Tin iodide (SnI2)

Diiodure d’étain

10305-76-7

Phosphoric acid, aluminum sodium salt (8:3:1), tetrahydrate

Acide phosphorique, sel d’aluminium et de sodium (8:3:1), tétrahydrate

10326-21-3

Chloric acid, magnesium salt

Chlorate de magnésium

10361-76-9

Peroxymonosulfuric acid, potassium salt (1:2)

Acide peroxymonosulfurique, sel de potassium (1:2)

10476-84-3

Octadecanoic acid, manganese salt (1:?)

Acide octadécanoïque, sel de manganèse (1:?)

10476-86-5

Strontium iodide (SrI2)

Iodure de strontium

11092-32-3

Aluminum oxide (AlO2)

oxyde d’aluminium

11108-73-9

Uranium alloy, base, U,Nb,Zr (Mulberry)

Alliage d’uranium, base, U, Nb, Zr (Mulberry)

12018-01-8

Chromium oxide (CrO2)

Dioxyde de chrome

12122-15-5

Nickel carbonate hydroxide (Ni5(CO3)2(OH)6)

Hydroxyde de carbonate de nickel (Ni5(CO3)2(OH)6)

12217-41-3

C.I. Basic Blue 22

Basic Blue 22 du C.I.

12217-43-5

9,10-Anthracenedione, 1-amino-4-[[4-[(dimethylamino)methyl]phenyl]amino]-

1-amino-4-[[4-[(diméthylamino)méthyl]phényl]amino]anthraquinone

12221-52-2

C.I. Basic Red 22

C.I. rouge basique 22

12222-04-7

C.I. Direct Blue 199

Direct Blue 199 du C.I.

12640-40-3

Bismuth oxide

oxyde de bismuth

12651-23-9

Titanium hydroxide

hydroxyde de titane

12684-19-4

Lead iodide

Iodure de plomb

13103-75-8

Benzenamine, N,N-dimethyl-4-(2-pyridinylazo)-

N,N-Diméthyl-4-(2-pyridylazo)aniline

13408-62-3

Ferrate(3-), hexakis(cyano-κC)-, (OC-6-11)-

Ferrate(3-), hexakis(cyano-κC)-, (OC-6-11)-

13429-07-7

2-Propanol, 1-(2-methoxypropoxy)-

1-(2-méthoxypropoxy)propane-2-ol

13557-75-0

Dodecanoic acid, 2-(1-carboxyethoxy)-1-methyl-2-oxoethyl ester, sodium salt (1:1)

laurate de sodium et de 2-(1-carboxylatoéthoxy)-1-méthyl-2-oxoéthyle

13682-92-3

Aluminum, (glycinato-N,O)dihydroxy-, (ß-4)-

Glycinate de dihydroxyaluminium

13779-98-1

Plumbane, tetraiodo-

Plumbane, tétraiodo-

14452-57-4

Magnesium peroxide (Mg(O2))

Dioxyde de magnésium

14465-68-0

9,12,15-Octadecatrienoic acid, 1,1′,1″-(1,2,3-propanetriyl) ester, (9Z,9′Z,9″Z,12Z,12′Z,12″Z,15Z,15′Z,15″Z)-

tris[(9Z,12Z,15Z)-octadéca-9,12,15-triénoate] de propane-1,2,3-triyle

14639-25-9

2-Pyridinecarboxylic acid, chromium(3+) salt (3:1)

Acide 2-pyridinecarboxylique, sel de chrome (3+) (3:1)

15454-75-8

Zinc, bis(5-oxo-L-prolinato-κN1,κO2)-, (T-4)-

bis(5-oxo-L-prolinato-N1,O2)zinc

15763-02-7

Butanedioic acid, 2-hydroxy-, 1,4-dioctyl ester

2-hydroxybutanedioate de 1,4-dioctyle

15792-51-5

Benzenesulfonic acid, 2,5-dichloro-4-[4,5-dihydro-3-methyl-5-oxo-4-[[3-[(phenylamino)sulfonyl]phenyl]azo]-1H-pyrazol-1-yl]-, monosodium salt

4-[4-[[3-(anilinosulfonyl)phényl]azo]-4,5-dihydro-3-méthyl-5-oxo-1H-pyrazole-1-yl]-2,5-dichlorobenzènesulfonate de sodium

15876-39-8

Spiro[isobenzofuran-1(3H),9′-[9H]xanthen]-3-one,2′,4′,5′,7′-tetrabromo-3′,6′-dihydroxy, aluminum salt (3:2)

tris[2-(2,4,5,7-tétrabromo-6-oxydo-3-oxoxanthène-9-yl)benzoate] de dialuminium

15905-86-9

Nitric acid, uranium salt

Acide nitrique, sel d’uranium

16040-38-3

Phosphoric acid, lead salt

Acide phosphorique, sel de plomb

16057-43-5

Ethanol,2{2-(octadecyloxy)ethoxy}-

Éthanol, 2{2-(octadécyloxy)éthoxy}-

16508-79-5

2-Naphthalenecarboxylic acid, 3-hydroxy-4-(2-phenyldiazenyl)-, barium salt (2:1)

Acide 3-hydroxy-4-(2-phényldiazényl)-2-naphtalènecarboxylique, sel de baryum (2:1)

16508-80-8

Benzoic acid, 2-(2,4,5,7-tetrabromo-6-hydroxy-3-oxo-3H-xanthen-9-yl)-, aluminum salt (1:?)

acide 2-(2,4,5,7-tétrabromo-3,6-dihydroxyxanthène-9-yl)benzoïque, sel d’aluminium

16561-29-8

Tetradecanoic acid, (1aR,1bS,4aR,7aS,7bS,8R,9R,9aS)-9a-(acetyloxy)-1a,1b,4,4a,5,7a,7b,8,9,9a-decahydro-4a,7b-dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-5-oxo-1H-cyclopropa[3,4]benz[1,2-e]azulen-9-yl ester

Tétradécanoate de (1aR,1bS,4aR,7aS,7bS,8R,9R,9aS)-9a-(acétyloxy)-1a,1b,4,4a,5,7a,7b,8,9,9a-décahydro-4a,7b-dihydroxy-3-(hydroxyméthyl)-1,1,6,8-tétraméthyl-5-oxo-1H-cyclopropa[3,4]benz[1,2-e]azulén-9-yle

16693-53-1

Glycine, N-methyl-N-(1-oxododecyl)-, compd. with 2,2′,2″-nitrilotris[ethanol] (1:1)

N-Méthyl-N-(1-oxododécyl)glycine, composé avec le 2,2′,2″-nitrilotri(éthanol) (1:1)

16824-78-5

Phenol, 2,4,6-trinitro-, calcium salt

Phénol, 2,4,6-trinitro-, sel de calcium

17026-85-6

1-Hexadecanol, 1-(dihydrogen phosphate), potassium salt (1:?)

1-hexadécanol, 1-(dihydrogen phosphate), potassium salt (1:?)

17121-12-9

1,3,5,7,2,4,6,8-Tetroxatetraphosphocane, 2,4,6,8-tetrahydroxy-,2,4,6,8-tetraoxide,ion(4-)

1,3,5,7,2,4,6,8-tétroxatétraphosphocane, 2,4,6,8-tétrahydroxy-,2,4,6,8-tétraoxyde, ionique (-4)

17375-37-0

Carbonic acid, manganese salt

acide carbonique, sel de manganèse

17619-86-2

Ethanol, 2-amino-, sulfite (salt)

Éthanol, 2-amino-, sulfite (sel)

17672-22-9

Phenol, 2-amino-6-methyl-

Phénol, 2-amino-6-méthyl-

17879-97-9

Benzenepropanoic acid, 3-amino-α-ethyl-2,4,6-triiodo-, (R)-

Acide (R)-3-amino-α-éthyl-2,4,6-triiodobenzènepropanoïque

17949-65-4

Zinc, bis(2-pyridinecarboxylato-κN1,κO2-, (T-4)-

picolinate de zinc

18089-54-8

Silanol, methyl-

Silanol, méthyl-

18358-13-9

2-Propenoic acid, 2-methyl-, ion(1-)

Acide 2-méthyl-2-propénoïque ionique (1-)

18507-89-6

3-Quinolinecarboxylic acid, 6-(decyloxy)-7-ethoxy-4-hydroxy-, ethyl ester

6-décyloxy-7-éthoxy-4-hydroxy-3-quinoleinate d’éthyle

18917-91-4

Aluminum, tris(2-hydroxypropanoato-O1,O2)-

Trilactate d’aluminium

20636-48-0

3,6,9,12-Tetraoxatetradecan-1-ol, 14-(4-nonylphenoxy)-

3,6,9,12-tétraoxatétradécan-1-ol, 14-(4-nonylphénoxy)-

20858-25-7

3,6,9,12-Tetraoxatetracosanoic acid

Acide 3,6,9,12-tétraoxatétracosanoïque

20882-75-1

9H-Xanthen-9-one, 1,2,8-trihydroxy-6-methoxy-

9H-xanthén-9-one, 1,2,8-trihydroxy-6-méthoxy-

21034-17-3

Oxazolium, 3,4-dimethyl-2-[2-(phenylamino)ethenyl]-, iodide

iodure de 3,4-dimethyl-2-[2-(phénylamino)vinyl]oxazolium

21109-95-5

Barium sulfide (BaS)

Sulfure de baryum

21127-45-7

3,6,9,12,15-Pentaoxaheptacosanoic acid

Acide 3,6,9,12,15-pentaoxaheptacosanoïque

21245-01-2

Benzoic acid, 4-(dimethylamino)-, 3-methylbutyl ester

Padimate

21542-96-1

1-Docosanamine, N,N-dimethyl-

N,N-diméthyldocosylamine

22204-24-6

2-naphthalenecarboxylic acid, 4,4′-methylenebis[3-hydroxy-, compd. with 1,4,5,6-tetrahydro-1-methyl-2-[(1E)-2-(2-thienyl)ethenyl]pyrimidine (1:1)

acide 4,4′-méthylènebis[3-hydroxy-2-naphtoïque], composé avec (E)-1,4,5,6-tétrahydro-1-méthyl-2-[2-(2-thiényl)vinyl]pyrimidine (1:1)

22366-99-0

9,10-Anthracenedione, 1-[(3-aminopropyl)amino]-4-(methylamino)-

1-[(3-aminopropyl)amino]-4-(méthylamino)anthraquinone

22801-45-2

9-Octadecenoic acid (9Z)-, 2-octyldodecyl ester

oléate de 2-octyldodécyle

23059-38-3

Cyclohexanecarboxylic acid, 1,4-dimethyl-, methyl ester, cis-

cis-1,4-Diméthylcyclohexanecarboxylate de méthyle

23250-42-2

Cyclohexanecarboxylic acid, 1,4-dimethyl-, methyl ester (trans)

trans-1,4-Diméthylcyclohexanecarboxylate de méthyle

24292-52-2

2-Propen-1-one, 1-[4-[[6-O-(6-deoxy-α-2-mannopyranosyl)-β-D-glucopyranosyl]oxy]2-hydroxy-6-methoxyphenyl]-3-(3-hydroxy-4-methoxyphenyl)-, (E)-

1-[4-[[6-O-(6-Désoxy-α-2-mannopyranosyl)-β-D-glucopyranosyl]oxy]-2-hydroxy-6-méthoxyphényl]-3-(3-hydroxy-4-méthoxyphényl)prop-2-én-1-one

24545-86-6

Spiro[isobenzofuran-1(3H),9′-[9H]xanthen]-3-one, 3′,6′-dihydroxy-4′,5′-dinitro-

3′,6′-dihydroxy-4′,5′-dinitrospiro[isobenzofuranne-1(3H),9′-[9H]xanthène]-3-one

24905-87-1

Ethanol, 2-[(4-amino-3-nitrophenyl)amino]-

2-(4-amino-3-nitroanilino)éthanol

25136-75-8

2-Propen-1-aminium, N,N-dimethyl-N-2-propenyl-, chloride, polymer with 2-propenamide and 2-propenoic acid

Chlorure de diallyldiméthylammonium polymérisé avec l’acrylamide et l’acide acrylique

25482-78-4

Peroxymonosulfuric acid, potassium salt

Acide peroxymonosulfurique, sel de potassium

25709-83-5

Spiro[isobenzofuran-1(3H),9′-[9H]xanthen]-3-one, 2′,4′,5′-tribromo-3′,6′-dihydroxy-

Spiro[isobenzofuran-1(3H),9′-[9H]xanthén]-3-one, 2′,4′,5′-tribromo-3′,6′-dihydroxy-

25709-84-6

Spiro[isobenzofuran-1(3H),9′-[9H]xanthen]-3-one, 2′,4′,7′-tribromo-3′,6′-dihydroxy-

Spiro[isobenzofuran-1(3H),9′-[9H]xanthén]-3-one, 2′,4′,7′-tribromo-3′,6′-dihydroxy-

25852-45-3

Poly(oxy-1,2-ethanediyl), α-phosphono-ω-(dodecyloxy)-

α-Phosphono-ω-(dodécyloxy)poly(oxyéthylène)

25999-20-6

Benzoic acid, 6-[(3R,4S,5S,7R)-7-[(2S,3S,5S)-5-ethyl-5-[(2R,5R,6S)-5-ethyltetrahydro-5-hydroxy-6-methyl-2H-pyran-2-yl]tetrahydro-3-methyl-2-furanyl]-4-hydroxy-3,5-dimethyl-6-oxononyl]-2-hydroxy-3-methyl-, monosodium salt

acide benzoïque, [[éthyl-5 (éthyl-5 tétrahydrohydroxy-5 méthyl-6 2H-pyrannyl-2)-5 tétrahydrométhyl-3 furannyl-2]-7 hydroxy-4 diméthyl-3,5 oxononyl-6]-6 hydroxy-2 méthyl-3, sel monosodique, [2R-[2α[2S* (3R*,4S*,5S*,7R*),3S*,5S*],5α,6.bêta.]]-

26264-02-8

3,6,9,12-Tetraoxatetradecan-1-ol, 14-(nonylphenoxy)-

14-(nonylphénoxy)-3,6,9,12-tétraoxatétradécane-1-ol

26538-44-3

1H-2-Benzoxacyclotetradecin-1-one, 3,4,5,6,7,8,9,10,11,12-decahydro-7,14,16-trihydroxy-3-methyl-, [3S-(3R,7S)]-

Zéranol

26545-51-7

Benzamide, N,N-diethylmethyl-

Benzamide, N,N-diéthylméthyl-

26658-83-3

2-Propenoic acid, 2-methyl-, butyl ester, polymer with 2-(dimethylamino)ethyl 2-methyl-2-propenoate

2-méthyl-2-propénoate de butyle, polymérisé avec le 2-méthyl-2-propénoate de 2-(diméthylamino)éthyle

26915-12-8

Benzenamine, ar-methyl-

Toluidine

26920-62-7

1-Docosanaminium, N-(carboxymethyl)-N,N-dimethyl-, inner salt

(carboxylatométhyl)docosyldiméthylammonium

27177-03-3

3,6,9,12,15,18-Hexaoxaeicosan-1-ol, 20-(nonylphenoxy)-

20-(nonylphénoxy)-3,6,9,12,15,18-hexaoxaicosane-1-ol

27177-07-7

3,6,9,12,15,18,21,24,27-Nonaoxanonacosan-1-ol, 29-(octylphenoxy)-

3,6,9,12,15,18,21,24,27-nonaoxanonacosan-1-ol, 29-(octylphénoxy)-

27636-82-4

2,4-imidazolidinedione, (hydroxymethyl)-5,5-dimethyl-

2,4-imidazolidinedione, (hydroxyméthyl)-5,5-diméthyl-

27640-89-7

13-Docosenoic acid, (13Z)-13-docosen-1-yl ester, (13Z)-

(Z)-docos-13-énoate de (Z)-docos-13-ényle

28212-44-4

Poly(oxy-1,2-ethanediyl), α-(carboxymethyl)-ω-(4-nonylphenoxy)-

α-(Carboxyméthyl)-ω-(p-nonylphénoxy)poly(oxyéthylène)

28261-54-3

Pyrrolidinone

Pyrrolidinone

28602-69-9

Diphosphoric acid, ammonium manganese(2+) salt (2:2:3)

Acide diphosphorique, sel d’ammonium et de manganèse(2+) (2:2:3)

28855-27-8

Benzenemethanaminium, ar-dodecyl-ar,N,N,N-tetramethyl-, chloride

chlorure de (dodécylméthylbenzyl)triméthylammonium

30599-15-6

1,3-Propanediol, 2,2-bis(hydroxymethyl)-, polymer with oxirane

2,2-Bis(hydroxyméthyl)propane-1,3-diol polymérisé avec l’oxirane

31282-04-9

D-Streptamine, O-6-amino-6-deoxy-L-glycero-D-galacto-heptopyranosylidene-(1.fwdarw.2-3)-O-β-D-talopyranosyl-(1.fwdarw.5)-2-deoxy-N3-methyl-

hygromycine B

31512-74-0

Poly[oxy-1,2-ethanediyl(dimethyliminio)-1,2-ethanediyl(dimethyliminio)-1,2-ethanediyl chloride (1:2)]

Poly[oxy-1,2-éthanediyl(diméthyliminio)-1,2-éthanediyl(diméthyliminio)-1,2-éthanediyle, chlorure (1:2)]

31692-79-2

Poly[oxy(dimethylsilylene)], α-hydro-ω-hydroxy-

Poly[oxy(diméthylsilylène)], α-hydro-oméga-hydroxy-

31846-06-7

Cyclohexanol, 3-(1,1-dimethylethyl)-, acetate

Acétate de 3-tert-butylcyclohexanyle

32310-26-2

Androstene

Androstène

33239-19-9

Spiro[isobenzofuran-1(3H),9′-[9H]xanthen]-3-one, 3′,6′-dihydroxy-4′,5′-diiodo-, sodium salt (1:2)

2-(4,5-diiodo-6-oxydo-3-oxoxanthène-9-yl)benzoate de disodium

33907-46-9

Octadecanoic acid, hydroxy-, 2-hydroxyethyl ester

Hydroxyoctadécanoate de 2-hydroxyéthyle

33907-47-0

Octadecanoic acid, hydroxy-, monoester with 1,2-propanediol

acide hydroxyoctadécanoïque, monoester avec propane-1,2-diol

34452-51-2

Acetic acid, mercapto-, monopotassium salt

Mercaptoacétate de potassium

34464-38-5

Isodecane

isodécane

34769-44-3

1,3(2H,9bH)-Dibenzofurandione, 2,6-diacetyl-7,9-dihydroxy-8,9b-dimethyl-, sodium salt (1:1)

2,6-diacétyl-7,9-dihydroxy-8,9b-diméthyldibenzofuranne-1,3(2H,9bH)-dione, sel de monosodium

34965-01-0

Pyrrolidine, 1-[2-(dodecyloxy)ethyl]-, hydrochloride

Pyrrolidine, 1-[2-(dodécyloxy)éthyl]-, chlorhydrate

35602-69-8

Cholest-5-en-3-ol (3β)-, 3-octadecanoate

sterate de cholest-5-ène-3-β-yle

36284-86-3

Octadecanamide, N-(2-hydroxy-1,1-dimethylethyl)-

Octadécanamide, N-(2-hydroxy-1,1-diméthyléthyl)-

37220-90-9

Silicic acid, lithium magnesium salt

Acide silicique, sel de lithium et de magnésium

37222-66-5

Potassium peroxymonosulfate sulfate (K5(HSO5)2(HSO4)(SO4))

Sulfate de peroxymonosulfate de potassium (K5(HSO5)2(HSO4)(SO4))

37286-92-3

Benzenesulfonic acid, ethenyl-, homopolymer, calcium salt

Acide éthénylbenzènesulfonique, homopolymère, sel de calcium

38480-64-7

1-Dodecanesulfonic acid, ion(1-)

Acide 1-dodécanesulfonique, ionique (1-)

38577-97-8

Spiro[isobenzofuran-1(3H),9′-[9H]xanthen]-3-one, 3′,6′-dihydroxy-4′,5′-diiodo-

3′,6′-Dihydroxy-4′,5′-diiodospiro[isobenzofurane-1(3H),9′-[9H]xanthène]-3-one

38621-51-1

Octadecanoic acid, 12-hydroxy-, monoester with 1,2-propanediol

Acide hydroxyoctadécanoïque, monoester avec le propane-1,2-diol

38866-20-5

Morpholinium, 4-[3-[(9,10-dihydro-4-hydroxy-9,10-dioxo-1-anthracenyl)amino]propyl]-4-methyl-, methyl sulfate (1:1)

sulfate de 4-[3-[(9,10-dihydro-4-hydroxy-9,10-dioxoanthryl)amino]propyl]-4-méthylmorpholinium et de méthyle

38886-21-4

Phenol, 2-methoxynitro-

Phénol, 2-méthoxynitro-

38975-03-0

3,6,9,12,15-Pentaoxaheptacosanoic acid, sodium salt

Acide 3,6,9,12,15-pentaoxaheptacosanoïque, sel sodique

39322-04-8

Chromium potassium oxide

Oxyde de chrome et de potassium

39456-59-2

Phosphoric acid, mixt. with sodium fluoride (NaF)

Acide phosphorique, mélange avec le fluorure de sodium (NaF)

40160-92-7

Poly(oxy-1,2-ethanediyl), α-(3-pentadecylphenyl)-ω-hydroxy-

α-(3-Pentadécylphényl)-ω-hydroxypoly(oxyéthane-1,2-diyl)

40188-41-8

Octanenitrile, 3,7-dimethyl-

3,7-Diméthyloctanonitrile

40738-57-6

2-Propenoic acid, ethenylidene ester, homopolymer

2-propénoate d’éthénylidène, homopolymère

40754-59-4

Butanedioic acid, 2-sulfo-, 4-[2-[2-[2-(dodecyloxy)ethoxy]ethoxy]ethyl] ester, sodium salt (1:2)

2-sulfonatosuccinate de disodium et de 4-[2-[2-[2-(dodécyloxy)éthoxy]éthoxy]éthyle

41080-66-4

Poly(oxy-1,2-ethanediyl), α,α′,α″-1,2,3-propanetriyltris[ω-[(1-oxooctadecyl)oxy]-

Poly(oxy-1,2-éthanediyle), α,α′,α″-1,2,3-propanetriyltris[oméga-[(1-oxooctadécyl)oxy]-

41669-40-3

Tetradecanoic acid, compd. with 2,2′,2″-nitrilotris[ethanol] (1:1)

Myristate de tris(2-hydroxyéthyl)ammonium

41927-88-2

Sodium iodide (Na123I)

Iodure de sodium (Na123I)

42131-25-9

Isononanoic acid, isononyl ester

Isononanoate d’isononyle

42766-91-6

Poly (oxy-1, 2-ethanediyl), α-[(3b, 5a)-cholestan-3-yl]-ω-hydroxy-

Poly(oxy-1, 2-éthanediyle), α-[(3b, 5a)-cholestan-3-yl]-oméga-hydroxy-

45267-19-4

Tetradecanamide, N-[3-(dimethylamino)propyl]-

N-[3-(Diméthylamino)propyl]myristamide

49625-21-0

Butanoic acid, 4-[[4-[[[(4-methoxy-2-nitrophenyl)amino]carbonyl]amino]benzoyl]amino]-2-oxo-

Acide 4-[[4-[[[(4-méthoxy-2-nitrophényl)amino]carbonyl]amino]benzoyl]amino]-2-oxobutanoïque

50545-60-3

Phenol, methyl-, tetrabromo deriv.

Phénol, méthyl-, dérivés tétrabromés

50610-28-1

Ethanol, 2-[(4-amino-2-chloro-5-nitrophenyl)amino]-

2-[(4-amino-2-chloro-5-nitrophényl)amino]éthanol

50643-20-4

Poly (oxy-1,2-ethanediyl), α-hexadecyl-ω-hydroxy-, phosphate

Poly(oxy-1,2-éthanediyle), α-hexadécyl-oméga-hydroxy-, phosphate

50800-85-6

Indium chloride (111InCl3)

Chlorure d’indium (111InCl3)

50982-74-6

Ethanol, 2-(4-amino-3-nitrophenoxy)-

Éthanol, 2-(4-amino-3-nitrophénoxy)-

50994-40-6

1,4-Benzenediamine, sulfate (1:?)

1,4-benzènediamine, sulfate (1:?)

51023-21-3

1H-Imidazolol, ethyldihydro[(9Z)-9-octadecen-1-yl]-

1H-imidazolol, éthyldihydro[(9Z)-9-octadécèn-1-yl]-

51192-09-7

Poly(oxy-1,2-ethanediyl), α-hydro-ω-hydroxy-, ether with 1,2,3-propanetriol mono-9-octadecenoate (2:1), (Z)-

α-Hydro-ω-hydroxypoly(oxyéthylène), éther (2:1) avec le monooléate du glycérol

51311-89-8

Antimony iodide

Iodure d’antimoine

51365-71-0

1,2-Benzenedicarboxamide, N,N′-dioctadecyl-

1,2-benzènedicarboxamide, N,N′-dioctadécyl-

51513-58-7

6,10-Dodecadienal, 3,7,11-trimethyl-, (6E)-

6,10-Dodécadiénal, 3,7,11-triméthyl-, (6E)-

51781-21-6

2(1H)-Quinolinone, 5-[3-[(1,1-dimethylethyl)amino]-2-hydroxypropoxy]-3,4-dihydro-, hydrochloride (1:1)

5-[3-[(tert-butyl)amino]-2-hydroxypropoxy]-3,4-dihydro-2-quinolone, monochlorhydrate

51810-70-9

Zinc phosphide

phosphure de zinc

51852-65-4

Poly(oxy-1,2-ethanediyl), α-[2-hydroxy-3-[(1-oxooctadecyl)oxy]propyl]-ω-hydroxy-

Poly(oxy-1,2-éthanediyle), α-[2-hydroxy-3-[(1-oxooctadécyl)oxy]propyl]-oméga-hydroxy-

52467-63-7

1-Hexadecanaminium, N,N-dihexadecyl-N-methyl-, chloride

Chlorure de N,N-dihexadécyl-N-méthyl-1-hexadécanaminium

52557-98-9

Bicyclo[2.2.1]heptane-2-carboxylic acid, 3,3-dimethyl-

Acide 3,3-diméthylbicyclo[2.2.1]heptane-2-carboxylique

52793-97-2

N,N,N-trimethyl-4-[(4,7,7-trimethyl-3-oxobicyclo[2.2.1]hept-2-ylidene)methyl]benzenaminim, methyl

sulfate de méthyle et de N,N,N-triméthyl-4-[(4,7,7-triméthyl-3-oxobicyclo[2.2.1]hept-2-ylidène)méthyl]anilinium

52845-07-5

Isoeicosane

Isoeicosane

53171-04-3

1-Propanaminium, 2-hydroxy-N,N,N-trimethyl-3-[(1-oxododecyl)oxy]-, chloride

1-propanaminium, 2-hydroxy-N,N,N-triméthyl-3-[(1-oxododécyl)oxy]-, chlorure

54182-58-0

Aluminum, hexadeca-.mu.-hydroxytetracosahydroxy[.mu.8-[[1,3,4,6-tetra-O-sulfo-β-D-fructofuranosyl α-D-glucopyranoside tetrakis(sulfato-κO′)](8-)]]hexadeca-

sucralfate

54422-45-6

N-[2-hydroxy-1-(hydroxymethyl)heptadecyl]-9-octadecenamide

9-octadécénamide, N-[2-hydroxy-1-(hydroxyméthyl)heptadécyl]-, (9Z)-

54590-52-2

Benzenesulfonic acid, 4-dodecyl-, compd. with 1-amino-2-propanol (1:1)

Acide p-dodécylbenzènesulfonique, composé avec le 1-aminopropan-2-ol (1:1)

55134-13-9

Salinomycin, 4-methyl-, (4S)-

narasine

55297-96-6

Acetic acid, [[2-(diethylamino)ethyl]thio]-, 6-ethenyldecahydro-5-hydroxy-4,6,9,10-tetramethyl-1-oxo-3a,9-propano-3aH-cyclopentacycloocten-8-yl ester, [3aS-(3aα,4β,5α,6α,8β,9α,9aβ,10S*)]-, (E)-2-butenedioate (1:1) (salt)

acide acétique, [[(diéthylamino)-2 éthyl]thio]-, ester d’éthényldécahydro-6 hydroxy-5 tétraméthyl-4,6,9,10 oxo-1 propano-3a,9 3aH-cyclopentacyclo-octényl-8, [3aS-(3aα,4.bêta.,5α,6α,8.bêta.,9α,9a.bêta.,10S*)]-, (E)-butènedioate-2 (1:1) (sel)

55837-20-2

4(3H)-Quinazolinone, 7-bromo-6-chloro-3-[3-[(2R,3S)-3-hydroxy-2-piperidinyl]-2-oxopropyl]-, rel-

4(3H)-quinazolinone, 7-bromo-6-chloro-3-[3-[(2R,3S)-3-hydroxy-2-pipéridinyl]-2-oxopropyl]-, rel-

55840-13-6

1,2,3-Propanetricarboxylic acid, 2-hydroxy-, ester with 1,2,3-propanetriol monooctadecanoate

acide propanetricarboxylique-1,2,3, hydroxy-2, ester avec le mono-octadécanoate de propanetriol-1,2,3

55852-15-8

Propanoic acid, 2-hydroxy-, compd. with N-[3-(dimethylamino)propyl]-16-methylheptadecanamide (1:1)

Acide lactique, composé (1:1) préparé avec le N-[3-(diméthylamino)propyl]-16-méthylheptadécanamide

55852-84-1

Bacitracin, methylenebis[2-hydroxybenzoate]

Méthylènedisalicylate de la bacitracine

55901-20-7

D2-Proline, 5-oxo-, compd. with 2,2′,2″-nitrilotris[ethanol] (1:1)

5-Oxo-D2-proline, composé avec le 2,2′,2″-nitrilotriéthanol (1:1)

55940-73-3

Benzoic acid, 2-hydroxy-, oxybis(methyl-2,1-ethanediyl) ester

disalicylate d’oxydipropylène

56038-13-2

α-D-Galactopyranoside, 1,6-dichloro-1,6-dideoxy-β-D-fructofuranosyl 4-chloro-4-deoxy-

4-chloro-4-désoxy-α-D-galactose de 1,6-dichloro-1,6-didésoxy-.bêta.-D-fructofurannosyle

56235-92-8

Butanedioic acid, hydroxy-, bis(2-ethylhexyl) ester

malate de bis(2-éthylhexyle)

56554-41-7

9,12,15-Octadecatrienoic acid, 2,3-dihydroxypropyl ester

9-octadécénamide, N-[2-hydroxy-1-(hydroxyméthyl)heptadécyl]-, (9Z)-

56639-51-1

Aluminum, hydroxybis(tetradecanoato-κO)-

hydroxybis(myristato-O)aluminium

56827-95-3

1-Hexadecanol, phosphate (3:1)

Phosphate de trihexadécyle

57072-40-9

1,2,3-Propanetricarboxylic acid, 2-hydroxy-, chromium(3+) salt (1:?)

acide citrique, sel de chrome

57524-53-5

Ethanol, 2-[(4-methoxy-2-nitrophenyl)amino]-

Éthanol, 2-[(4-méthoxy-2-nitrophényl)amino]-

57834-50-1

Benzoic acid, 4-[[[[4-(ethoxycarbonyl)phenyl]amino]methylene]amino]-, ethyl ester

p-({[p-(Éthoxycarbonyl)anilino]méthylène}amino)benzoate d’éthyle

57934-97-1

2-Cyclohexene-1-carboxylic acid, 2-ethyl-6,6-dimethyl-, ethyl ester

2-Éthyl-6,6-diméthylcyclohex-2-ène-1-carboxylate d’éthyle

57963-76-5

4a(2H)-Naphthalenol, octahydro-4,4,8a-trimethyl-,trans-

4a(2H)-naphtalénol, octahydro-4,4,8a-triméthyl-, trans-

57963-77-6

cis-1,1,10-Trimethyl-9-decahydronaphthol

cis-1,1,10-triméthyl-9-décahydronaphtol

58855-36-0

Ethanol, 2,2′-iminobis-, compd. with α-sulfo-ω-(dodecyloxy)poly(oxy-1,2-ethanediyl) (1:1)

Éthanol, 2,2′-iminobis-, composé avec l’α-sulfo-oméga-(dodécyloxy)poly(oxy-1,2-éthanediyle) (1:1)

59056-93-8

Ethanone, 1-[(2R,3S)-1,2,3,4,5,6,7,8-octahydro-2,3,8,8-tetramethyl-2-naphthalenyl]-, rel-

rel-1-[(2R,3S)-1,2,3,4,5,6,7,8-Octahydro-2,3,8,8-tétraméthylnaphtalén-2-yl]éthanone

59070-56-3

Poly(oxy-1,2-ethanediyl), α,α′.,α″-1,2,3-propanetriyltris[ω-hydroxy-, monododecanoate

Poly(oxy-1,2-éthanediyle), α,α′,α″-1,2,3-propanetriyltris[oméga-hydroxy]-, monododécanoate

59219-71-5

Hexanoic acid, 3,5,5-trimethyl-, 3,5,5-trimethylhexyl ester

3,5,5-Triméthylhexanoate de 3,5,5-triméthylhexyle

59587-08-5

1,3-Dioxolo[4,5-g]quinoline-7-carboxylic acid, 5-ethyl-5,8-dihydro-8-oxo-, sodium salt (1:1)

5-éthyl-5,8-dihydro-8-oxo-1,3-dioxolo[4,5-g]quinoléine-7-carboxylate de sodium

59599-53-0

Benzoic acid, 2-hydroxy-, 2-(2-hydroxy-1-methylethoxy)-1-methylethyl ester

2-hydroxybenzoate de 2-(2-hydroxy-1-méthyléthoxy)-1-méthyléthyle

59599-58-5

Benzenesulfonic acid, 4-tridecyl-, compd. with 2,2′,2″-nitrilotris[ethanol] (1:1)

Acide 4-tridécylbenzènesulfonique, composé avec le 2,2′,2″-nitrilotris[éthanol] (1:1)

59792-81-3

Aluminum, tris(5-oxo-L-prolinato-κN1,κO2)-

tris(5-oxo-L-prolinato-N1,O2)aluminium

59820-63-2

2-[3-(methylamino)-4-nitrophenoxy]ethanol

2-[3-(méthylamino)-4-nitrophénoxy]éthanol

59970-10-4

3,6,9,12-Tetraoxatriacontan-1-ol

3,6,9,12-tétraoxatriacontan-1-ol

60031-93-8

Cyclohexanemethanol, 4-ethenyl-α,α,4-trimethyl-3-(1-methylethenyl)-, acetate, [1R-(1α,3α,4β)]-

Acétate de [1R-(1α,3α,4β)]-3-isopropyl-α,α,4-triméthyl-4-vinylcyclohexaneméthanol

60270-33-9

Docosanamide, N-[3-(dimethylamino)propyl]-

N-[3-(diméthylamino)propyl]docosanamide

60684-33-5

2,5-Cyclohexadiene-1,4-dione, 2-(3,7,11,15,19,23,27,31,35,39-decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaen-1-yl)-5,6-dimethoxy-3-methyl-

2,5-cyclohexadiène-1,4-dione, 2-(3,7,11,15,19,23,27,31,35,39-décaméthyl-2,6,10,14,18,22,26,30,34,38-tétracontadécaén-1-yl)-5,6-diméthoxy-3-méthyl-

60778-99-6

Sulfuric acid, aluminum magnesium salt

Sulfates mixtes d’aluminium et de magnésium

60908-77-2

Isohexadecane

Isohexadécane

61692-77-1

2-Butenoic acid, 2-methyl-, 2-methylbutyl ester, (2Z)-

2-méthylisocrotonate de 2-méthylbutyle

61693-08-1

Heptadecane, 2,2,4,4,6,6,8,8,10,10,12,12,14,14,16,16-hexadecamethyl-

Heptadécane, 2,2,4,4,6,6,8,8,10,10,12,12,14,14,16,16-hexadécaméthyl-

61702-44-1

1,4-Benzenediamine, 2-chloro-, sulfate (1:1)

sulfate de 2-chloro-p-phénylénédiamine

61790-62-3

Fatty acids, coco, reaction products with N,N-dimethyl-1,3-propanediamine

Acides gras de coco, produits de réaction avec la N,N-diméthylpropane-1,3-diamine

61886-59-7

Benzenesulfonic acid, tridecyl-, compd. with 2,2′,2″-nitrilotris[ethanol] (1:1)

Acide tridécylbenzènesulfonique, composé avec le 2,2′,2″-nitrilotriéthanol (1:1)

62152-14-1

1-Propanesulfonic acid, 2-methyl-2-[(1-oxo-2-propen-1-yl)amino]-, ammonium salt (1:1), homopolymer

Acide 2-méthyl-2-[(1-oxo-2-propén-1-yl)amino]-1-propanesulfonique, sel d’ammonium (1:1), homopolymère

62406-73-9

6,10-Dioxaspiro[4.5]decane, 8,8-dimethyl-7-(1-methylethyl)-

6,10-dioxaspiro[4.5]décane,8,8-diméthyl-7-(-1-méthyléthyl)-

62625-14-3

Phenol, 2-amino-6-chloro-4-nitro-, monohydrochloride

2-Amino-6-chloro-4-nitrophénol , monochlorhydrate

63084-98-0

Phenol, 4-amino-, sulfate (2:1) (salt)

Sulfate de bis[(4-hydroxyphényl)ammonium]

63089-86-1

Poly(oxy-1,2-ethanediyl), α-hydro-ω-hydroxy-, ether with D-glucitol (6:1), tetra-9-octadecenoate, (all-Z)-

α-Hydro-ω-hydroxypoly(oxyéthylène), éther (6:1) avec le D-glucitol, tétraoléate

64924-67-0

4(3H)-Quinazolinone, 7-bromo-6-chloro-3-[3-[(2R,3S)-3-hydroxy-2-piperidinyl]-2-oxopropyl]-, monohydrobromide, rel-

4(3H)-quinazolinone, 7-bromo-6-chloro-3-[3-[(2R,3S)-3-hydroxy-2-pipéridinyl]-2-oxopropyl]-, monobromhydrate, rel-

65235-31-6

4-[(2-hydroxyethyl)amino]-3-nitrophenol

4-[(2-hydroxyéthyl)amino]-3-nitrophénol

65389-08-4

Indium-111In, tris(8-quinolinolato-κN1,κO8)-

Indium-111In, tris(8-quinolinolato-κN1,κO8)-

65405-96-1

Nickel, [.mu.-[carbonato(2-)-κO:κO′]]dihydroxydi-

[.mu.-[carbonato(2-)-O:O′]]dihydroxydinickel

65710-07-8

D-Streptamine, o-4-amino-4-deoxy-α-D-glucopyranosyl-(1→8)-o-(8R)-2-amino-2,3,7-trideoxy-7-(methylamino)-D-glycero-α-D-allo-octadialdo-1,5:8,4-dipyranosyl-(1→4)-2-deoxy-, sulfate (salt)

sulfate d’apramycine

66095-81-6

Ethanol, 2-[(2-methoxy-4-nitrophenyl)amino]-

2-[(2-méthoxy-4-nitrophényl)amino]éthanol

66575-29-9

1H-Naphtho[2,1-b]pyran-1-one, 5-(acetyloxy)-3-ethenyldodecahydro-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-, [3R-(3-α,4a-β,5-β,6-β,6a-α,10-α,10a-β,10b-α)]-

colforsine

66671-82-7

1,4-Benzenediamine, 2-methoxy-, sulfate (1:1)

Sulfate de 2-méthoxybenzène-1,4-diammonium

67783-98-6

Formaldehyde, polymer with 4,4′-(1-methylethylidene)bis[phenol] and 2-methylphenol

Formaldéhyde polymérisé avec le 4,4′-isopropylidènediphénol et l’o-crésol

67784-88-7

Glycerides, palm-oil mono- and di-, hydrogenated, ethoxylated

Mono- et diglycérides d’huile de palme, hydrogénées, éthoxylées

67846-16-6

1-Propanaminium, N-ethyl-N,N-dimethyl-3-[(1-oxooctadecyl)amino]-, ethyl sulfate

Sulfate d’éthyldiméthyl[3-[(1-oxooctadécyl)amino]propyl]ammonium et d’éthyle

67874-65-1

Propanoic acid, 3-mercapto-, 2,3-dihydroxypropyl ester

3-Mercaptopropionate de 2,3-dihydroxypropyle

67914-69-6

1-Piperazinecarboxylic acid, 4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-, ethyl ester, rel-

4-[4-[[(2R,4S)-2-(2,4-dichlorophényl)-2-(1H-imidazol-1-ylméthyl)-1,3-dioxolan-4-yl]méthoxy]phényl]-1-pipérazinecarboxylate d’éthyle, rel-

68015-98-5

1,3-Benzenediamine, 4-ethoxy-, sulfate (1:1)

Sulfate de 4-éthoxybenzène-1,3-diammonium

68187-29-1

2-Glutamic acid, N-coco acyl derivs., compds. with triethanolamine (1:1)

Acide 2-glutamique, dérivés N-acyles de coco, composés avec la triéthanolamine (1:1)

68239-79-2

Phenol, 3-(ethylamino)-4-methyl-, sulfate (2:1) (salt)

Sulfate de bis[éthyl(4-hydroxy-o-tolyl)ammonium]

68239-83-8

1,4-Benzenediamine, 2-nitro-, sulfate (1:1)

Sulfate de 2-nitrobenzène-1,4-diammonium

68239-84-9

Phenol, 3-(diethylamino)-, sulfate (2:1) (salt)

Sulfate de bis[(diéthylhydroxyphényl)ammonium]

68391-32-2

2-Naphthalenaminium, 8-[(4-amino-3-nitrophenyl)azo]-7-hydroxy-N,N,N-trimethyl-, chloride

Chlorure de [8-[(4-amino-3-nitrophényl)azo]-7-hydroxy-2-naphtyl]triméthylammonium

68413-33-2

Quaternary ammonium compounds, bis(2-hydroxy-C>10-alkyl)dimethyl, chlorides

Chlorures de bis(2-hydroxy-C>G10-alkyl)diméthylammonium quaternaire

68475-50-3

Aluminum, tris[5-amino-4-hydroxy-3-(phenylazo)-2,7-naphthalenedisulfonato(2-)]di-

Tris[5-amino-4-hydroxy-3-(phénylazo)naphtalène-2,7-disulfonato(2-)]dialuminium

68479-64-1

Butanedioic acid, 2-sulfo-, mono[2-[[(9Z)-1-oxo-9-octadecen-1-yl]amino]ethyl] ester, sodium salt (1:2)

2-Sulfonatosuccinate de disodium et de (Z)-[2-[(1-oxooctadéc-9-ényl)amino]éthyle]

68552-95-4

Fatty acids, vegetable-oil, ethoxylated

Acides gras d’huile végétale, éthoxylés

68607-24-9

Quaternary ammonium compounds, C20-22-alkyltrimethyl, chlorides

Composés de l’ion ammonium quaternaire, alkyle en C20-22 triméthyles, chlorures

68797-65-9

1-Propanaminium, N-ethyl-N,N-dimethyl-3-[(1-oxodocosyl)amino]-, ethyl sulfate

Sulfate de N-éthyl-3-docosanamido-N,N-diméthylpropan-1-aminium et d’éthyle

68814-13-1

1-Hexadecanol, phosphate

Hexadécan-1-ol, phosphate

68889-49-6

9-Octadecenoic acid (Z)-, 1,2,3-propanetriyl ester, polymer with α-hydro-ω-hydroxypoly(oxy-1,2-ethanediyl)

Trioléate de propane-1,2,3-triyle polymérisé avec l’α-hydro-ω-hydroxypoly(oxyéthylène)

68890-92-6

Poly(oxy-1,2-ethanediyl), α-(3-carboxy-1-oxosulfopropyl)-ω-hydroxy-, ethers with lanolin alcs., disodium salts

α-(3-Carboxysulfopropionyl)-ω-hydroxypoly(oxyéthylène), éthers avec des alcools de lanoline, sels disodiques

68910-56-5

Quaternary ammonium compounds, di-C12-15-alkyldimethyl, chlorides

Composés de l’ion ammonium quaternaire, dialkyle en C12-15 diméthyles, chlorures

68915-25-3

Keratins, lauroyl

Kératines, dérivés lauroyliques

68929-04-4

1H-Imidazolium, 1-[2-(2-carboxyethoxy)ethyl]-1-(2-carboxyethyl)-4,5-dihydro-2-undecyl-, hydroxide, disodium salt

Hydroxyde de disodium et de 1-[2-(2-carboxyéthoxy)éthyl]-1-(2-carboxyéthyl)-4,5-dihydro-2-undécyl-1H-imidazolium

68935-40-0

1H-Indene-2-propanoic acid, 2,3-dihydro-1-oxo-5,6-bis(phenylmethoxy)-2-propyl-

Acide 2,3-dihydro-1-oxo-5,6-bis(phénylméthoxy)-2-propyl-1H-indène-2-propanoïque

68953-59-3

Ethanaminium, 2-amino-N-(2-aminoethyl)-N-(2-hydroxyethyl)-N-methyl-, N,N′-bis(hydrogenated tallow acyl) derivs., Me sulfates (salts)

Bis(2-aminoéthyl)(2-hydroxyéthyl)méthylammonium, dérivés N,N′-diacylés de suif hydrogéné, sulfates mixtes de méthyle (sels)

68953-68-4

Aluminum, chloro propylene glycol complexes

Aluminium, complexes chloro de propylèneglycol

69537-38-8

1-Propanaminium, 2-hydroxy-N,N,N-trimethyl-3-[(1-oxodocosyl)oxy]-, chloride (1:1)

chlorure de 2-hydroxy-3-[(1-oxodocosyl)oxy]propyltriméthylammonium

70131-69-0

Silsesquioxanes, Phenyl

Phénylsilsesquioxanes

70729-68-9

Heptanoic acid, oxybis(2,1-ethanediyloxy-2,1-ethanediyl) ester

Diheptanoate d’oxybis(éthane-2,1-diyloxyéthane-2,1-diyle)

70729-87-2

Isooctadecanoic acid, compd. with N,N-dimethyl-1-dodecanamine (1:1)

Acide isooctadécanoïque, composé avec le N,N-diméthyldodécylamine (1:1)

70914-02-2

Glycerides, C14-18 and C16-18-unsatd. mono- and di-, ethoxylated

Mono- et diglycérides en C14-18 et en C16-18 insaturés, éthoxylés

71060-72-5

Quaternary ammonium compounds, tri-C14-18-alkylmethyl, chlorides

Chlorures de tri-C14-18-alkylméthylammonium quaternaire

71329-50-5

Guar gum, 2-hydroxypropyl 2-hydroxy-3-(trimethylammonio)propyl ether, chloride

Gomme de guar, éthers 2-hydroxypropylique et 2-hydroxy-3-(triméthylammonio)propylique, chlorure

71463-34-8

1H-Imidazolium, 1-(carboxymethyl)-4,5-dihydro-1-(2-hydroxyethyl)-2-undecyl-, hydrogen sulfate (salt), monosodium salt

1H-imidazolium, 1-(carboxyméthyl)-4,5-dihydro-1-(2-hydroxyéthyl)-2-undécyl-, hydrogénosulfate (sel), sel monosodique

71735-79-0

13-Oxabicyclo[10.1.0]trideca-4,8-diene, trimethyl-

Triméthyl-13-oxabicyclo[10.1.0]tridéca-4,8-diène

71812-38-9

Sorbitan, isooctadecanoate (2:3)

Sorbitane, isooctadécanoate (2:3)

71850-81-2

1-Propanaminium, N-(carboxymethyl)-3-[(12-hydroxy-1-oxo-9-octadecenyl)amino]-N,N-dimethyl-, hydroxide, inner salt, [R-(Z)]-

[R-(Z)]-N-(Carboxyméthyl)-3-[(12-hydroxy-1-oxooctadéc-9-ényl)amino]-N,N-diméthylpropan-1-aminium, hydroxyde, sel interne

71957-08-9

Cobalt, bis(D-gluconato-κO1,κO2)-,(T-4)-

bis(D-gluconato-O1,O2)cobalt

72175-39-4

Poly(oxy-1,2-ethanediyl), α-hydro-ω-hydroxy-, ether with methyl D-glucopyranoside (4:1), octadecanoate (2:3)

Octadécanoate (2:3) d’α-hydro-ω-hydroxypoly(oxyéthane-1,2-diyl) éther avec le méthyl-D-glucopyranoside (4:1)

72230-86-5

Terpenes and Terpenoids, cedarwood-oil, Texan, hydroxy, acetates

Esters de l’acide acétique avec les alcools terpéniques tirés de l’essence du bois de cèdre du Texas

72484-69-6

Oxirane, methyl-, polymer with oxirane, mono(2-decyltetradecyl) ether

Oxirane, méthyl-, polymérisé avec l’oxirane, éther mono(2-décyltétradécylique)

73231-34-2

Acetamide, 2,2-dichloro-N-[(1S,2R)-1-(fluoromethyl)-2-hydroxy-2-[4-(methylsulfonyl)phenyl]ethyl]-

Acétamide, 2,2-dichloro-N-[(1S,2R)-1-(fluorométhyl)-2-hydroxy-2-[4-(méthylsulfonyl)phényl]éthyl]-

73296-86-3

Isooctadecanoic acid, ester with oxybis[propanediol]

Acide isooctadécanoïque, ester avec l’oxybis[propanediol]

73772-45-9

1-Propanaminium, N-(carboxymethyl)-N,N-dimethyl-3-[(1-oxodecyl)amino]-, hydroxide, inner salt

Hydroxyde de (carboxyméthyl)diméthyl-3-[(1-oxodécyl)amino]propylammonium

73772-46-0

1-Propanaminium, N-(carboxymethyl)-N,N-dimethyl-3-[(1-oxooctyl)amino]-, hydroxide, inner salt

Hydroxyde de (carboxyméthyl)diméthyl-3-[(1-oxooctyl)amino]propylammonium

74610-55-2

Tylosin, (2R,3R)-2,3-dihydroxybutanedioate (1:1) (salt)

Tylosine, (2R,3R)-2,3-dihydroxybutanedioate (1:1) (sel)

75018-70-1

Ethanesulfonic acid, 2-[[[[(3α,5β,7α,12α,20S)-3,7,12-trihydroxy-20-methylpregnan-21-yl]seleno-75Se]acetyl]amino]-

Acide éthanesulfonique, 2-[[[[(3α,5bêta,7α,12α,20S)-3,7,12-trihydroxy-20-méthylprégnan-21-yl]séléno-75Se]acétyl]amino]-

75911-79-4

Bicyclo[3.2.1]octan-8-ol, 1,5-dimethyl-, acetate

Acétate de 1,5-diméthylbicyclo[3.2.1]oct-8-yle

77851-07-1

2-Cyclohexene-1-carboxylic acid, 2,3,6,6-tetramethyl-, ethyl ester

2,3,6,6-Tétraméthylcyclohex-2-ène-1-carboxylate d’éthyle

77923-28-5

Cyclododecane, (2-methoxyethoxy)-

(2-Méthoxyéthoxy)cyclododécane

78509-74-7

1-(hexadecyloxy)octadecan-2-ol)

1-(hexadécyloxy)octadécan-2-ol)

78616-98-5

Dodecanoic acid, 2-aminoethyl ester

Dodécanoate de 2-aminoéthyle

79120-33-5

Litharge (PbO)

Litharge (PbO)

79702-63-9

Butanedioic acid, 2-sulfo-, mono[2-[[(9Z)-1-oxo-9-octadecen-1-yl]amino]ethyl] ester, sodium salt (1:2)

2-Sulfonatosuccinate de disodium et de (Z)-[2-[(1-oxooctadéc-9-ényl)amino]éthyle]

80435-42-3

Iron alloy, base, Fe 63-74,Cr 12.0-15.0,Ni 12.0-15.0, W 1.50-3.00,Mn 0-1.00,Si 0.30-0.80,C 0.35-0.50, Mo 0.20-0.50,P 0-0.045,S 0-0.030 (UNS S66009)

Alliage de fer, base, Fe 63-74, Cr 12,0-15,0, Ni 12,0-15,0, W 1,50-3,00, Mn 0-1,00, Si 0,30-0,80, C 0,35-0,50, Mo 0,20-0 50, P 0-0,045, S 0-0,030 (UNS S66009)

81783-01-9

6,8-Nonadien-3-one,2,4,4,7-tetramethyl-,oxime

2,4,4,7-Tétraméthylnona-6,8-dièn-3-one-oxime

81818-54-4

1,4-Naphthalenedione, 2-methyl-3-(3,7,11,15-tetramethyl-2-hexadecenyl)-

2-méthyl-3-(3,7,11,15-tétraméthylhexadec-2-ényl)-1,4-naphtoquinone

81907-73-5

3-Cyclopentene-1-acetic acid, 2,2,3-trimethyl-, ethyl ester

2,2,3-Triméthylcyclopent-3-ène-1-acétate d’éthyle

83120-95-0

2-Propenoic acid, 2-methyl-, dodecyl ester, polymer with 1-ethenyl-2-pyrrolidinone and 2-propenoic acid

Méthacrylate de dodécyle polymérisé avec la 1-vinylpyrrolidin-2-one et l’acide acrylique

83615-24-1

Cholest-5-en-3-ol (3β)-, 3-isooctadecanoate

Cholest-5-én-3-ol (3bêta)-, 3-isooctadécanoate

83763-47-7

Ethanol, 2-[(3-amino-4-methoxyphenyl)amino]-

2-[(3-amino-4-méthoxyphényl)amino]éthanol

83763-48-8

Ethanol, 2-[(3-amino-4-methoxyphenyl)amino]-, sulfate (1:1)

sulfate de (3-ammonio-4-méthoxyphényl)(2-hydroxyéthyl)ammonium

84041-77-0

Ethanol, 2,2′-[(2-nitro-1,4-phenylene)diimino]bis-

2,2′-[(2-nitro-1,4-phénylène)diimino]biséthanol

84366-81-4

Riboflavin 5′-(trihydrogen diphosphate), 5′→5′-ester with adenosine, disodium salt

5′-(trihydrogénodiphosphate) de riboflavine, 5′→5′-ester avec adénosine, sel de disodium

84563-62-2

Chitosan, hexanedioate (salt)

Chitosane, hexanedioate (sel)

84605-12-9

13-Docosenoic acid, 13-docosenyl ester

docos-13-enoate de docos-13-ényle

84608-82-2

2-hydroxy-3-(oleoyloxy) propyl 5-oxo-L-prolinate

5-oxo-L-prolinate de 2-hydroxy-3-(oléoyloxy)propyle

84642-57-9

Cyclopentanone, 2-[(3,3,5-trimethylcyclohexyl)acetyl]-

2-[(3,3,5-triméthylcyclohexyl)acétyl]cyclopentane-1-one

84643-53-8

1-Hexadecanaminium, 2-hydroxy-N-(2-hydroxyethyl)-N,N-dimethyl-, chloride (1:1)

chlorure de (2-hydroxyéthyl)(2-hydroxyhexadécyl)diméthylammonium

84753-08-2

1, 3-bis(2-ethylhexyl)cyclohexane

1,3-bis(2-éthylhexyl)cyclohexane

84878-33-1

Isononanoic acid, hexadecyl ester

isononanoate d′hexadécyle

84878-34-2

Isononanoic acid, octadecyl ester

isononanoate d’octadécyle

84878-61-5

2H-Pyran-2-acetic acid, 6-[(1R)-1-[(2S,5R,7S,8R,9S)-2-[(2S,2′R,3′S,5R,5′R)-3′-[(2,6-dideoxy-3,4-di-O-methyl-β-L-arabino-hexopyranosyl)oxy]octahydro-2-methyl-5′-[(2S,3S,5R,6S)-tetrahydro-6-hydroxy-3,5,6-trimethyl-2H-pyran-2-yl][2,2′-bifuran]-5-yl]-9-hydroxy-2,8-dimethyl-1,6-dioxaspiro[4.5]dec-7-yl]ethyl]tetrahydro-2-hydroxy-4,5-dimethoxy-3-methyl-, ammonium salt (1:1), (2R,3S,4S,5R,6S)-

sel d’ammonium de la maduramicine

85058-43-1

1-Piperazinecarboxylic acid, 4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-, ethyl ester, rel-

4-[4-[[(2R,4S)-2-(2,4-dichlorophényl)-2-(1H-imidazol-1-ylméthyl)-1,3-dioxolan-4-yl]méthoxy]phényl]-1-pipérazinecarboxylate d’éthyle, rel-

85066-57-5

Poly(oxy-1,2-ethanediyl), α-(1-oxooctadecyl)-ω-(octadecyloxy)-

Poly(oxy-1,2-éthanediyle), α-(1-oxooctadécyl)-oméga-(octadécyloxy)-

85252-25-1

Benzoic acid, 2-hydroxy-, isodecyl ester

salicylate d’isodécyle

85264-33-1

1H-Pyrazole-1-methanol, 3,5-dimethyl-

3,5-diméthyl-1H-pyrazole-1-méthanol

85563-48-0

1-Hexadecanaminium, N-(2-hydroxyethyl)-N,N-dimethyl-, phosphate (1:1) (salt)

dihydrogénophosphate d’hexadécyl(2-hydroxyéthyl)diméthylammonium

85586-07-8

Sulfuric acid, mono-C12-14-alkyl esters, sodium salts

acide sulfurique, esters de mono-alkyles en C12-14, sels de sodium

85765-48-6

Ethanol, 2-[4-[(2-aminoethyl)amino]-3-nitrophenoxy]-

Éthanol, 2-[4-[(2-aminoéthyl)amino]-3-nitrophénoxy]-

86050-77-3

D-glucitol, 1-deoxy-1-(methylamino)-, [N,N-bis[2-[bis[(carboxy-κO)methyl]amino-κN]glycinato(5-)-κN,κO]gadolinate(2-) (2:1)

gadopentétate de diméglumine

86419-69-4

1,2-Ethanediamine, N1-(5-methoxy-2-nitrophenyl)-, hydrochloride (1:1)

1,2-éthanediamine, N1-(5-méthoxy-2-nitrophényl)-, chlorhydrate (1:1)

86481-08-5

Poly(oxy-1,2-ethanediyl), α, α′.-(1-methyl-1,2-ethanediyl)bis[ω-[[(9Z)-1-oxo-9-octadecenyl]oxy]-

Poly(oxy-1,2-éthanediyle), α, α′-(1-méthyl-1,2-éthanediyl)bis[oméga-[[(9Z)-1-oxo-9-octadécényl]oxy]-

88103-59-7

13-Docosenoic acid, 2-octyldodecyl ester, (13Z)-

13-docosénoate de 2-octyldodécyle, (13Z)-

90274-24-1

benzenemethanol, 4-hydroxy-α-[[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]methyl]-, hydrochloride

Benzèneméthanol, 4-hydroxy-a-[[[3-(4-hydroxyphényl)-1-méthylpropyl]amino]méthyl]-, chlorhydrate (1:1)

90283-04-8

1-Dodecanaminium, N-[2-(dodecyloxy)-2-oxoethyl]-N,N-dimethyl-, chloride

1-dodécanaminium, N-[2-(dodécyloxy)-2-oxoéthyl]-N,N-diméthyl-, chlorure

90411-68-0

Hexanoic acid, 2-ethyl-, C16-18-alkyl esters

acide hexanoïque, éthyl-2, esters d’alkyles en C16-18

90457-82-2

Bicyclo[2.2.1]heptane-1-methanesulfonic acid, 3,3′-(1,4-phenylenedimethylidyne)bis[7,7-dimethyl-2-oxo-

Acide 3,3′-(1,4-phénylènediméthylidyne)bis[7,7-diméthyl-2-oxo-bicyclo[2.2.1]heptane-1-méthanesulfonique

90529-57-0

1-Propanaminium, 3-amino-N-ethyl-N,N-dimethyl-, N-soya acyl derivs., Et sulfates

propanaminium-1, amino-3 N-éthyl N,N-diméthyl-, dérivés N-acyles de soja, sulfates d’’éthyle

90604-80-1

Zirconium, chloro glycine hydroxy aluminum complexes

zirconium, complexes de glycine chloro et d’aluminium hydroxy

90817-34-8

2,3-Pyridinediamine, 6-methoxy-N2-methyl-

2,3-pyridinediamine, 6-méthoxy-N2-méthyl-

91032-11-0

Fatty acids, C12-20, reaction products with triethanolamine, di-Me sulfate-quaternized

Acides gras en C12-20, produits de la réaction avec du 2,2′,2″-nitrilotriséthanol, quaternarisé avec du sulfate de diméthyle

91995-81-2

Fatty acids, C10-20 and C16-18-unsatd., reaction products with triethanolamine, di-Me sulfate-quaternized

acides gras en C10-20 et insaturés en C16-18, produits de réaction avec la triéthanolamine, quaternisés par le sulfate de diméthyle

92045-76-6

Paraffin waxes and Hydrocarbon waxes, microcryst., hydrotreated

cires de paraffine et cires d’hydrocarbures microcristallines, hydrotraitées

92045-77-7

Petrolatum (petroleum), hydrotreated

pétrolatum (pétrole), hydrotraité

92201-88-2

Imidazolium compounds, 2-(C9-19 and C9-19-unsatd. alkyl)-1-[(C10-20 and C10-20-unsatd. amido)ethyl]-4,5-dihydro-1-Me, Me sulfates

composés de l’ion imidazolium, (alkyl en C9-19, saturé et insaturé)-2 [(amido en C10-20, saturé et insaturé)éthyl]-1 dihydro-4,5 méthyl-1, sulfates de méthyle

92348-62-4

Octanoic acid, hydroxy-

Acide hydroxyoctanoïque

92761-26-7

Bicyclo[2.2.1]heptane-1-methanesulfonic acid, 3,3′-(1,4-phenylenedimethylidyne)bis[7,7-dimethyl-2-oxo-

Acide 3,3′-(1,4-phénylènediméthylidyne)bis[7,7-diméthyl-2-oxo-bicyclo[2.2.1]heptane-1-méthanesulfonique

92952-81-3

Phenol, 4-[(3-hydroxypropyl)amino]-3-nitro-

Phénol, 4-[(3-hydroxypropyl)amino]-3-nitro-

93106-60-6

3-Quinolinecarboxylic acid, 1-cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-1,4-dihydro-4-oxo-

Acide 1-cyclopropyl-7-(4-éthyl-1-pipérazinyl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylique

93166-05-3

1-Propanaminium, N-(2-aminoethyl)-N-(carboxymethyl)-2-hydroxy-N-(2-hydroxyethyl)-3-(phosphonooxy)-, N-C6-18 acyl derivs ., hydroxides, inner salts, disodium salts

N-(2-Aminoéthyl)-N-(carboxyméthyl)-2-hydroxy-N-(2-hydroxyéthyl)-3-(phosphonooxy)propan-1-aminium, dérivés acyles en N-C6-18, hydroxydes, sels internes, sels disodiques

93385-03-6

3,6,9,12-Tetraoxaoctacosan-1-ol, 11-methyl-, acetate

3,6,9,12-tétraoxaoctacosan-1-ol, 11-méthyl-, acétate

93385-13-8

Ethanol, 2-[2-[2-[2-(isohexadecyloxy)propoxy]ethoxy]ethoxy]-, acetate

Éthanol, 2-[2-[2-[2-(isohexadécyloxy)propoxy]éthoxy]éthoxy]-, acétate

93385-14-9

1,2,3-Propanetricarboxylic acid, 2-hydroxy-, 1,2,3-triisohexadecyl ester

2-hydroxy-1,2,3-propanetricarboxylate de 1,2,3-triisohexadécyle

93507-51-8

1-Propanaminium, 3-[(2-hydroxy-1-oxopropyl)amino]-N,N,N-trimethyl-, chloride (1:1)

1-propanaminium, 3-[(2-hydroxy-1-oxopropyl)amino]-N,N,N-triméthyl-, chlorure (1:1)

93841-25-9

Benzeneethanol, 2,5-diamino-, sulfate (1:1)

sulfate de 3-(2-hydroxyéthyl)-p-phénylènediammonium

94158-13-1

Ethanol, 2,2′-[(4-amino-3-nitrophenyl)imino]bis-, monohydrochloride

2,2′-[(4-amino-3-nitrophényl)imino]biséthanol, chlorhydrate

94158-14-2

Ethanol, 2-(1,3-benzodioxol-5-ylamino)-, hydrochloride (1:1)

2-(1,3-benzodioxole-5-ylamino)éthanol, chlorhydrate

94201-62-4

Docosanoic acid, 2-hydroxy-1,3-propanediyl ester

didocosanoate de 2-hydroxypropane-1,3-diyle

94247-26-4

Tetradecyl isooctadecanoate

isooctadécanoate de tétradécyle

94277-32-4

1,2-Hexadecanediol, 1,1′-(hydrogen phosphate), monosodium salt

phosphate de sodium et de bis(2-hydroxyhexadécyle)

94333-50-3

1-Cyclohexene-1-carboxylic acid, 2-ethyl-3,6,6-trimethyl-, ethyl ester

2-Éthyl-3,6,6-triméthylcyclohexènecarboxylate d’éthyle

94333-51-4

Cyclohexanecarboxylic acid, 6-ethylidene-2,2,5-trimethyl-, ethyl ester

6-Éthylidène-2,2,5-triméthylcyclohexanecarboxylate d’éthyle

94400-98-3

Naphth[2,3-b]oxirene, 1a,2,3,4,5,6,7,7a-octahydro-1a,3,3,4,6,6-hexamethyl-, (1aα,4α,7aα)-

(1aα,4α,7aα)-1a,3,3,4,6,6-Hexaméthyl-1a,2,3,4,5,6,7,7a-octahydronapht[2,3-b]oxirène

94891-31-3

Quaternary ammonium compounds, di-C16-18-alkyldimethyl, salts with hectorite

composés de l’ion ammonium quaternaire, dialkyl en C16-18 diméthyles, sels avec l’hectorite

95193-70-7

Amines, N-(C8-18 and C18-unsatd. alkyl)trimethylenedi-, reaction products with 2-chloroethanol and sodium chloroacetate

amines, N-(alkyl en C8-18 et insaturé en C18)triméthylènedi-, produits de réaction avec le chloro-2 éthanol et le chloracétate de sodium

95193-83-2

1H-Indene-1,3(2H)-dione, 2-(2-quinolinyl)-, sulfonated, sodium salts

2-(quinolin-2-yl)-1H-indène-1,3(2H)-dione, sulfonée, sels de sodium

95371-16-7

Sulfonic acids, C14-16-1-alkene, sodium salts

acides sulfoniques, alcène-1 en C14-16, sels de sodium

95576-89-9

1,2-Propanediol, 3-[(4-amino-2-chloro-5-nitrophenyl)amino]-

1,2-propanediol, 3-[(4-amino-2-chloro-5-nitrophényl)amino]-

95576-92-4

1,2-Propanediol, 3,3′-[(2-chloro-5-nitro-1,4-phenylene)diimino]bis-

1,2-propanediol, 3,3′-[(2-chloro-5-nitro-1,4-phénylène)diimino]bis-

96081-39-9

Alkyl(C16-18)polyethyleneglycol tetra decylene glycolether

Poly(oxy-1,2-éthanediyle), α-(2-hydroxytétradécyl)-oméga-hydroxy-, oméga-alkyloxydes en C16-18

97375-39-8

C.I. Food Yellow 4:2

zirconium, complexes de dihydro-4,5 oxo-5 (sulfo-4 phényl)-1 [(sulfo-4 phényl)azo]-4 1H-pyrazole carboxylate-3

97862-59-4

1-Propanaminium, 3-amino-N-(carboxymethyl)-N,N-dimethyl-, N-C8-18 acyl derivs., hydroxides, inner salts

propanaminium-1, amino-3 N-(carboxyméthyl) N,N-diméthyl-, dérivés N-acyles en C8-18, hydroxydes, sels internes

97862-76-5

Foots oil (petroleum), carbon-treated

huile de ressuage (pétrole), traitée au charbon

97862-89-0

Paraffin waxes (petroleum), carbon-treated

cires paraffiniques (pétrole), traitées au charbon

97862-97-0

Petrolatum (petroleum), carbon-treated

pétrolatum (pétrole), traité au charbon

97952-68-6

Quaternary ammonium compounds, benzylbis(hydrogenated tallow alkyl)methyl, salts with montmorillonite

composés de l’ion ammonium quaternaire, benzyl bis(alkyl de suif hydrogéné)méthyles, sels avec la montmorillonite

99542-23-1

1-Propanaminium, N-ethyl-N,N-dimethyl-3-[[(9Z,12Z)-1-oxo-9,12-octadecadienyl]amino]-, ethyl sulfate

1-propanaminium, N-éthyl-N,N-diméthyl-3-[[(9Z,12Z)-1-oxo-9,12-octadécadiényl]amino]-, sulfate d’éthyle

99610-72-7

Phenol, 2-[(2-hydroxyethyl)amino]-4,6-dinitro-

Phénol, 2-[(2-hydroxyéthyl)amino]-4,6-dinitro-

99948-86-4

2-[(dihydroxymethylsilyl)oxy]propionic acid

acide 2-[(dihydroxyméthylsilyl)oxy]propionique

100418-33-5

Ethanol, 2-[(4-methyl-2-nitrophenyl)amino]-

Éthanol, 2-[(4-méthyl-2-nitrophényl)amino]-

100684-33-1

Petrolatum (petroleum), clay-treated

pétrolatum (pétrole), traité à la terre

100684-38-6

Residual oils (petroleum), clay-treated solvent-dewaxed

huiles résiduelles (pétrole), déparaffinées au solvant et traitées à la terre

100684-49-9

Slack wax (petroleum), carbon-treated

gatsch (pétrole), traité au charbon

101831-37-2

Benzeneacetonitrile, 2,6-dichloro-α-(4-chlorophenyl)-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3H)-yl)-

diclazuril

102868-96-2

Zinc, bis[N-(acetyl-κO)-L-methioninato-κO]-, (T-4)-

Zinc, bis[N-(acétyl-κO)-L-méthioninato-κO]-, (T-4)-

103055-07-8

Benzamide, N-[[[2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)phenyl]amino]carbonyl]-2,6-difluoro-

lufénuron

103622-85-1

3,6,9,12-Tetraoxatriacont-21-en-1-ol

3,6,9,12-tétraoxatriacont-21-én-1-ol

103810-94-2

Methanone, diphenyl-, dihydroxy deriv.

Méthanone, diphényl-, dérivés dihydroxy

104226-19-9

3-((4-(bis(2-hydroxyethyl)amino)-2-nitrophenyl)amino)-1-propanol

3-((4-(bis(2-hydroxyéthyl)amino)-2-nitrophényl)amino)-1-propanol

104333-00-8

1,2-Propanediol, 3-[[2-nitro-4-(trifluoromethyl)phenyl]amino]-

1,2-propanediol, 3-[[2-nitro-4-(trifluorométhyl)phényl]amino]-

104365-75-5

2-Propenoic acid, homopolymer, ester with 1,2,3-propanetriol

Acide 2-propénoïque, homopolymère, ester avec le 1,2,3-propanetriol

105859-93-6

Propanoic acid, 2,2-dimethyl-, tridecyl ester

2,2-diméthylpropanoate de tridécyle

105883-51-0

Copper, bis[N-(acetyl-κO)-L-methioninato-κO]-

Cuivre, bis[N-(acétyl-κO)-L-méthioninato-κO]-

105883-52-1

Cobalt, bis[N-(acetyl-κO)-L-methioninato-κO]-

Cobalt, bis[N-(acétyl-κO)-L-méthioninato-κO]-

106233-09-4

Poly(oxy-1,2-ethanediyl),α-hydro-ω-hydroxy-,mono-C16-18-alkyl ethers, phosphates

Poly(oxy-1,2-éthanediyle), α-hydro-oméga-hydroxy-, éthers monoalkyliques en C16-18, phosphates

106392-12-5

Oxirane, 2-methyl-, polymer with oxirane, block

Oxirane, 2-méthyl-, polymérisé avec l’oxirane, séquencé

106631-38-3

1-Naphthalenepropanol, α-ethenyldecahydro-α,5,5,8a-tetramethyl-2-methylene-

α-Vinyldécahydro-α,5,5,8a-tétraméthyl-2-méthylènenaphtalène-1-propanol

108050-54-0

Tylosin, 4A-O-de(2,6-dideoxy-3-C-methyl-α-L-ribo-hexopyranosyl)-20-deoxo-20-[(3R,5S)-3,5-dimethyl-1-piperidinyl]-

Tylosine, 4A-O-dé(2,6-didésoxy-3-C-méthyl-α-L-ribo-hexopyranosyl)-20-désoxo-20-[(3R,5S)-3,5-diméthyl-1-pipéridinyl]-

108347-90-6

Poly[oxy(methyl-1-,2-ethanediyl)], α-benzoyl-ω-(octadecyloxy)-

α-Benzoyl-ω-(octadécyloxy)poly(oxypropylène)

109423-22-5

Benzoic acid, 2-hydroxy-, 5-methyl-2-(1-methylethyl)cyclohexyl ester

salicylate de menthyle

109485-61-2

Nonane, 2,2,4,4,6,6,8-heptamethyl-

2,2,4,4,6,6,8-heptaméthylnonane

110332-91-7

Oxirane, methyl-, polymer with oxirane, monoacetate, isohexadecyl ether, block

Oxirane, méthyl-, polymérisé avec l’oxirane, monoacétate, éther isohexadécylique, séquencé

113010-52-9

Benzoic acid, 4-amino-, ethyl ester, polymer with oxirane

4-aminobenzoate d’éthyle, polymérisé avec l’oxirane

113089-59-1

Collagens, hydrolyzates, reaction products with 3-chloro-2-hydroxy-N,N,N-trimethyl-1-propanaminium chloride

Collagènes, hydrolysats, produits de réaction avec le chlorure de 3-chloro-2-hydroxy-N,N,N-triméthyl-1-propanaminium

113221-73-1

2-Naphthalenecarboxaldehyde, 5,6,7,8-tetrahydro-5,5,7,8,8-pentamethyl-

5,5,7,8,8-Pentaméthyl-5,6,7,8-tétrahydronaphtalène-2-carbaldéhyde

113431-54-2

1,2,3-Propanetricarboxylic acid, 2-hydroxy-, triisooctadecyl ester

2-hydroxy-1,2,3-propanetricarboxylate de triisooctadécyle

113507-06-5

Milbemycin B, 5-O-demethyl-28-deoxy-25-[(1E)-1,3-dimethyl-1-butenyl]-6,28-epoxy-23-(methoxyimino)-, (6R,23E,25S)-

Moxidectine

115340-78-8

1-Propanaminium, 3-amino-N-ethyl-N,N-dimethyl-, N-apricot-oil acyl derivs., Et sulfates

1-propanaminium, 3-amino-N-éthyl-N,N-diméthyl-, dérivés N-acylés d’huile d’abricot, sulfates d’éthyle

117704-25-3

Avermectin A1a, 25-cyclohexyl-5-O-demethyl-25-de(1-methylpropyl)-

Doramectine

119691-49-5

1-Eicosanol, 2-tetradecyl-

2-Tétradécylicosan-1-ol

119831-19-5

Poly(oxy-1,2-ethanediyl), α-hydro-ω-hydroxy-, ether with methyl D-glucopyranoside (4:1), dioctadecanoate

Poly(oxy-1,2-éthanediyle), α-hydro-oméga-hydroxy-, éther avec le méthyl-D-glucopyranoside (4:1), dioctadécanoate

120066-54-8

Gadolinium, [10-[2-(hydroxy-κO)propyl]-1,4,7,10-tetraazacyclododecane-1,4,7-triacetato(3-)-κN1,κN4,κN7,κN10,κO1,κO4,κO7]-

Gadolinium, [10-[2-(hydroxy-κO)propyl]-1,4,7,10-tétraazacyclododécane-1,4,7-triacétato(3-)-κN1,κN4,κN7,κN10,κO1,κO4,κO7]-

121546-77-8

Alcohols, C12-15 ethoxylate, sulfonate, sodium salt

Alcools, éthoxylate en C12-15, sulfonate, sel sodique

121684-92-2

α-D-Glucopyranoside, β-D-fructofuranosyl, acetate dioctadecanoate

α-D-glucopyranoside, bêta-D-fructofuranosyl-, acétate, dioctadécanoate

121734-19-8

1,3-Benzenediamine, 4-methoxy-, sulfate

1,3-benzènediamine, 4-méthoxy-, sulfate

121888-66-2

Quaternary ammonium compounds, benzylbis(hydrogenated tallow alkyl)methyl, benzoate lauryl sulfate, salts with bentonite

Composés d’ammonium quaternaires, benzylbis(alkyle de suif hydrogéné)méthyle, benzoate sulfate de lauryle, sels avec le bentonite

121888-67-3

Quaternary ammonium compounds, benzylbis(hydrogenated tallow alkyl)methyl, bis(hydrogenated tallow alkyl)dimethylammonium salt with hectorite

Composés d’ammonium quaternaires, benzylbis(alkyle de suif hydrogéné)méthyle, sel de bis(alkyle de suif hydrogéné)diméthylammonium avec l’hectorite

121888-68-4

Quaternary ammonium compounds, benzyl(hydrogenated tallow alkyl)dimethyl, stearates, salts with bentonite

Composés d’ammonium quaternaires, benzyl(alkyle de suif hydrogéné) diméthyle, stéarates, sels avec le bentonite

123776-56-7

1-Propanaminium, 3-(acetylamino)-N,N,N-trimethyl-, chloride (1:1)

1-propanaminium, 3-(acétylamino)-N,N,N-triméthyl-, chlorure (1:1)

123997-26-2

Avermectin B1, 4"-(acetylamino)-4"-deoxy-, (4"R)-

Eprinomectine

124046-05-5

Benzenemethanaminium, N-(3-aminopropyl)-N,N-dimethyl-, N-babassu-oil acyl derivs., chlorides

Benzèneméthanaminium, N-(3-aminopropyl)-N,N-diméthyl-, dérivés N-acylés d’huile de babassu, chlorures

124046-40-8

Amides, wheat germ-oil, N-[3-(dimethylamino)propyl], lactates

Amides, huile de germe de blé, N-[3-(diméthylamino)propyl]-, lactates

125109-85-5

Benzenepropanal, β-methyl-3-(1-methylethyl)-

β-Méthyl-3-isopropylbenzènepropanal

125804-04-8

Docosanoic acid, compd. with N-[3-(dimethylamino)propyl]docosanamide (1:1)

Acide docosanoïque, composé avec le N-[3-(diméthylamino)propyl]docosanamide (1:1)

125804-08-2

Docosanoic acid, 2-octyldodecyl ester

Docosanoate de 2-octyldodécyle

125804-10-6

9,12-Octadecadienoic acid (9Z,12Z)-, dimer, compd. with (9Z,12Z)-N-[3-(dimethylamino)propyl]-9,12-octadecadienamide (1:1)

Acide (9Z,12Z)-9,12-octadécadiénoïque, dimère, composé avec le (9Z,12Z)-N-[3-(diméthylamino)propyl]-9,12-octadécadiénamide (1:1)

126121-35-5

1,2,3-Propanetricarboxylic acid, 2-hydroxy-, 1,2-bis(2-octyldodecyl) 3-(2-octyl-7-pentylheptyl) ester

2-hydroxy-1,2,3-propanetricarboxylate de 1,2-bis(2-octyldodécyle) et de 3-(2-octyl-7-pentylheptyle)

126506-93-2

1,3,2-Dioxastibolane-4,5-dicarboxylic acid, 2-hydroxy-, 2-oxide

Acide 2-hydroxy-1,3,2-dioxastibolane-4,5-dicarboxylique, 2-oxyde

126595-07-1

Propanoic acid, 3,3′-(1,3-dioxo-1,3-digermoxanediyl)bis-, homopolymer

Acide 3,3′-(1,3-dioxo-1,3-digermoxanediyl)bispropanoïque, homopolymère

127061-56-7

L-Ascorbic acid, 2-[(2R)-3,4-dihydro-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-2H-1-benzopyran-6-YL hydrogen phosphate], potassium salt (1:1)

Acide L-ascorbique, 2-[(2R)-3,4-dihydro-2,5,7,8-tétraméthyl-2-[(4R,8R)-4,8,12-triméthyltridécyl]-2H-1-benzopyran-6-ylhydrogénophosphate], sel de potassium (1:1)

127311-98-2

1-Propanaminium, 3-[[(9Z,12R)-12-hydroxy-1-oxo-9-octadecenyl]amino]-N,N,N-trimethyl-, chloride

1-propanaminium, 3-[[(9Z,12R)-12-hydroxy-1-oxo-9-octadécènyl]amino]-N,N,N-triméthyl-, chlorure

128729-28-2

1,3-bis[(4-aminophenyl)(2-hydroxyethyl)amino]-2-propanol, tetrahydrochloride

2-propanol, 1,3-bis[(4-aminophényl)(2-hydroxyéthyl)amino]-, chlorhydrate (1:4)

128973-71-7

Siloxanes and Silicones, a-D-mannopyranuronoyloxy Me, hydroxy-terminated

Siloxanes et silicones, a-D-mannopyranuronoyloxyméthyl-, à terminaison hydroxy

128973-73-9

Siloxanes and Silicones, Me[1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxo-7H-purin-7-yl)acetyl]oxy, hydroxy-terminated

Siloxanes et silicones, méthyl[1,2,3,6-tétrahydro-1,3-diméthyl-2,6-dioxo-7H-purin-7-yl)acétyl]oxy-, à terminaison hydroxy

128973-74-0

Siloxanes and Silicones, (2S-trans)-[[4-hydroxy-2-pyrrolidinyl)carbonyl]oxy] Me, hydroxyl-terminated

Siloxanes et silicones, (2S-trans)-[[4-hydroxy-2-pyrrolidinyl)carbonyl]oxy]méthyl-, à terminaison hydroxyle

129496-10-2

Milbemycin, oxime

Milbemycin, oxime

129541-40-8

Tetradecanamide, N-[3-(dimethylamino)propyl]-, phosphate (1:1)

Tétradécanamide, N-[3-(diméthylamino)propyl]-, phosphate (1:1)

129757-76-2

2-Oxepanone, polymer with 1,6-diisocyanatohexane and 2-ethyl-2-(hydroxymethyl)-1,3-propanediol

Oxépan-2-one polymérisée avec le 1,6-diisocyanate d’hexane et le propylidynetriméthanol

130291-58-6

2-Propenoic acid, 2-methyl-, 2-(dimethylamino)ethyl ester, homopolymer, compd. with bromomethane

2-méthyl-2-propénoate de 2-(diméthylamino)éthyle, homopolymère, composé avec le bromométhane

130353-64-9

Quaternary ammonium compounds, coco alkyl(2,3-dihydroxypropyl)dimethyl, 3-ethers with cellulose 2-hydroxyethyl ether, chlorides

Composés d’ammonium quaternaire, cocoalkyl(2,3-dihydroxypropyl)diméthyl, 3-éthers avec l’éther 2-hydroxyéthylique de cellulose, chlorures

130381-02-1

Protein hydrolyzates, soya, [3-(dodecyldimethylammonio)-2-hydroxypropyl], chlorides

Hydrolysats de protéines, soja, [3-(dodécyldiméthylammonio)-2-hydroxypropyl]-, chlorures

130381-04-3

Protein hydrolyzates, wheat germ, [3-(coco alkyldimethylammonio)-2-hydroxypropyl], chlorides

Hydrolysats de protéines, germe de blé, [3-(cocoalkyldiméthylammonio)-2-hydroxypropyl]-, chlorures

130381-05-4

Protein hydrolyzates, wheat germ, [3-(dimethyloctadecylammonio)-2-hydroxypropyl], chlorides

Hydrolysats de protéines, germe de blé, [3-(diméthyloctadécylammonio)-2-hydroxypropyl], chlorures

131044-77-4

Copper, N-acetyl-L-tyrosine hydroxy-terminated (S)-[2-(acetylamino)-3-(4-hydroxyphenyl)-1-oxopropoxy] Me siloxanes

Cuivre, complexes de N-acétyl-L-tyrosine et de (S)-[2-(acétylamino)-3-(4-hydroxyphényl)-1-oxopropoxy]méthylsiloxanes à terminaison hydroxy

131044-78-5

Copper, hydroxy-terminated Me (S)-[[(5-oxo-2-pyrrolidinyl) carbonyl]oxy] siloxanes 5-oxo-L-proline complexes

Cuivre, complexes de (S)-[[(5-oxo-2-pyrrolidinyl)carbonyl]oxy]méthylsiloxanes et de 5-oxo-L-proline

131216-83-6

Siloxanes and Silicones, 2-(acetylamino)-4-(methylthio)-1-oxobutyoxy Me, hydroxy-terminated

Siloxanes et silicones, 2-(acétylamino)-4-(méthylthio)-1-oxobutyoxyméthyl-, à terminaison hydroxy

131410-48-5

Gadolinium, [5,8-bis[(carboxy-κO)methyl]-11-[2-(methylamino)-2-(oxo-κO)ethyl]-3-(oxo-κO)-2,5,8,11-tetraazatridecan-13-oato(3-)-κN5,κN8,κN11,κO13]-

Gadodiamide

131812-48-1

1,3-Dioxolane, 2,4-dimethyl-2-(5,6,7,8-tetrahydro-3,5,5,6,8,8-hexamethyl-2-naphthalenyl)-

2,4-Diméthyl-2-(5,6,7,8-tétrahydro-3,5,5,6,8,8-hexaméthylnapht-2-yl)-1,3-dioxolane

131812-49-2

Naphthalene, 7-(diethoxymethyl)-1,2,3,4-tetrahydro-1,1,2,4,4-pentamethyl-

7-(Diéthoxyméthyl)-1,2,3,4-tétrahydro-1,1,2,4,4-pentaméthylnaphtalène

131812-51-6

1,3-Dioxolane, 2,4-dimethyl-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-, cis-

1,3-dioxolane, 2,4-diméthyl-2-(5,6,7,8-tétrahydro-5,5,8,8-tétraméthyl-2-naphtalènyl)-, cis-

131812-52-7

1,3-Dioxolane, 2,4-dimethyl-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-, trans-

1,3-dioxolane, 2,4-diméthyl-2-(5,6,7,8-tétrahydro-5,5,8,8-tétraméthyl-2-naphtalènyl)-, cis-

131812-67-4

1,3-Dioxolane, 2,4-dimethyl-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-

2,4-Diméthyl-2-(5,6,7,8-tétrahydro-5,5,8,8-tetraméthyl-2-naphtyl)-1,3-dioxolane

131954-48-8

1-Propanaminium, N,N,N-trimethyl-3-[(2-methyl-1-oxo-2-propen-1-yl)amino]-, chloride (1:1), polymer with 1-ethenyl-2-pyrrolidinone

1-propanaminium, N,N,N-triméthyl-3-[(2-méthyl-1-oxo-2-propén-1-yl)amino]-, chlorure (1:1), polymérisé avec la 1-éthényl-2-pyrrolidinone

132467-76-6

1-Octadecanaminium, N-[2-hydroxy-3-[3-hydroxy-4-[(3-hydroxypropyl)amino]-2,2-dimethyl-4-oxobutoxy]propyl]-N,N-dimethyl-, chloride

1-Octadécanaminium, N-[2-hydroxy-3-[3-hydroxy-4-[(3-hydroxypropyl)amino]-2,2-diméthyl-4-oxobutoxy]propyl]-N,N-diméthyl-, chlorure

133934-09-5

1-Propanaminium, 3-amino-N-(carboxymethyl)-N,N-dimethyl-, N-wheat-oil acyl derivs., inner salts

1-propanaminium, 3-amino-N-(carboxyméthyl)-N,N-diméthyl-, dérivés N-acylés d’huile de blé, sels internes

134112-42-8

1-Propanaminium, N-[2-(dodecyloxy)-2-oxoethyl]-N,N-dimethyl-3-[(1-oxoisooctadecyl)amino]-,chloride

1-propanaminium, N-[2-(dodécyloxy)-2-oxoéthyl]-N,N-diméthyl-3-[(1-oxoisooctadécyl)amino]-, chlorure

134375-99-8

Aluminum Zirconium Trichlorohydrex Glycine

Aluminum zirconium trichlorohydrex glycine

135326-54-4

Propanol, (tetradecyloxy)-, acetate

Propanol, (tétradécyloxy)-, acétate

136207-49-3

3,6,9,12,15-Pentaoxaheptatriacontan-1-ol

3,6,9,12,15-pentaoxaheptatriacontan-1-ol

136504-87-5

1-Propanaminium, 3-amino-N-(carboxymethyl)-N,N-dimethyl-,N-soya acyl derivs., inner salts

3-Amino-N-(carboxyméthyl)-N,N-diméthylpropan-1-aminium, dérivés N-(acyl de soya), sels internes

136505-01-6

2-Propenenitrile, homopolymer, hydrolyzed, block, reaction products with N,N-dimethyl-1,3-propanediamine

2-propènenitrile, homopolymère, hydrolysé, séquencé, produits de réaction avec la N,N-diméthyl-1,3-propanediamine

136920-08-6

1-Propanaminium, N-(3-aminopropyl)-2,3-dihydroxy-N,N-dimethyl-, N-coco acyl derivs., chlorides

1-propanaminium, N-(3-aminopropyl)-2,3-dihydroxy-N,N-diméthyl-, dérivés N-cocoacylés, chlorures

137044-11-2

1-Propanaminium, 3-[2-(acetylamino)ethoxy]-N,N,N-trimethyl-, chloride

1-propanaminium, 3-[2-(acétylamino)éthoxy]-N,N,N-triméthyl-, chlorure

137330-13-3

Tylosin, 4A-O-de(2,6-dideoxy-3-C-methyl-a-L-ribo-hexopyranosyl)-20-deoxo-20-[(3R,5S)-3,5-dimethyl-1-piperidinyl]-, phosphate (1:1) (salt)

Tylosine, 4A-O-dé(2,6-didésoxy-3-C-méthyl-a-L-ribo-hexopyranosyl)-20-désoxo-20-[(3R,5S)-3,5-diméthyl-1-pipéridinyl]-, phosphate (1:1) (sel)

139096-04-1

Indate(2-)-111In, [N,N-bis[2 [bis(carboxymethyl)amino]ethyl]glycinato(5-)]-, disodium

Indate(2-)-111In, [N,N-bis[2 [bis(carboxyméthyl)amino]éthyl]glycinato(5-)]-, disodique

139247-28-2

Poly(oxy-1,2-ethanediyl), α,α′,α″-1,2,3-propanetriyltris[ω-hydroxy-, benzoate

Poly(oxy-1,2-éthanediyle), α,α′,α″-1,2,3-propanetriyltris(oméga-hydroxy)-, benzoate

142104-11-8

2-Butenedioic acid (2E)-, di-C12-15-alkyl esters

(2E)-2-butènedioate de dialkyles en C12-15

142164-39-4

Nickel carbonate hydroxide

Hydroxyde de carbonate de nickel

142657-60-1

Siloxanes and Silicones, di-Me, 3-hydroxypropyl Me, ethers with polyethylene glycol mono[[(3-coco amidopropyl)dimethylammonio]acetate], chlorides

Siloxanes et silicones, diméthyl-, 3-hydroxypropylméthyl-, éthers avec le mono[[(3-cocoamidopropyl)diméthylammonio]acétate] de polyéthylèneglycol, chlorures

142891-20-1

2-Propenoic acid, 2-chloro-3-[2-chloro-5-(1,3,4,5,6,7-hexahydro-1,3-dioxo-2H-isoindol-2-yl)phenyl]-, ethyl ester, (2Z)-

cinidon-éthyl

144377-73-1

4,6-Dioxa-14-aza-10-azonia-5-phosphadotriaconta-23,26-dien-1-aminium, 5-[3-[dimethyl[3-[[(9Z,12Z)-1-oxo-9,12-octadecadien-1-yl]amino]propyl]ammonio]-2-hydroxypropoxy]-2,8-dihydroxy-N,N,10,10-tetramethyl-15-oxo-N-[3-[[(9Z,12Z)-1-oxo-9,12-octadecadien-1-yl]amino]propyl]-, 5-oxide, chloride (1:3), (23Z,26Z)-

4,6-dioxa-14-aza-10-azonia-5-phosphadotriaconta-23,26-dién-1-aminium, 5-[3-[diméthyl[3-[[(9Z,12Z)-1-oxo-9,12-octadécadién-1-yl]amino]propyl]ammonio]-2-hydroxypropoxy]-2,8-dihydroxy-N,N,10,10-tétraméthyl-15-oxo-N-[3-[[(9Z,12Z)-1-oxo-9,12-octadécadién-1-yl]

144610-93-5

Propanoic acid, 2,2-dimethyl-, tetradecyl ester

2,2-diméthylpropanoate de tétradécyle

145269-34-7

Hydrolyzed wheat protein hydroxypropyltriammonium

Hydroxypropyltriammonium de protéines de blé hydrolysées

146192-98-5

2-Butenedioic acid (2Z)-, monobutyl ester, polymer with ethenyl acetate and 1,7,7-trimethylphenylbicyclo[2.2.1]hept-2-yl 2-propenoate

(2Z)-2-butènedioate de monobutyle, polymérisé avec l’acétate d’éthényle et le 2-propénoate de 1,7,7-triméthylphénylbicyclo[2.2.1]hept-2-yle

146632-08-8

Siloxanes and Silicones, di-Me, Bu group- and 3-[(2-methyl-1-oxo-2-propenyl)oxy]propyl group-terminated, polymers with 2-[[(heptadecafluorooctyl)sulfonyl]methylamino]ethyl acrylate and iso-Bu methacrylate

Siloxanes et silicones, diméthyl-, à terminaison butyle et 3-[(2-méthyl-1-oxo-2-propényl)oxy]propyle, polymérisés avec l’acrylate de 2-[[(heptadécafluorooctyl)sulfonyl]méthylamino]éthyl et le méthacrylate d’isobutyle

147398-77-4

Ethanaminium, N-(carboxymethyl)-N,N-dimethyl-2-[(2-methyl-1-oxo-2-propen-1-yl)oxy]-, inner salt, polymer with methyl 2-methyl-2-propenoate

Éthanaminium, N-(carboxyméthyl)-N,N-diméthyl-2-[(2-méthyl-1-oxo-2-propén-1-yl)oxy]-, sel interne, polymérisé avec le 2-méthyl-2-propénoate de méthyle

147550-61-6

Copper carbonate hydroxide

Hydroxyde de carbonate de cuivre

148506-50-7

Poly[oxy-1,2-ethanediyl(dimethyliminio)-1,3-propanediylimino(1,6-dioxo-1,6-hexanediyl)imino-1,3-propanediyl(dimethyliminio)-1,2-ethanediyl chloride (1:2)]

Poly[oxy-1,2-éthanediyl(diméthyliminio)-1,3-propanediylimino(1,6-dioxo-1,6-hexanediyl)imino-1,3-propanediyl(diméthyliminio)-1,2-éthanediyle, chlorure (1:2)]

148812-63-9

Protein hydrolyzates, wheat, reaction products with palmitoyl chloride

Hydrolysats de protéines, blé, produits de réaction avec le chlorure de palmitoyle

150599-70-5

1H-Imidazolium, 1-ethenyl-3-methyl-, methyl sulfate (1:1), polymer with 1-ethenyl-2-pyrrolidinone

Méthylsulfate de 1-vinyl-3-méthyl-1H-imidazolium polymérisé avec la 1-vinylpyrrolid-2-one

155601-30-2

1H-Pyrazole-1-ethanol,4,5-diamino-, sulfate (1:1)

1H-Pyrazole-1-éthanol, 4,5-diamino-, sulfate (1:1)

155683-77-5

Oxirane, 2-methyl-, polymer with oxirane, monoisodecyl ether

Oxirane, 2-méthyl-, polymérisé avec l’oxirane, éther monoisodécylique

155715-93-8

Gelatins, polymers with keratin hydrolyzates and L-lysine, hydroxy-N,N,N-trimethyl-1 propanaminium chloride-quaternized

Gélatines, polymérisées avec les hydrolysats de kératine et la L-lysine, chlorure d’hydroxy-N,N,N-triméthyl-1 propanaminium quaternisé

156028-14-7

1H-Imidazolium, 1-(carboxymethyl)-4,5-dihydro-1-(2-hydroxyethyl)-2-undecyl-, inner salt, sodium salt (1:1)

1H-imidazolium, 1-(carboxyméthyl)-4,5-dihydro-1-(2-hydroxyéthyl)-2-undécyl-, sel interne, sel sodique (1:1)

156679-41-3

N-dodecyl-[3-(4-dimethylamino)benzamido)-propyl]dimethylammonium tosylate

Tosylate de N-dodécyl-[3-(4-diméthylamino)benzamido)propyl]diméthylammonium

156715-43-4

Protein hydrolyzates, soya, [3-(cocoalklydimethylammonio)-2-hydroxypropyl], chlorides

Hydrolysats de protéines, soja, [3-(cocoalklydiméthylammonio)-2-hydroxypropyl]-, chlorures

156798-09-3

Keratins, hydrolyzates, [3-(coco alkyldimethylammonio)-2-hydroxypropyl], chlorides

Kératines, hydrolysats, [3-(cocoalkyldiméthylammonio)-2-hydroxypropyl]-, chlorures

156798-11-7

Protein hydrolyzates, wheat, [2-hydroxy-3-(trimethylammonio)propyl] chlorides

Hydrolysats de protéines, blé, [2-hydroxy-3-(triméthylammonio)propyl]-, chlorures

157009-77-3

9,12-Octadecadienoic acid (9Z,12Z)-, dimer, diisoeicosyl ester

(9Z,12Z)-9,12-octadécadiénoate de diisoeicosyle, dimère

158483-23-9

Poly(oxy-1,2-ethanediyl),α,α′,α"-1,2,3-propanetriyltris[ω-hydroxy-,2-hydroxypropanoate

Poly(oxy-1,2-éthanediyle), α,α′,α"-1,2,3-propanetriyltris[oméga-hydroxy-,2-hydroxypropanoate

158765-79-8

Micrococcus luteus, lysate

Micrococcus luteus, lysat

159317-32-5

Acetic acid, hydroxy-, isooctadecyl ester

Hydroxyacétate d’isooctadécyle

162030-43-5

Mannopyranuronic acid, 1-O-[hydroxymethyl [[(1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxo-7H-purin-7-yl)acetyl]oxy]silyl]-

Acide mannopyranuronique, 1-O-[hydroxyméthyl [[(1,2,3,6-tétrahydro-1,3-diméthyl-2,6-dioxo-7H-purin-7-yl)acétyl]oxy]silyl]-

162353-59-5

Quaternary ammonium compounds, (C10-20 and C10-20-unsatd. alkyl) (3-chloro-2-ydroxypropyl) dimethyl, chlorides, reaction products with silk protein hydrolyzates

Composés d’ammonium quaternaire, (alkyles en C10-20 et alkyles insaturés en C10-20) (3-chloro-2-hydroxypropyl)diméthyl, chlorures, produits de réaction avec des hydrolysats de protéines de soie

162888-05-3

Octadecanoic acid, 12-hydroxy-, 16-methylheptadecyl ester

12-hydroxy-octadécanoate de 16-méthylheptadécyle

164288-56-6

1-Propanaminium, 3-amino-N-[2-[(2-hydroxyethyl)amino]-2-oxoethyl]-N,N-dimethyl-, N-C12-18 acyl derivs., chlorides

1-propanaminium, 3-amino-N-[2-[(2-hydroxyéthyl)amino]-2-oxoéthyl]-N,N-diméthyl-, dérivés N-acylés en C12-18, chlorures

165745-27-7

Carbamic acid, N-butyl-, 3-iodo-2-propyn-1-yl ester, mixt. with N-[1,3-bis(hydroxymethyl)-2,5-dioxo-4-imidazolidinyl]-N,N′-bis(hydroxymethyl)urea

N-butylcarbamate de 3-iodo-2-propyn-1-yle, mélange avec la N-[1,3-bis(hydroxyméthyl)-2,5-dioxo-4-imidazolidinyl]-N,N′-bis(hydroxyméthyl)urée

168677-75-6

Poly(oxy-1,2-ethanediyl), α,α′-[[(9Z,12Z)-(2,3-dihydroxypropyl)-9,12-octadecadien-1-yliminio]di-2,1-ethanediyl]bis[ω-hydroxy-, chloride (1:1)

Poly(oxy-1,2-éthanediyle), α,α′-[[(9Z,12Z)-(2,3-dihydroxypropyl)-9,12-octadécadién-1-yliminio]di-2,1-éthanediyl]bis(oméga-hydroxy)-, chlorure (1:1)

169590-61-8

Protein hydrolyzates, silk, [2-hydroxy-3-(trimethylammonio)propyl], chlorides

Hydrolysats de protéines, soie, [2-hydroxy-3-(triméthylammonio)propyl]-, chlorures

172376-82-8

6,10-Dodecadienal, 3,7,11-trimethyl-, (6Z)-

6,10-Dodécadiénal, 3,7,11-triméthyl-, (6Z)-

173010-79-2

Quaternary ammonium compounds, coco alkyl(2,3-dihydroxypropyl)dimethyl, 3-phosphates (esters), chlorides, sodium salts

Sels de sodium, chlorures, 3-phosphates (esters) de composés coco alkyl(2,3-dihydroxypropyl)diméthyl ammonium quaternaire

173763-15-0

Aluminum Sesquichlorohydrate

sesquichlorohydrate d’aluminium

174761-16-1

1H-Imidazolium, 1-ethenyl-3-methyl-, methyl sulfate (1:1), polymer with 1-ethenylhexahydro-2H-azepin-2-one and 1-ethenyl-2-pyrrolidinone

1H-imidazolium, 1-éthényl-3-méthyl-, sulfate de méthyle (1:1), polymérisé avec la 1-éthénylhexahydro-2H-azépin-2-one et la 1-éthényl-2-pyrrolidinone

175357-18-3

L-Phenylalanine, N-(1-oxo-10-undecen-1-yl)-

L-phénylalanine, N-(1-oxo-10-undécén-1-yl)-

175893-70-6

Poly(oxy-1,2-ethanediyl), α-hydro-ω-hydroxy-, diesters with caroboxymethyl wheat protein hydrolyzates

Poly(oxy-1,2-éthanediyle), α-hydro-oméga-hydroxy-, diesters avec des hydrolysats de protéines de blé carbométhylés

175893-71-7

2-Propenamide, N-[3-(dimethylamino)propyl]-2-methyl-, polymer with 1-ethenyl-2-pyrrolidinone, sulfate

N-[3-(diméthylamino)propyl]-2-méthylpropèn-2-amide, polymérisée avec la 1-vinyl-2-pyrrolidinone, sulfate

177080-35-2

Phenol, 4-[(3-hydroxypropyl)amino]-2-nitro-

Phénol, 4-[(3-hydroxypropyl)amino]-2-nitro-

177190-98-6

1-Propanaminium, N,N,N-trimethyl-3-[(1-oxo-3-phenyl-2-propen-1-yl)amino]-,chloride (1:1)

1-propanaminium, N,N,N-triméthyl-3-[(1-oxo-3-phényl-2-propén-1-yl)amino]-, chlorure (1:1)

179005-04-0

Siloxanes and Silicones, 3-[4-[[[3-[(2,3-dihydroxypropyl)dimethylammonio]propyl]amino]carbonyl]-2-oxo-1-pyrrolidinyl]propyl Me, di-Me, 3-[3-[[3-(C8-22-acylamino)propyl]dimethylammonio]-2-hydroxypropyl phosphates], chlorides, sodium salts

Siloxanes et silicones, méthyl-3-[4-[[[3-[(2,3-dihydroxypropyl)diméthylammonio]propyl]amino]carbonyl]-2-oxo-1-pyrrolidinyl]propyl, diméthyl-, 3-[3-[[3-(C8-22-acylamino)propyl]diméthylammonio]-2-hydroxypropyl phosphates], sels de chlorures et de sodium

182700-78-3

Siloxanes and Silicones, 3-[(3-aminopropyl)amino]propyl Me, di-Me, 3-hydroxypropyl Me, ethoxylated, [(hydroxydimethylsilyl)oxy]-terminated

Siloxanes et silicones, 3-[(3-aminopropyl)amino]propylméthyl-, diméthyl, 3-hydroxypropylméthyl-, éthoxylés, à terminaison [(hydroxydiméthylsilyl)oxy]

183476-82-6

L-Ascorbic acid, 2,3,5,6-tetrakis(2-hexyldecanoate)

Acide 2,3,5,6-tétrakis(2-hexyldécanoate)-L-ascorbique

185018-43-3

L-Ascorbic acid, 2-[(3β)-cholest-5-en-3-yl hydrogen phosphate], monosodium salt

Acide L-ascorbique, 2-[hydrogénophosphate de (3bêta)-cholest-5-én-3-yle], sel monosodique

185429-83-8

Ethanone, 1-(1,2,3,4,5,6,7,8-octahydro-1,2,8,8-tetramethyl-2-naphthalenyl)-, cis-

Éthanone, 1-(1,2,3,4,5,6,7,8-octahydro-1,2,8,8-tétraméthyl-2-naphthalényl)-, cis-

187175-42-4

Silsesquioxanes, Me, hydroxy-terminated, alginate, compds. with caffeine

Silsesquioxanes, méthylés, à terminaison hydroxy, alginate, composés avec la caféine

187991-39-5

L-ascorbic acid, 6-O-(dihydroxymethylsilyl)-

Acide L-ascorbique, 6-O-(dihydroxyméthylsilyl)-

190270-74-7

L-Lysine dihydroxymethylsilyl ester

L-lysinate de dihydroxyméthylsilyle

193888-44-7

1-Propanaminium, N-(carboxymethyl)-2-hydroxy-N-(2-hydroxyethyl)-N-[2-[(1-oxododecyl)amino]ethyl]-3-(phosphonooxy)-, inner salt, monosodium salt

1-propanaminium, N-(carboxyméthyl)-2-hydroxy-N-(2-hydroxyéthyl)-N-[2-[(1-oxododécyl)amino]éthyl]-3-(phosphonooxy)-, sel interne, sel monosodique

193892-43-2

Poly[oxy(dimethylsilylene)], α-docosyl-ω-(docosyloxy)-

Poly[oxy(diméthylsilylène)], α-docosyl-oméga-(docosyloxy)-

197969-51-0

1-Propanaminium, N,N,N-trimethyl-3-[(2-methyl-1-oxo-2-propen-1-yl)amino]-, chloride (1:1), polymer with methyl 2-propenoate and 2-propenoic acid

1-propanaminium, N,N,N-triméthyl-3-[(2-méthyl-1-oxo-2-propén-1-yl)amino]-, chlorure (1:1), polymérisé avec le 2-propénoate de méthyle et l’acide 2-propénoïque

198404-98-7

Cyclopropanemethanol, 1-methyl-2-[(1,2,2-trimethylbicyclo[3.1.0]hex-3-yl)methyl]-

1-méthyl-2-[(1,2,2-triméthylbicyclo[3.1.0]hex-3-yl)méthyl]cyclopropaneméthanol

205537-77-5

Poly[oxy(dimethylsilylene)], α-hydro-ω-hydroxy-, mixt. with dimethicone

Poly[oxy(diméthylsilylène)], α-hydro-oméga-hydroxy-, mélange avec la diméthicone

208126-52-7

Resin acids and Rosin acids, mixed esters with dipentaerythritol and 12-hydroxyoctadecanoic acid and stearic acid

Acides résiniques et colophaniques, esters mixtes avec le dipentaérythritol, l’acide 12-hydroxyoctadécanoïque et l’acide stéarique

208126-56-1

Octadecanoic acid, 12-hydroxy-, mixed esters with dipentaerythritol and isostearic acid

Acide 12-hydroxyoctadécanoïque, esters mixtes avec le dipentaérythritol et l’acide isostéarique

213127-10-7

2-Propen-1-aminium,N,N-dimethyl-N-2propenyl-, chloride, polymer with 2-propenoic acid AND partially neutralized sodium salt

2-propèn-1-aminium, N,N-diméthyl-N-2-propényl-, chlorure, polymérisé avec l’acide 2-propénoïque, sel sodique

214047-00-4

L-Serine, N2-(1-oxohexadecyl)-L-lysyl-L-threonyl-L-threonyl-L-lysyl-

L-sérine, N2-(1-oxohexadécyl)-L-lysyl-L-thréonyl-L-thréonyl-L-lysyl-

220119-17-5

Avermectin A1a, 25-cyclohexyl-4′-O-de(2,6-dideoxy-3-O-methyl-α-L-arabino-hexopyranosyl)-5-demethoxy-25-de(1-methylpropyl)-22,23-dihydro-5-(hydroxyimino)-, (5Z)-

Avermectine A1a, 25-cyclohexyl-4′-O-dé(2,6-didésoxy-3-O-méthyl-α-L-arabino-hexopyranosyl)-5-déméthoxy-25-dé(1-méthylpropyl)-22,23-dihydro-5-(hydroxyimino)-, (5Z)-

220714-63-6

Siloxanes and Silicones, di-Me, 3-hydroxypropyl Me, ethers with polyethylene glycol mono[3-(dimethyloctadecylammonio)-2-hydroxypropyl hydrogen phosphate], inner salts

Siloxanes et silicones, diméthyl-, 3-hydroxypropylméthyl-, éthers avec le mono[3-(diméthyloctadécylammonio)-2hydroxypropylhydrogénophosphate] de polyéthylèneglycol, sels internes

220828-91-1

1-Propanaminium, N-(2-hydroxyethyl)-N,N-dimethyl-3-[(1-oxodocosyl)amino]-, chloride (1:1)

1-propanaminium, N-(2-hydroxyéthyl)-N,N-diméthyl-3-[(1-oxodocosyl)amino]-, chlorure (1:1)

222400-35-3

Protein hydrolyzates, wheat, isostearoyl, compds. with 2-amino-2-methyl-1-propanol

Hydrolysats de protéines, blé, isostéaroyl-, composés avec le 2-amino-2-méthyl-1-propanol

223717-75-7

Poly(oxy-1,2-ethanediyl), α-hydro-ω-hydroxy-, ether with methyl D-glucopyranoside (4:1), tri-(9Z)-9-octadecenoate

Poly(oxy-1,2-éthanediyle), α-hydro-oméga-hydroxy-, éther avec le méthyl-D-glucopyranoside (4:1), tri-(9Z)-9-octadécénoate

224948-78-1

Poly(oxy-1,2-ethanediyl),α-[2-[bis(2-aminoethyl)methylammonio]ethyl]-ω-hydroxy-,N,N′-di-C14-18 acyl derivs., Me sulfates (salts)

Poly(oxy-1,2-éthanediyle), α-[2-[bis(2-aminoéthyl)méthylammonio]éthyl]-oméga-hydroxy-, dérivés N,N′-diacylés en C14-18, sulfates de méthyle (sels)

227200-22-8

L-Ascorbic acid, reaction products with methylsilanetriol and pectin

Acide L-ascorbique, produits de réaction avec le méthylsilanetriol et la pectine

227605-22-3

Lithium magnesium sodium oxide silicate (Li0.03Mg0.39Na0.07O0.15(Si2O5)0.28)

Silicate d’oxyde de lithium, de magnésium et de sodium (Li0.03Mg0.39Na0.07O0.15(Si2O5)0.28)

243133-67-7

Poly(oxy-1,2-ethanediyl), α-(2-hydroxytetradecyl)-ω-hydroxy-,ω-C16-18-alkyl ethers

Poly(oxy-1,2-éthanediyle), α-(2-hydroxytétradécyl)-oméga-hydroxy-, oméga-alkyloxydes en C16-18

243137-53-3

Siloxanes and Silicones, di-Me, polymers with mono[(ethenyldimethylsilyl)oxy]-terminated di-Me siloxanes

Siloxanes et silicones, diméthyl-, polymérisés avec des diméthylsiloxanes à terminaison mono[(éthényldiméthylsilyl)oxy]

245443-07-6

L-Glutamic acid, N-(1-oxododecyl)-, mixed (3β)-cholest-5-en-3-yl 2-octyldodecyl esters

Mélange de N-(1-oxododécyl)-L-glutamate de (3β)-cholest-5-én-3-yle et de 2-octyldodécyle

246864-39-1

Decanoic acid, 1,2,3-propanetriyl ester, reaction products with polyethylene glycol and 1,2,3-propanetriyl trioctanoate

Décanoate de 1,2,3-propanetriyle, produits de réaction avec le polyéthylèneglycol et le trioctanoate de 1,2,3-propanetriyle

261713-82-0

Poly(oxy-1,2ethanedily),α(2-hydoxypropyl)-w-[1-methyl-2-[(1-oxododecyl)oxy]ethoxy]ethoxy-(9Cl)

Poly(oxy-1,2-éthanediyle), alpha-(2-hydroxypropyl)-oméga-[1-méthyl-2-[1-méthyl-2-[(1-oxododécyl)oxy]éthoxy]éthoxy]-

288839-50-9

1-Octadecanaminium, N,N-dimethyl-N-octyl-, methyl sulfate (1:1)

1-octadécanaminium, N,N-diméthyl-N-octyl-, sulfate de méthyle (1:1)

305812-16-2

Poly(oxy-1,2-ethanediyl),α,α′., α".-1,2,3-propanetriyltris [ω-methoxy-

Poly(oxy-1,2-éthanediyle), α,α′,α"-1,2,3-propanetriyltris(oméga-méthoxy)-

308067-11-0

Glycerides, C8-10 mono-, di- and tri-, ethoxylated

Glycérides, C8-10, mono-, di- et tri-, éthoxylés

308068-34-0

Glycerides, C16-18 mono-, ethoxylated

Glycérides, C16-18, mono-, éthoxylés

308068-94-2

Imidazolium compounds, 2-C12-14-alkyl-1-(carboxymethyl)-4,5-dihydro-1-(2-hydroxyethyl)-, inner salts

Composés d′imidazolium, 2-alkyles en C12-14-1-(carboxyméthyl)-4,5-dihydro-1-(2-hydroxyéthyl)-, sels internes

308068-97-5

Onium compounds, isoquinolinium, C12-18-alkyl, bromides

Composés d’onium, isoquinolinium, alkyles en C12-18, bromures

308074-11-5

Protein hydrolyzates, compds. with (Z)-N-[3-(dimethylamino)propyl]-9-octadecenamide

Hydrolysats de protéines, composés avec le (Z)-N-[3-(diméthylamino)propyl]-9-octadécénamide

321735-39-1

Siloxanes and Silicones, di-Me, 3-hydroxypropyl group- and 3-[(2-methyl-1-oxo-2-propenyl)oxy]propyl group-terminated, polymers with iso-Bu methacrylate

Siloxanes et silicones, diméthyl-, à terminaison 3-hydroxypropyle et 3-[(2-méthyl-1-oxo-2-propényl)oxy]propyle, polymérisés avec le méthacrylate d’isobutyle

321735-42-6

Siloxanes and Silicones, di-Me, 3-hydroxypropyl group- and 3-[(2-methyl-1-oxo-2-propenyl)oxy]propyl group-terminated, polymers with iso-Bu methacrylate and 2,2,2-trifluoroethyl methacrylate

Siloxanes et silicones, diméthyl-, à terminaison 3-hydroxypropyle et butyle et 3-[(2-méthyl-1-oxo-2-propényl)oxy]propyle, polymérisés avec le méthacrylate d’isobutyle et le méthacrylate de 2,2,2-trifluoroéthyle

329925-33-9

Oxacyclopentadec-10-en-2-one, 13-methyl-

13-Méthyloxacyclopentadéc-10-èn-2-one

345648-01-3

1-Propanaminium N- (3-aminopropyl) -2,3-dihydroxy-N,N-dimethyl-,N-limnanthes alba seed-oil acyl derivs., chlorides

Minéraux du groupe des micas

348120-88-7

Hexanoic acid, 3,5,5 -trimethyl-, octadecyl ester

3,5,5 –triméthylhexanoate d’octadécyle

350708-35-9

Aspartic acid, compd. with α-methylbenzeneethanamine (1:1)

Acide aspartique, composé avec l’α-méthylbenzèneéthanamine (1:1)

350708-40-6

D-Glucaric acid, compd. with (αS)-α-methylbenzeneethanamine (1:2)

Acide D-glucarique, composé avec l’(αS)-α-méthylbenzèneéthanamine (1:2)

361459-38-3

Glycerides, mixed decanoyl and octanoyl mono-, di- and tri-, ethoxylated

Mélange de mono-, di- et tri- décanoyl et octanoylglycérides, éthoxylés

480995-77-5

2-Propenoic acid, 2-methyl-, polymer with butyl 2-propenoate, hexadecyleicosyl 2-methyl-2-propenoate and methyl 2-methyl-2-propenoate

Acide 2-méthyl-2-propénoïque, polymérisé avec le 2-propénoate de butyle, le 2-méthyl-2-propénoate d’hexadécylicosyle et le 2-méthyl-2-propénoate de méthyle

642072-46-6

Ethanol, 2,2′-iminobis-,compd. with α-sulfo-ω-(tetradecyloxy)poly(oxy-1,2-ethanediyl)

Éthanol, 2,2′-iminobis-, composé avec l’α-sulfo-oméga-(tétradécyloxy)poly(oxy-1,2-éthanediyle)

756819-45-1

Siloxanes and Silicones, di-Me, mono[3-[(2-methyl-1-oxo-2-propenyl)oxy]propyl] group-terminated, polymers with Bu methacrylate, 2-ethylhexyl acrylate and Me methacrylate

Polydiméthylsiloxanes à terminaisons mono[3-[(2-méthylprop-2-énoyl)oxy]propyles, polymérisés avec du méthacrylate de butyle, de l’acrylate de 2-éthylhexyle et du méthacrylate de méthyle

827596-80-5

Octadecanoic acid, 12-hydroxy-, polymer with oxirane, triblock

Acide 12-hydroxyoctadécanoïque, polymérisé avec l’oxirane, à trois blocs

869734-19-0

acids, Cannabis sativa seed-oil, esters with polyethylene glycol ether with glycerol (3:1)

Acides, huile de Cannabis sativa, esters avec l’éther de polyéthylèneglycol avec le glycérol (3:1)

915223-67-5

Siloxanes and Silicones, di-Me, Me 3,3,4,4,5,5,6,6,6-nonafluorohexyl, Me stearyl

Siloxanes et silicones, diméthyl-, méthyl-3,3,4,4,5,5,6,6,6-nonafluorohexyl-, méthyl-stéaryl-

958873-87-5

ethanaminium, 2-amino-N-(2-aminoethyl)-N-[2-(2-hydroxyethoxy)ethyl]-N-methyl-, N,N′-di-limnanthes alba seed-oil acyl derivs., Me sulfates (salts)

Éthanaminium, 2-amino-N-(2-aminoéthyl)-N-[2-(2-hydroxyéthoxy)éthyl]-N-méthyl-, dérivés N,N′-diacylés d’huile de graines de Limnanthes alba, sulfates de méthyle (sels)

1007304-55-3

Poly(oxy-1,2-ethanediyl), ω′-hydroxy-ω-[(1- oxoisooctadecyl)oxy]-ω″-[[(5-oxo-2-pyrrolidinyl)carbonyl]oxy]- α,α′,α″-1,2,3-propanediyltris-

Poly(oxy-1,2-éthanediyle), oméga′-hydroxy-oméga-[(1-oxoisooctadécyl)oxy]-oméga″-[[(5-oxo-2-pyrrolidinyl)carbonyl]oxy]-α,α′,α″-1,2,3-propanediyltris-

1034015-50-3

Polysaccharides, sugarcane, 3-(dimethyloctadecylammonio)-2-hydroxypropyl ethers, chlorides

Polysaccharides, canne à sucre, éthers 3-(diméthyloctadécylammonio)-2-hydroxypropyliques, chlorures

1072005-10-7

Decanoic acid, mixed diesters with octanoic acid and 1,3-propanediol

Acide décanedioïque, diesters mixtes avec l’acide octanoïque et le 1,3-propanediol

1384982-80-2

Quaternary Ammonium Compounds, dimethylbis (mixed C12-15-alkyl and cetyl and stearyl), chlorides

Composés d’ammonium quaternaire, diméthylbis(mélange d’alkyles en C12-15, de cétyle et de stéaryle), chlorures

1429320-75-1

Butanedioic acid, 2-sulfo-, 1(or 4)-C10-16-alkyl esters, disodium salts

2-sulfobutanedioate de 1(ou 4)-alkyles en C10-16, sels disodiques

SCHEDULE 2

Persons required to provide information

  • 1. This notice applies to any person who, during the 2014 or 2015 calendar year, manufactured a total quantity greater than 100 kg of a substance listed in Part 1, Part 2 or Part 3 of Schedule 1 to this notice.
  • 2. This notice applies to any person who, during the 2014 or 2015 calendar year, manufactured a total quantity greater than 100 kg of a substance listed in Part 4 of Schedule 1 to this notice that is a cosmetic, food, therapeutic product or natural health product subject to the Food and Drugs Act or is intended to be a component in such products.
  • 3. This notice applies to any person who, during the 2014 or 2015 calendar year, imported a total quantity greater than 100 kg of a substance listed in Part 1, Part 2 or Part 3 of Schedule 1 to this notice, whether the substance is
    • (a) alone;
    • (b) at a concentration equal to or above 0.1% by weight (w/w%) in a mixture or in a product; or
    • (c) listed in Part 3 of Schedule 1 and at a concentration equal to or above 0.1% by weight (w/w%) in a manufactured item that is
      • (i) intended to be used by or for children under the age of six years,
      • (ii) intended to come into contact with the mucosa of an individual, other than eyes,
      • (iii) cookware, or a cooking or serving utensil that is intended to come into direct contact with heated food within a residence, unless the component that comes into direct contact with heated food is made of glass, stainless steel or porcelain,
      • (iv) food packaging that is intended to come into direct contact with food, unless the component that comes into direct contact with food is made of glass, stainless steel or porcelain,
      • (v) a reusable food or beverage container, unless the component that comes into direct contact with food or beverage is made of glass, stainless steel or porcelain,
      • (vi) intended to release the substance during conditions of use such that the substance may be inhaled or come into dermal contact with an individual,
      • (vii) clothing or footwear,
      • (viii) bedding, a sleeping bag or a towel,
      • (ix) furniture, a mattress, a cushion or a pillow intended to be used in a residence, where the substance is contained in foam or leather or in a textile fibre, yarn or fabric, or
      • (x) carpet, vinyl or laminate flooring, or foam underlay for flooring, intended to be used in a residence.
  • 4. This notice applies to any person who, during the 2014 or 2015 calendar year, imported a total quantity greater than 100 kg of a substance, listed in Part 4 of Schedule 1 to this notice, that is, is contained in, or is intended to be a component in, a cosmetic, food, therapeutic product or natural health product subject to the Food and Drugs Act.
  • 5. Any person for whom the criteria set out in Schedule 2 have been met for both the 2014 and 2015 calendar years shall provide information prescribed in sections 6 to 10 of Schedule 3 to this notice for the 2015 calendar year only.
  • 6. This notice does not apply to a substance listed in Schedule 1, whether alone, in a mixture, in a product, or in a manufactured item, that
    • (a) is in transit through Canada;
    • (b) is Tin fluoride (CAS RN 7783-47-3) contained in dental care products or mixtures;
    • (c) is, or is contained in, a hazardous waste or hazardous recyclable material within the meaning of the Export and Import of Hazardous Waste and Hazardous Recyclable Material Regulations and was imported pursuant to a permit issued under these Regulations;
    • (d) is, or is contained in, a pest control product registered under the Pest Control Products Act;
    • (e) is, or is contained in, a fertilizer or supplement registered under the Fertilizers Act;
    • (f) is, or is contained in, a feed registered under the Feeds Act; or
    • (g) is mixed with, or attached to, a seed registered under the Seeds Act.
  • 7. If a person provided information under the New Substances Notification Regulations, for a substance listed in Part 4 of Schedule 1, a response from that person is not required under this notice for that substance.
  • 8. Any person to whom this notice applies who
    • (a) manufactured, or imported alone, in a mixture or in a product, a substance listed in Part 1 or Part 3, shall provide the information requested in sections 4, 5, 6, 7, and 8 of Schedule 3;
    • (b) manufactured, or imported alone, in a mixture or in a product, a substance listed in Part 2, shall provide the information requested in sections 4, 5, 6, 7, 8 and 9 of Schedule 3;
    • (c) manufactured, or imported alone, in a mixture or in a product, a substance listed in Part 4, shall provide the information requested in sections 4, 5, 7, and 8 of Schedule 3;
    • (d) imported a substance listed in Part 3 or Part 4 in a manufactured item shall provide the information requested in sections 4, 5, and 10 of Schedule 3.

SCHEDULE 3

Information required

  • 1. The definitions in this section apply in this notice.
  • “manufacture” includes the incidental production of a substance.
  • “manufactured item” An item that is formed into a specific physical shape or design during manufacture and has, for its final use, a function or functions dependent in whole or in part on its shape or design.
  • “mixture” A combination of substances that does not produce a substance that is different from the substances that were combined, including prepared formulations and reaction mixtures that are fully characterized in terms of their constituent substances, hydrates, and homogenous and heterogeneous alloys.
  • “product” excludes “mixture” and “manufactured item.”
  • 2. If the person subject to the notice is a company that owns more than one facility, a single response to the notice shall be submitted. Except for the purpose of section 6 of this Schedule, the single response shall amalgamate the information from all facilities owned by the company for each applicable question in the notice.
  • 3. Where information required under Schedule 3 to this notice has already been sent to the Government of Canada, it may be relied on as a response to any question in Schedule 3 to this notice if
    • (a) the information previously submitted is applicable to the calendar year for which the person is reporting;
    • (b) the person provides the following information:
      • (i) the CAS RN or Confidential Accession Number of the substance to which the submitted information relates,
      • (ii) the date on which the information was submitted,
      • (iii) the name of the person who submitted the information, and
      • (iv) the program and/or individuals to which the information was submitted.
  • 4. Any person to whom this notice applies shall provide the following information: name of the person (e.g. company name), Canadian head office address, Federal Business Number (see footnote 18) and contact name and information.
  • 5. For each substance listed in Schedule 1 that a person manufactured, or imported alone, in a mixture, in a product or in a manufactured item, during either the 2014 or 2015 calendar year, for which the criteria set out in Schedule 2 have been met, the person shall provide the following information:
    • (a) the CAS RN or the Confidential Accession Number of the substance; and
    • (b) whether the person manufactured a quantity greater than 100 kg of the substance, or imported a quantity greater than 100 kg of the substance whether alone, or in a mixture, a product, or a manufactured item at a concentration equal to or above 0.1% by weight (w/w%), during each of the 2012, 2013, 2014, and 2015 calendar years, by indicating “yes” or “no”.
  • 6. For each of the person’s facilities where substances listed in Part 1, 2 or 3 of Schedule 1 were manufactured, or to which they were imported alone, in a mixture or in a product, for activities other than distribution and warehousing during the calendar year for which the person is responding to this notice, the person to whom this notice applies shall provide
    • (a) the name and address;
    • (b) the CAS RN or the Confidential Accession Number of the substance; and
    • (c) each applicable six-digit North American Industry Classification System (NAICS) (see footnote 19) code.
  • 7. For each substance listed in Schedule 1 that a person manufactured, or imported alone, in a mixture or in a product, during the calendar year for which the person is responding to this notice, for which the criteria set out in Schedule 2 have been met, the person shall provide the following information:
    • (a) the CAS RN or the Confidential Accession Number of the substance; and
    • (b) the total quantity of the substance that the person manufactured, imported and exported, reported in kilograms (rounded to two significant digits).
  • 8. (1) For each substance listed in Schedule 1 that a person manufactured, or imported alone, in a mixture or in a product, during the calendar year for which the person is responding to this notice, for which the criteria set out in Schedule 2 have been met, the person shall provide the following information:
    • (a) the CAS RN or the Confidential Accession Number of the substance;
    • (b) the Substance Function Code(s) set out in section 11 that apply to the substance;
    • (c) for each Substance Function Code provided, the Consumer and Commercial Code(s) set out in section 12 that describe the known or anticipated final goods containing the substance;
    • (d) for each Consumer and Commercial Code provided, the quantity of the substance, reported in kilograms (rounded to two significant digits);
    • (e) for each Consumer and Commercial Code provided, whether any known or anticipated final goods containing the substance are intended for use in commercial activities, by indicating “yes” or “no”;
    • (f) for each Consumer and Commercial Code provided, whether any known or anticipated final goods containing the substance are intended for use in consumer activities, by indicating “yes” or “no”; and
    • (g) for each Consumer and Commercial Code provided, whether any known or anticipated final goods containing the substance are intended for use by or for children 14 years of age or younger, by indicating “yes” or “no.”
  • 8. (2) Where code U999 is provided for paragraph (1)(b), a written description of the substance function must be provided.
  • 8. (3) Where code C105, C108 or C999 is provided for paragraph (1)(c), a written description of the known or anticipated final goods containing the substance must be provided.
  • 9. (1) For each substance listed in Part 2 of Schedule 1 that a person manufactured, or imported alone, in a mixture or in a product, during the calendar year for which the person is responding to this notice, for which the criteria set out in Schedule 2 have been met, the person shall provide the following information:
    • (a) the CAS RN;
    • (b) the name, city and province of the 10 persons in Canada to whom the largest quantity of the substance above 100 kg was sold; and
    • (c) the total quantity of the substance sold to each person, reported in kilograms (rounded to two significant digits).
  • 9. (2) Subsection (1) does not apply to importers of the substance in a mixture or a product intended for use by consumers for non-commercial purposes.

10. (1) For each substance listed in Part 3 or Part 4 of Schedule 1 that a person imported in a manufactured item during the calendar year for which the person is responding to this notice, for which the criteria set out in Schedule 2 have been met, the person shall provide the following information:

  • (a) the CAS RN or the Confidential Accession Number of the substance;
  • (b) for a substance in Part 3, each applicable category of manufactured items listed in subparagraphs 3(c)(i) to (x) of Schedule 2;
  • (c) for a substance in Part 4, whether it is, is contained in, or is intended to be a component in a cosmetic, food, therapeutic product or natural health product subject to the Food and Drugs Act;
  • (d) the Consumer and Commercial Code(s) set out in section 12 that describe the manufactured item containing the substance;
  • (e) for each Consumer and Commercial Code provided, whether the manufactured item containing the substance is intended for use in commercial activities, by indicating “yes” or “no”;
  • (f) for each Consumer and Commercial Code provided, whether the manufactured item containing the substance is intended for use in consumer activities, by indicating “yes” or “no”; and
  • (g) for each Consumer and Commercial Code provided, whether the manufactured item containing the substance is intended for use by or for children 14 years of age or younger, by indicating “yes” or “no.”

10. (2) Where code C105, C108 or C999 is provided for paragraph (1)(c), a written description of the manufactured item containing the substance must be provided.

11. For the purpose of section 8, the following are the substance function codes and their corresponding descriptions:

Substance function codes

Title

Description

U001

Abrasives

Substances used to wear down or polish surfaces by rubbing against the surface.

U002

Adhesives and sealant substances

Substances used to promote bonding between other substances, promote adhesion of surfaces, or prevent seepage of moisture or air.

U003

Adsorbents and absorbents

Substances used to retain other substances by accumulation on their surface or by assimilation.

U004

Agricultural substances (non-pesticidal)

Substances used to increase the productivity and quality of farm crops.

U005

Anti-adhesive agents

Substances used to prevent bonding between other substances by discouraging surface attachment.

U006

Bleaching agents

Substances used to lighten or whiten a substrate through chemical reaction, usually an oxidative process which degrades the colour system.

U007

Corrosion inhibitors and anti-scaling agents

Substances used to prevent or retard corrosion or the formation of scale.

U008

Dyes

Substances used to impart colour to other materials or mixtures by penetrating into the surface of the substrate.

U009

Fillers

Substances used to provide bulk, increase strength, increase hardness, or improve resistance to impact.

U010

Finishing agents

Substances used to impart such functions as softening, static-proofing, wrinkle resistance, and water repellence.

U011

Flame retardants

Substances used on the surface of or incorporated into combustible materials to reduce or eliminate their tendency to ignite when exposed to heat or a flame.

U012

Fuels and fuel additives

Substances used to create mechanical or thermal energy through chemical reactions, or which are added to a fuel for the purpose of controlling the rate of reaction or limiting the production of undesirable combustion products, or which provide other benefits such as corrosion inhibition, lubrication, or detergency.

U013

Functional fluids (closed systems)

Liquid or gaseous substances used for one or more operational properties in a closed system. This code does not include fluids used as lubricants.

U014

Functional fluids (open systems)

Liquid or gaseous substances used for one or more operational properties in an open system.

U015

Intermediates

Substances consumed in a reaction to produce other substances for commercial advantage.

U016

Ion exchange agents

Substances that are used to selectively remove targeted ions from a solution. This code also includes aluminosilicate zeolites.

U017

Lubricants and lubricant additives

Substances used to reduce friction, heat, or wear between moving parts or adjacent solid surfaces, or that enhance the lubricity of other substances.

U018

Odour agents

Substances used to control odours, remove odours, mask odours, or impart odours.

U019

Oxidizing and reducing agents

Substances used to alter the valence state of another substance by donating or accepting electrons or by the addition or removal of hydrogen to a substance.

U020

Photosensitive substances

Substances used for their ability to alter their physical or chemical structure through absorption of light, resulting in the emission of light, dissociation, discoloration, or other chemical reaction.

U021

Pigments

Substances used to impart colour to other materials or mixtures by attaching themselves to the surface of the substrate through binding or adhesion.

U022

Plasticizers

Substances used in plastics, cement, concrete, wallboard, clay bodies, or other materials to increase their plasticity or fluidity.

U023

Plating agents and surface treating agents

Substances applied to metal, plastic, or other surfaces to alter physical or chemical properties of the surface.

U024

Process regulators

Substances used to change the rate of a reaction, start or stop the reaction, or otherwise influence the course of the reaction.

U025

Processing aids, specific to petroleum production

Substances added to water, oil, or synthetic drilling muds or other petroleum production fluids to control foaming, corrosion, alkalinity and pH, microbiological growth or hydrate formation, or to improve the operation of processing equipment during the production of oil, gas, and other products or mixtures from beneath the earth’s surface.

U026

Processing aids, not otherwise covered in this table

Substances used in applications other than the production of oil, gas, or geothermal energy to control foaming, corrosion or alkalinity and pH, or to improve the operation of processing equipment.

U027

Propellants and blowing agents

Substances used to dissolve or suspend other substances and either to expel those substances from a container in the form of an aerosol or to impart a cellular structure to plastics, rubber, or thermo set resins.

U028

Solids separation agents

Substances used to promote the separation of suspended solids from a liquid.

U029

Solvents (for cleaning or degreasing

Substances used to dissolve oils, greases and similar materials from textiles, glassware, metal surfaces, and other articles.

U030

Solvents (which become part of formulation or mixture)

Substances used to dissolve another substance to form a uniformly dispersed solution at the molecular level.

U031

Surface active agents

Substances used to modify surface tension when dissolved in water or water solutions, or reduce interfacial tension between two liquids or between a liquid and a solid or between liquid and air.

U032

Viscosity adjustors

Substances used to alter the viscosity of another substance.

U033

Laboratory substances

Substances used in a laboratory for chemical analysis, chemical synthesis, extracting and purifying other chemicals, dissolving other substances, and similar activities.

U034

Paint additives and coating additives not otherwise covered in this table

Substances used in a paint or coating formulation to enhance properties such as water repellence, increased gloss, improved fade resistance, ease of application or foam prevention.

U061

Pest control substances

Substances used as active ingredients in products, mixtures or manufactured items used for directly or indirectly controlling, destroying, attracting or repelling a pest or for mitigating or preventing its injurious, noxious or troublesome effects.

U062

Active ingredients in health products

Substances used as active ingredients in natural health products or prescription or non-prescription drugs.

U063

Flavourants

Substances used as non-medicinal ingredients or excipients in foods, natural health products, and drugs that impart a certain flavor to the food, natural health product or drug.

U064

Contaminants

Substances naturally present in a reactant or substances that are produced as a result of the manufacturing process and have no beneficial properties in the final product, mixture or manufactured item.

U065

By-products

Substances resulting from the manufacturing process that can be partially or completely removed from the intended product, mixture or manufactured item and have commercial value on their own or when added to another product, mixture or manufactured item.

U066

Wastes

Substances that are removed from the final product, mixture or manufactured item during the manufacturing process and have no commercial value.

U999

Other (specify)

Substances with a function not otherwise described in this table. A written description must be provided when using this code.

12. For the purpose of sections 8 and 10, the following are the consumer and commercial codes and their corresponding descriptions:

Table 1: Furnishings, cleaning, treatment or care

Consumer and commercial codes

Title

Description

C101

Floor coverings

Substances contained in floor coverings. This code does not include wood and pressed wood flooring products included in Building or construction materials — Wood and engineered wood code.

C102

Foam seating and bedding

Substances contained in foam mattresses, pillows, cushions, and any seating, furniture and furnishings containing foam.

C103

Furniture and furnishings not otherwise covered in this table

Substances contained in furniture and furnishings made from metal, wood, leather, plastic or other materials. This code does not include foam seating and bedding products.

C104

Fabric, textile and leather articles not otherwise covered in this table

Substances contained in fabric, textile and leather products to impart color and other desirable properties such as water, soil, stain repellence, wrinkle resistance, or flame resistance.

C105

Cleaning and furnishing care (specify)

Substances contained in products, mixtures or manufactured items that are used to remove dirt, grease, stains, and foreign matter from furniture and furnishings, or to cleanse, sanitize, bleach, scour, polish, protect, or improve the appearance of surfaces. A written description must be provided when using this code.

C106

Laundry and dishwashing

Substances contained in laundry and dishwashing products, mixtures or manufactured items.

C107

Water treatment

Substances contained in water treatment products, mixtures or manufactured items that are designed to disinfect, reduce contaminants or other undesirable constituents, and condition or improve aesthetics of water. Excludes any substance contained in pest control products as defined under the Pest Control Products Act.

C108

Personal care and cosmetics (specify)

Substances contained in personal care products, mixtures or manufactured items that are used for cleansing, grooming, improving or altering skin, hair, or teeth. A written description must be provided when using this code.

C109

Air care

Substances contained in products, mixtures or manufactured items that are used to odorize or deodorize indoor air in homes, offices, motor vehicles, and other enclosed spaces.

C110

Apparel and footwear care

Substances contained in apparel and footwear care products, mixtures or manufactured items that are applied post-market.

C160

Pet care

Substances contained in pet care products, mixtures or manufactured items that are used for cleansing, grooming, improving or altering skin, hair or teeth and intended for animal use.

Table 2: Construction, paint, electrical or metal

Consumer and commercial codes

Title

Description

C201

Adhesives and sealants

Substances contained in adhesive or sealant products or mixtures used to fasten other materials together or prevent the passage of liquid or gas.

C202.01

Paints and coatings

Substances contained in paints or coatings.

C202.02

Paint thinners and removers

Substances contained in paint thinners and removers.

C203

Building or construction materials — Wood and engineered wood

Substances contained in building and construction materials made of wood and pressed or engineered wood products, mixtures or manufactured items.

C204

Building or construction materials not otherwise covered in this table

Substances contained in building and construction materials not otherwise covered in this table.

C205

Electrical and electronics

Substances contained in electrical and electronic products, mixtures or manufactured items.

C206

Metal materials not otherwise covered in this table

Substances contained in metal products, mixtures or manufactured items not otherwise covered in this table.

C207

Batteries

Substances contained in non-rechargeable and rechargeable batteries including dry and wet cell units that store energy.

Table 3: Packaging, paper, plastic or hobby

Consumer and commercial codes

Title

Description

C301

Food packaging

Substances contained in single or multi-layered packaging consisting of paper, plastic, metal, foil or other materials which have or may have direct contact with food.

C302

Paper products, mixtures or manufactured items

Substances contained in paper products, mixtures or manufactured items.

C303.01

Plastic materials not otherwise covered in this table

Substances contained plastic products, mixtures or manufactured items not otherwise covered in this table.

C303.02

Rubber materials not otherwise covered in this table

Substances contained in rubber products, mixtures or manufactured items not otherwise covered in this table.

C304

Toys, playground and sporting equipment

Substances contained in toys, playground, and sporting equipment made of wood, metal, plastic or fabric.

C305

Arts, crafts and hobby materials

Substances contained in arts, crafts, and hobby materials.

C306

Ink, toner and colourants

Substances contained in ink, toners and colourants used for writing, printing, creating an image on paper; and substances contained in other substrates, or applied to substrates to change their colour or hide images.

C307

Photographic supplies, film and photo-chemicals

Substances contained in photographic supplies, film, photo-processing substances, and photographic paper.

Table 4: Automotive, fuel, agriculture or outdoor use

Consumer and commercial codes

Title

Description

C401

Automotive care

Substances contained in products, mixtures or manufactured items used in automotive cleaning and care of exterior and interior vehicle surfaces. This code does not include antifreeze, de-icing products, or lubricants.

C402

Lubricants and greases

Substances contained in products, mixtures or manufactured items to reduce friction, heat generation and wear between solid surfaces.

C403

Anti-freeze and de-icing

Substances added to fluids to reduce the freezing point of the mixture, or substances applied to surfaces to melt or prevent build-up of ice.

C404

Fuels and related products, mixtures or manufactured items

Substances burned to produce heat, light or power, or added to inhibit corrosion, provide lubrication, increase efficiency of use, or decrease production of undesirable by-products.

C405

Explosive materials

Substances capable of producing a sudden expansion, usually accompanied by the production of heat and large changes in pressure upon ignition.

C406

Agricultural products, mixtures or manufactured items (non-pesticidal)

Substances used to increase the productivity and quality of plants, animals or forestry crops, produced on a commercial scale. Includes animal feed (any substance or mixture of substances for consumption by livestock, providing the nutritional requirements of livestock, or the purpose of preventing or correcting nutritional disorders of livestock, as defined in the Feeds Act and Regulations).

C407

Lawn and garden care

Substances contained in lawn, garden, outdoor or potted plant and tree care products, mixtures or manufactured items. Excludes any substance contained in pest control products as defined under the Pest Control Products Act.

C461

Pest control

Substances contained in any product, mixture or manufactured item for directly or indirectly controlling, preventing, destroying, mitigating, attracting, or repelling any pest.

C462

Automotive, aircraft and transportation

Substances contained in automobiles, aircraft and other types of transportation, or used in their manufacture.

C463

Oil and natural gas extraction

Substances that are, or are contained in, any mixtures, products or manufactured items, used for oil and natural gas drilling, extraction and processing.

Table 5: Items for food, health or tobacco

Consumer and commercial codes

Title

Description

C562

Food and beverage

Substances contained in food and beverage products, mixtures or manufactured items.

C563

Drugs

Substances contained in prescription and non-prescription drugs intended for humans or animals.

C564

Natural health

Substances contained in natural health products, mixtures or manufactured items intended for humans or animals.

C565

Medical devices

Substances contained in products, mixtures or manufactured items used for either the diagnosis, treatment, mitigation or prevention of a disease, disorder, or an abnormal physical state; or those used in restoring, correcting or modifying organic functions in humans or animals.

C566

Tobacco products, mixtures or manufactured items

Substances contained in products, mixtures or manufactured items composed in whole or in part of tobacco, including tobacco leaves and any extract of tobacco leaves.

Table 6: Products, mixtures or manufactured items not described by other codes

Consumer and commercial codes

Title

Description

C999

Other (specify)

Substances contained in products, mixtures or manufactured items that are not described within any other consumer and commercial code.

EXPLANATORY NOTE

(This note is not part of the notice.)

Announced as a key component of the Chemicals Management Plan (CMP), an update to the commercial status of substances of interest in Canada is critical to support priority setting and decision making for work post-CMP. To date, two inventory updates have been conducted. The first phase of the Domestic Substances List (DSL) Inventory Update (IU) was conducted in 2009 and gathered information on approximately 500 inanimate and 50 animate substances. Building on the first phase, the second phase of the DSL IU was carried out to collect information on approximately 2 700 substances. Whereas previous IUs were limited to DSL substances, the scope has been expanded and now considers emerging science, evolving domestic and international programs and the need to keep pace with chemical landscape fluctuations in order to ensure future priorities are reflective of Canada’s dynamic market.

The Notice with respect to substances included as part of the 2017 Inventory Update applies to approximately 1 500 substances. The scope of the notice allows the Government of Canada to capture critical information on commercial status, downstream use and yearly market fluctuations between 2012 and 2015.

Substances included in Part 4 of Schedule 1 are currently on the revised In Commerce List (ICL). The scope of the information being collected on these substances is limited to Food and Drugs Act–related activities, such as therapeutic products (including human and veterinary drugs, and medical devices), natural health products, foods (including food additives) and cosmetics. Substances in Part 4 of Schedule 1 that are imported or manufactured with respect to use patterns beyond the scope of the Food and Drugs Act are subject to notification requirements under the New Substances Notification Regulations of the Canadian Environmental Protection Act, 1999 (hereinafter referred to as the “Act”).

Pursuant to subsection 71(3) of the Act, every person to whom this notice applies shall comply with this notice within the time specified in the notice. The time specified in this notice is July 17, 2017, 3 p.m., Eastern Daylight Saving Time. Any person making a written request pursuant to subsection 71(4) of the Act should include the name of the party requiring an extension, the Chemical Abstracts Service Registry Number (CAS RN) of the substances for which the person will provide information, as well as the reason of the extension request.

Any person making a written request pursuant to section 313 of the Act should identify each part of the information that is to be considered confidential, and provide a rationale for the sensitivity of the information.

Persons not subject to this notice who have a current or future interest in a substance set out in Schedule 1 to this notice may identify themselves as a “stakeholder” for the substance by completing the voluntary Declaration of Stakeholder Interest using the online reporting system via Environment and Climate Change Canada’s Single Window at https://ec.ss.ec.gc.ca/. The person may be contacted for further information regarding their interest in the substance.

Persons who do not meet the requirements to respond and have no commercial interest in the substances covered by this notice may submit a Declaration of Non-Engagement for the notice using the online reporting system via Environment and Climate Change Canada’s Single Window at https://ec.ss.ec.gc.ca/.

The Minister of the Environment and the Minister of Health are also inviting interested stakeholders to submit additional information that is deemed beneficial. Organizations that may be interested in submitting additional information in response to this invitation include those that manufacture, import, export or use these substances whether alone, in a mixture, in a product or in a manufactured item.

Compliance with the Act is mandatory and specific offences are established by subsections 272(1), 272.1(1), 272.2(1), 272.4(1) and 272.5(1) of the Act. Amendments to the fine scheme of the Act came into force on June 22, 2012. Subsections 272(2), (3) and (4) and 272.1(2), (3) and (4) of the Act set the penalties for persons who commit an offence under the Act. Offences include the offence of failing to comply with an obligation arising from the Act and the offence of providing false or misleading information. Penalties for the most serious offences include minimum fines, and the amount of the fine can range from a minimum of $5,000 for an individual convicted following summary proceedings to a maximum of $6,000,000 for a large corporation convicted on indictment. The fine range doubles for second or subsequent offences and individuals may also be liable to a term of imprisonment of up to three years. Offences other than those in the category of “serious offences” are punishable by fines capped at a maximum that ranges from $25,000 for an individual convicted following summary proceedings to $500,000 for a large corporation convicted on indictment. The maximum fines are doubled for second or subsequent offences.

The current text of the Act, including the most recent amendments, is available on the Department of Justice’s website: http://laws-lois.justice.gc.ca/eng/acts/C-15.31/.

The Act is enforced in accordance with the Compliance and Enforcement Policy for the Canadian Environmental Protection Act, 1999 available at www.ec.gc.ca/lcpe-cepa/default.asp?lang=En&n=5082BFBE-1. Suspected violations under the Act can be reported to the Enforcement Branch by email at ec.dale-enviroinfo-eed-enviroinfo.ec@canada.ca.

Responses to the notice must be provided no later than July 17, 2017, 3 p.m., Eastern Daylight Saving Time, using the online reporting system available through Environment and Climate Change Canada’s Single Window at https://ec.ss.ec.gc.ca/.

An electronic copy of this notice is available at the following website: www.chemicalsubstanceschimiques.gc.ca.

[2-1-o]

DEPARTMENT OF THE ENVIRONMENT

WILD ANIMAL AND PLANT PROTECTION AND REGULATION OF INTERNATIONAL AND INTERPROVINCIAL TRADE ACT

Notice of intent to modify the Wild Animal and Plant Trade Regulations

Notice is hereby given that the Minister of the Environment intends to recommend to the Governor in Council that amendments be made to the Wild Animal and Plant Trade Regulations (WAPTR), pursuant to section 21 of the Wild Animal and Plant Protection and Regulation of International and Interprovincial Trade Act.

The purpose of these amendments is to update domestic regulations in order to meet international obligations. These amendments will reflect changes to the Appendices of the Convention on International Trade in Endangered Species of Wild Fauna and Flora (CITES) agreed to by the Parties to the Convention during the 17th Conference of the Parties (CoP17). These changes include additions, deletions and reclassifications of species listings as well as nomenclature modifications.

The 49 amendments to the CITES Appendices that were adopted at CoP17 and that will be reflected in Schedule I of WAPTR affect 72 taxa in total. Depending on the amendment, taxa can refer to a family, genus, species, subspecies or population. In total, these amendments involve over 400 species or subspecies. Amendments that result in a decrease of trade controls have been adopted either because the controls are no longer needed or because they are not providing a conservation benefit. These amendments include

  • 2 taxa deleted from Appendix II (removal of export controls), including one Canadian subspecies, the Wood bison (Bison bison athabascae);
  • 33 taxa added to Appendix II (new export controls), including one Canadian species, the Common thresher shark (Alopias vulpinus);
  • 9 taxa added to Appendix I (new import and export controls);
  • 8 taxa transferred from Appendix I to Appendix II (removal of import controls and decrease of export controls), including one Canadian subspecies, the Eastern cougar (Puma concolor couguar);
  • 14 taxa transferred from Appendix II to Appendix I (new import controls and increased export controls); and
  • modifications to the annotations of 6 taxa listed in Appendix II in order to better facilitate trade in accordance with the conservation status of the taxa involved.

In addition, modifications to the CITES Appendices will also take into account changes that have been made to Appendix III, as requested by the Parties between January 2016 and November 2016. These amendments include the addition of 15 taxa to Appendix III (new export controls), including 2 species listed by the United States that are also found in Canada: the Spiny softshell turtle (Apalone spinifera) and the Common snapping turtle (Chelydra serpentina). One taxon was also deleted from Appendix III (removal of all trade controls). Other minor changes to Schedule I of WAPTR, such as nomenclature updates and changes to address miscellaneous issues identified by the Standing Joint Committee for the Scrutiny of Regulations, will also be made.

The Convention was established to help ensure that international trade in specimens of wild animals and plants does not threaten their survival. More than 35 000 species of animals and plants are listed in the three Appendices to CITES and are also listed in Schedule I to WAPTR. Species listed in Appendix I are considered threatened with extinction and generally may not be traded for commercial purposes. However, these species may be traded for non-commercial purposes such as educational, scientific and reintroduction purposes, under strict conditions. These conditions include the prior issuance of import and export permits by the importing and exporting countries, respectively. Appendix II species are those that are not considered threatened with extinction but that may become so if their trade is not regulated. Species may also be listed in Appendix II if they are similar in appearance to Appendices I and II species, to ensure the protection of the species of concern. Only export permits issued by the exporting country are required for Appendix II species. Species listed in Appendix III are under special management in a country and are listed unilaterally by that country in order to receive the assistance of other countries in preventing unauthorized exports. The export of Appendix III species requires either an export permit or a certificate of origin, depending on the circumstances.

For more information on these amendments, please refer to the following address: http://www.ec.gc.ca/cites/default.asp?lang=En&n=46CAFD9E-1.

Robert McLean
Director General
Assessment and Regulatory Affairs
Canadian Wildlife Service

[2-1-o]

DEPARTMENT OF FINANCE

POOLED REGISTERED PENSION PLANS ACT

Effective date for the amendments to the Multilateral Agreement Respecting Pooled Registered Pension Plans and Voluntary Retirement Savings Plans

Notice is hereby given, pursuant to paragraph 6(4)(b) of the Pooled Registered Pension Plans Act, that the effective date for the amendments to the Multilateral Agreement Respecting Pooled Registered Pension Plans and Voluntary Retirement Savings Plans is March 31, 2017.

William Francis Morneau
Minister of Finance

[2-1-o]

DEPARTMENT OF FINANCE

POOLED REGISTERED PENSION PLANS ACT

2017 Agreement Amending the Multilateral Agreement Respecting Pooled Registered Pension Plans and Voluntary Retirement Savings Plans

2017 AGREEMENT AMENDING THE MULTILATERAL AGREEMENT RESPECTING POOLED REGISTERED PENSION PLANS AND VOLUNTARY RETIREMENT SAVINGS PLANS

Between

Canada, represented by the Minister of Finance;

British Columbia, represented by the Minister of Finance;

Nova Scotia, represented by the Minister of Finance and Treasury Board;

The government of Quebec, represented by the Minister of Finance and by the Minister responsible for Canadian Relations and the Canadian Francophonie;

The Autorité des marchés financiers, represented by the President and Chief Executive Officer;

and

Saskatchewan, represented by the Minister of Justice and Attorney General;

RECITALS

Whereas Canada, British Columbia, Nova Scotia, Quebec, the Autorité des marchés financiers and Saskatchewan (hereinafter referred to as the “parties”) entered into the Multilateral Agreement Respecting Pooled Registered Pension Plans and Voluntary Retirement Savings Plans (hereinafter referred to as the “Agreement”) which came into effect on June 15, 2016, and a copy of which is attached as Annex 1;

Whereas Quebec and the Autorité des marchés financiers agree to be bound by only Parts I, with the exception of subsections 2(6) and (7), II, VI, and VII of the Agreement;

Whereas, in accordance with Section 18 of the Agreement, Ontario wishes to become a party to the Agreement, as it will be amended by the 2017 Agreement Amending the Multilateral Agreement Respecting Pooled Registered Pension Plans and Voluntary Retirement Savings Plans (hereinafter referred to as the “2017 Agreement”);

Whereas, in accordance with Section 18 of the Agreement, the parties unanimously consent to Ontario becoming a party to the Agreement, as it will be amended by the 2017 Agreement;

Whereas the parties unanimously consent to entering into the 2017 Agreement, in accordance with Section 21 of the Agreement;

Now, therefore, the parties agree as follows:

Additional Party

1. The parties, in accordance with Section 18 of the Agreement, unanimously consent to Ontario becoming a party to the Agreement, as amended by the 2017 Agreement.

Amendments to the Agreement

2. In the list of parties to the Agreement, appearing directly before the recitals to the Agreement:

(1) The word “and” is deleted; and

(2) The following words are included at the end of the list:

and Ontario, represented by the Minister of Finance;

3. The title of Part III in the section “Contents of Agreement” of the English version of the Agreement is replaced by the following:

PART III PLAN REGISTRATION

4. The definitions “federal PRPP Act” and “voluntary retirement savings plan” in subsection 1(1) of the English version of the Agreement are replaced by the following, in alphabetical order:

“federal PRPP Act” means the Pooled Registered Pension Plans Act (S.C. 2012, c. 16) and any subordinate legislation made under that Act, both as amended from time to time.

“voluntary retirement savings plan” or VRSP means a plan registered under the VRSP Act.

5. The title following section 2 of the English version of the Agreement is replaced with the following

PART II LICENSING

6. Subsection 9(3) of the Agreement is replaced by the following:

(3) A decision that is made by the Superintendent under the authority of this Agreement and that relates to the application of a provincial PRPP Act that determines a matter addressed in Schedule C, subsection 11(4) or subsection 11(5) is deemed to be a decision of the supervisory authority of the applicable province and is not subject to judicial review under the Federal Courts Act (R.S.C., (1985) c. F-7), but instead is subject to the processes for review and appeal under the laws of that province.

7. Subparagraph 11(1)(b)(ii) of the French version of the Agreement is replaced by the following:

(ii) est un employé ou un travailleur indépendant ou, s’il n’est pas actuellement un employé ou un travailleur indépendant, le dernier emploi qu’il occupait ou le dernier travail qu’il effectuait et pour lequel il participait au RPAC était au Yukon, dans les Territoires du Nord-Ouest ou au Nunavut, et il contribuait au RPAC.

8. Subsection 11(2) of French version of the Agreement is replaced by the following:

(2) Pour l’application de cet article, « dernier emploi qu’il occupait » ou « dernier travail qu’il effectuait » fait référence uniquement à un emploi ou à un travail indépendant dans une autorité législative liée par la présente partie.

9. The Agreement is amended by adding the following after subsection 11(4):

(5) Despite anything in the Agreement, the valuation or division of funds, on the breakdown of a spousal or common-law relationship, in a PRPP member’s account or funds that have been transferred from a PRPP account is governed by the law of a jurisdiction that would otherwise apply to a member and their spouse, former spouse, common-law partner, or former common-law partner if this Agreement did not exist.

10. Section 13 of the French version of the Agreement is replaced by the following:

13. Il est entendu que le présent accord ne s’applique pas aux dispositions de la Loi fédérale sur les RPAC ou des Lois provinciales sur les RPAC concernant les autorisations à obtenir et les exigences qui doivent être satisfaites pour conclure le présent accord, de le modifier ou d’y ajouter des Parties, ainsi que les dispositions concernant l’effet de l’accord.

11. Subsection 14(2) of the French version of the Agreement is replaced by the following:

(2) Lorsqu’une décision du Surintendant fait l’objet d’une révision ou d’un appel en vertu des lois d’une province tel qu’il est prévu en vertu du paragraphe 9(3), le Surintendant, sur demande, communique à l’organisme de surveillance de cette province le dossier dont il disposait lorsqu’il a pris cette décision.

12. Section 15 of the French version of the Agreement is replaced by the following:

15. À la suite de la résiliation du présent accord ou du retrait d’une Partie, l’article 14 continue d’avoir effet aux seules fins de répondre aux demandes en cours.

13. Section 18 of the Agreement is replaced with the following:

18. A province may become a party

  • (a) with the unanimous consent of the parties; and
  • (b) if the province has executed a signature page that is substantially similar to those that form part of this Agreement, and has provided copies of that page to all parties.

14. Section 19 of the Agreement is replaced with the following:

19. This Agreement shall be to the benefit of and be binding upon the parties and the supervisory authorities, as of the date referred to, as the case may be, in paragraph (a) or (b) of section 17.

15. Subsection 20(4) of the French version of the Agreement is replaced with the following:

(4) Si une Partie autre que le Canada a transmis un avis aux autres parties de son intention de se retirer de l’accord, le Surintendant doit, dans un délai raisonnable et sous réserve de toute restriction législative, transmettre à l’organisme de surveillance de cette Partie les copies des documents concernant les RPAC touchés transmis au Surintendant en vertu de la Loi fédérale sur les RPAC par l’administrateur du régime qui sont nécessaires à la surveillance continue des RPAC et informer les organismes de surveillance des décisions administratives prises par le Surintendant concernant les RPAC touchés.

16. Schedule A of the Agreement is amended by adding the following at the end of the list of “Provincial PRPP Acts”:

Ontario

Pooled Registered Pension Plans Act, 2015, S.O. 2015, c. 9

17. Paragraphs (a), (b), (d) and (e) of Schedule B of the English version of the Agreement are replaced by the following:

  • (a) be an insurer holding a life insurance class licence issued under the Act respecting insurance (CQLR, chapter A-32) in conformity with the Regulation under the Act respecting insurance (CQLR, chapter A-32, r. 1), a trust company holding a licence issued under the Act respecting trust companies and savings companies (CQLR, chapter S-29.01) or an investment fund manager registered in accordance with Title V of the Securities Act (CQLR, chapter V-1.1);
  • (b) complete and file the application form for authorization to act as administrator of a VRSP;
  • (d) pay the required fees to the AMF in accordance with the Regulation respecting fees and costs payable for the issuance of an authorization under the Voluntary Retirement Savings Plans Act (CQLR, chapter R-17.0.1, r. 2);
  • (e) provide the following information in accordance with the Regulation respecting applications for authorization and liability insurance coverage for administrators of voluntary retirement savings plans (CQLR, chapter R-17.0.1, r. 1):
    • (i) a confirmation that the amount by which the assets of the corporation exceed its liabilities is at least equal to the amount determined by regulation, or an irrevocable letter of credit or a suretyship, which letter or suretyship is in an amount determined by regulation and is issued by a financial institution licensed as an insurer, trust company or deposit institution under an Act of Canada or of a Canadian province or territory;
    • (ii) a confirmation that the corporation holds liability insurance in accordance with the requirements determined by regulation;

18. Paragraphs (d) and (g) of Schedule B of the French version of the Agreement are replaced by the following:

  • d) payer les droits requis à l’Autorité en application du Règlement sur les droits et frais exigibles pour la délivrance d’une autorisation en vertu de la Loi sur les régimes volontaires d’épargne-retraite (RLRQ, chapitre R-17.0.1, r. 2);
  • g) s’assurer que les représentants qui distribuent des RVER sont titulaires d’un certificat valide ou sont dûment inscrits pour offrir le produit financier (assurance ou valeurs mobilières).

Execution in Counterparts

19. The 2017 Agreement may be executed in counterparts.

Execution in English and French

20. The 2017 Agreement shall be executed in both English and French, each text being equally authoritative.

Effective Date

21. This 2017 Agreement comes into force on March 31, 2017. Upon its coming into force, and providing Ontario has signed a signature page agreeing to join the Agreement as amended by this 2017 Agreement, Ontario will become one of the parties, and its signed signature page will be included as Annex 2 to this 2017 Agreement.

Agreement Unaffected

22. Except as set forth in the 2017 Agreement, the Agreement is unaffected and shall continue in full force and effect in accordance with its terms.

2017 AGREEMENT AMENDING THE MULTILATERAL AGREEMENT RESPECTING POOLED REGISTERED PENSION PLANS AND VOLUNTARY RETIREMENT SAVINGS PLANS

For Canada

IN WITNESS WHEREOF, the undersigned, being duly authorized, has signed the 2017 Agreement Amending the Multilateral Agreement Respecting Pooled Registered Pension Plans and Voluntary Retirement Savings Plans.

Signed at Ottawa,

The 8th day of December, 2016.

The Honourable William Francis Morneau

Minister of Finance

2017 AGREEMENT AMENDING THE MULTILATERAL AGREEMENT RESPECTING POOLED REGISTERED PENSION PLANS AND VOLUNTARY RETIREMENT SAVINGS PLANS

For British Columbia

IN WITNESS WHEREOF, the undersigned, being duly authorized, has signed the 2017 Agreement Amending the Multilateral Agreement Respecting Pooled Registered Pension Plans and Voluntary Retirement Savings Plans.

Signed at Victoria,

The 6th day of December, 2016.

The Honourable Michael de Jong

Minister of Finance

2017 AGREEMENT AMENDING THE MULTILATERAL AGREEMENT RESPECTING POOLED REGISTERED PENSION PLANS AND VOLUNTARY RETIREMENT SAVINGS PLANS

For Nova Scotia

IN WITNESS WHEREOF, the undersigned, being duly authorized, has signed the 2017 Agreement Amending the Multilateral Agreement Respecting Pooled Registered Pension Plans and Voluntary Retirement Savings Plans.

Signed at Halifax,

The 13th day of December, 2016.

The Honourable Randy Delorey

Minister of Finance and Treasury Board

2017 AGREEMENT AMENDING THE MULTILATERAL AGREEMENT RESPECTING POOLED REGISTERED PENSION PLANS AND VOLUNTARY RETIREMENT SAVINGS PLANS

IN WITNESS WHEREOF, the undersigned, being duly authorized, has signed the 2017 Agreement Amending the Multilateral Agreement Respecting Pooled Registered Pension Plans and Voluntary Retirement Savings Plans.

Signed at Québec,

The 14th day of December, 2016.

For the government of Quebec

The Honourable Carlos Leitão

Minister of Finance

The Honourable Jean-Marc Fournier

Minister responsible for Canadian Relations and the Canadian Francophonie

For the Autorité des marchés financiers

Louis Morrisset

President and Chief Executive Officer

2017 AGREEMENT AMENDING THE MULTILATERAL AGREEMENT RESPECTING POOLED REGISTERED PENSION PLANS AND VOLUNTARY RETIREMENT SAVINGS PLANS

For Saskatchewan

IN WITNESS WHEREOF, the undersigned, being duly authorized, has signed the 2017 Agreement Amending the Multilateral Agreement Respecting Pooled Registered Pension Plans and Voluntary Retirement Savings Plans.

Signed at Regina,

The 13th day of December, 2016.

The Honourable Gordon Wyant

Minister of Justice and Attorney General

ANNEX 1

MULTILATERAL AGREEMENT RESPECTING POOLED REGISTERED PENSION PLANS AND VOLUNTARY RETIREMENT SAVINGS PLANS

Between

Canada, represented by the Minister of Finance;

British Columbia, represented by the Minister of Finance;

Nova Scotia, represented by the Minister of Finance and Treasury Board;

The government of Quebec, represented by the Minister of Finance and by the Minister responsible for Canadian Relations and the Canadian Francophonie;

The Autorité des marchés financiers, represented by the President and Chief Executive Officer;

and

Saskatchewan, represented by the Minister of Justice and Attorney General

RECITALS

  • (1) Whereas each party to this Agreement is authorized by its laws to be bound by this Agreement;
  • (2) Whereas Quebec and the Autorité des marchés financiers agree to be bound by only Parts I, with the exception of subsections 2(6) and (7), II, VI, and VII of this Agreement;
  • (3) Whereas a pooled registered pension plan may be subject to the legislation of more than one party;
  • (4) Whereas to establish an efficient and low cost regulatory environment for pooled registered pension plans, the parties, other than Quebec and the Autorité des marchés financiers as provided in this Agreement, intend to specify the law that applies to pooled registered pension plans that are otherwise subject to the federal Pooled Registered Pension Plans Act and the pooled registered pension plan legislation of at least one province and allow, to the extent provided in this Agreement, a single supervisory authority to exercise with respect to any such pooled registered pension plans all of the licensing, registration and supervisory powers to which such pooled registered pension plans are subject;
  • (5) Whereas the laws of the parties allow for entering into an Agreement respecting any matter relating to pooled registered pension plans that are subject to the federal Pooled Registered Pension Plans Act and the pooled registered pension plan legislation of at least one province, including the reciprocal application of legislative provisions and administrative powers of the supervisory authorities concerned;
  • (6) Now, therefore, the parties agree as follows:

Contents of Agreement

PART I DEFINITIONS AND APPLICATION OF THIS AGREEMENT

PART II LICENSING

PART III REGISTRATION

PART IV SUPERVISION

PART V APPLICABLE LAW

PART VI RELATIONS BETWEEN PARTIES AND SUPERVISORY AUTHORITIES

PART VII EXECUTION, AMENDMENTS TO, WITHDRAWAL FROM AND COMING INTO FORCE OF AGREEMENT

PART I DEFINITIONS AND APPLICATION OF THIS AGREEMENT

Definitions

1. (1) For the purposes of this Agreement, unless the context indicates a different meaning:

  • “AMF” means Autorité des marchés financiers.
  • “federal PRPP Act” means the Pooled Registered Pension Plans Act, S.C. 2012, c. 16, and any subordinate legislation made under that Act, both as amended from time to time.
  • “federal PRPP licence” means a licence issued by the Superintendent in accordance with section 11 of the federal PRPP Act authorizing a corporation to be an administrator of a pooled registered pension plan.
  • “federally-licensed administrator” means the holder of a federal PRPP licence or an entity designated by the Superintendent under subsection 21(1) of the federal PRPP Act.
  • “federally-registered PRPP” means a PRPP that has been registered in accordance with section 12 of the federal PRPP Act.
  • “member” means a person who holds an account with a PRPP.
  • “party” means a signatory to this Agreement as authorized to enter into it by the federal PRPP Act, a provincial PRPP Act or, in the case of Quebec and the AMF, the laws of Quebec.
  • “pooled registered pension plan” or “PRPP” means a pooled registered pension plan that is required to be registered under the federal PRPP Act or a provincial PRPP Act as applicable.
  • “provincial PRPP Act” means the legislation of a province listed in Schedule A and any subordinate legislation made under that Act, both as amended from time to time.
  • “Superintendent” means the Superintendent of Financial Institutions appointed under section 5 of the Office of the Superintendent of Financial Institutions Act (R.S.C. (1985), c. 18 (3rd Supp.)).
  • “supervisory authority” means the government ministry, department or agency of a party that has supervisory powers with respect to PRPPs under its laws and, in Quebec, the AMF with respect to a VRSP licence.
  • “voluntary retirement savings plan” or VRSP means a plan registered under the VRSP Act.
  • “VRSP Act” means the Voluntary Retirement Savings Plans Act, (CQLR, chapter R-17.0.1), and any subordinate legislation made under that legislation, both as amended from time to time.
  • “VRSP administrator” means the holder of a VRSP licence.
  • “VRSP licence” means an authorization issued by the AMF under section 29 of the VRSP Act.

Schedules

(2) The following Schedules form part of this Agreement:

  • (a) Schedule A — Provincial PRPP Acts
  • (b) Schedule B — Requirements to be met under the VRSP Act for the AMF to Issue a VRSP Licence to the Holder of a Federal PRPP Licence
  • (c) Schedule C — Matters for the Purposes of Subsection 11(1).

Application of this Agreement

  • 2. (1) Subject to subsections (4) and (5), this Agreement applies in respect of a PRPP that is required to be registered under the federal PRPP Act and one or more provincial PRPP Acts and any related matters, including its registration and supervision, the issuance of a licence authorizing a corporation to be an administrator of a PRPP, and the law applicable to a PRPP, its administrators, members and their spouse or common law partner, survivors and other beneficiaries (or the equivalent in the respective jurisdiction), and the employers offering it.
  • (2) This Agreement applies, to the extent that it provides for it, in respect of the issuance of a VRSP licence.
  • (3) Only Parts I, with the exception of subsections 2(6) and (7), II, VI and VII of this Agreement apply with regards to a VRSP licence.
  • (4) This Agreement does not apply in respect of a PRPP that prohibits individuals in respect of whom the federal PRPP Act applies from becoming members of the PRPP.
  • (5) For greater certainty, this Agreement does not apply in respect of a PRPP that is only registered provincially.
  • (6) This Agreement applies despite any conflicting provision in any document that creates or supports a PRPP.
  • (7) Where any provision of this Agreement conflicts with any provision of the federal PRPP Act or a provincial PRPP Act, this Agreement prevails to the extent of the conflict.

PART II LICENCES

Licensing Requirements

  • 3. (1) A corporation that holds a federal PRPP licence or a VRSP licence is exempt from the requirement to obtain a licence under the applicable provincial PRPP Act.
  • (2) A corporation is exempt from the requirement to obtain a licence under the federal PRPP Act if the corporation holds a VRSP licence.
  • (3) The AMF shall issue a VRSP licence to a corporation that holds a federal PRPP licence if the requirements listed in Schedule B are met.
  • (4) For greater certainty, this Agreement does not prohibit a provincial supervisory authority from issuing a PRPP licence under its provincial PRPP Act.

Suspension or Revocation of a VRSP Licence

  • 4. Despite subsections 3(1) and (2), a VRSP administrator that has its VRSP licence revoked by the AMF is no longer exempt from the requirement to obtain a licence under the federal PRPP Act or the applicable provincial PRPP Act.
  • 5. The AMF shall notify the Superintendent as soon as practicable if it has suspended or revoked the VRSP licence of a VRSP administrator, where that VRSP administrator administers a federally-registered PRPP and does not hold a federal PRPP licence.

PART III PLAN REGISTRATION

Registration Requirements

  • 6. (1) A federally-licensed administrator that has a PRPP registered under the federal PRPP Act is exempt from the requirement to have that PRPP registered under the applicable provincial PRPP Act.
  • (2) A VRSP administrator that has a PRPP registered under the federal PRPP Act is exempt from the requirement to have that PRPP registered under a provincial PRPP Act.
  • (3) For greater certainty, this Agreement does not prohibit a provincial supervisory authority from registering a PRPP under its PRPP Act.
  • (4) For greater certainty, any corporation that has a PRPP registered under the federal PRPP Act is subject to the powers of the Superintendent in respect of a federally-licensed administrator.
  • (5) For greater certainty, a federally-registered PRPP and a VRSP are distinct plans.

Notification

7. The Superintendent shall notify the AMF as soon as practicable if, in relation to a federally-registered PRPP administered by a VRSP administrator, the Superintendent has ordered the VRSP administrator to transfer the federally-registered PRPP and all of its assets to an entity designated by the Superintendent, or has terminated the federally-registered PRPP.

PART IV SUPERVISION

Role of the Superintendent

  • 8. The Superintendent shall supervise all federally-registered PRPPs that are subject to this Agreement.
  • 9. (1) With respect to the supervision of a federally-registered PRPP, the Superintendent shall exercise the powers of a supervisory authority of a province as set out in and in accordance with this Agreement.
  • (2) The Superintendent shall determine any matter or question related to supervision and related to the exercise of its powers pursuant to this Agreement.
  • (3) A decision that is made by the Superintendent under the authority of this Agreement and that relates to the application of a provincial PRPP Act that determines a matter addressed in Schedule C or in subsection 11(4) is deemed to be a decision of the supervisory authority of the applicable province and is not subject to judicial review under the Federal Courts Act (R.S.C., (1985) c. F-7), but instead is subject to the processes for review and appeal under the laws of that province.

PART V APPLICABLE LAW

Application of the Federal PRPP Act

10. Subject to section 11, the provisions of the federal PRPP Act apply to a federally-registered PRPP, including in respect of all members, and their spouses or common law partners, survivors and other beneficiaries (or the equivalent in the respective jurisdiction), its administrator, the Superintendent, and the employer offering the PRPP, instead of the provisions of a provincial PRPP Act in respect of corresponding matters that would otherwise apply if this Agreement did not exist.

Exceptions

  • 11. (1) The following legislation applies in respect of a member of a federally-registered PRPP, and their spouse, common law partner, survivor or other beneficiary (or the equivalent in the respective jurisdiction), in relation to a matter referred to in Schedule C or addressed under subsection (4):
    • (a) subject to paragraph (b), the provincial PRPP Act of the province in which the member is employed or self-employed or, if the member is not currently employed or self-employed, was last employed or self-employed and contributed to that PRPP, or
    • (b) the federal PRPP Act if the member
      • (i) is employed in included employment as defined in the federal PRPP Act with an employer that participates or participated in that PRPP or, if the member is not currently employed, was last so employed and contributed to that PRPP; or
      • (ii) is employed or self-employed or, if the member is not currently employed or self-employed, where he or she was last so employed or self-employed and a member of that PRPP in Yukon, the Northwest Territories or Nunavut, and contributed to that PRPP.
  • (2) For the purposes of this section, “last employed” or “last self-employed” refers only to employment or self-employment in jurisdictions bound by this Part.
  • (3) Where legislation referred to in subsection (1) applies in respect of amounts in a member’s account, it applies in relation to the entire balance of the member’s account.
  • (4) For greater certainty, the provisions of a provincial PRPP Act in relation to which there are no corresponding matters addressed under the federal PRPP Act apply notwithstanding anything in this Part.
  • 12. The provisions of the federal PRPP Act are adapted to the extent necessary to give effect to this Part.
  • 13. For greater certainty, this Agreement does not apply to provisions of the federal PRPP Act or a provincial PRPP Act regarding authorities and requirements for entering into this Agreement, amending it, or adding parties to it as well as provisions regarding the effect of the Agreement.

PART VI RELATIONS BETWEEN PARTIES AND SUPERVISORY AUTHORITIES

Requests for assistance

  • 14. (1) Each supervisory authority shall:
    • (a) upon request of another supervisory authority, assist each other in any matter concerning the exercise of powers or responsibilities under this Agreement as is reasonable in the circumstances;
    • (b) upon request of another supervisory authority, provide any information that it is able to regarding amendments to legislation that have been tabled and regulations that have been filed or published, to the extent that such amendments affect the application of this Agreement;
    • (c) seek an amicable resolution to any dispute that arises between them with respect to the interpretation of this Agreement.
  • (2) Where a decision of the Superintendent is being subjected to a review or appeal process under the laws of a province as provided for under subsection 9(3), the Superintendent shall, upon request, provide to the supervisory authority of the province the record that was before the Superintendent in making that decision.

Survival

15. Following the termination of this agreement or following the withdrawal of a party, section 14 shall survive only for the purposes of responding to pending requests.

Information on policy developments

16. Subject to any rules concerning Cabinet confidences and solicitor-client privilege, and any other confidentiality rule applicable to a party, each party shall provide to each other on a timely basis relevant information on policy developments in relation to the federal PRPP Act, a provincial PRPP Act, or the VRSP Act as applicable.

PART VII EXECUTION, AMENDMENTS TO, WITHDRAWAL FROM AND COMING INTO FORCE OF AGREEMENT

Effective Date

17. This Agreement comes into force:

  • (a) on June 15, 2016, in respect of each party that signed this Agreement on or before that date; and
  • (b) after June 15, 2016, in respect of any other province that wishes to become a party, on the date unanimously agreed to by all parties.

Additional Parties

18. A province may become a party:

  • i) with the unanimous consent of the parties; and
  • ii) if the province has executed a signature page that is substantially similar to those that form part of this Agreement, and has provided copies of that page to all parties.

Effects

19. This Agreement shall be to the benefit of and be binding upon the parties and the supervisory authorities, as of the date referred to, as the case may be, in clause (a) or (b) of section 17.

Withdrawal from Agreement

  • 20. (1) A party may withdraw from the Agreement by giving at least 12 months’ written notice to all the other parties to the Agreement and to the administrators of federally-registered PRPPs affected by the withdrawal. Upon expiry of the period indicated in the notification, the withdrawing party shall cease to be a party to the Agreement.
  • (2) Despite subsection (1), Canada shall provide written notice to all other parties at least 18 months prior to withdrawal.
  • (3) Once a party has notified the other parties that it intends to withdraw from the Agreement, but before the withdrawal takes effect, that party’s supervisory authority shall work with any other supervisory authorities that would be affected to facilitate the transfer of supervisory responsibilities in respect of PRPPs affected by the withdrawal.
  • (4) If a withdrawing party, other than Canada, has notified the other parties that it intends to withdraw from this Agreement, the Superintendent shall, in a reasonable time and subject to any legislative restrictions, provide to that party’s supervisory authority copies of documents relating to the affected PRPPs that have been filed with the Superintendent pursuant to the federal PRPP Act by the plan administrator that are necessary for the continued supervision of those PRPPs and shall inform the supervisory authority of any administrative decisions taken by the Superintendent concerning the affected PRPPs.
  • (5) If Canada has notified the other parties that it intends to withdraw from this Agreement, the Agreement shall be terminated at the end of the period referred to in subsection (2).

Amendments

  • 21. (1) This Agreement may be amended with the unanimous written consent of the parties.
  • (2) Despite subsection (1), the portions of Schedule A or B applicable to a specific party is amended at the initiative of that party.
  • (3) Notice of an amendment to Schedule A or B shall be provided to all other parties.

Execution in Counterparts

22. This Agreement and any amendment to this Agreement may be executed in counterparts.

Execution in English and French

23. This Agreement and any amendment to this Agreement shall be executed in both English and French, each text being equally authoritative.

SCHEDULE A

Provincial PRPP Acts

British Columbia

Pooled Registered Pension Plans Act, S.B.C. 2014, c. 17

Nova Scotia

Pooled Registered Pension Plans Act, S.N.S. 2014, c. 37

Saskatchewan

The Pooled Registered Pension Plans (Saskatchewan) Act, S.S. 2013, c.P-16.101

SCHEDULE B

Requirements to be met under the VRSP Act for the AMF to Issue a VRSP Licence to the Holder of a Federal PRPP Licence

In order to obtain a licence to act as administrator pursuant to the VRSP Act, a corporation must:

  • (a) be an insurer holding a life insurance class licence issued under the Act respecting insurance (chapter A-32) in conformity with the Regulation under the Act respecting insurance (chapter A-32, r. 1), a trust company holding a licence issued under the Act respecting trust companies and savings companies (chapter S-29.01) or an investment fund manager registered in accordance with Title V of the Securities Act (chapter V-1.1);
  • (b) complete and file the Application form for Authorization to Act as Administrator of a VRSP;
  • (c) be incorporated under a jurisdiction other than the province of Quebec;
  • (d) pay the required fees to the AMF in accordance with the Regulation respecting fees and costs payable for the issuance of an authorization under the VRSP Act;
  • (e) provide the following information in accordance with the Regulation respecting applications for authorization and liability insurance coverage for administrators of voluntary retirement savings plans (R-17.0.1, r. 1):
    • (i) a confirmation that the amount by which the assets of the corporation exceed its liabilities is at least equal to the amount determined by regulation, or an irrevocable letter of credit or a suretyship, which letter or suretyship is in an amount determined by regulation and is issued by a financial institution licensed as an insurer, trust company or deposit institution under an Act of Canada or of a Canadian province or territory;
    • (ii) a confirmation that the corporation holds liability insurance in accordance with the requirements determined by regulation;
  • (f) provide a five-year business plan dealing with the proposed development of activities related to the voluntary retirement savings plan and showing how the corporation intends to comply with the conditions and obligations applicable under the VRSP Act; and
  • (g) ensure representatives distributing VRSPs hold a valid licence or registration for the financial product they are providing (insurance or securities).

SCHEDULE C

Matters for the Purposes of Subsection 11(1)

For the purposes of subsection 11(1), a matter is any of the following:

  • (a) provisions relating to the definition of spouse, former spouse, common-law partner and survivor (or the equivalent in the respective jurisdiction);
  • (b) the locking-in, withdrawal, and surrender of funds from a member’s PRPP account;
  • (c) rules respecting variable payments, including the election of a member to receive variable payments from his or her PRPP account, and the annual variable payment amount;
  • (d) the transfer, payment or surrender of funds or entitlement to funds in a member’s account on the death of that member;
  • (e) the transfer of funds from a member’s PRPP account to a pension plan, retirement savings plan, locked-in account or life annuity or other similar product, as well as the rules applicable to these products, including the rules applicable to the transfer of funds from these products;
  • (f) rules regarding agreements or arrangements to transfer, charge, anticipate, assign, give as security or surrender any rights or interests in:
    • (i) funds in a PRPP account; and
    • (ii) funds transferred from a PRPP account.

MULTILATERAL AGREEMENT RESPECTING POOLED REGISTERED PENSION PLANS AND VOLUNTARY RETIREMENT SAVINGS PLANS

For Canada

IN WITNESS WHEREOF, the undersigned, being duly authorized, has signed the Multilateral Agreement Respecting Pooled Registered Pension Plans and Voluntary Retirement Savings Plans.

Signed at Ottawa,

The 10 day of June, 2016.

The Honourable William Francis Morneau

Minister of Finance

MULTILATERAL AGREEMENT RESPECTING POOLED REGISTERED PENSION PLANS AND VOLUNTARY RETIREMENT SAVINGS PLANS

For British Columbia

IN WITNESS WHEREOF, the undersigned, being duly authorized, has signed the Multilateral Agreement Respecting Pooled Registered Pension Plans and Voluntary Retirement Savings Plans.

Signed at Victoria,

The 9th day of June, 2016.

The Honourable Michael de Jong

Minister of Finance

MULTILATERAL AGREEMENT RESPECTING POOLED REGISTERED PENSION PLANS AND VOLUNTARY RETIREMENT SAVINGS PLANS

For Nova Scotia

IN WITNESS WHEREOF, the undersigned, being duly authorized, has signed the Multilateral Agreement Respecting Pooled Registered Pension Plans and Voluntary Retirement Savings Plans.

Signed at Halifax,

The 7 day of June, 2016.

The Honourable Randy Delorey

Minister of Finance and Treasury Board

MULTILATERAL AGREEMENT RESPECTING POOLED REGISTERED PENSION PLANS AND VOLUNTARY RETIREMENT SAVINGS PLANS

IN WITNESS WHEREOF, the undersigned, being duly authorized, agree to be bound by Parts I, with the exception of subsections 2(6) and (7), II, VI and VII of the Multilateral Agreement Respecting Pooled Registered Pension Plans and Voluntary Retirement Savings Plans.

Signed at Québec,

The 15th day of June, 2016.

For the government of Quebec

The Honourable Carlos Leitão

Minister of Finance

The Honourable Jean-Marc Fournier

Minister responsible for Canadian Relations and the Canadian Francophonie

For the Autorité des marchés financiers

Louis Morrisset

President and Chief Executive Officer

MULTILATERAL AGREEMENT RESPECTING POOLED REGISTERED PENSION PLANS AND VOLUNTARY RETIREMENT SAVINGS PLANS

For Saskatchewan

IN WITNESS WHEREOF, the undersigned, being duly authorized, has signed the Multilateral Agreement Respecting Pooled Registered Pension Plans and Voluntary Retirement Savings Plans.

Signed at Regina,

The 26 day of, May 2016.

The Honourable Gordon Wyant

Minister of Justice and Attorney General

ANNEX 2

Multilateral Agreement Respecting Pooled Registered Pension Plans and Voluntary Retirement Savings Plans, as amended by the 2017 Agreement Amending the Multilateral Agreement Respecting Pooled Registered Pension Plans and Voluntary Retirement Savings Plans

For Ontario

Ontario hereby agrees to become a party to the Multilateral Agreement Respecting Pooled Registered Pension Plans and Voluntary Retirement Savings Plans as amended by the 2017 Agreement Amending the Multilateral Agreement Respecting Pooled Registered Pension Plans and Voluntary Retirement Savings Plans;

IN WITNESS WHEREOF, the undersigned, being duly authorized, has signed the Multilateral Agreement Respecting Pooled Registered Pension Plans and Voluntary Retirement Savings Plans as amended by the 2017 Agreement Amending the Multilateral Agreement Respecting Pooled Registered Pension Plans and Voluntary Retirement Savings Plans.

Effective March 31, 2017.

Signed at Toronto,

The 9th day of January, 2017.

The Honourable Charles Sousa

Minister of Finance

EXPLANATORY NOTE

Proposal

Pursuant to subsection 6(1) of the Pooled Registered Pension Plans Act (PRPP Act), this Order authorizes the Minister of Finance to enter into the Multilateral Agreement Respecting Pooled Registered Pension Plans and Voluntary Retirement Savings Plans with Ontario.

Objective

To enable the Government of Ontario to join the Multilateral Agreement Respecting Pooled Registered Pension Plans and Voluntary Retirement Savings Plans.

Background

The federal PRPP Act applies to pooled registered pension plans (PRPPs) that are linked to employment that falls under federal jurisdiction. Areas of employment that fall under federal jurisdiction include work in connection with navigation and shipping, banking, inter-provincial transportation and communications, and work in the Yukon, Northwest Territories or Nunavut.

PRPPs are a new, accessible, large-scale and low-cost pension option for employers, employees and the self-employed. A PRPP is administered by a corporation that holds a PRPP administrator licence. The Office of the Superintendent of Financial Institutions (OSFI) is responsible for supervising PRPPs offered to areas of employment under federal jurisdiction.

Self-employed individuals and employers in provincially regulated sectors may also join a PRPP if their respective province has PRPP legislation in place. British Columbia, Alberta, Saskatchewan, Ontario and Nova Scotia have passed PRPP legislation. Quebec has passed similar legislation called the Voluntary Retirement Savings Plans Act (VRSP). Provincial pension supervisors would normally supervise the aspects of multi-jurisdictional PRPPs that relate to members in provincially regulated employment areas. In order to streamline the supervision of PRPPs, the federal PRPP Act allows the Minister of Finance to enter into a multilateral agreement with provinces that have passed similar legislation.

Effective June 15, 2016, the Minister of Finance entered into the Multilateral Agreement Respecting Pooled Registered Pension Plans and Voluntary Retirement Savings Plans (the Agreement) with British Columbia, Saskatchewan, Quebec and Nova Scotia. Ontario’s PRPP legislation is now in force, and regulatory amendments to the Pooled Registered Pension Plans Regulations have been made to designate Ontario as a province with whom the Minister can enter into the Agreement.

Implications

The Agreement helps make an attractive new retirement savings option available to those millions of Canadians — roughly 60% — who do not have access to a workplace pension plan. Additional provinces, such as Ontario, who join the Agreement, will facilitate the creation of large PRPPs with members across multiple jurisdictions, thereby increasing the number of Canadians with workplace pension plans and generating economies of scale and reducing costs.

In addition to amendments to the Agreement to include Ontario, the Agreement has also been amended to clarify that it doesn’t dictate which jurisdiction’s legislation would apply to the valuation or division of funds in a PRPP member’s account on the breakdown of a spousal or common-law relationship and to make minor edits to the text.

Consultation

In December 2010, Canada’s finance ministers agreed on a framework for PRPPs to provide Canadians with a new, low-cost, efficiently managed, portable and accessible savings vehicle that will help them meet their retirement objectives. The federal PRPP legislative framework was therefore developed in consultation with the provinces. The governments of British Columbia, Alberta, Saskatchewan, Ontario, Quebec and Nova Scotia have been involved in the drafting of the Agreement.

On June 25, 2016, the Agreement was published in the Canada Gazette, Part I, and was tabled in Parliament on August 17, 2016. The current signatory provinces have been consulted and unanimously support Ontario entering the Agreement. OSFI has also been consulted and supports the proposal.

Contact

Lisa Pezzack
Director
Financial Systems Division
Department of Finance Canada
90 Elgin Street, 13th Floor
Ottawa, Ontario
K1A 0G5
Email: Lisa.Pezzack@canada.ca

[2-1-o]

DEPARTMENT OF INDUSTRY

BOARDS OF TRADE ACT

North Battleford Chamber of Commerce

Notice is hereby given that His Excellency the Governor General in Council, by Order in Council dated December 2, 2016, has been pleased to change the name of the North Battleford Chamber of Commerce to the Battlefords Chamber of Commerce and to change its boundaries to City of North Battleford, Town of Battleford, Rural Municipality of Battle River # 438, Rural Municipality of North Battleford # 437 and Rural Municipality of Meota # 468, in Saskatchewan, upon petition made therefor under sections 4 and 39 of the Boards of Trade Act.

December 20, 2016

Virginie Ethier
Director

For the Minister of Industry

[2-1-o]

DEPARTMENT OF PUBLIC SAFETY AND EMERGENCY PREPAREDNESS

CRIMINAL CODE

Designation as fingerprint examiner

Pursuant to subsection 667(5) of the Criminal Code, I hereby designate the following person of the New Westminster Police Department as a fingerprint examiner:

David Stengert

Ottawa, December 20, 2016

Kathy Thompson
Assistant Deputy Minister
Community Safety and Countering Crime Branch

[2-1-o]

DEPARTMENT OF PUBLIC SAFETY AND EMERGENCY PREPAREDNESS

CRIMINAL CODE

Designation as fingerprint examiner

Pursuant to subsection 667(5) of the Criminal Code, I hereby designate the following persons of the Royal Newfoundland Constabulary as fingerprint examiners:

  • Lisa Fitzgerald
  • Ron Simms
  • James Smith

Ottawa, December 20, 2016

Kathy Thompson
Assistant Deputy Minister
Community Safety and Countering Crime Branch

[2-1-o]

DEPARTMENT OF PUBLIC SAFETY AND EMERGENCY PREPAREDNESS

CRIMINAL CODE

Designation as fingerprint examiner

Pursuant to subsection 667(5) of the Criminal Code, I hereby designate the following persons of the Saskatoon Police Service as fingerprint examiners:

  • Bryon Sommacal
  • Leslie van den Beuken

Ottawa, December 20, 2016

Kathy Thompson
Assistant Deputy Minister
Community Safety and Countering Crime Branch

[2-1-o]

DEPARTMENT OF PUBLIC SAFETY AND EMERGENCY PREPAREDNESS

CRIMINAL CODE

Revocation of designation as fingerprint examiner

Pursuant to subsection 667(5) of the Criminal Code, I hereby revoke the designation of the following persons of the Royal Newfoundland Constabulary as fingerprint examiners:

  • Mitchell Rumbolt
  • John Turpin

Ottawa, December 20, 2016

Kathy Thompson
Assistant Deputy Minister
Community Safety and Countering Crime Branch

[2-1-o]

DEPARTMENT OF PUBLIC SAFETY AND EMERGENCY PREPAREDNESS

CRIMINAL CODE

Revocation of designation as fingerprint examiner

Pursuant to subsection 667(5) of the Criminal Code, I hereby revoke the designation of the following persons of the Windsor Police Service as fingerprint examiners:

  • Tracey Bloomfield
  • Douglas Cowper
  • Scott D. Robinson

Ottawa, December 20, 2016

Kathy Thompson
Assistant Deputy Minister
Community Safety and Countering Crime Branch

[2-1-o]

(Erratum)

GLOBAL AFFAIRS CANADA

Consultations on the fifth review of the Record of Discussion on Trade in Pharmaceutical Products

Notice is hereby given that the email address of the point of contact for questions or comments regarding Canadian tariffs in the French version of the notice bearing the above-mentioned title published in the Canada Gazette, Part I, Vol. 150, No. 52, dated Saturday, December 24, 2016, contained an error on page 4164, and should have read as follows:

fin.tariff-tarif.fin@canada.ca

[2-1-o]

PRIVY COUNCIL OFFICE

Appointment opportunities

We know that our country is stronger — and our government more effective — when decision-makers reflect Canada’s diversity. Moving forward, the Government of Canada will use an appointment process that is transparent and merit-based, strives for gender parity, and ensures that Indigenous Canadians and minority groups are properly represented in positions of leadership. We will continue to search for Canadians who reflect the values that we all embrace: inclusion, honesty, fiscal prudence, and generosity of spirit. Together, we will build a government as diverse as Canada.

The Government of Canada is currently seeking applications from diverse and talented Canadians from across the country who are interested in the following positions.

Current opportunities

The following opportunities for appointments to Governor in Council positions are currently open for applications. Every opportunity is open for a minimum of two weeks from the date of posting on the Governor in Council Appointments website (http://www.appointments-nominations.gc.ca/slctnPrcs.asp?menu=1&lang=eng).

Position

Organization

Closing date

Chairperson

Canadian Centre on Substance Abuse

January 16, 2017

Director

Canadian Centre on Substance Abuse

January 16, 2017

Members

Canadian Institutes of Health Research

January 16, 2017

Chairperson

Canadian Museum for Human Rights

January 23, 2017

Chairperson

Canadian Museum of History

January 23, 2017

Vice-Chairperson

Canadian Museum of History

January 23, 2017

Chairperson

Canadian Museum of Immigration at Pier 21

January 23, 2017

Chairperson

Canadian Museum of Nature

January 23, 2017

Permanent Members

Canadian Nuclear Safety Commission

January 29, 2017

Chairperson

Great Lakes Pilotage Authority Canada

February 19, 2017

Clerk of the House of Commons

House of Commons

February 26, 2017

Chief Science Advisor

Innovation, Science and Economic Development Canada

January 27, 2017

Directors

The Jacques Cartier and Champlain Bridges Incorporated

February 3, 2017

Chairperson

Laurentian Pilotage Authority Canada

February 5, 2017

Directors

Marine Atlantic Inc.

January 22, 2017

Members

National Film Board

January 15, 2017

Chairperson

National Gallery of Canada

January 23, 2017

Vice-Chairperson

National Gallery of Canada

January 23, 2017

Director of Public Prosecutions

Office of the Director of Public Prosecutions

January 22, 2017

Executive Vice-Chairperson and Member

Parole Board of Canada

February 5, 2017

Chairperson

Payment in Lieu of Taxes Dispute Advisory Panel

January 15, 2017

Members

Payment in Lieu of Taxes Dispute Advisory Panel

January 15, 2017

Chief Public Health Officer

Public Health Agency of Canada

February 12, 2017

Directors

Royal Canadian Mint

January 29, 2017

Member

Telefilm Canada

January 15, 2017

Directors

VIA Rail Canada Inc.

January 29, 2017

Upcoming opportunities

New opportunities that will be posted in the coming weeks.

Position

Organization

President (Chief Executive Officer)

Atomic Energy of Canada Limited

Commissioner for Workers

Canada Employment Insurance Commission

Chairperson

Canada Foundation for Innovation

President

Canadian Centre for Occupational Health and Safety

Chairperson

Canadian International Trade Tribunal

Directors

Canadian Race Relations Foundation

Citizenship Judges

Citizenship Commission

Directors

Farm Credit Canada

Directors

First Nations Financial Management Board

Sergeant-at-Arms

House of Commons

Members

National Arts Centre Corporation

Chairperson

National Battlefields Commission

Commissioner

National Battlefields Commission

Full-time Member

National Energy Board

Procurement Ombudsman

Office of the Procurement Ombudsman

Chairperson

Patented Medicine Prices Review Board

Member

Patented Medicine Prices Review Board

Chairperson and Member

Standards Council of Canada

Ongoing opportunities

Opportunities posted on an ongoing basis.

Position

Organization

Full-time and Part-time Members

Immigration and Refugee Board

Members — All regional divisions (full-time positions and part-time positions)

Parole Board of Canada

Full-time and Part-time Members (Appeal Division)

Social Security Tribunal

Full-time and Part-time Members (General Division — Employment Insurance Section)

Social Security Tribunal

Full-time and Part-time Members (General Division — Income Security Section)

Social Security Tribunal

[2-1-o]

  • Footnote 1
    Environment Canada and Health Canada. 2015. Review of current Significant New Activity Orders and Notices (http://www.chemicalsubstanceschimiques.gc.ca/plan/approach-approche/snac-nac/index-eng.php).
  • Footnote 2
    The policy on the use of SNAc provisions is available at http://www.ec.gc.ca/ese-ees/default.asp?lang=En&n=5CA18D66-1.
  • Footnote 3
    Significant New Activity Notice No. 13712: http://publications.gc.ca/gazette/archives/p1/2005/2005-06-18/pdf/g1-13925.pdf.
  • Footnote 4
    The full text of the CCPSA is available at this address: http://laws-lois.justice.gc.ca/eng/acts/C-1.68/FullText.html.
  • Footnote 5
    The full text of the New Substances Notification Regulations (Chemicals and Polymers) is available at this address: http://laws-lois.justice.gc.ca/eng/regulations/SOR-2005-247/FullText.html.
  • Footnote 6
    The Guidelines for the Notification and Testing of New Substances (Chemicals and Polymers) are available at http://www.ec.gc.ca/subsnouvelles-newsubs/default.asp?lang=En&xml=FA59945E-8DD5-D745-8A55-EA6667737FE5.
  • Footnote 7
    A comprehensive listing of substances that are subject to SNAc provisions is available at http://www.ec.gc.ca/subsnouvelles-newsubs/default.asp?lang=En&n=0F76206A-1.
  • Footnote 8
    Formerly Material Safety Data Sheet (MSDS). Please refer to the Regulations amending the New Substances Notification Regulations (Chemicals and Polymers) and the Export of Substances on the Export Control List Regulations for reference to this amendment (http://gazette.gc.ca/rp-pr/p2/2015/2015-02-11/html/sor-dors19-eng.php).
  • Footnote 9
    The Substances Management Advisory Note Clarification in relation to the submission of Significant New Activity Notifications in application of the Canadian Environmental Protection Act, 1999 is available at http://www.ec.gc.ca/subsnouvelles-newsubs/default.asp?lang=En&n=CC526AE6-1.
  • Footnote 10
    The Substances Management Information Line can be contacted at eccc.substances.eccc@canada.ca (email), 1-800-567-1999 (toll-free in Canada), and 819-938-3232 (outside of Canada).
  • Footnote 11
    The Compliance and Enforcement Policy is available at https://www.ec.gc.ca/alef-ewe/default.asp?lang=en&n=AF0C5063-1.
  • Footnote 12
    This Annex is provided for information purposes only. In the event of a discrepancy between this document and the CCPSA, the CCPSA shall prevail.
  • Footnote 13
    List of substances in the Consumer Product SNAc Review Group: http://www.chemicalsubstanceschimiques.gc.ca/plan/approach-approche/snac-nac/group-eng.php#a2.
  • Footnote 14
    The Guidelines for the Notification and Testing of New Substances: Chemicals and Polymers is available at http://publications.gc.ca/site/eng/280464/publication.html.
  • Footnote 15
    This Annex is provided for information purposes only. In the event of a discrepancy between this document and the CCPSA, the CCPSA shall prevail.
  • Footnote 16
    CAS RN: Chemical Abstracts Service Registry Number. The Chemical Abstracts Service Registry Number is the property of the American Chemical Society, and any use or redistribution, except as required in supporting regulatory requirements and/or for reports to the Government of Canada when the information and the reports are required by law or administrative policy, is not permitted without the prior, written permission of the American Chemical Society.
  • Footnote 17
    The Confidential Accession Numbers are used to identify substances listed on the confidential portion of the Domestic Substances List (DSL).
  • Footnote 18
    The Federal Business Number is a nine-digit registration number issued by the Canada Revenue Agency (CRA) to Canadian businesses that register for one or more of the following: corporate income tax; importer/exporter account number; payroll (source) deductions (trust accounts); or goods and services tax. This number can be found on all forms issued to a business by the CRA. The first nine digits that appear on these forms is the Federal Business Number.
  • Footnote 19
    A list of six-digit North American Industry Classification System (NAICS) codes is available at the following Statistics Canada website: http://www23.statcan.gc.ca/imdb/p3VD.pl?Function=getVDPage1&db=imdb&dis=2&adm=8&TVD=118464. Note that this address is case sensitive.
  • Footnote a
    SOR/94-311
  • Footnote b
    S.C. 1999, c. 33
  • Footnote c
    Order 2012-87-06-01 Amending the Domestic Substances List to apply the Significant New Activity provisions of CEPA 1999 to Pigment Red 3: http://www.gazette.gc.ca/rp-pr/p2/2012/2012-10-10/pdf/g2-14621.pdf.
  • Footnote d
    Order 2013-87-08-01 Amending the Domestic Substances List to apply the Significant New Activity provisions of CEPA 1999 to n-BGE and MK: http://canadagazette.gc.ca/rp-pr/p2/2013/2013-08-28/pdf/g2-14718.pdf.
  • Footnote e
    Order 2013-87-11-01 Amending the Domestic Substances List to apply the Significant New Activity provisions of CEPA 1999 to 2-nitropropane, DTBSBP and MAPBAP acetate: http://www.gazette.gc.ca/rp-pr/p2/2014/2014-01-15/pdf/g2-14802.pdf.
  • Footnote f
    Order 2014-87-01-01 Amending the Domestic Substances List to apply the Significant New Activity provisions of CEPA 1999 to Methyl eugenol, TGOPE and potassium bromate: http://www.gazette.gc.ca/rp-pr/p2/2014/2014-03-12/pdf/g2-14806.pdf.
  • Footnote g
    Order 2013-87-01-01 Amending the Domestic Substances List to apply the Significant New Activity provisions of CEPA 1999 to dimethyl sulfate, diethyl sulfate, and TCEP: http://www. gazette.gc.ca/rp-pr/p2/2013/2013-01-30/pdf/g2-14703.pdf.
  • Footnote h
    Order 2012-87-06-02 Amending the Domestic Substances List to apply the Significant New Activity provisions of CEPA 1999 to phenoxymethyl oxirane: http://www.gazette.gc.ca/rp-pr/p2/2013/2013-05-22/pdf/g2-14711.pdf.
  • Footnote i
    Order 2010-87-03-03 Amending the Domestic Substances List to apply the Significant New Activity provisions of CEPA 1999 to Solvent Blue 4: http://publications.gc.ca/gazette/archives/p2/2010/2010-03-31/pdf/g2-14407.pdf.
  • Footnote j
    Order 2011-87-04-01 Amending the Domestic Substances List to apply the Significant New Activity provisions of CEPA 1999 to Phenyl-D4 and MDnM-hydride: http://www.gazette.gc.ca/rp-pr/p2/2011/2011-09-14/pdf/g2-14519.pdf.
  • Footnote k
    Order 2010-87-05-01 Amending the Domestic Substances List to apply the Significant New Activity provisions of CEPA 1999 to 2-EEA: http://publications.gc.ca/gazette/archives/p2/2010/2010-11-10/pdf/g2-14423.pdf.
  • Footnote l
    Order 2010-87-07-01 Amending the Domestic Substances List to apply the Significant New Activity provisions of CEPA 1999 to FAZ: http://publications.gc.ca/gazette/archives/p2/2010/2010-08-18/pdf/g2-14417.pdf.
  • Footnote m
    Order 2012-87-07-01 Amending the Domestic Substances List to apply the Significant New Activity provisions of CEPA 1999 to thiourea and epichlorohydrin: http://www.gazette.gc.ca/rp-pr/p2/2012/2012-07-18/pdf/g2-14615.pdf.
  • Footnote n
    Order 2011-87-12-01 Amending the Domestic Substances List to apply the Significant New Activity provisions of CEPA 1999 to methyloxirane, ethyloxirane, and hydroquinone: http://www.gazette.gc.ca/rp-pr/p2/2011/2011-12-21/pdf/g2-14526.pdf.
  • Footnote o
    Order 2013-87-05-01 Amending the Domestic Substances List to apply the Significant New Activity provisions of CEPA 1999 to benzyl chloride: http://www.gazette.gc.ca/rp-pr/p2/2013/2013-05-08/pdf/g2-14710.pdf.
  • Footnote p
    Order 2007-87-09-01 Amending the Domestic Substances List to apply the Significant New Activity provisions of CEPA 1999 to 2-Pyrrolidinone, 1-(2-hydroxyethyl)-: http://publications.gc.ca/gazette/archives/p2/2007/2007-01-10/pdf/g2-14101.pdf.
  • Footnote q
    Environment Canada and Health Canada. 2015. Review of current Significant New Activity Orders and Notices (http://www.chemicalsubstanceschimiques.gc.ca/plan/approach-approche/snac-nac/index-eng.php).
  • Footnote r
    The Policy on the Use of Significant New Activity Provisions of the Canadian Environmental Protection Act, 1999 is available at http://www.ec.gc.ca/ese-ees/default.asp?lang=En&n=5CA18D66-1.
  • Footnote s
    The SNAN risk assessment summaries for existing substances is available at http://www.ec.gc.ca/lcpe-cepa/default.asp?lang=En&n=725CDE50-1.
  • Footnote t
    The full text of the New Substances Notification Regulations (Chemicals and Polymers) is available at this address: http://laws-lois.justice.gc.ca/eng/regulations/SOR-2005-247/FullText.html.
  • Footnote u
    The full text of the Canada Consumer Product Safety Act is available at http://laws-lois.justice.gc.ca/eng/acts/c-1.68/.
  • Footnote v
    A comprehensive listing of substances that are subject to SNAc provisions is available at http://www.ec.gc.ca/subsnouvelles-newsubs/default.asp?lang=En&n=0F76206A-1.
  • Footnote w
    Formerly Material Safety Data Sheet (MSDS). Please refer to the Regulations Amending the New Substances Notification Regulations (Chemicals and Polymers) and the Export of Substances on the Export Control List Regulations for reference to this amendment (http://gazette.gc.ca/rp-pr/p2/2015/2015-02-11/html/sor-dors19-eng.php).
  • Footnote x
    The advisory note “Clarification in relation to the submission of Significant New Activity Notifications in application of the Canadian Environmental Protection Act, 1999” is available at http://www.ec.gc.ca/subsnouvelles-newsubs/default.asp?lang=En&n=CC526AE6-1.
  • Footnote y
    The Substances Management Information Line can be contacted at eccc.substances.eccc@canada.ca (email), 1-800-567-1999 (toll-free in Canada), or 819-938-3232 (outside of Canada).
  • Footnote z
    The Compliance and Enforcement Policy is available at https://www.ec.gc.ca/alef-ewe/default.asp?lang=en&n=AF0C5063-1.